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1. INTRODUCTION 
 
 
“The best thing for being sad,” replied Merlin, beginning to puff and blow, “is to learn 
something. That’s the only thing that never fails. You may grow old and trembling in your 
anatomies, you may lie awake at night listening to the disorder of your veins, you may miss 
your only love, you may see the world about you devastated by evil lunatics, or know your 
honour trampled in the sewers of baser minds. There is only one thing for it then — to learn. 
Learn why the world wags and what wags it. That is the only thing which the mind can never 
exhaust, never alienate, never be tortured by, never fear or distrust, and never dream of 
regretting. Learning is the only thing for you. Look what a lot of things there are to learn.” 
 
T.H. White, The Once and Future King. 
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1.1. Asymmetric Synthesis 
 
“L’universe est dissymétrique” 
 
Louis Pasteur 
 
With this statement the scientific environment became aware of the existence of the chirality1 
no more as philosophic concept or geometric property but as fundamental characteristic of the 
matter. In fact thanks to this breakthrough it was possible to understand that the chirality is a 
common leitmotif of the Nature that is able to amaze the most skeptic observer. Nature, using 
enzymes as catalyst, all along it was considered the uncontested master at producing chiral 
compounds in enantiomerically pure form. The chemist scenario itself, that has ever taken 
inspiration from the natural world and trying to emulate it, started to design stereoselective 
processes with the aim of create chemically and tridimensional unique molecules.  
Nowadays the achievement of chiral molecules in enatiopure form is a central topic in 
bioscience field in particular in pharmacology and pharmaceutical industry. For the 
construction of chiral compound it is possible to start from chiral-pool sources with required 
stereocenters incorporated, or otherwise it is possible to forge them during the synthesis.2 
The most common founts of chirality that come from nature are α-amino acids, terpenes, 
hydroxyl acids, and alkaloids.3 If the target stereocenters are not present in this easy available 
sources they can be established through achiral synthesis and resolution protocols, the use of 
chiral auxiliary, or asymmetric catalysis. 
Even if the first two methods are the most applied in industry due especially for their 
robustness in academic research, the asymmetric catalysis has a role of primary interest and 
importance. The assignment of the chemistry Nobel Prize in 2001 Sharpless, Noyori and 
Knowels for the study and the development of Asymmetric catalytic Oxidation and 
Hydrogenation reactions is a proof of this (Scheme 1). 
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Scheme 1: Asymmetric Catalytic Epoxidation and Hydrogenation reactions developed by Sharpless 
Noyori and Knowels 
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In Scheme 1b is reported the asymmetric epoxidation of allylic alcohols under the catalysis of 
Titanium diethyl-tartrate complex, also named Sharpless epoxidation.4 Still exploiting the 
ability of a transition metal to dress itself with chiral ligands and drive the stereoselctivity of a 
process, Noyori developed the asymmetric reduction of β-ketoesthers using BINAP-Ruthenium 
complex5 Scheme 1b.Conteporany Knowles showed that this concepts could be applied to the 
synthesis of L-DOPA, a drug use to treat Parkinson’s disease developed in the research 
laboratories of Monsanto (Scheme 1c).6 
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This asymmetric protocols had the merit of convinced, with their elegance and atom economy, 
many chemical companies that asymmetric catalysis was possible on large scale. 
At the end of the last century, as consequence of the excitement that was around this 
synthetic strategies both in academic and in industrial field, another branch of the asymmetric 
synthesis appeared on the stage of chemistry research. 
This was no more based upon organometallic complex as catalyst for stereoselective synthesis 
but simple organic molecules. 
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1.2. Asymmetric Organocatalysis 
 
The miles stone of the organocatalysis was laid in 1971 when the research group of Hajos 
Parrish Wiechert, Eder, and Sauer published the first intramolecular aldol reaction catalyzed by 
L-Proline (Scheme 1).7 
Scheme 1:  
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Today seems strange that, apart from few sporadic publications, it is only in 2000 that the 
chemical community recognized the opportunity to use chiral organic molecules as catalysts in 
stereoselective processes. 
As mentioned in previous paragraph, following the general excitement of the scientific 
panorama around the asymmetric catalysis at the end of the last century, in the early 2000 
two research groups published independently the organocatalytic activation of aldehydes for 
their α and β functionalization, mediated by chiral secondary amines (Scheme 2).8, 9 
Scheme 2: Enamine and Iminium ion activation of carbonyl compounds 
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List, Lerner and Barbas reported for the first time the organocatalyzed aldol reaction between 
acetone and a wide range of aldehydes (Scheme 2a). The activation of this unmodified ketone 
occur via HOMO-raising (through the formation of an enamine) through L-Proline 
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condensation. This simple amino acid also direct selectively the approach of the electrophile to 
only one face of the nucleophilic intermediate; the action mechanism of Proline fascinated 
numerous chemist, and from my point of view the most faschinating (sorry) and elegant 
description of it was made by Jacobsen Movassaghi that named Proline the simplest enzyme.10 
In Scheme 2b is described a complementary organocatalytic approach for the activation of 
α,β-unsaturated aldehydes via LUMO-lowering of this substrates. MacMillan Ahrendt and 
Borths developed the first Diels-Alder reaction of acroleins, designing ad hoc a new catalyst II 
easily prepared from (L)-Phenylalanine. This secondary amine is able to activate the substrate 
generating an iminium ion intermediate via condensation with the starting material. 
In this way a great scientific competition, nowadays described as “Asymmetric Aminocatalysis 
Gold Rush”,
11
 started with the aim of expand the general scope of this two activation mode.   
This challenge gave a tremendous impulse to the design of other organocatalytic kinds of 
activation founded upon Chiral Brønsted Base, Brønsted Acid, H-Bond donors, Phase transfer 
Catalyst and Carbenes Thus in this years the organocatalysis gained the attention of the 
scientific community (Figure 1). 
Figure 1: Number of articles published on Organocatalysis (Source SciFinder Scolar) 
 
 
 
 
 
 
 
 
 
 
 
 
As demonstrated by this statistic (made just typing the term Organocatalysis in SciFinder 
Scholar) this strategy has become a complementary tool to the catalysis through Lewis acid 
and transition metal complex. 
In the follow chapters will be described the result obtained during my Phd, in particular in the 
field of aminocatalysis, thus a brief introduction will be done to explain the state of art and the 
problems of this kind of activation. 
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1.3. Asymmetric Aminocatalysis 
 
The pioneristic works of List, Lerner and Barbas and MacMillan Ahrendt and Borths, besides 
offering asymmetric and catalytic alternative methodologies for two fundamental C-C bond 
forming reaction, constituted the basis for two novel organocatalytic activation modes of 
carbonyl compounds, pinpointing the origin of asymmetric aminocatalysis. In fact afterwards it 
was understood that it was possible to design an unlimited number of new reactions just using 
various electrophiles and nucleophiles for the functionalization of saturated ketones, 
aldehydes and enals. As consequence of this philosophy List reported the first, direct, catalytic 
and asymmetric Mannich reaction between an aldehyde, p-anisidine and a ketone, catalyzed 
by Proline.12  
In Figure 1 it is represented a summary of the reaction catalyzed by (L)-Proline published in the 
last decades. 
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In addition to Proline several catalysts were developed with the aim of solve some problems 
pointed out in its employ, as poor stereoselectivity with substrates with low aptitude to form 
H-bonding interactions. In this context, in early 2005, Jørgensen’s research group presented to 
the scientific community a new class of secondary amine organocatalysts, derived from 
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Diphenyl prolinol,13 able to control the attack-face of the enamine through its steric hindrance 
(Scheme 2a). 
Scheme 1: Comparison between the enantioselection mechanism of L-Proline and Jørgensen’s catalyst 
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At the same time the enamine geometry is fixed as consequence of the non bonding 
interaction between the bulky substituent on the pirrolidine ring and the reactive carbon (E-
anti geometry of the enamine, Scheme 1b).14 
It is important to notice that the mechanism of enatio-discrimination did not rely upon the 
structure of the electrophile. For this reason this catalyst was alredy use for the α-
functionalizzation of aldehydes in several asymmetric substitution reactions and nucleophilic 
additions, for example conjugate additions,2, 15 Mannich reactions,2 C-N (α-amination2 and 
oxyamination16), C-C17 and C-O bond-forming reactions,18 as well as α-halogenation, 
selenenylation19 and phosphination20 reactions.  
On the other bank, also the iminim ion activation demonstrated to be a general activation not 
anly confined to DA or [3+2] reactions.21 
The MacMillan’s imiladazolidinone II controlled the stereochemical outcome of the reaction in 
the same way of Jørgensen’s catalyst (Scheme 2) and also in this case it was possible to extend 
this methodology to the most disparate nucleophile.22 
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Scheme 2: Iminium ion geometry control and pi-facial shielding by imidazolidinone catalyst II 
 
 
 
 
 
 
 
Several catalysts based upon this strategy of stereoselection were developed by MacMillan 
and coworkers, making possible the activation of the α,β-unsaturated ketones too.23 24, 25, 26, 27 
Moreover the similitude between chiral amine II and III was easily understood in the meaning 
of the possibility to use Jørgensen’s catalyst in iminium ion activation of aldehydes,13-16 and 
MacMillan’s Imidazolidinone in the α-functionalizzation of enals.28 
The Asymmetric Aminocatalysis, as demonstrated in this chapter, have been dominated by 
three privileged organocatalysts: Proline, the simplest enzyme, MacMillan’s Imidazolidinone 
and Jørgensen’s catalyst. 
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1.3.1. ASYMMETRIC ORGANOCATALYTIC CASCADE REACTIONS 
 
“The circle symbolizes T'ai Chi 
 which is formless and above duality. 
Here it is manifesting itself as the progenitor of the universe. 
It is divided into yin (the dark) and yang (the light) 
which signify the negative and positive poles. 
Pairs of opposites, passive and active, 
female and male, moon and sun.” 
 
 
Franco Battiato  
Il Ballo del Potere 
 
 
After this initial stage aminocatalisys have started to take different directions always exploiting 
its fundamentals concepts that can be summarized in LUMO-lowering and, more useful for 
further explorations, HOMO raising activations. In this chapter will be discussed the origins of 
the Aminocatalytic Tandem reactions and the origins of the Asymmetric Counter Anion 
Directed Catalysis two of the most interesting fields of amminocatalysis. 
The comprehension that the face-shielding catalysts gave the possibility to activate without 
distinction α,β-unsaturated and saturated aldehydes and the knowledge accumulated on the 
mechanism of iminium ion and enamine catalysis, drove to the design of amino-catalyzed 
Domino Reactions. This important goal was achieved thanks also to the observation that in the 
two catalytic cycles there are common intermediate. 
Observing the LUMO-lowering activation (Scheme 3a) we can see that, as consequence of the 
addition of the nucleophile to the iminium ion, an enamine is formed. After its protonation and 
hydrolysis this nucleophilic intermediate furnishes the β-functionalized product.  
In HOMO-raising activation (Scheme 3b) an enamine intermediate is formed through the 
deprotonation of an iminium-ion. The reactive enamine generated intercepts an electrophile 
thus forming a functionalized iminium species which affords, after hydrolysis the α-
functionalized product. 
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Scheme 3: Catalytic cycles of LUMO-lowering HOMO-raising activation. 
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This concepts and the significance of its application are well explained in this sentence:  
 
“Like the ying and yang, the two catalytic intermediates are opposite, yet interdependent, and 
they consume and support each other”.
29
 
 
As well described in this review and in two independently works appeared in 2005, developing 
this idea it is possible to design a tandem organocascade sequence where an α,β-unsaturated 
aldehyde is activated via iminium ion for the stereoselective attack of a nucleophile leading to 
an enamine formation. This intermediate at this point can intercepts an electrophile (H+ is the 
simplest one) present in the system and drives to the formation of the α,β-functionalized 
product (Scheme 4). 
Scheme 4: Catalytic cycle for the Tandem Organocascade reaction. 
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Despite some excellent intramolecular tandem reactions had been realized, for example the 
cyclopropanation30 and epoxidation,31 the complete success of this strategy was associate with 
the two intermolecular protocols reported in Scheme 5. 
Scheme 5: Tandem Organocascade reactions presented by the MacMillan’s and Jørgensen’s groups. 
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In Scheme 5a it was reported Michael/Chlorination tandem reaction of α,β-unsaturated 
aldehydes developed by MacMillan et al. In this reaction a new kind of imidazolidinone where 
the face-shielding is ensured by an indolyl moiety32was introduced.  
At the same time Jørgensen presented the first sulfa/Ammination domino strategy for the 
functionalization of enals, catalyzed by O-TMS DiArylProlinol Ether (Scheme 5b).33 
Since these two examples tandem reactions have been reported, the enormous potentiality of 
this approach appeared clear and multiple efforts have been made by chemists to further 
expand the applicability and the reliability of this strategy. In 2006 Enders and co-workers 
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reported a triple domino reaction based on an enamime-iminium-enamine activation able to 
forge and to control completely four stereocenters in a one-pot process through a 
Michael/Michael/aldol condensation sequence catalyzed by O-TMS diphenyl catalyst IIIc 
(Scheme 7).34 
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This triple organocascade was composed by three reactions that were activated time-
selectively by the chiral amine catalyst. This synthetic protocol could be applied to other 
Michael acceptors in place of nitrostyrene.35 
 
1.3.2. ASYMMETRIC COUNTER ANION DIRECTED CATALYSIS (ACDC) 
 
La ricerca scientifica consiste nel vedere ciò che tutti vedono, 
 ma nel pensare ciò che nessuno ha ancora pensato 
 
Anonimo 
 
 
In the activation of carbonyl compounds via iminium ion or enamine we can observe often the 
presence of catalytic amount of an acidic additive. The role of this additive has not been 
completely clarified and might be not the same in all the reactions. By the analysis of the 
empiric results it is possible to observe that acids are able to increase the rate of the overall 
catalytic processes by accelerating the formation and the hydrolysis of reaction intermediates.  
Moreover in the LUMO-Lowering activation the characteristic of the counter anion have a 
direct effect on the stereoselection of the reaction; this is a consequence of the cationic nature 
of iminium ion, the active intermediate of the process. These concepts have been exploited for 
the first time by Mayer and List which reported an asymmetric transfer hydrogenation of β,βI-
disubstituted enals. The authors introduced for the first time the ACDC Asymmetric 
Counteranion Directed Catalysis. 
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The new catalytic salt designed by the authors was the combination of morpholine for the 
activation of the substrates through iminium ion formation and the chiral phosphoric acid IV 
for directing the stereoselction of the reaction (Scheme 7).36 
 
Scheme 7: Asymmetric Counteranion Directed Catalysis 
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The great results obtained in terms of enantiomeric excess confirmed that during  the attack of 
the active nucleophile to the intermediate, (the stereoselction determining step), the 
counteranion was close to the iminium ion. 
Continuing to study this phenomena List et al. minded to use a catalytic salt made with double 
chirality both in amine and in the counteranion. This strategy will be discussed in the next 
chapter in the context of primary amine catalysis. 
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1.3.3. PRIMARY AMINE CATALYSIS 
 
“..dove la Natura finisce di produrre le sue spezie 
, l’uomo quivi comincia con le cose naturali, 
 con l’aiutoro di essa Natura, a creare infinite spezie..” 
 
“…where Nature finishes producing its species 
, there man begins with natural things to make, 
 with the aid of this Nature, an infinite number of species…”  
 
Leonardo da Vinci  
 
 
The asymmetric Aminocatalysis has been developed thanks to the discover of some privileged 
catalysts. This chiral amine are named privileged because are general toward a wide range of 
nucleophiles or electrophiles. In fact several protocol for the functionalizzation of α,β-
unsaturated and saturated aldehydes appear in this decade. Moreover another strong point of 
this catalysts is that are easily available like L-Proline ( less than 1€/1g.), or are synthesizable 
from natural amino acids in few steps. 
Despite the great evolution of the aminocatalysis, the activation of α,β-unsaturated ketones 
has remained an elusive transformation until 2006. 
The reasons of the little progress in this field probably is the inherent difficulties of generating 
congested covalent iminium ion intermediate from ketone and privileged chiral secondary 
amine (Figure 2). 
Figure 2: Steric factors in iminium ion activation of α,β-unsaturated ketones. 
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In 2006 some reports have shown the ability of chiral primary amine derivatives to efficiently 
activate ketones.37 In fact primary amine catalyst, owing to reduced steric constraints offer the 
unique possibility to activate more encumbered substrates overcoming the limitations of chiral 
secondary amines.38 
Following some seminal reports on the Michael addition of simple ketones to nitrostyrenes via 
enamine intermediate, where it was described the activation of the carbonylic substrates by a 
primary amine thiourea catalyst, our and other few groups introduced the use of primary 
amines for the activation of enones (Scheme 8). 
Scheme 8: Development of the ACDC: enantioselective transfer hydrogenation of α,a-unsaturated 
ketones 
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In the previous scheme is briefly describe the enantioselective transfer hydrogenation of α,β-
unsaturated ketones activated by a catalytic salt formed by a chiarl primary α-aminoacid ester 
and a chiral phosphoric acid.39 This methodology allowed to the products formation in high 
yield and high enatiomeric excess; it is important to notice how the combination between the 
two chiral entities had dramatically effect on the stereoselection of the reaction. Using L-
Aminoacid ester and R-TRIP (matched pair) it is performeded the reduction of 3-Methyl 
Cyclohexenone with 94% of enantiomeric excess and good yield, in the other case, using L-
Aminoacid ester and S-TRIP (mismatched pair), it is obtained the product in lower yield and as 
racemic mixture.  
In this context, our group, independently from other two different research groups,40, 41 has 
established a new chiral primary amines directly derived from natural cinchona alkaloids, as 
highly efficient catalysts for iminium ion activation of enones (Figure 3). 
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Figure 3: Primary amine based on cinchona alkaloid structure as catalyst for LUMO-lowering activation 
of α,β-unsaturated ketones. 
 
 
 
 
 
 
 
 
 
 
 
The catalytic salt reported in figure 3 were formed by 9-amino-9-deoxy-Epi-Quinine (or 9-
amino-9-deoxy-Epi-HydroQuinine), synthesized in one step from Quinine or Hydro-Quinine, 
and a chiral N-Boc aminoacid. In analogy with the List’s report we observed a moderate 
influence on the stereoselectivity due the combinations of two chiral entities. 
In the following chapter will be discussed my Phd results, most of them are focused on the use 
of primary amine in aminocatalysis for the activation of encumbered carbonylic compounds. 
During these last years the primary amine A, thanks to the efforts of some research groups, 
has become a general catalyst for the functionalization of sterically demanding substrates, 
thus it gained the appellative of privileged catalyst.  
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2. DISCUSSION 
 
 
Un uomo che coltiva il suo giardino, come voleva Voltaire. 
Chi è contento che sulla terra esista la musica. 
Chi scopre con piacere una etimologia. 
Due impiegati che in un caffè del Sud giocano in silenzio agli scacchi. 
Il ceramista che intuisce un colore e una forma. 
Il tipografo che compone bene questa pagina che forse non gli piace. 
Una donna e un uomo che leggono le terzine finali di un certo canto. 
Chi accarezza un animale addormentato. 
Chi giustifica o vuole giustificare un male che gli hanno fatto. 
Chi è contento che sulla terra ci sia Stevenson. 
Chi preferisce che abbiano ragione gli altri. 
Tali persone, che si ignorano, stanno salvando il mondo. 
 
“I giusti”. Jorge Luis Borges 
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2.1 CHALLENGES 
 
2.1.1. Asymmetric aziridination of α,β-usatured ketones 
Discussion 
Aziridines are three membered heterocycles containing a nitrogen atom. This class of 
compounds is present as a structural motif in a wide variety of strongly biological active 
molecules. Natural Mitomicyn A, B, and C represent an important family of antitumor and 
antibiotic agents. Through a structure-activity relationship is possible identify the aziridine ring 
as being essential for such antitumour activity (Figure 1).42 
Figure 1: Family of Mitomycins and its mode of action 
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In figure 1 is represented the mode of action of Mitomicin.43 In the first step of the postulated 
mechanism, the natural products are converted from native quinone form to the 
hydroquinone one. The DNA alkylation occurs thanks to the formation of the elettrophilic 
intermediate 3, generated by mean of aziridine ring-opening process. The intramolecular 
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nucleophilic substitution with the elimination of the carbamate leads to DNA cross-link 
blocking its replication. This kind of activity is also observed in synthetic compound bearing the 
aziridine moiety increasing the interest in this class of heterocycles. Moreover since their 
discovery, aziridines have attracted the attention as starting material. Transformations of this 
stable but strain-loaded (27 kcal·mol-1) ring allow for regio- and stereoselective installation of a 
wide range of functional groups in a 1,2-relationship to nitrogen (Scheme 1a), while 
cicloaddition of N protected aziridines with various substrates furnish complex heteroclyclic 
system (Scheme 1b).44 
Scheme 1: Principal reaction of aziridines 
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For these reasons the development of novel efficient methodologies for the stereoselective 
preparation of chiral aziridines is an important synthetic target.45 
The catalytic asymmetric aziridinations of olefins provide a direct and useful access to such 
privileged scaffold, and great efforts and progress have been made in this field using almost 
exclusively transition metal complex.46 The principal methodologies are the nitrene transfer to 
olefins and addition of metallocarbenes to imines, however a general and highly 
stereoselective aziridination of simple α,β-unsaturated enones is still lacking. In fact 
asymmetric aziridinations of enones have severe restrictions in scope, as only chalcones are 
suitable substrates: metal-based systems can provide highly enantioenriched compounds 
protected as N-tosyl derivatives, a protecting group that can prove difficult to remove. 
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Whereas two ingenious organocatalytic entries to non-protected aziridines, showing moderate 
enantioselectivity (up to 67% ee), were recently reported based on the use of chiral tertiary 
amines (Figure 2).47 
 
Figure 2: Organocatalytic aziridination of calcones through the formation of N-N ylides 
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Both of them are based on the concept that an aminide, formed from a tertiary or secondary 
amine and a primary amide derived from sulfonic or phosphoric acid, can directly iminate 
chalcones giving aziridines, through the formation of an N-N ylide in presence of an inorganic 
base. 
In this context we minded to apply our knowledge in the primary amine organocatalisys for 
address to this problem. 
Recently, the spectacular advances achieved in the field of chiral secondary amine catalysis[6] 
have set the conditions for the development of an highly chemo- and stereoselective 
aziridination of α,β-unsaturated aldehydes.48 Central to the success of this approach was the 
ability of the organocatalyst to integrate orthogonal activation modes (iminium ion and 
enamine catalysis) into a more elaborate reaction sequence,49 thus promoting first the 
nucleophilic addition of a N-centered nucleophile followed by an intramolecular cyclization. On 
the other hand the use of a primary amine catalyst offer the unique possibility to activate 
efficiently enones and other classes of encumber carbonyl compounds, overcoming the 
inherent difficulties of chiral secondary amines.50 
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With this in mind we envisaged that the catalytic salt A formed from 9-Epi-HQ-NH2 and the (D) 
N-Boc Phenylglycine could promoted the aziridination reaction. As previously described the 
primary amine might activate, thanks to its reduced steric hindrance, the α,β-unsaturated 
ketones, while the chiral counter anion offer the possibility to enhance the steroinduction of 
the reaction.51 In the first study of this project we started to evaluate the conjugate addition of 
N-centered nucleophile to α,β-usatured ketones.52 We focused on the use of the commercially 
available N-protected hydroxylamines 7 as the nucleophilic components, activating the α,β-
usautured ketones toward a domino Michael addition-intramolecular aldol sequence.53 This 
strategy leads to 5-hydroxyisoxazolidines 8, useful chiral scaffolds,54 in high yield and with ee 
values ranging from 93 to 99%. As shown in Table 1, a wide range of orthogonal carbamate 
protecting group (Cbz to Boc or CO2Et) can be used without affecting the enantioselectivity of 
the system (entries 1-3). A broad scope is also achieved in the ketone component and even the 
highly challenge chalcone could be used successfully, leading in all cases to products with high 
optical purity. 
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Table 1: Scope of the enantioselective amine conjugate addition to enones.
[a] 
[a] Reactions carried out on a 0.2 mmol scale with 1.2 equiv of 7 and 10 mol% of the 
catalyst salt A, unless noted. [b] Determined by 1H NMR analysis. [c] Overall isolated 
yield (sum of 8 and 9). [d] Determined by chiral HPLC analysis. [e] 20 mol% of the 
catalyst 
It Is important to notice that the reaction products are constituted from two forms at the 
equilibrium: the tandem and the conjugate addition products 8 and 9 rispectively. The relative 
amount of this two compounds at room temperature is strongly dependent on the electronic 
as well as the steric contribution of the R2 enone substituents. Studies for the protection of the 
hydroxy group of 8 with the aim of freeze this equilibrium are currently on going. 
Having demonstrated the ability of salt A to promote a highly enantioselective amine addition 
to enones, we moved toward the principal aim of our investigations, the development of a 
Entry 7 R
1 
R
2 
T (° C), h 8:9
[b]
 [%] yield
[c]
 [%] ee
[d]
 
1 a Pent Me RT, 72 9:1 85 99 
2 b Pent Me RT, 72 9:1 77 99 
3 c Pent Me RT, 72 9:1 43 99 
4 a Me Me RT, 72 8:1 63 95 
5
[e]
 a Ph Me 30, 72 5:1 78 94 
6
[e]
 a p-Cl Ph Me 30, 72 5:1 68 93 
7
[e]
 a Ph Ph 50, 96 1:3 51 95 
8
[e]
 a CO2Et Me 30, 72 5.5:1 65 95 
9 a c-hexyl 0, 40 0:100 85 95 
Catalyst salt A
10 - 20 mol%
Toluene 0.25 M
Pg N
H
OH
R1 R2
O
7a: Pg = Cbz; 7b: Pg = Boc
7c: Pg = CO2Et
6
R1 R2
ONPg
OH
8 9
+
ON
R1
Pg
OH
R27
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domino conjugate-cyclization sequence, leading to chiral aziridines. From the outset, we 
recognized the choice of the nitrogen-atom source as the crucial parameter for developing an 
efficient aziridination methodology. During the reaction it should change its polarity and first 
act as nucleophile and attack the iminium ion in 4 position and at a later stage become 
electrophilic facilitating the enamine-catalyzed cyclization step. We started our investigation 
by reacting enone 6a using as nitrogen source the O-Acyl N-protected hydrolamine 10a that 
was successfully employed in the aziridination of enals under secondary amine catalysis by 
Cordova et al. As highlighted in Table 2 the reaction provided only the conjugate addition 
product (entry 1). 
Table 2: Optimization of the Nitrogen source 
 
Entry 10 LG Conv % T:M d.r. ee 
1 a OAc 21 1:99 - 77 
2 b OMs 67 1.1:1 - 86 
3 c OTos 78 4.3:1 4:1 81 
 
Gratifyingly, the installation of a better leaving group such as a tosylate (10c, entry 3) allowed 
to selectively partition the reaction manifold toward the tandem sequence, leading to the 
desired aziridine T as the major product.  
Further optimization of the standard reaction parameters (Table 3) revealed that the solvent 
choice (compare entries 1-4), the reagent concentration and the stoichiometric ratio of the 
reagents (entry 5) were important factors to improve the efficiency and generality of the 
catalytic system. After this studies the enantioselectivity was increased up to ee= 95% and d.r= 
9/1 but the conversion in the aziridine adduct was yet not so high conv= 56% T/M= 9:1. Finally, 
we envisaged that the p-toluenesulfonic acid, generated during the enamine-induced ring 
closing step when using 10c, may affect the activity of the catalyst. We reasoned that the 
presence of an inorganic base could have a beneficial effect on both the reaction rate and the 
selectivity of the aziridination.55  
Catalyst salt A
20 mol%
CHCl3 (0.25 M) 
RT
Cbz N
H
LG
Pent Me
O
10a: LG= OAc,
10b: LG= OMs,
10c: LG= OTos
6a
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N
Me
O
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+
T
+
Pent
N
Me
OCbz
LG
M
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Table 3: Study of the effect of an external basic additive  
Catalyst salt A
20 mol%
CHCl3 0.25M
22 h, RT
Cbz N
H
OTos
Pent Me
O
Pent Me
ONCbz
OR
+
Pent
N
Me
O
Cbz
T M6a 10c
+
 
Entry solvent additive Conv % T:M d.r. ee 
1 CHCl3 0,25M - 56 9:1 9:1 95 
2 CHCl3 0,25M K2CO3 <10 >99:1 - - 
3 CHCl3 0,25M NaHCO3 (aq) 45 >99:1 >19:1 80 
4 CHCl3 0,25M NaHCO3 (s) >95 >99:1 19:1 96 
 
Carrying out the aziridination in CHCl3 0.25 M using 1.2 equiv of 10c and 2 equiv of solid 
NaHCO3 induced higher chemo-, diastereo- and enantio-selectivity (entry 4), and these 
catalytic conditions were selected for further explorations  in order to expand the scope of this 
transformation. With this condition in hands we analyzed the scope of the aziridination of α,β-
unsaturated ketones. 
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Table 4. Asymmetric organocatalytic aziridination of enones.[a] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[a]The reactions were carried out on a 0.2 mmol scale with 1.2 equiv of 8 
and 20 mol% of the catalyst salt combination A at room temperature in 
CHCl3 0.25 M . [b] Isolated yield. [c] Determined by 
1H NMR analysis of the 
crude mixture. [d] Determined by chiral HPLC analysis. [e] 5  mol% of the 
catalyst salt A was employed. [f] The absolute configuration of 8g was 
determined to be (2S, 3R)  by means of TD-DFT calculations of the 
electronic circular dichroism (ECD) spectra, see Supporting Information for 
details. 
A wide range of N-Cbz as well as N-Boc ketoaziridines 11 could be obtained in good yield and 
with high levels of both enantio- and diastereo-selectivity. Increasing the reaction time, it was 
also possible to decrease the catalyst loading to 5 mol%, keeping the efficiency of the system. 
Importantly, different sterically and electronically substitutents on the ketonic substrates are 
well tolerate, enabling access to a broad variety of both aliphatic and aromatic aziridines. With 
further optimization was also possible extend this procedure to the functionalization of cyclic 
hexenones. In fact changing the hydroxylamine protecting group, form Cbz to Boc, and setting 
the reaction stoichiometry (1.2 equiv of ketone) we synthesized a small library of cyclic keto-
aziridines obtaining both the antipodes of the products just using the pseudoenantiomeric 
Entry R
1 
R
2 
PG 11 Time [h]
 
yield
[b]
 dr
[c]
 [%] ee
[d]
 
1 Pent Me Cbz a 24 93 19:1 96 
2 Pent Me Boc b 24 82 >19:1 99 
3 Me Me Cbz c 16 96 >19:1 93 
4
[e]
 Me Me Cbz c 72 79 >19:1 93 
5 Me Et Cbz d 48 94 19:1 98 
6 CO2Et Me Cbz e 48 74 >19:1 95 
7 Ph Me Cbz f 72 85 >19:1 73 
8 p-NO2 Ph Me Cbz g 72 92 >19:1 99
[f] 
9 c-hexyl Cbz h 20 86 >19:1 98 
Catalyst salt A
20 mol%
CHCl3 (0.25 M) 
23 °C
PG N
H
OTs
R1 R2
O
10a: PG = Cbz;
 10d: PG = Boc
10 R1
N
R2
O
PG
11
+
6
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form of the catalyst salt (Table 5). This catalyst is made from 9-epi-NH2-HQD and (L) N-Boc 
Phenylglycine (catalyst salt B). When we used the mismatched combinations (9-epi-NH2-HQ + 
(L) N-Boc Phenylglycine and 9-epi-NH2-HQD and (D) N-Boc Phenylglycine) we observed lower 
reactivity and slightly decrease enantioselectivity (88% ee vs. 92% ee) in the reaction of 3-
Methyl 2-cyclohexanone and N Boc O tosyl hydroxylamine.56 
In table 5 is reported the scope of the aziridination of cyclic enones developed by us. 
 
Table 5. Scope of the aziridination of cyclic enones.[a], [b], [c] 
O
R
N
H
OTosBoc
O
R
+
Catalyst salt
A or B
(20 mol%)
NaHCO3 (2 equiv)
CHCl3 (0.25 M), RT
N Boc N
N
OMe
NH3
Boc-HN
COO
Ph
catalytic salt A
H
1.5
12 1310d
 
O
N Boc
 
O
N Boc
 
O
N Boc
 
O
N Boc
Me  
13 13a 13b 13c 
y= 73% (51)[d]  
ee= 99% (99)[d] 
ent 13 y= 76% 
ee= 99% 
y= 84% 
ee= 98% 
ent 13a y= 84% 
ee= 98% 
y= 33% 
ee= 98% 
ent 13b y= 53% 
ee= 98% 
y= 75% 
ee= 92% 
ent 13c y= 88% 
ee= 86% 
O
N Boc
Ph
[e]
 
O
N Boc  
O
N Boc
Me
[f]
 
O
N Boc
 
13d 13e 13f 13g 
y= 93% 
ee= 95% 
ent 13d y= 85% 
ee= 93% 
y= 39% 
ee= 93% 
ent 13e y= 44% 
ee= 97% 
y= 52% 
ee= 85% 
ent 13f y= 68% 
ee= 61% 
y= 90% 
ee= 98% 
ent 13g y= 98% 
ee= 94% 
[a] A single diastereoisomer has always been detected by 1H NMR spectroscopicanalysis of the crude 
mixture. Reactions carried out at room temperature for 24 h using 1.2 equiv of enone 12 on a 0.2 mmol 
scale. [b] Yield of isolated product. [c] ee of 13 was determined by HPLC analysis. [d] Number in 
parenthesis refers to reaction carried out using 10 mol% of catalyst salt A. [e] 48 h reaction time. [f] 
Using 2 equiv of enone, 72 h reaction time. 
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In addition cyclopentanone and cyclohepanone could be converted into the correspondent N-
Boc protected aziridines with good yield and very high stereoselectivity. Moreover it is possible 
to activate 3 substitued cyclic enones leading to the formation of a quaternary stereocenter 
adjacent a tertiary one. Notably, all this product are obtained as single distereoisomer and 
increasing the reaction time, it is also possible to decrease the catalyst loading up to 10%. The 
relative and absolute configurations of aziridines 13d, 13e, and 13h were assigned by NMR 
NOE spectroscopic analyses and by means of time-dependent (TD) DFT calculations of the 
electronic circular dichroism (ECD) spectra, as described in the experimental part. 
Finally, we explored the possibility of extending the aziridination method to indenone 
derivative 4, a challenging compound that has never served before as a suitable substrate for 
iminium catalysis due to the severe steric hindrance which hampers the condensation with the 
catalyst. Optimizing the reaction time in order to overcome the low reactivity of this 
compound is possible to prepare both the antipodes of the corresponding tricyclic aziridine 
derivative 15 with good chemical yield and very high enantioselectivity (Scheme 2). 
 
Scheme 2. aziridination of 1H-inden-1-one 
O
N
H
OTosBoc
+
O
N Boc
Catalyst salt  A or B
(20 mo%)
Na HCO3 (2 equiv)
CHCl3 (0.25 M)
RT/ 72 h
14 10 15
67% yield
98% ee
ent-15
53% yield, 96% ee
O
N O
NH2
OMe
MeO
MeO
NCS676892
 
 
Extension to such a compound class opens up new opportunities to prepare in a 
stereoselective manner complex chiral molecules that possess an indane moiety, a framework 
that is found in a large number of bioactive and pharmaceutically important molecules.57 
NSC67689214b is only one example of the potentially bioactive tricyclic, aziridine-containing 
heterocycle that may be synthesized by using the present method. 
In summary, in this part of my Phd thesis are described the studies on the aza-Michael reaction 
and on asymmetric aziridination of α,β-usatured ketones illustrating the increasing utility 
gained by chiral primary amine catalysis in the realm of asymmetric synthesis.  
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The reported protocols that use easily available reagents and catalysts establish a new 
platform for the aza-functionalizzation and aziridination of enones and are the starting point 
for further synthesis of biologiacally active compounds. 
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Experimental Part 
 
General Methods. The 1H and 13C NMR spectra were recorded at 600 MHz and 150 MHz, 
respectively. The chemical shifts (δ) for 1H and 13C are given in ppm relative to residual signals 
of the solvents (CHCl3). Coupling constants are given in Hz. Carbon types were determined 
from DEPT 13C NMR experiments. The following abbreviations are used to indicate the 
multiplicity: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; bs, broad signal. 
Purification of reaction products was carried out by flash chromatography (FC) on silica gel 
(230-400 mesh) according to the method of Still.1 Organic solutions were concentrated under 
reduced pressure on a Büchi rotary evaporator. ESI spectra were obtained from the 
Department of Organic Chemistry “A. Mangini”. Optical rotations are reported as follows: [α]rtD 
(c in g per 100 mL, solvent). All reactions were carried out in air and using undistilled solvent, 
without any precautions to exclude moisture unless otherwise noted. 
Materials. Commercial grade reagents and solvents were used without further purification; 
otherwise, where necessary, they were purified as recommended.2 α,β-unsaturate ketones 
were 
purchased from Aldrich or Lancaster and used as received, or prepared by Wittig reaction 
between  
commercially available acetylmethylene-triphenylphosphorane and the corresponding 
aldehydes (i. e. ethyl glyoxalate, and p-nitro benzaldehyde in DCM for 48 h at RT). N-Protected 
hydroxylamines 4a-c were purchased from Aldrich (4b-c) or Alfa Aesar (4a) and used as 
received. Compounds 8a-d were prepared following the literature procedures.3 9-Amino(9-
deoxy)epi-hydroquinine VIII was prepared from commercially available hydroquinine following 
the literature procedure.4 D-N-Boc-Phenyl glycine  was purchased from Fluka and used as 
received.  
Determination of Enantiomeric Purity. Chiral HPLC analysis was performed on an Agilent 
1100-series instrumentation. Daicel Chiralpak AD-H or AS-H columns and Daicel Chiralcel OD-H 
or OB-H column with i-PrOH/hexane as the eluent were used. HPLC traces were compared to 
racemic samples prepared by carrying out the reactions with stoichiometric amount of 
benzylamine or pyrrolidine as the catalyst in the presence of 0.5 equiv of benzoic acid. 
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Determination of the Relative and Absolute Configurations. 
Aziridination Products. The relative trans configuration was assigned by analysis of the J 
constants. The absolute configuration of compound xxg was assigned by means of TD-DFT 
calculations of the Electronic Circular Dichroism (ECD) spectra. The experimental ECD spectra 
match with the theoretical ones. Other absolute configurations were assigned by analogy 
considering an uniform mechanistic path. The absolute configurations are in agreement with 
related aminocatalytic conjugate additions promoted by catalyst A.5 
DFT Calculations. Geometry optimization were carried out at the B3LYP/6-31G level by means 
of the Gaussian 03 series of programs:6 the standard Berny algorithm in redundant internal 
coordinates and default criteria of convergence were employed. The reported energy values 
are not ZPE corrected. Harmonic vibrational frequencies were calculated for all the stationary 
points. For each optimized ground state the frequency analysis showed the absence of 
imaginary frequencies. TD-DFT calculations were obtained at the B3LYP/6-31+G(d,p)//B3LYP/6-
31G level. In order to cover the whole 200-400 nm range, 60 transition were calculated. The 
CD spectrum was then obtained applying a 0.3 eV Gaussian bandshape. 
 
ECD spectra and Absolute Configuration of compound 10g 
10g
(R)
(S)
Me
O
N
Cbz
NO2  
                                                           
5
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The lack of a suitable heavy atom precludes the use of the Bijovet method, based on 
anomalous X-ray dispersion, to unambiguously assign the absolute configuration (AC) of the 
single enantiomer of 10g. Using a different approach, the Electronic Circular Dichroism (ECD) 
spectrum can be calculated by theoretical methods and its shape (and intensity) compared 
with that of the experimental spectrum. If they match, the AC assumed in the calculations 
should then be assigned to the enantiomer whose experimental spectrum has been recorded. 
Theoretical calculation was carried out by means of TD-DFT method, since such a technique 
has been successfully employed several times7 to predict ECD spectra and to assign the AC of 
organic molecules. A preliminary conformational search, starting from the relative 
configuration derived from NMR spectra, was performed using Molecular Mechanics (MMFF 
force field, Montecarlo algorithm implemented in TITAN 1.0.4). The analysis of the output 
structures revealed that the three best structures differ only for the position of the benzyl 
group with respect to the carboxamide moiety. These structures were further optimized at the 
B3LYP/6-31G level, and for each of the optimized structures, the ECD spectrum was calculated 
in the 200-400 nm region at the B3LYP/6-31+G(d,p) level. As shown in Figure S1 the three 
calculated spectra are very similar, and this result reduces the possibility of errors in the final 
comparison of the calculated spectrum. In fact, in the case of flexible molecules, geometrically 
different conformations might give substantially different contributions to the ECD spectra.8 
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Figure S1. Calculated ECD spectra (B3LYP/6-31+G(d,p)//B3LYP/6-31G) for the best three 
conformers of 10g (energies are in kcal/mol) 
The final ECD spectrum to be compared with the experimental one was calculated taking into 
account the relative population of the three conformations at +25°C (14%, 43%, and 43%, 
respectively), and weighting the calculated spectra in the same ratio. As shown in Figure S2, 
the ECD spectrum calculated assuming the 2S,3R configuration shows a shape and relative 
intensities that match that of the experimental spectrum, with a strong positive Cotton effect 
at 300 nm, followed by a negative band at 265 nm. Accordingly, the 2S,3R configuration should 
be assigned to the single enantiomer obtained for compound 10g.  
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Figure S2: experimental (black trace) and calculated (red trace) ECD spectrum for compound 
10g 
Relative configuration of 5-hydroxyisoxazolidines 6f: NOE studies 
The relative configuration of compound 6f was assigned by extensive NOE studies. 
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O
O
Ph
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Figure S3. Bottom: part of the 1H-NMR spectrum of 6f (400 MHz, in CDCl3). Middle trace: DPFGSE-NOE 
obtained on saturation of the Ha(4) signal, showing a NOE effect on the Hb(4) signal and on the signal of 
the CH3(5), and showing no NOE effect on the CH(3) signal. Top trace: DPFGSE-NOE obtained on 
saturation of the CH(3) signal, showing NOE effect on the Hb(4) signal. Except for those relevant to the 
NOE spectra, all the hydrogens are omitted for clarity. 
 
Experimental Procedures 
General Procedure for the Organocatalytic Asymmetric Amine Conjugate Addition to Enones.  
Catalyst salt 1a
10 - 20 mol%
Toluene 0.25 M
Pg N
H
OH
R1 R2
O
4a: Pg = Cbz; 4b: Pg = Boc
4c: Pg = CO2Et
5
R1 R2
ONPg
OH
6 7
+
ON
R1
Pg
OH
R24
 
All the reactions were carried out in undistilled toluene. In an ordinary vial equipped with a 
Teflon-coated stir bar, 9-Amino(9-deoxy)epi-hydroquinine VIII (0.02 mmol, 6.5 mg, 10 mol%) 
was dissolved in 0.8 mL of toluene. After addition of D-N-Boc-phenylglycine 3 (0.04 mmol, 10 
mg, 20 mol%), the solution was stirred for 10 minutes at room temperature. After addition of 
α,β-unsaturated ketones 5 (0.2 mmol), the mixture was stirred at the indicated temperature 
for 10 minutes. Then N-Protected hydroxylamines 4a-c (0.24 mmol, 1.2 equiv) was added and 
stirring was continued for the indicated time. Upon completion of the reaction, the crude 
reaction mixture was diluted with CH2Cl2 (1 mL) and flushed through a short plug of silica, using 
dichloromethane/Et2O 1/1 as the eluent. Solvent was removed in vacuo, and the residue was 
purified by flash chromatography (FC) to yield the desired products. The ratio between the 
tandem or the conjugate addition products 6 and 7, respectively, was determined by 1H NMR 
Ha
Hb
4
53
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analysis of the crude mixture. 5-hydroxyisoxazolidines 6 were formed in diasteromerically pure 
form. Unfortunately, the two compounds 6 and 7 can not be separated by means of flash 
chromatography.  
 
5-Hydroxy-5-methyl-3-pentyl-isoxazolidine-2-carboxylic acid 
benzyl ester 6a (Table 1, entry 1) – The reaction was carried out 
following the general procedure to furnish the crude product 
[6a:7a ratio = 8:1, determined by integration of one set of 1H NMR 
signal (δmajor 4.28-4.38 ppm, m, δminor 4.45-4.54 ppm, m]. The title 
compound was isolated as a colourless oil by column 
chromatography (Hexane/Ethyl Acetate = 7/3) in 85% yield and 99% ee. HPLC analysis on a 
Chiralcel AD-H column: 95/5 hexane/i-PrOH, flow rate 0.75 mL/min, λ = 214, 254 nm; major 
diastereomer (99% ee): τmajor = 16.7 min, τminor = 17.3 min. [α]rtD = -5.8 (c=1.04, CHCl3, 99% ee) 
1H NMR: δ = 0.81-0.93 (m, 3H), 1.16-1.36 (m, 8H), 1.63 (s, 3H), 1.73 (dd, J=12.5, J=7.3, 1H), 2.48 
(dd, J=12.2,J=8.2, 1H), 3.60 (bs, 1H), 4.29-4.37(m, 1H), 5.18 (dd, J=39.10,J=12.5, 2H), 7.30-7.39 
(m, 5H). 13C NMR: δ = 14.1 (CH3), 22.8 (CH2), 23.8 (CH3), 26.0 (CH2), 31.7 (CH2), 36.3 (CH2), 43.9 
(CH2), 60.5 (CH), 68.1 (CH2), 106.5 (C), 128.4 (CH), 128.7 (CH), 136.3 (C), 160.1 (C). 
 
5-Hydroxy-5-methyl-3-pentyl-isoxazolidine-2-carboxylic acid 
tert-butyl ester 6b (Table 1, entry 2) – The reaction was carried 
out following the general procedure to furnish the crude product 
[6b:7b ratio = 9.5:1, determined by integration of one set of 1H 
NMR signal (δmajor 4.16-4.28 ppm, m, δminor 4.39-4.49 ppm, m]. The 
title compound was isolated as a colourless oil by column chromatography (Hexane/Ethyl 
Acetate = 8/2) in 77% yield and 99% ee. HPLC analysis on a Chiralcel AD-H column: 98/2 
hexane/i-PrOH, flow rate 0.75 mL/min, λ = 214, 254 nm; major diastereomer (99% ee): τmajor = 
11.3 min, τminor = 11.77 min. [α]rt
D = -4.5 (c=1.02, CHCl3, 99% ee) 
1H NMR: δ = 0.81-0.94 (m, 3H), 
1.19-1.38 (m, 8H), 1.46 (s, 9H), 1.63 (s, 3H), 1.67 (dd, J=12.2,J=7.4, 1H), 2.44 (dd,J=12.1,J=8.0, 
1H), 4.02 (bs, 1H), 4.17-4.26 (m, 1H). 13C NMR: δ = 14.2 (CH3), 22.8 (CH2), 23.7 (CH3), 26.2 (CH2), 
28.4 (CH3), 31.8 (CH2), 36.5 (CH2), 46.2 (CH2), 60.4 (CH), 81.8 (C), 106.1 (C), 159.5 (C). 
5-Hydroxy-5-methyl-3-pentyl-isoxazolidine-2-carboxylic acid 
ethyl ester 6c (Table 1, entry 3) – The reaction was carried out 
following the general procedure to furnish the crude product 
[6c:7c ratio = 6:1, determined by integration of one set of 1H NMR 
signal (δmajor 1.65 ppm, s, δminor 2.18 ppm, s]. The title compound 
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was isolated as a colourless oil by column chromatography (Hexane/Ethyl Acetate = 8/2) in 
43% yield and 99% ee. HPLC analysis on a Chiralcel AD-H column: 95/5 hexane/i-PrOH, flow 
rate 0.75 mL/min, λ = 214, 254 nm; major diastereomer (99% ee): τmajor = 10.7 min, τminor = 11.1 
min. [α]rt
D = -2.4 (c=1.04, CHCl3, 99% ee) 
1H NMR: δ = 0.82-0.97 (m, 3H), 1.2-1.40 (m, 11H), 1.64 
(s, 3H), 1.70-1.76 (m, 1H), 2.48 (dd, J=8.2,J=12.4, 1H), 3.29 (ds, 1H), 4.14-4.25 (m, 2H), 4.26-
4.34 (m, 1H). 13C NMR: δ = 14.2 (CH3), 14.7 (CH3), 22.8 (CH2), 23.9 (CH3), 26.0 (CH2), 31.7 (CH2), 
36.3 (CH2), 45.9 (CH2), 60.3 (CH), 62.5 (CH2), 106.4 (C), 157.9 (C). 
 
5-Hydroxy-3,5-dimethyl-isoxazolidine-2-carboxylic acid benzyl ester 6 d 
(Table 1, entry 4) – The reaction was carried out following the general 
procedure to furnish the crude product [6d:7d ratio = 3:1, determined by 
integration of one set of 1H NMR signal (δmajor 4.39-4.49 ppm, m, δminor 
4.59-4.65 ppm, m]. The title compound was isolated as a colourless oil 
by column chromatography (DCM/Acetone = 7/3) in 63% yield and 95% ee. HPLC analysis on a 
Chiralcel OD-H column: 95/5 hexane/i-PrOH, flow rate 0.75 mL/min, λ = 214, 254 nm; major 
diastereomer (95% ee): τmajor = 10.5 min, τminor = 11.4 min. [α]rt
D = -11.0 (c=0.83, CHCl3, 95% ee) 
1H NMR: δ = 1.32 (d, J=6.44, 3H), 1.65 (s, 3H), 1.70-1.78 (m, 1H), 2.51 (dd, J=7.9,J=12.2, 1H), 
4.38-4.50 (m, 1H), 5.13-5.25 (m, 2H), 7.27-7.42 (m, 5H). 13C NMR: δ = 21.8 (CH3) , 23.7 (CH3), 
47.6 (CH2), 56.3 (CH), 68 (CH2), 106.3 (C), 128.1 (CH), 128.4 (CH), 128.8 (CH) , 136.3 (C), 159.6 
(C). 
 
5-Hydroxy-5-methyl-3-phenyl-isoxazolidine-2-carboxylic acid benzyl 
ester 6 e (Table 1, entry 5) – The reaction was carried out following the 
general procedure to furnish the crude product [6e:7e ratio = 7.5:1, 
determined by integration of one set of 1H NMR signal (δmajor 5.42 ppm, 
t, δminor 5.67 ppm, dd]. The title compound was isolated as a colourless 
oil by column chromatography (Hexane/Ethyl Acetate = 8/2) in 78% yield and 94% ee. HPLC 
analysis on a Chiralcel OD-H column:  80/20 hexane/i-PrOH, flow rate 0.75 mL/min, λ = 214, 
254 nm; major diastereomer (94% ee): τmajor = 6.7 min, τminor = 7.7 min. []rt
D = -31.4 (c=0.958, 
CHCl3, 94% ee) 
1H NMR: δ = 1.73 (s, 3H), 2.14 (dd, J=12.3,J=8.3, 1H), 2.86 (dd, J=12.4,J=8.3, 1H), 
5.14-5.22 (m, 2H), 5.42 (t, J=8.3, 1H), 7.19-7.40 (m, 10H). 13C NMR: δ = 23.3 (CH3), 49.6 (CH2), 
63.5 (CH2), 68.1 (CH2), 106.5 (C), 126.3 (CH), 127.7 (CH), 128.0 (CH), 128.3 (CH), 128.7 (CH), 
128.9 (CH), 136.1 (C), 141.9 (C), 159.5 (C). 
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3-(4-Chloro-phenyl)-5-hydroxy-5-methyl-isoxazolidine-2-
carboxylic acid benzyl ester 6f (Table 1, entry 6) – The reaction was 
carried out following the general procedure to furnish the crude 
product [6f:7f ratio = 5.5:1, determined by integration of one set of 
1H NMR signal (δmajor 5.38 ppm, t, δminor 5.55-5-61 ppm, m]. The title 
compound was isolated as a white solid by column 
chromatography (Hexane/Ethyl Acetate = 7/3) in 68% yield and 93% ee. HPLC analysis on a 
Chiralcel AD-H column: 8/2 hexane/i-PrOH, flow rate 0.75 mL/min, λ = 214, 254 nm; major 
diastereomer (93% ee): τmajor = 11.3 min, τminor = 10.5 min. [α]rt
D = -46.6 (c=0.88, CHCl3, 93% ee) 
1H NMR: δ = 1.69 (s, 3H), 2.04-2.12 (m, 1H), 2.84 (dd, J=8.5,J=12.4, 1H), 3.36 (ds, 1H), 5.13-5.24 
(m, 2H), 5.38 (t, J=8.36, 1H), 7.22-7.35 (m, 9H). 13C NMR: δ = 23.4 (CH3), 49.5 (CH2), 63.0 (CH), 
68.3 (CH2), 106.5 (C), 127.7 (CH), 128.0 (CH), 128.4 (CH), 128.7 (CH), 129.0 (CH), 133.5 (C), 
136.0 (C), 140.4 (C), 159.5 (C).   
 
Benzyl hydroxy(3-oxo-1,3-diphenylpropyl)carbamate 7g (Table 1, 
entry 7) – The reaction was carried out following the general 
procedure to furnish the crude product [6g:7g ratio = 1:3, 
determined by integration of one set of 1H NMR signal (δmajor 5.81 
ppm, dd, δminor 5.56 ppm, t]. The title compound was isolated as a 
white solid by column chromatography (Hexane/Ethyl Acetate = 8/2) 
in 51% yield and 95% ee. HPLC analysis on a Chiralcel AD-H column: 
8/2 hexane/i-PrOH, flow rate 0.75 mL/min, λ = 214, 254 nm; major diastereomer (95% ee): 
τmajor = 23.8 min, τminor = 26.6 min. [α]rt
D = -29.5 (c=0.95, CHCl3, 95% ee) 
1H NMR: δ = 1.66 (bs, 
1H), 3.50-3.60 (m, 1H), 3.78-3.89 (m, 1H), 5.07 (d, J=12.2, 1H), 5.12 (d, J=12.2, 1H), 5.81 (dd, 
J=5.5, J=9.0, 1H), 7.19-7.64 (m, 14H), 7.95-8.01 (m, 1H). 13C NMR: δ = 40.7 (CH2), 59.1 (CH), 68.4 
(CH2), 127.6 (CH), 128.14 (CH), 128.2 (CH), 128.55 (CH), 128.7 (CH), 128.72 (CH), 128.83 (CH), 
129.0 (CH), 133.77 (CH), 136.1 (C), 136.8 (C), 139.4 (C), 157.33 (C), 197.9 (C). 
 
5-Hydroxy-5-methyl-isoxazolidine-2,3-dicarboxylic acid 2-benzyl 
ester 3-ethyl ester 6h(Table 1, entry 8) – The reaction was carried 
out following the general procedure to furnish the crude product 
[6h:7h ratio = 9:1, determined by integration of one set of 1H NMR 
signal (δmajor 4.90-4.97, m, δminor 4.63-4.67 ppm, m]. The title 
compound was isolated as a colourless oil by column 
chromatography (DCM/Acetone = 97/3) in 65% yield and 95% ee. HPLC analysis on a Chiralcel 
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AD-H column:  80/20 hexane/i-PrOH, flow rate 0.75 mL/min, λ = 214, 254 nm; major 
diastereomer (95% ee): τmajor = 10.0 min, τminor = 12.1 min. [α]rt
D = -15.6 (c=0.83, CHCl3, 95% ee) 
1H NMR: δ = 1.20 (t, J=7.2, 3H), 1.66 (s, 3H), 2.27-2.35 (m, 1H), 2.67 (dd, J=9.1, J=12.4, 1H), 
4.11-4.19 (m, 2H), 4.90-4.97 (m, 1H), 5.13-5.30 (m, 2H), 7.28-7.42 (m, 5H). 13C NMR: δ = 14.2, 
14.3, 30.5, 42.3, 58.6, 68.6, 106.3 (C), 128.4 (CH), 128.6 (CH), 128.8 (CH), 135.9 (C), 149.9 (C), 
170.6 (C).  
Benzyl hydroxy(3-oxocyclohexyl)carbamate 7i (Table 1, entry 9) – 
The reaction was carried out following the general procedure to 
furnish the crude product [6i:7i ratio = 0:100, no signal detected for 
the hydroxyisoxazolidine 6i]The title compound was isolated as a 
colourless oil by column chromatography (DCM/Acetone = 95/5) in 
85% yield and 95% ee. HPLC analysis on a Chiralcel OD-H column:  95/5 hexane/i-PrOH, flow 
rate 0.75 mL/min, λ = 214, 254 nm; major diastereomer (95% ee): τmajor = 40.0 min, τminor = 38.0 
min. [α]rt
D = -5.1 (c=0.89, CHCl3, 95% ee) 
1H NMR: δ = 1.51-1.64 (m, 1H), 1.84-1.94 (m, 1H), 
1.94-2.13 (m, 2H), 2.18-2.39 (m, 2H), 2.47 (dd, J=14.3,J=5.2, 1H), 2.76 (dd, J=14.2,J=11.2, 1H), 
4.25-4.36 (m, 1H), 5.11-5.21 (m, 2H), 7.28-7.38 (m, 5H), 7.72 (bs, 1H). 13C NMR: δ = 21.7 (CH2), 
27.7 (CH2), 40.4 (CH2), 44.4 (CH2), 57.2 (CH), 68.2 (CH2), 128.1 (CH), 128.4 (CH), 128.6 (CH), 
135.6 (C), 156.9 (C), 209.8 (C). 
 
General Procedure for the Organocatalytic Asymmetric Aziridination of Enones.  
Catalyst salt A
20 mol%
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All the reactions were carried out in undistilled chloroform and using the catalytic salt 
combination 1b (1.5 equiv of D-N-Boc-phenylglycine 3 relative to 9-Amino(9-deoxy)epi-
hydroquinine 2). In an ordinary vial equipped with a Teflon-coated stir bar, 9-Amino(9-
deoxy)epi-hydroquinine 2 (0.04 mmol, 13 mg, 20 mol%) was dissolved in 0.8 mL of CHCl3. After 
addition of D-N-Boc-phenylglycine 3 (0.06 mmol, 15 mg, 30 mol%), the solution was stirred for 
10 minutes at room temperature. After addition of α,β-unsaturated ketones (0.2 mmol), the 
mixture was stirred at room temperature for 10 minutes. Then nucleophile  8 (0.24 mmol, 1.2 
equiv) was added followed , after 5 minutes stirring, by the addition of NaHCO3 (0.4 mmol, 32 
mg, 2 equiv) in one portion. Stirring was continued for the indicated time, then the crude 
reaction mixture was diluted with CH2Cl2 (1 mL) and flushed through a short plug of silica, using 
O
N
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dichloromethane/Et2O 1/1 as the eluent. Solvent was removed in vacuo, and the residue was 
purified by flash chromatography (FC) to yield the desired products.  
 
Benzyl 2-acetyl-3-phenylaziridine-1-carboxylate 10a 
(Table 3, entry 1) – The reaction was carried out following the 
general procedure to furnish the crude product [dr = 19:1, 
determined by integration of one set of 1H NMR signal (δmajor 3.04 
ppm, δminor 3.10 ppm - d)]. The title compound was isolated as a 
colourless oil by column chromatography (Hexane/Et2O = 85/15) in 93% yield and 96% ee. 
HPLC analysis on a Chiralpak AD-H column: 9/1 hexane/i-PrOH, flow rate 0.75 mL/min, λ = 214, 
254 nm; major diastereomer (96% ee): τmajor = 10.84 min, τminor = 13.13 min; HRMS: m/z calcd 
for C18H17NO3: 289.1678; found: 233.1053. [α]rt
D = +12.7 (c=0.96, CHCl3, 96% ee) 
1H NMR: δ = 
0.80-0.93 (m, 3H), 1.20-1.35 (m, 3H), 2.25 (s, 3H), 2.65-2.70 (m, 1H), 3.04 (d, J=2.72, 1H), 5.08 
(d, J=12.1, 1H), 5.17 (d, J=12.1, 1H), 7.28-7.36 (m, 5H). 13C NMR: δ = 13.9 (CH3), 22.3 (CH2), 26.3 
(CH2), 29.0 (CH3), 31.38 (CH2), 31.40  (CH2), 45.9 (CH2), 46.6 (CH2), 68.2 (CH2), 128.2 (CH), 128.3 
(CH), 128.4 (CH), 135.5 (C), 160.3(C), 202.3 (C). 
 
tert-Butyl 2-acetyl-3-pentylaziridine-1-carboxylate 
10b (Table 3, entry 2) – The reaction was carried out following the 
general procedure to furnish the crude product [dr > 19:1, 
determined by integration of one set of 1H NMR signal (δmajor 2.97 
ppm, δminor 3.16 ppm - d)]. The title compound was isolated as a 
colourless oil by column chromatography (Hexane/Et2O = 8/2) in 82% yield and 99% ee. HPLC 
analysis on a Chiralpak AS-H column: 95/5 hexane/i-PrOH, flow rate 0.75 mL/min, λ = 214, 254 
nm; major diastereomer (99% ee): τmajor = 5.8 min, τminor = 6.0 min; HRMS: m/z calcd for 
C14H25NO3: 255.1834; found: 233.1053. [α]rt
D = +7.0 (c=1.04, CHCl3, 99% ee) 
1H NMR: δ = 0.83-
0.93 (m, 3H), 1.20-1.35 (m, 8H), 1.45 (s, 9H), 2.26 (s, 3H), 2.62-2.66 (m, 1H), 2.97 (d, J=2.8, 1H). 
13C NMR: δ = 14.2 (CH3), 22.7 (CH3), 26.7 (CH2), 28.16 (CH3), 29.3 (CH3), 31.46 (CH2), 31.49 (CH2), 
45.8 (CH), 46.9 (CH), 81.9 (C), 159.4(C), 202.9(C). 
 
2-Acetyl-3-methyl-aziridine-1-carboxylic acid benzyl ester 10c (Table 3, 
entry 3) – The reaction was carried out following the general procedure to 
furnish the crude product [dr > 19:1, determined by integration of one set of 
1H NMR signal (δmajor 2.98 ppm, δminor 3.02 ppm - d)]. The title compound 
was isolated as a colourless oil by column chromatography 
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(Hexane/Acetone = 95/5) in 96% yield and 93% ee. HPLC analysis on a Chiralcel OD-H column: 
95/5 hexane/i-PrOH, flow rate 0.75 mL/min, λ = 214, 254 nm; major diastereomer (93% ee): 
τmajor = 16.7 min, τminor = 17.9 min; HRMS: m/z calcd for C13H15NO3: 233.1052; found: 233.1053. 
[α]rt
D = +5.2 (c=0.89, CHCl3, 93% ee) 
1H NMR: δ = 1.33 (d, J=5.4, 3H), 2.23 (s, 3H), 2.73-2.80 (m, 
1H), 3.00 (d, J=2.5, 1H) 5.09 (d, J=12.1, 1H), 5.19 (d, J=12.1, 1H), 7.29-7.40 (m, 5H). 13C NMR: δ 
= 17.0 (CH3), 28.8 (CH3), 41.4 (CH), 68.6 (CH2), 128.6 (CH), 128.7 (CH), 128.8 (CH), 135.8 (C), 
160.5 (C), 202.9 (C).  
 
2-Methyl-3-propionyl-aziridine-1-carboxylic acid benzyl ester 10d (Table 
3, entry 5) – The reaction was carried out following the general procedure 
to furnish the crude product [dr = 19:1, determined by integration of one 
set of 1H NMR signal (δmajor 1.33 ppm, δminor 1.75 ppm - d)]. The title 
compound was isolated as a colourless oil by column chromatography 
(Hexane/Ethyl Acetate = 9/1) in 94% yield and 98% ee. HPLC analysis on a 
Chiralcel OB-H column: 8/2 hexane/i-PrOH, flow rate 0.75 mL/min, λ = 214, 254 nm; major 
diastereomer (98% ee): τmajor = 18.1 min, τminor = 21.1 min; HRMS: m/z calcd for C14H17NO3: 
247.1208; found: 247.1207. [α]rt
D = +12.3 (c=0.77, CHCl3, 98% ee) 
1H NMR: δ = 1.06 (t, J=7.9, 
3H), 1.33 (d, J=5.6, 3H), 2.51-2.65 (m, 2H), 2.76 (dq, J=5.6, J=2.8, 1H), 3.00 (d, J=2.8, 1H), 5.10 
(d, J=12.1, 1H), 5.16 (d, J=12.1, 1H), 7.29-7.39 (m, 5H). 13C NMR: δ = 7.4 (CH3), 16.9 (CH3), 35.6 
(CH2), 41.33 (CH), 47.1 (CH), 68.5 (CH2), 128.5 (CH), 128.66 (CH), 128.7 (CH), 135.9 (C), 160.7 
(C), 205.3 (C). 
 
1-Benzyl 2-ethyl 3-acetylaziridine-1,2-dicarboxylate 10e (Table 3, 
entry 6) – The reaction was carried out following the general 
procedure to furnish the crude product [dr > 19:1, determined by 
integration of one set of 1H NMR signal (δmajor 3.29 ppm, δminor 3.21 
ppm - d)]. The title compound was isolated as a colourless oil by 
column chromatography (Hexane/Acetone = 95/5) in 74% yield and 
95% ee. HPLC analysis on a Chiralpak AD-H column: 9/1 hexane/i-PrOH, flow rate 0.75 mL/min, 
λ = 214, 254 nm; major diastereomer (95% ee): τminor = 21.5 min, τmajor = 23.6 min; HRMS: m/z 
calcd for C15H17NO5: 291.1107; found: 291.1107. [α]rt
D = +22.6 (c=1.005, CHCl3, 95% ee) 
1H 
NMR: δ = 1.26 (t, J=7.3, 3H), 2.33 (s, 3H), 3.29 (d, J=2.4, 1H), 3.50 (d, J=2.4, 1H), 4.14-4.23 (m, 
2H), 5.11 (d, J=11.9, 1H), 5.20 (d, J=11.9, 1H), 7.30-7.39 (m, 5H). 13C NMR: δ = 14.2 (CH3), 
27.7(CH3), 40.8(CH), 46.0(CH), 62.7(CH2), 69.2 (CH2), 128.8 (3CH), 135.3 (C), 158.6 (C), 166.6 (C), 
201.0 (C). 
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Benzyl 2-acetyl-3-phenylaziridine-1-carboxylate 10f 
(Table 3, entry 7) – The reaction was carried out following the general 
procedure to furnish the crude product [dr > 19:1, determined by 
integration of one set of 1H NMR signal (δmajor 3.75 ppm, δminor 3.87 
ppm - d)]. The title compound was isolated as a white solid by column 
chromatography (Hexane/Ethyl Acetate = 9/1) in 85% yield and 73% 
ee. HPLC analysis on a Chiralpak AD-H column: 8/2 hexane/i-PrOH, flow rate 0.75 mL/min, λ = 
214, 254 nm; major diastereomer (73% ee): τmajor = 12.40 min, τminor = 15.79 min; HRMS: m/z 
calcd for C18H17NO3: 295.1208; found: 295.1207. [α]rt
D = +15.2 (c=0.89, CHCl3, 73% ee) 
1H NMR: 
δ = 2.36 (s, 3H), 3.36 (d, J=2.3, 1H), 3.75 (d, J=2.3, 1H), 5.11 (d, J=12.1, 1H), 5.25 (d, J=12.1, 1H), 
7.28-7.40 (m, 10H). 13C NMR: δ = 30.4 (CH3), 47.2 (CH), 50.0 (CH), 68.8 (CH2), 126.6 (CH), 128.6 
(CH), 128.7 (2CH), 128.8 (CH), 128.9 (CH), 135.5 (C), 135.7 (C), 160.2 (C), 201.1(C). 
 
(2S,3R)-2-Acetyl-3-(4-nitro-phenyl)-aziridine-1-carboxylic acid 
benzyl ester 10g (Table 3, entry 8) – The reaction was carried out 
following the general procedure to furnish the crude product [dr > 
19:1, determined by integration of one set of 1H NMR signal (δmajor 
3.34 ppm, δminor 3.12 ppm - d)]. The title compound was isolated as 
a yellow solid by column chromatography (Hexane/Ethyl Acetate = 
9/1) in 92% yield and 99% ee. HPLC analysis on a Chiralpak AD-H column: 8/2 hexane/i-PrOH, 
flow rate 0.75 mL/min, λ = 214, 254 nm; major diastereomer (99% ee): τmajor = 33.5 min, τminor = 
42.0 min; HRMS: m/z calcd for C13H15NO3: 340.1059; found: 340.1056. [α]rt
D = +94.0 (c=0.75, 
CHCl3, 99% ee) 
1H NMR: δ = 2.37 (s, 3H), 3.35 (d, J=2.3, 1H), 3.83 (d, J=2.3, 1H), 5.11 (d, J=12.1, 
1H), 5.24 (d, J=12.1, 1H), 7.29-7.42 (m, 5H), 7.44-7.50 (m, 2H), 8.15-8.21 (m, 2H). 13C NMR: δ = 
30.7 (CH3), 45.8 (CH), 50.0 (CH), 69.1 (CH2), 124.1 (CH), 127.5 (CH), 128.77 (CH), 128.80 (CH), 
128.81 (CH), 135.4 (C), 142.8 (C), 148.2 (C), 159.6 (C), 200.3 (C).  
 
2-Oxo-7-aza-bicyclo[4.1.0]heptane-7-carboxylic acid benzyl ester 
10h 
(Table 3, entry 9) – The reaction was carried out following the general 
procedure to furnish the crude product [dr = 9:1, determined by 
integration of one set of 1H NMR signal (δmajor 2.99 ppm, δminor 2.85 
ppm - d)]. The title compound was isolated as a colourless oil by column chromatography 
(Hexane/Ethyl Acetate = 9/1) in 86% yield and 98% ee. HPLC analysis on a Chiralpak AD-H 
column: 8/2 hexane/i-PrOH, flow rate 0.75 mL/min, λ = 214, 254 nm; major diastereomer (98% 
Me
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O
N
O
O
Ph
10h
Me
ON
O O
Ph
NO2 10g
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ee): τmajor = 9.8 min, τminor = 12.2 min; HRMS: m/z calcd for C15H17NO3: 245.1052; found: 
245.1053. [α]rt
D = - 7.3 (c=0.87, CHCl3, 98% ee). 
1H NMR: δ = 1.59-1.70 (m, 1H), 1.73-1.85 (m, 
1H), 1.89-2.12 (m, 2H), 2.21-2.31 (m, 1H), 2.45-2.54 (m, 1H), 2.99 (d, J=5.9, 1H), 3.12-3.17 (m, 
1H), 5.14 (s, 2H), 7.30-7.38 (m, 5H). 13C NMR: δ = 17.3 (CH2), 22.8 (CH2), 37.1 (CH2), 40.8 (CH), 
43.2 (CH), 68.9  (CH2), 128.6 (CH), 128.8 (CH), 128.9 (CH), 135.5 (C), 161.8(C), 204 (C). 
 
Determination of the Relative and Absolute Configurations 
 
 
Scheme 1 
Fortunately, high resolution NOE-NMR experiments coupled with bi-dimensional spectra, can 
reliably determine the relative configuration of the stereogenic centres, and can also give 
precious hints about the molecular conformations populated in solution. Compounds 3d, 3e, 
3h were selected as representative samples in order to determine the relative and absolute 
configuration.  
 
Compound xxe 
Full assignment of the protons signals (and carbons as well) of compound 13e was preliminary 
determined by gs-HSQC, gs-HMBC and g-COSY bi-dimensional NMR spectra. The analysis of the 
proton spectrum (see Supplementary Figure 1) reveals some diagnostic features. The signal of 
H-1 at 2.67 ppm shows a relatively large coupling constant with H-6 (6.0 Hz), whereas the 
signal of H-6 at 4.01 ppm exibits an additional small 4J coupling with one of the two 
diastereotopic hydrogens H-3eq  (1.6 Hz). This coupling constant has a significative value 
because of a “W” relationship of H-1 and H-3eq . 
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Supplementary Figure 1. 1H NMR spectrum of compound 13e (600 MHz, CDCl3 solution, 
+25°C). Proton assignments were deduced by HSQC, HMBC and COSY spectra.  
 
Two of the signals belonging to hydrogens in position 3 (1.94 ppm) and 4 (2.17 ppm) show a 
large vicinal coupling (12.2 Hz), indicating a trans-diaxial relationship (therefore they are 
indicated as H-3ax and H-4ax). The two remaining signals at 2.36 ppm and 1.29 ppm correspond 
to the two hydrogens H-4eq and H-3eq that lie in the equatorial positions. 
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Supplementary Figure 2. DPFGSE-NOE spectra of 13e. Trace a): control spectrum. Traces b-d: 
NOE spectra obtained on saturation of H-6, H-1, and the methyl anti to the nitrogen atom. 
Observed NOE are indicated as double arrows in the DFT-optimized structure  
 
In order to determine the relative configuration of carbons C-1 and C-6, NOE spectra were 
obtained by means of the DPFGSE-NOE sequence9, and saturating the signals corresponding to 
the two CH of the aziridine, and to the signal of the two diastereotopic methyls in position 2. 
Selected traces are shown in Supplementary Figure 2. The most indicative spectrum 
corresponds to trace c), in which the signal corresponding to H-1 is irradiated. Large NOE 
effects are visible on H-6 and on the signals of the two diastereotopic methyls in position 210. 
On saturation of the Methyl signal at 1.04 ppm, large NOEs are observed for the other methyl 
group, for H-1, for H-4ax and for H-3eq. A small but meaningful enhancement is also observable 
on H-6. These NOE constraints suggest that the two CHs of the aziridine ring are in a cis 
relationship (this is also confirmed by the J-coupling of 6.0 Hz, that correspond to a dihedral of 
nearly 0°), and that the Methyl at 1.04 ppm corresponds to the methyl anti to the nitrogen 
atom. In fact, only this methyl group can generate a NOE effect on H-6, being the cis one too 
far to induce NOE on the same hydrogen (about 4.95 Å in the DFT optimized structure). The 
enhancements observed on H-4ax and H-3eq indicate that the methyl anti to the nitrogen 
occupies the axial position of C-2. Consequently, the NOE on H-4ax is due to a 1-3 diaxial 
relationship with the Methyl. This precious information about the conformation of the 
cyclohexanone ring will help in the following conformational analysis (vide infra). Finally, when 
H-6 is saturated (trace b), the absence of any NOE except for the “control” enhancement on H-
1 indicates that H-6 occupies the equatorial position. From the NOE data the relative 
configuration of the two chiral carbons of 13e is 1R*, 6R*. 
 
Conformational Analysis and Absolute Configuration 
In the present case, the absolute configuration determination was carried out by means of TD-
DFT method. Since the acting chromophors of the molecule are the two carbonyl groups, a 
very accurate  determination of the conformation of the molecule in solution is crucial for the 
calculation of the ECD spectrum. Starting from the relative configuration obtained by NMR 
analysis, a conformational search has been carried out using Monte Carlo searching together 
                                                           
9 (a) Stott, K.; Stonehouse, J.; Keeler, J.; Hwand, T.-L.; Shaka, A. J. J. Am. Chem. Soc. 1995, 117, 4199. (b) Stott, K.; 
Keeler, J.; Van, Q. N.; Shaka, A. J. J. Magn. Resonance 1997, 125, 302. (c) Van, Q. N.; Smith, E. M.; Shaka, A. J. J. 
Magn. Resonance 1999, 141, 191. (d) See also: Claridge, T.D.W. High Resolution NMR Techniques in Organic 
Chemistry; Pergamon: Amsterdam, 1999. 
10 this is a NOE enhancement that must be observed, and it serves as a check of the reliability of the experiment. 
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with the MMFF94 molecular mechanics force field (as implemented in Titan 1.0.5). All 
conformations within a 5 kcal/mol window were then optimized using DFT at the B3LYP/6-
31G(d) level11, and the harmonic vibrational frequencies of each conformation were calculated 
at the same level to confirm their stability (no imaginary frequencies observed), and to 
evaluate the free energy of each conformation. After DFT minimization, the MMFF structures 
clustered into two conformations (a and c), that are different because of the different shape of 
the cyclohexanone. In both the optimized structures, the dihedral angle C6-N-C=O is close to -
120° (Supplementary Figure 3) 
a
E = 0.0
c
E = 1.0
1
6
N Boc
O
 
Supplementary Figure 3: DFT optimized conformations a and c of compound 13e, showing the 
different conformation of carbons 3 and 4 of the cyclohexanone moiety. Conformations b and 
d have the Boc group rotated by 180°. BOC hydrogens are omitted for convenience.  
 
It seemed strange to us that conformations with the same dihedral close to 60° (i.e.  
corresponding to a 180° rotation of the Boc group), were not identified by MM search. Visual 
inspection of the MM optimized geometries revealed that the Boc group was wrongly 
calculated to be perpendicular to the aziridine plane, and not nearly coplanar, as in the DFT 
minimized structures (this is a known problem of the MM force fields that does not account for 
the partial double bond character of the CO-N bond in amides). For this reason two more 
conformations were built starting from the former by 180° rotation of the Boc group around 
the C6-N-C=O dihedral. When subjected to DFT minimization, two new energy minima were 
                                                           
11 Gaussian 03, Revision E.01, Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. 
R.; Montgomery, Jr., J. A.; Vreven, T.; Kudin, K. N.; Burant, J. C.; Millam, J. M.; Iyengar, S. S.; Tomasi, J.; Barone, V.; 
Mennucci, B.; Cossi, M.; Scalmani, G.; Rega, N.; Petersson, G. A.; Nakatsuji, H.; Hada, M.; Ehara, M.; Toyota, K.; 
Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Klene, M.; Li, X.; Knox, J. E.; 
Hratchian, H. P.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, 
A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Ayala, P. Y.; Morokuma, K.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; 
Zakrzewski, V. G.; Dapprich, S.; Daniels, A. D.; Strain, M. C.; Farkas, O.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; 
Foresman, J. B.; Ortiz, J. V.; Cui, Q.; Baboul, A. G.; Clifford, S.; Cioslowski, J.; Stefanov, B. B.; Liu, G.; Liashenko, A.; 
Piskorz, P.; Komaromi, I.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; 
Challacombe, M.; Gill, P. M. W.; Johnson, B.; Chen, W.; Wong, M. W.; Gonzalez, C.; Pople, J. A.; Gaussian, Inc., 
Wallingford CT, 2004. 
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located (b and d), with energies close to the first two conformations. In summary, four stable 
conformations enclosed in a 2 kcal/mol range were located by DFT calculation. Comfortably, 
the lowest energy minimum is fully compatible with the NOE constraints, in particular for the 
axial position of the methyl anti to the nitrogen, and for its position with respect to H4ax. (see 
Supplementary Figure 3). 
 
Supplementary Table 1: Calculated relative free energies (ΔG) of the conformations of 3e (in 
kcal/mol, B3LYP/6-31G(d) level). Populations percentages (P) are calculated assuming 
Boltzmann statistics at T=25°C. 
 
Molecule Conf. ΔG P(%) 
13e  
a  0 62 
b  0.47 28 
c  1.30 7 
d  1.90 3 
 
To fully confirm the geometry of the cycle, J-coupling calculation was carried out by DFT 
methods at the B3LYP/6-311++G(2d,p)//B3LYP/6-31G(d) level12. (Supplementary Table 2). The 
values calculated for the lowest energy structure are in very good agreement with the 
experimental ones. This suggests that this conformation of the cycle is the most populated in 
solution, together with the structure with the Boc rotated by 180° (conformation b). Also the 
calculated free energies of the four conformation agree with this experimentally deduced 
situation. Calculation of the Electronic Circular Dichroism spectrum was carried out using the 
TD-DFT method at the B3LYP/6-311++G(2d,p)//B3LYP/6-31G(d) level, and assuming 1S, 6S 
absolute configuration13. Rotational strength were calculated in both length and velocity 
representation. The resulting values are very similar, therefore the errors due to basis set 
incompleteness are very small.14 Electronic excitation energies and rotational strengths have 
been calculated for the four conformation, and the ECD spectra were obtained by applying a 
0.4 eV Gaussian shaped line width15 (Supplementary Figure 4). In order to cover the 170-400 
nm range, 30 transition were calculated for each conformation. 
                                                           
12 Calculations were performed taken into account the Fermi contact term, under the keyword 
“NMR(spinspin,mixed)” 
13 The use of a moderate basis set is dictated by the molecular size, and by the need of limiting the computational 
time (about 20-24 hours on a 8-core Xeon X7355 server) 
14 Stephens, P.J.; McCann, D.M.; Devlin, F.J., Cheeseman, J.R.; Frisch, M.J. J.Am.Chem.Soc. 2004, 126, 7514-7521 
15 Gaussview 4.1.2, Semichem Inc., 2006 
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Supplementary Table 2: experimental and calculated coupling constant for conformations a 
and c. Values are expressed in Hz.  
Coupled spins Exp. J Calcd J. 
conf. a 
Calcd J. 
Conf. C 
H1-H6 6.0 6.4 6.5 
H1-H3eq 1.6 1.6 -0.4 
H3eq-H3ax -13.7 -14.7 -15.0 
H3eq-H4eq 2.3 1.5 0.4 
H3eq-H4ax 7.2 7.8 4.8 
H3ax-H4eq 6.4 6.6 3.6 
H3ax-H4ax 12.2 14.3 16.4 
H4eq-H4ax -19.1 -22.7 -14.5 
 
The most important feature of the simulated spectra is the transition centred at about 290 nm, 
corresponding to the n-pi* transition of the carbonyl group of cyclohexanone.  
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Supplementary Figure 4. Top: calculated ECD spectra for the four conformations of 13e. 
Bottom: experimental (black) and calculated ECD spectra (red), weighted on the calculated 
free energies of the conformations, and blue shifted by 12 nm. Molecular CD (Δε) is expressed 
in L mol-1cm-1. Solvent was acetonitrile. The vertical scale of the final simulated spectrum was 
scaled to obtain the best fit with the experimental trace. 
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This transition is calculated to have negative chirality in all the four conformations, and the 
trend of the four spectra are quite similar, indicating that the resulting weighted ECD spectrum 
is weakly influenced by the relative population of the conformations. The final simulated ECD 
spectra was obtained taking into account the 62:28:7:3 population ratios determined starting 
from the calculated free energies at the B3LYP/6-31G(d) level, and assuming Boltzmann 
statistics. Despite the small intensities of the experimental Cotton effects, the simulated 
spectrum is in very good agreement with the experimental one, and the 1S, 6S configuration 
can be reliably assigned to compound 13e. As suggested by some authors,2i,16 the use of more 
than one chirooptic method is always desirable; in the present compound the calculation of 
the [α]D is reasonable reliable, the experimental value being -106°. The calculated value (-61°) 
is negative and small, as experimentally observed. It has also to be pointed out that the well 
known octant rule17, when applied to the present case, assigned the opposite configuration, 
probably because of the presence of the second carbonyl group of the Boc moiety. 
 
Compound 13d. 
Compound 13d bears a quaternary carbon in position 1. In order to confirm the reaction path, 
the absolute configuration has to be checked again. As in the case of 13e, full assignment of 
the proton spectrum was obtained by bi-dimensional NMR. The proton spectrum of 13d is 
quite complicated because of superimpositions of some hydrogens belonging to C-2 and C-3. 
Consequently, a full analysis of the coupling constants is not feasible. NOE spectra obtained on 
saturation of H-6 and Me-2 (See Supplementary Figure 5) confirm that the aziridine ring has 
again the methyl and the CH cis to each other. Saturation of the methyl also shows NOE effects 
on both the diastereotopic hydrogens of C-3 (assigned by HSQC). The relative configuration is 
therefore the same for 13e, i.e. 1R*, 2R* conformation analysis of 13d was managed in the 
same way of 13e. MM conformational search was preliminary performed, and the minima 
included in a 5 kcal/mol windows were subsequently minimized by DFT at the B3LYP/6-31G(d) 
level, that clustered them in two conformation. As in the case of 13e, the MMFF force field 
failed to determine the correct geometry of the Boc moiety. For this reason, starting from the 
two DFT optimized structure, a second pair of conformations was build by 180° rotation of the 
                                                           
16 (a) Polavarapu, P. L. Chirality, 2008, 20, 664; (b) Stephens, P. J.; Pan, J. J.; Devlin, F. J.; Krohn, K.; Kurtn, T. J. Org. 
Chem 2007, 72, 3521. 
17 See Berova, N; Nakanishi, K.; Woody, R.W. “Circular Dichroism. Principles and Applications “, Wiley-VCH, Chapter 
10, page 261 
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Boc group, and minimized again. In summary, four conformations were found to exist into a 2 
kcal/mol range (a-d in Supplementary Table 3). 
H-3’ H-3”
H-6
Me-2
H-6
t-Bu
H-6
a)
b)
c)
 
Supplementary Figure 5. DPFGSE-NOE spectra of 13d. Trace a): control spectrum. Traces b-c: 
NOE spectra obtained on saturation of H-6 and Me-2.  
 
Supplementary Table 3: Calculated free energies (ΔG) of the conformations of 3d (in 
kcal/mol, B3LYP/6-31G(d) level). Populations percentages (P) are calculated assuming 
Boltzmann statistics at T=25°C. 
 
Molecule Conf. ΔG P(%) 
3d  
a  0.00 55 
b  0.28 35 
c  1.36 6 
d  1.48 5 
 
The two pairs of conformations show a different conformation of the cyclohexanone ring 
(Supplementary Figure 6), and both are compatible with the observed NOEs. Accordingly, in 
this case the conformational analysis relies only on the computed energies, that showed a 
good accuracy in the case of 13d. 
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Supplementary Figure 6: DFT optimized conformations a and c of compound 13d, showing the 
different conformation of the cyclohexanone ring. Conformations b and d have the Boc group 
rotated by 180°. Boc hydrogens are omitted for convenience. Calculation of the Electronic 
Circular Dichroism spectrum was carried out using the TD-DFT method at the B3LYP/6-
311++G(2d,p)//B3LYP/6-31G(d) level, and assuming 1S, 6S absolute configuration13. Rotational 
strength were calculated in both length and velocity representation. The resulting values are 
very similar, therefore the errors due to basis set incompleteness are very small.14 Electronic 
excitation energies and rotational strengths have been calculated for the four conformation, 
and the ECD spectra were obtained by applying a 0.4 eV Gaussian shaped line width 
(Supplementary Figure 7). In order to cover the 170-400 nm range, 30 transition were 
calculated for each conformation. From 400 to 200 nm, the four resulting spectra are quite 
similar, indicating that the trend of the resulting weighted ECD spectrum will not be largely 
influenced by the relative population of the conformations. The final simulated ECD spectra 
was obtained taking into account the 55:35:6:5 population ratios determined by Boltzmann 
statistics from the calculated free energies at the B3LYP/6-31G(d) level (Supplementary Table 
3). To compensate the solvent effect, the simulated trace had to be blue shifted by 10 nm, in 
order to match the experimental wavelengths. Being the agreement with the experimental 
spectrum very good, the 1S, 6S absolute configuration can be assigned to compound 13d. As in 
the case of 13e, the low-energy n-pi* transition is negative, indicating that the sign of this 
transition is not influenced by the substitution of the cycle.  
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Supplementary Figure 7. Top: calculated ECD spectra for the four conformations of 13d. 
Bottom: experimental (black) and calculated ECD spectra (red), weighted on the calculated 
free energies of the four conformations and blue shifted by 10 nm. Molecular CD (Δε) is 
expressed in L mol-1cm-1. Solvent was acetonitrile. The vertical scale of the final simulated 
spectrum was scaled to obtain the best fit with the experimental trace. 
Compound 13h. 
The cycloheptanone ring contained in compound 13h has a greater conformational freedom 
with respect to 13e and 13d. For this reason compound 13h was chosen as model of a more 
flexible system. NMR spectra show that also in this case the two CH of the aziridine ring are in 
a cis relationship. MM conformational search was performed also in this case to localize all the 
energy minima. Quite surprisingly, one structure was found to be much more stable than the 
others. DFT minimization of the energy minima found by MM in a 5 kcal/mol window 
confirmed this trend. As in the case of 13e and 13d, a second conformation was built by 180° 
rotation of the Boc group and subsequently optimized. (see Supplementary Figure 8). 
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Supplementary Figure 8 DFT optimized conformations compound 13h, showing the different 
conformation of the Boc group and the chair-like conformation of the cycloheptanone ring. 
Boc hydrogens are omitted for convenience.  
 
Supplementary Table 4: Calculated free energies (ΔG) of the conformations of 13h (in 
kcal/mol, B3LYP/6-31G(d) level). Populations percentages (P) are calculated assuming 
Boltzmann statistics at T=25°C. 
Molecule Conf. ΔG P(%) 
13h  
a  0.00 75 
b  0.65 25 
 
The cycloheptanone ring, due to the geometry requirements imposed by the three-membered 
ring, exibits a chair-like conformation, in which the carbonyl moiety occupies a pseudo-axial 
position. The structure in which the carbonyl is pseudo-equatorial is higher in energy by 3.8 
kcal/mol, and represents the second conformation in the energy scale. Calculation of the ECD 
spectrum was carried out only for the two conformation of Supplementary Figure 8 using the 
TD-DFT method at the B3LYP/6-311++G(2d,p)//B3LYP/6-31G(d) level. Electronic excitation 
energies and rotational strengths have been calculated for both conformation, and the ECD 
spectra were obtained by applying a 0.4 eV Gaussian shaped line width (Supplementary Figure 
9). The two simulated spectra have different shapes below 240 nm, and both show negative 
chirality at the n-pi* transition. When weighted by Boltzmann statistics from the calculated 
free energies at the B3LYP/6-31G(d) level (Supplementary Table 4), the resulting spectrum is in 
very good agreement with the experimental. To compensate the solvent effect, the simulated 
trace had to be shifted by 10 nm, in order to match the experimental wavelengths. Being the 
agreement with the experimental spectrum very good, the 1S, 7S absolute configuration can 
be assigned to compound 13h. 
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Supplementary Figure 9. Top: calculated ECD spectra for the two conformations of 13h. 
Bottom: experimental (black) and calculated ECD spectra (red), weighted on the calculated 
free energies of the conformations and blue shifted by 10 nm. Molecular CD (Δε) is expressed 
in L mol-1cm-1. Solvent was acetonitrile. The vertical scale of the final simulated spectrum was 
scaled to obtain the best fit with the experimental trace. 
 
General Procedure for the Organocatalytic Asymmetric Aziridination of Cyclic Enones. 
O
n
R NH
OTsPG
Catalytic Salt 1
20% mol
CHCl3 (0.25M)
NaHCO3, 25°C
O
n
R N PG
 
All the reactions were carried out in undistilled chloroform and using the catalytic salt 
combination A or B  (1.5 equiv of D-N-Boc-phenylglycine or L-N-Boc-phenylglycine relative to 
9-Amino(9-deoxy)epi-hydroquinine or 9-Amino(9-deoxy)epi-hydroquinidine). Both of the 
antipodes of the aziridine products can be accessed simply selecting the appropriate catalyst 
enantiomer. In an ordinary vial equipped with a Teflon-coated stir bar, 9-Amino(9-deoxy)epi-
hydroquinine or 9-Amino(9-deoxy)epi-hydroquinidine (0.04 mmol, 13 mg, 20 mol%) was 
dissolved in 0.8 mL of CHCl3. After addition of D-N-Boc-phenylglycine or L-N-Boc-phenylglycine  
(0.06 mmol, 15 mg, 30 mol%), the solution was stirred for 10 minutes at room temperature. 
After addition of α,β-unsaturated ketones (0.24 mmol, 1.2 equiv), the mixture was stirred at 
room temperature for 10 minutes. Then nucleophile 2 (0.2 mmol) was added followed, after 5 
minutes stirring, by the addition of NaHCO3 (0.4 mmol, 32 mg, 2 equiv) in one portion. Stirring 
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was continued for the indicated time, then the crude reaction mixture was diluted with CH2Cl2 
(1 mL) and flushed through  a short plug of silica, using dichloromethane/Et2O 1/1 as the 
eluent. Solvent was removed in vacuo, and the residue was purified by flash chromatography 
(FC) to yield the desired products. 
 
2-Oxo-7-aza-bicyclo[4.1.0]heptane-7-carboxylic acid benzyl ester 3a 
(Table 1, entry 1) – The reaction was carried out following the general 
procedure and using catalyst salt A to furnish the crude product as a 
single diastereomer. The title compound was isolated as a colourless 
oil by column chromatography (Hexane/Ethyl Acetate = 9/1) in 86% yield and 98% ee. HPLC 
analysis on a Chiralpak AD-H column: 8/2 hexane/i-PrOH, flow rate 0.75 mL/min, λ = 214, 254 
nm; major diastereomer (98% ee): τmajor = 9.8 min, τminor = 12.2 min; HRMS: m/z calcd for 
C15H17NO3: 245.1052; found: 245.1053. [α]rt
D = - 7.3 (c = 0.87, CHCl3, 98% ee). 
1H NMR: δ = 
1.59-1.70 (m, 1H), 1.73-1.85 (m, 1H), 1.89-2.12 (m, 2H), 2.21-2.31 (m, 1H), 2.45-2.54 (m, 1H), 
2.99 (d, J = 5.9 Hz, 1H), 3.12-3.17 (m, 1H), 5.14 (s, 2H), 7.30-7.38 (m, 5H). 13C NMR: δ = 17.3 
(CH2), 22.8 (CH2), 37.1 (CH2), 40.8 (CH), 43.2 (CH), 68.9  (CH2), 128.6 (CH), 128.8 (CH), 128.9 
(CH), 135.5 (C), 161.8(C), 204 (C). 
 
2-Oxo-7-aza-bicyclo[4.1.0]heptane-7-carboxylic acid tert-butyl ester 3b 
(Table 1, entry 2) – The reaction was carried out following the general 
procedure using catalyst salt A to furnish the crude product as a single 
diastereomer. The title compound was isolated as a colourless oil by column chromatography 
(Hexane/Acetone = 8/2) in 73% yield and 99% ee. The ee was determined by HPLC analysis on 
a Chiralcel AD-H column: 90/10 hexane/i-PrOH, flow rate 0.75 mL/min, λ = 214, 254 nm: τmajor = 
7.6 min, τminor = 8.2 min. [α]rt
D = -95.5 (c = 0.74, CHCl3, 99% ee). ESI: [M+Na]
+= 234, [M+1]+= 212. 
1H NMR: δ = 1.45 (s, 9H), 1.63-1.68 (m, 1H) 1.74-1.82 (m, 1H), 1.92-1.08 (m, 2H), 2.20-2.27 (m, 
1H), 2.47-2.52 (m, 1H), 2.88 (d, J = 5.89 Hz, 1H), 3.05-3.09 (m, 1H). 13C NMR: δ = 17.5 (CH2), 
22.8 (CH2), 28.0 (CH3), 37.1 (CH2), 40.6 (CH), 43.4 (CH), 82.5 (C), 160.8 (C), 204.5 (C).   
 
1-Methyl-5-oxo-7-aza-bicyclo[4.1.0]heptane-7-carboxylic acid benzyl 
ester 3c (Table 1, entry 3) – The reaction was carried out following 
the general procedure using catalyst salt A to furnish the crude 
product. The title compound was isolated as a colourless oil by 
column chromatography (Hexane/Acetone = 9/1) in 84% yield and 73% ee. HPLC analysis on a 
Chiralpak AD-H column: 95/5 hexane/i-PrOH, flow rate 0.75 mL/min, λ = 214, 254 nm; major 
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diastereomer (75% ee): τmajor = 15.79 min, τminor = 16.32 min; HRMS: m/z calcd for C15H17NO3: 
259.1208; found: 259.1208 [α]rt
D = -15.6 (c = 0.797, CHCl3, 73% ee) 
1H NMR: δ = 1.36 (s, 3H), 
1.62-1.72 (m, 2H), 1.90-2.08 (m, 2H), 2.11-2.20 (m, 1H), 2.38-2.50 (m, 1H), 2.86 (s, 1H), 5.12-
5.19 (m, 2H), 7.30-7.40 (m, 5H). 13C NMR: δ = 17.5 (CH2) , 20.6 (CH3), 29.3 (CH2), 36.3 (CH2), 
48.2 (C), 49.8 (CH), 68.7 (CH2), 128.7 (2CH), 128.8 (CH), 135.8 (C), 160.2 (C), 205.1 (C). 
 
1-Methyl-5-oxo-7-aza-bicyclo[4.1.0]heptane-7-carboxylic acid tert-butyl 
ester 3d (Table 1, entry 4) – The reaction was carried out following the 
general procedure using catalyst salt A to furnish the crude product as a 
single diastereomer. The title compound was isolated as a white solid by column 
chromatography (Hexane/Et2O/CHCl3 = 50/33/17) in 75% yield and 92% ee. The ee was 
determined by HPLC analysis on a Chiralcel AD-H column: 95/5 hexane/i-PrOH, flow rate 0.75 
mL/min, λ = 214, 254 nm:  τminor = 8.20 min τmajor = 10.38 min. ESI: [M+Na]
+= 248, [M+1]+= 226. 
1H NMR: δ = 1.44 (s, 3H), 1.51 (s, 9H), 1.64-1.75 (m, 2H), 2.01-2.10 (m, 2H), 2.14-2.22 (m, 1H), 
2.44-2.52 (m, 1H), 2.83 (s, 1H). 13C NMR: δ = 17.4 (CH), 20.2 (CH3), 27.9 (CH3), 29.1 (CH), 36.0 
(CH), 47.4 (C), 49.5 (CH), 81.9 (C), 158.9 (C), 205.4 (C).  
 
2,2-Dimethyl-5-oxo-7-aza-bicyclo[4.1.0]heptane-7-carboxylic acid tert-
butyl ester 3e (Table 2, entry 2) – The reaction was carried out following 
the general procedure using catalyst salt A to furnish the crude product as 
a single diastereomer. The title compound was isolated as a white solid by 
column chromatography (Hexane/Acetone = 8/2) in 84% yield and 98% ee. HPLC analysis on a 
Chiralcel AD-H column: 90/10 hexane/i-PrOH, flow rate 0.75 mL/min, λ = 214, 254 nm: τminor = 
5.98 min, τmajor = 6.86 min. [α]rt
D = -106.7 (c = 0.98, CHCl3, 98% ee. ESI: [M+Na]
+= 262, [M+1]+= 
240. 1H NMR: δ = 1.03 (s, 3H), 1.21 (s, 3H), 1.26-1.38 (m, 1H), 1.44 (s, 9H), 1.88-1.95 (m, 1H), 
2.12-2.20 (m, 1H), 2.35 (ddd, J = 19.23 Hz, J = 8.93 Hz, J = 19.11 Hz, 1H), 2.64-2.67 (dd, J = 5.89 
Hz, J = 1.47 Hz, 1H), 2.92 (d, J = 5.91 Hz, 1H). 13C NMR: δ = 23.4 (CH3), 27.8 (CH3), 28.0 (CH3), 
30.42 (CH2), 33.82 (CH2), 44.25 (CH), 50.2 (CH), 82.3 (C), 160.5 (C), 204.8 (C).  
 
4,4-Dimethyl-2-oxo-7-aza-bicyclo[4.1.0]heptane-7-carboxylic acid 
tert-butyl ester 3f (Table 2, entry 3) – The reaction was carried out 
following the general procedure using catalyst salt A to furnish the 
crude product as a single diastereomer. The title compound was 
isolated as a colourless oil by column chromatography (Hexane/Etyl Acetate = 8/2) in 33% yield 
and 98% ee. The ee was determined by HPLC analysis on a Chiralcel AD-H column: 99/1 
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hexane/i-PrOH, flow rate 0.650 mL/min, λ = 214, 254 nm: τminor = 18.44 min,  τmajor= 20.47 min. 
[α]rt
D = +43.4 (c=0.65, CHCl3, 98% ee). ESI: [M+Na]
+= 262, [M+1]+= 240. 1H NMR: δ = 0.88 (s, 
3H), 1.00 (s, 3H), 1.44 (s, 9H), 1.78-1.83 (m, 2H), 1.94 (d, J = 14.60 Hz, 1H), 2.58 (d, J = 14.00 Hz, 
1H), 2.87 (d, J = 6.46 Hz, 1H), 2.97 (t, J = 6.18 Hz, 1H). 13C NMR: δ = 27.4 (CH3), 27.8 (CH3), 30.8 
(CH3), 36.8 (CH2), 37.7 (C), 41.0 (CH), 42.8 (CH), 48.8 (CH2), 82.3 (C), 160.3 (C), 206.0 (C). 
 
1-Benzyl-5-oxo-7-aza-bicyclo[4.1.0]heptane-7-carboxylic acid tert-butyl 
ester 3g (Table 2, entry 5) – The reaction was carried out following the 
general procedure using catalyst salt A to furnish the crude product as a 
single diastereomer. The title compound was isolated as a colourless oil by 
column chromatography (Hexane/Et2O = 7/3) in 93% yield and 95% ee. The ee was determined 
by HPLC analysis on a Chiralcel AD-H column: 95/5 hexane/i-PrOH, flow rate 0.75 mL/min, λ = 
214, 254 nm: τminor = 12.52 min,  τmajor = 15.15 min. [α]rt 
D = -59.7 (c = 0.73, CHCl3, 95% ee). ESI: 
[M+Na]+= 324. 1H NMR: δ = 1.48 (s, 9H), 1.51-1.59 (m, 2H), 1.86-1.98 (m, 2H), 2.01-2.07 (m, 
1H), 2.35-2.41 (m, 1H), 2.46 (d, J = 14.45 Hz, 1H), 3.05 (s, 1H), 3.23 (d, J = 14.53 Hz, 1H), 7.20 (d, 
J = 7.79 Hz, 2H), 7.23-7.27 (m, 1H), 7.28-7.32 (m, 2H). 13C NMR: δ = 1.2 (CH3), 17.6 (CH2), 26.3 
(CH2), 28.2 (CH), 36.3 (CH2), 41.5 (CH2), 48.9 (CH), 51.3 (C), 82.4 (C), 127.4 (CH), 128.9 (CH), 
129.6 (CH), 136.5 (C), 205.2 (C). 
 
2-Oxo-8-aza-bicyclo[5.1.0]octane-8-carboxylic acid tert-butyl ester 3h 
(Table 2, entry 6) – The reaction was carried out following the general 
procedure using catalyst salt A to furnish the crude product as a single 
diastereomer. The title compound was isolated as a colourless oil by column 
chromatography (Hexane/Et2O = 7/3) in 90% yield and 98% ee. The ee was determined by 
HPLC analysis on a Chiralcel AD-H column: 95/5 hexane/i-PrOH, flow rate 0.75 mL/min, λ = 214, 
254 nm: τmajor = 8.07 min, τminor = 8.88 min. [α]rt
D = -103.2 (c = 0.8, CHCl3, 98% ee). ESI: [M+Na]
+ 
= 248, [M+1]+ = 226. 1H NMR: δ = 0.92-1.01 (m, 1H), 1.44 (s, 9H), 1.60-1.67 (m, 1H), 1.67-1.68 
(m, 2H), 1.79-1.85 (m, 1H), 2.23-2.30 (m, 1H), 2.39-2.46 (m, 1H), 2.72-2.78 (m, 1H), 2.84-2.88 
(m, 1H), 3.00-3.02 (dd, J = 1.61 Hz, J = 7.22 Hz, 1H).13C NMR: δ = 23.67 (CH2), 23.85 (CH2), 28 
(CH2), 28.08 (CH3), 40.57 (CH2), 40.99 (CH), 47.57 (CH), 82.20 (C), 161.11 (C), 209.50 (C). 
 
 2-Oxo-6-aza-bicyclo[3.1.0]hexane-6-carboxylic acid tert-butyl ester 3i 
(Table 2, entry 7) – The reaction was carried out following the general 
procedure using catalyst salt A to furnish the crude product as a single 
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diastereomer. The title compound was isolated as a pale yellow oil by column chromatography 
(Hexane/Etyl Acetate = 8/2) in 39% yield and 93% ee. The ee was determined by HPLC analysis 
on a Chiralcel AD-H column: 90/10 hexane/i-PrOH, flow rate 0.750 mL/min, λ = 214, 254 nm: 
τminor = 10.66 min,  τmajor= 11.42 min. [α]rt
D = +43.4 (c = 0.72, CHCl3, 93% ee). ESI: [M+Na]
+= 220, 
[M+1]+= 198. 1H NMR: δ = 1.46 (s, 9H), 1.93-2.03 (m, 1H), 2.07-2.22 (m, 2H), 2.47-2.51 (m, 1H), 
3.01 (d, J= 3.09 Hz, 1H), 3.38 (t, J= 3.11 Hz, 1H). 13C NMR: δ = 21.5 (CH2), 28.1 (CH3), 31.7 (CH2), 
44.1 (CH), 44.3 (CH), 129.9 (C). 
 
1-Methyl-4-oxo-6-aza-bicyclo[3.1.0]hexane-6-carboxylic acid tert-butyl ester 
3j (Table 2, entry 8) – The reaction was carried out following the general 
procedure to furnish the crude product as a single diastereomer. The title 
compound was isolated as a colourless oil by column chromatography 
(Hexane/Acetone = 8/2) in 52% yield and 85% ee. The ee was determined by HPLC analysis on 
a Chiralcel AD-H column: 90/10 hexane/i-PrOH, flow rate 0.750 mL/min, λ = 214, 254 nm: τminor 
= 6.83 min,  τmajor= 12.54 min. [α]rt
D = +39.9 (c = 0.90, CHCl3, 85% ee). ESI: [M+Na]
+= 234, 
[M+1]+= 212. 1H NMR: δ = 1.45 (s, 9H), 1.51 (s, 3H), 1.94-2.04 (m, 2H), 2.19-2.28 (m, 1H), 2.46-
2.54 (m, 1H), 2.83 (s, 1H). 13C NMR: δ = 19.5 (CH3), 26.3 (CH2), 28.1 (CH3), 33.6 (CH2), 50.3 (CH), 
52.6 (C), 82.4 (C), 158.1 (C), 207.9 (C). 
 
6-Oxo-6,6a-dihydro-1aH-1-aza-cyclopropa[a]indene-1-carboxylic acid tert-
butyl ester 5 (Scheme 1) – The reaction was carried out following the 
general procedure using catalyst salt A to furnish the crude product as a 
single diastereomer. The title compound was isolated as a red solid by 
column chromatography (Hexane/Acetone = 85/15) in 67% yield and 98% ee. The ee was 
determined by HPLC analysis on a Chiralcel AD-H column: 95/50 hexane/i-PrOH, flow rate 0.75 
mL/min, λ = 214, 254 nm: τmajor = 15.71 min, τminor = 16.39 min. [α]rt
D = +24.5 (c = 0.86, CHCl3, 
98% ee). ESI: [M+Na]+= 268. 1H NMR: δ = 1.12 (s, 9H), 3.53 (d, J = 2.87 Hz, 1H), 4.09 (d, J = 2.77 
Hz, 1H), 7.41 (td, J = 1.16 Hz, J = 7.46 Hz, 1H), 7.58 (dt, J = 1.26 Hz, J = 7.40 Hz, 1H), 7.62 (dt, J = 
1.09 Hz, J = 7.60 Hz, 1H), 7.70 (dt, J = 0.59 Hz, J = 7.59 Hz, 1H). 13C NMR: δ = 27.6 (CH3), 42.4 
(CH), 43.1 (CH), 82.6 (C), 125.4 (CH), 127.1 (CH), 129.6 (CH), 133.1 (C), 134.5 (CH), 146.6 (C), 
157.8 (C), 195.3 (C). 
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2.1.2. Asymmetric Organocatalytic Cascade Reactions with α-Substituted α,β-
Unsaturated Aldehydes 
Discussion 
In asymmetric synthesis the activation of a new class of compounds represents the 
opportunity to expand both knowledge limits and the tools array in the chemist hands. In this 
context the development, in the past decade, of the aminocatalytic strategies offered the 
unique possibility to activate carbonyl compounds such as saturated aldehydes and enals, 
enabling previously inaccessible transformations.58, 59 Since early 2007 it was also possible, as 
consequence of the simultaneous efforts of four independently groups, to activate the α,β-
unsaturated ketones into an iminium ion strategy.60 
The discover route of new activation modes in asymmetric aminocatalysis arrived at the end of 
2000s when the activation of α,β-unsaturated α-substituted aldehydes has been realized, 
furnishing three different protocols for their functionalizzation (Figure 1).  
 
Figure 1: organocatalytic activation modes of α,β-unsaturated α-substituted aldehydes  
R2
O
R1
R1
O
H2O2, dioxane
primary amine TRIP
R2
O
R1
O
primary amine TRIPR2
R1
O
R2
Ar
Ar
CHCl3
OH
NMe2Me2N
R2
O
R1
primary amine TFA
CHCl3 I E
Nu, E R
2
Nu
ER1
O
Epoxidation, JACS 2010
γ-Alkylation, Angew. Chem. 2010
Iminium ion-Enamine Cascade Sequence, Angew. Chem. 2009
ee up to 95%
ee up to 98%
ee up to >99%
 
In Figure 1 are reported three different kinds of activation of α-branched aldehydes recently 
reported by the groups of Mechiorre et. al.61 and the group of List et. al.62 
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In 2010 was reported the first organocatalytic epoxidation of α-branched enals. The catalytic 
system is based upon a double chiral catalytic salt, formed by 9-amino-9-deoxy-epi-Quinine 
and (R)-TRIP as chiral counter anaion. 
The reaction furnished an excellent way for the epoxidation of α-branched aliphatic aldehydes 
with enantiomeric excess up to 98% through an intramolecular iminium ion-enamine cascade 
mechanism catalyzed by the primary amine catalyst. Importantly, the chiral phosphoric acid 
provides additional enantiodiscrimination in both steps as a chiral counterion of the iminium 
ion intermediate and as a Brønsted acid in the ring closure step making easy the elimination of 
water. 
In the middle of Figure 1 is reported the γ-alkylation of α,β-unsaturated α-substituted 
aldehydes, through SN1 pathway, published by Melchiorre et al. few months ago. In this paper 
these scientists activated for the first time the α-branched enals via dienamine,63 generating a 
γ-nucleophilic intermediate that is able to intercept a stabilized carbocation formed in situ 
from bis(4-dimethylaminophenyl)methanol.64 The activation of aldehyde was realized by a 
primary amine catalyst easily derived from Quinidine in two steps (Scheme 1) 
Scheme 1: Proposed mechanistic model for the Asymmetric γ-Alkilation of α-Branched Enals 
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In this reaction the chiral phosphoric acid at first promote the formation of the carbocation 
and then act as counter anion both for the quinuclidine moiety and for the benzhydryl cation 
ensuring an excellent stereoselection of the process.  
During my Phd we were caught by stimulating game of address the challenges in the field of 
the asymmetric synthesis. At the end of 2008, when it was consolidated the ability of the 
primary amine catalyst in the activation of enones, we started to study the activation of 
another class of α,β-unsaturated carbonyl compounds: the α-branched aldehydes. We showed 
for the first time that a primary amine catalyst was able to activate these substrates toward a 
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well defined iminium ion-enamine tandem sequence (Figure 1 below) building the way for 
their further activation. 
Ispired by the pioneeristic work of Ishihara et- al. (Scheme 2) we minded from the outset that 
a primary amine could activate the α-branched enals via iminium ion 
Scheme 2: Organocatalyzed Enantioselective Diels-Alder reaction with a-Acyloyacroleins 
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The authors reported the first Diels Alder reaction catalyzed by a primary amine with excellent 
enantiomeric excess. In their report Ishihara and Nakano postulated that the active form of the 
catalyst 1 readily derived from L-amino acid and HX induces its asymmetry to DA adducts 
through a five-membered cyclic cis-transition state (Figure 2). The protonation of the amine 
groups arises to the formation of two ion pairs where, after the condensation with the 
aldehyde, the counter anion X- select the geometry of the iminium ion through non bond 
interaction, and the benzyl group shields one of the two possible attack-face.  
Figure 2: Proposed transition state for the DA reaction of α-acyloxy acroleins reported by 
Ishihara et. al. 
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On this ground other groups tried to solve the problem of the activation of α-branced 
aldehydes obtaining good results only employing acroleins,65 thus the use of this substrates 
still represents an 
elusive and fundamental target for asymmetric aminocatalysis.66 This is particularly true since 
an alternative asymmetric metal-catalyzed strategy for the functionalization of this class of 
compounds is also lacking. In order to face this problem we thought to avail ourself of the 
primary amine A ability in the activation of α,β-unsaturated α-substituted aldehydes. At first 
we wanted design a Michael addition/protonation cascade using 2-Methyl-indole as 
nucleophile. 
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Scheme 3: Preliminary studies on the asymmetric Michael addition/protonation tandem 
seqience 
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Unfortunately the catalytic system furnished a good enatioselection, but it was not able to 
control enamine protonation step, in fact we obtain the product as equal mixture of 
diastereoisomer (Scheme 3). 
Encouraged by the high stereocontrol in the Michael addition we minded to trap the enamine 
intermediate with another electrophile the diazocarboxylate, creating multifunctional 
compounds with two contiguous stereocenters in a one-step process. Besides the benefit to 
generate complex scaffolds in a rapid and atom-economical way,67 the combination of multiple 
asymmetric transformations in a cascade sequence also imparts increased enantiomeric excess 
to the final product when compared to the corresponding discrete transformations.68 
Our organocascade strategy was first examined mixing three commercially available reagents, 
(E)-2-methylpent-2-enal, 2-methyl-1H-indole and diethyl azodicarboxylate (Table 1, entry 1). 
Such a reagents combination is rather challenging, due to the competitive coupling between 
the π-electronrich nucleophile and the electrophilic component.69 A survey of the reaction 
conditions revealed that using a 1:1.2:1.5 ratio of enal 2, nucleophile 3 and electrophile 4, 
respectively, in the presence of the catalytic salt, made by combining A (20 mol%) and TFA (30 
mol%) in CHCl3 (0.5M) as solvent, provides product 5a with excellent levels of stereoinduction 
and in good yield, thus minimizing deleterious side reactions.  
The scope of the reaction is examined in Table 1. 
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Table 1: Scope of the aryl/amination tandem sequence for the functionalization of α,β-
unsaturated α-substituted aldehydes. 
R1
R2
N
H
R3
N
N R5
R5
CHCl3 0.5 M
48h, RT
 Catalyst A
(20 mol%)
TFA (30 mol%)
2 3 4
R4 R2
N
H
CHO
CHO
R1 N
H
N
R5 R
5
5
R3
 
[a]Yield of isolated 5 [b] Determined by 1H NMR analysis of the crude reaction mixture. 
[c]Determined by HPLC analysis using chiral stationary phases. [d] Reaction conducted at - 10°C 
over 96 h. [e] Reaction conducted at 0°C over 65 h. 
 
Different azodicarboxylates having orthogonal protecting groups are suitable as electrophilic 
component for the process (Entries 1-3). On basis of the superior diastereomeric ratio and 
isolated yield, tert-butyl azodicarboxylate was selected for further explorations. A wide scope 
of the different substituents on the indole core can be achieved, since electronic modification 
of the aromatic ring can be accomplished without affecting the system efficiency, leading to 
valuable tryptophane derivatives 5 in good yields and very high diastereo- and enantio-
selectivity (entries 3-7). As expected, a more encumbered ethyl group (R1) at the α-position of 
aldehyde, decreases the overall reaction rates (entry 8) while the necessity to perform the 
reaction at room temperature leads to a slightly lower level of stereocontrol in the formation 
of 5h (83% ee).  
To probe the scope of the nucleophilic component and further expand the synthetic utility of 
this organocascade methodology, by forging a quaternary stereocenter contiguous to a C-S 
Entry R
1
 R
2
 R
3
 R
4
 R
5
 Yield [%]
a
 d.r.
b 
ee[%]
c
 
1 Me Et Me H CO2Et 57 (5a) 8:1 99 
2 Me Et Me H CO2Bn 49 (5b) 6:1 99 
3
 Me Et Me H CO2t-Bu 80 (5c) 11:1 98 
4
[d]
 Me Et H H CO2t-Bu 51 (5d) 3:1 94 
5
[e] Me Et H Cl CO2t-Bu 43 (5e) 4:1 91 
6
[d]
 Me Et H OMe CO2t-Bu 54 (5f) 3:1 96 
7
[d] Me Et H H CO2t-Bu 47 (5g) 3:1 91 
8 Et CH3(CH2)2 H H CO2t-Bu 31 (5h) 3:1 83 
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tertiary one with the tandem  sequence,70 we focused on a sulfa-Michael/amination sequence, 
using mercaptanes having easily removable and orthogonal sulphur protecting groups (Table 
2).71 
Table 2: Organocascade catalysis with α-branched α,β-unsaturated aldehydes: sulfa-
Michael/amination strategy 
 
R2
CHO
SH N
N
 Catalyst 1
(20 mol%)
TFA (30 mol%)
CHCl3 0.5 M
48-65h6a: R3 = tBu
6b: R3 = Bn
2 4
7
R3
S
R1 N
H
N
BocBoc
R3
R2
CHO
R1
Boc
Boc6
 
 
 
   
 
 
 
 
 
 
 
[a] 
Reactions conditions: 2 (1 equiv), 6 (1.2 equiv), and 4 (1.5 equiv). [b] Yield of the isolated, 
single, major diastereoisomer. [c] Determined by 1H NMR analysis of the crude reaction 
mixture. [d] Determined by HPLC analysis using chiral stationary phases. [e] Reaction carried 
out in toluene. [f] The ee value was dermined after reduction and cyclization to form 
oxazolidinone. [g] Sum of diastereoisomers (4.5:1 ratio). [h] Yield and ee value were 
determined after in situ reduction and cyclization.  
 
As summarized in Table 2, the reaction shows a good substrate generality: both tert-butyl and 
benzyl mercaptane are suitable nucleophiles, albeit the latter induces a less selective 
organocascade path (entries 1-3). There appears to be a remarkable latitude in the electronic 
and steric demands of the  
aldehydic component. Different aliphatic substituents and even a phenyl group in both the α- 
and β-position of the enals are well tolerated (entries 4-6), enabling access to a broad variety 
of multifunctional complex molecules having adjacent stereocenters with high 
stereoselectivity. For example, when α-substituted cinnamic aldehyde is involved in the 
organocascade, the corresponding product 7e is obtained almost as a single stereoisomer 
Entry R
1
 R
2
 
Thio
l 
t [°C] Yield [%]
 b
 d.r.
[c] 
ee[%]
d
 
1 Me Et 6a 0 54 (7a) 6.5:1 > 99 
2
[e]
 Me Et 6b 0 57 (7b) 5:1 72 
3
[e]
 Me Et 6b -20 27 (7b) 6:1 89 
4
[f]
 Et CH3(CH2)2 6b 40 45 (7c)
[g] 4:1 92 
5
 [h]
 Ph Et 6b 40 47 (7d) 4:1 92 
6 Me Ph 6a 40 40 (7e) 20:1 99 
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(entry 6, >20:1 dr, 99% ee). Notably, in most of the cases, compounds 7 are isolated as single 
diastereoisomer by standard chromatography.  
To further increase the complexity of our organo-cascade generated products, we finally 
explored the possibility to extend the organocascade to 1-cycloalkene-1-carboxaldehyde, to 
access complex products having a quaternary stereogenic center embedded in a cycle.9 
Satisfying, catalyst A proved efficient with this substrate class, leading to compound 8 with 
complete enantiocontrol (Scheme 4). 
Scheme 4: enantioselective sulfa-Michael/amination tandem sequence of the -cyclohexen-1-
carboxaldehyde 
 
 
 
 
 
The configuration of a derivative of compound 7 was unambiguously determined by 
anomalous dispersion X-ray crystallography,72 whereas the relative and absolute 
configurations of a derivative of compound 8 were assigned by NMR NOE analyses and by 
means of TD-DFT calculations of the electronic circular dichroism (ECD) spectra, as described in 
the Supplementary Information. 
In summary, reporting two organocascade reactions as the olefin aryl-amination and thio-
amination processes, we introduced α,β-disubstituted enals to the asymmetric amino-catalytic 
panorama, providing an efficient solution to their highly challenging activation. Specifically, our 
described strategy affords a straightforward access to valuable precursors of α-amino acids 
having two adjacent stereogenic centers, one of which quaternary, with very high optical 
purity. Importantly, we confirmed the applicability of primary amine Chincona alkaloids-
derivatives as general catalysts for highly encumbered substrates, giving our contribution to an 
envisaged affirmation of them as ‘privileged’ catalysts for the activation of sterically 
demanding partners.  
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Experimental Part 
 
General methods. 
The 1H and 13C NMR spectra were recorded at 400 MHz and 100 MHz, respectively, or at 600 
MHz for 1H and 150 MHz for 13C. NOE spectra were recorded using the DPFGSE-NOE 
sequence,73 using a mixing time of 2.00 s and “rsnob” 20 ÷ 50 Hz wide selective pulses, 
depending on the crowding of the spectra region. The chemical shifts (δ) for 1H and 13C are 
given in ppm relative to residual signals of the solvents (CHCl3 and CD3CN). Coupling constants 
are given in Hz. Carbon types were determined from DEPT 13C NMR experiments. The following 
abbreviations are used to indicate the multiplicity: s, singlet; d, doublet; t, triplet; q, quartet; 
m, multiplet; bs, broad signal. Purification of reaction products was carried out by flash 
chromatography (FC) on silica gel (230-400 mesh) according to the method of Still.74 Organic 
solutions were concentrated under reduced pressure on a Büchi rotary evaporator. High 
Resolution Mass spectra were obtained from the Department of Organic Chemistry “A. 
Mangini” Mass Spectroscopy facility. X-ray data were acquired at the Department of Physical 
and Inorganic Chemistry X-ray Crystallography facility, on a Bruker APEX-2 difractometer. 
Optical rotations are reported as follows: [α]rtD (c in g per 100 mL, solvent).
 All reactions were 
carried out in air and using undistilled solvent, without any precautions to exclude moisture 
unless otherwise noted. 
 
Materials. Commercial grade reagents and solvents were used without further purification; 
otherwise, where necessary, they were purified as recommended.75 Chiral primary amine 
catalysts, 9-Amino(9-deoxy)epi-hydroquinine A and the pseudo-enantiomer 9-Amino(9-
deoxy)epi-hydroquinidine B, were prepared from commercially available hydroquinine and 
hydroquinidine, respectively, following the literature procedure.76 2-Ethyl-Hex-2-enal (Table 1, 
entry 8 and Table 2, entry 4) was prepared through a self-condensation reaction treating 
butyraldehyde with 1M solution of NaOH at RT overnight. All other aldehydes employed are 
commercially available. Indole derivatives 3, azodicarboxylates 4, and thiols 6a and 6b were 
purchased from Aldrich or Lancaster and used as received. 
 
Determination of Diastereomeric Ratios. The diastereomeric ratio was determined by 1H NMR 
analysis of the crude reaction mixture, and confirmed by HPLC analysis on chiral stationary 
phases columns. 
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Determination of Enantiomeric Purity. HPLC analysis of the optical purity of the compounds 
was performed on an Agilent 1100-series instrumentation. Daicel Chiralpak AD-H or AS-H 
columns and Daicel Chiralcel OD-H with i-PrOH/hexane as the eluent were used. HPLC traces 
were compared with racemic samples obtained by mixing the products from individual 
reactions with 9-Amino(9-deoxy)epi-hydroquinine A and its pseudoenantiomer 9-Amino(9-
deoxy)epi-hydroquinidine B.  
 
Calculations. MM conformational searches were performed using the MonteCarlo method 
implemented in Titan 1.0.5.77 Geometry optimization were carried out at the B3LYP/6-31G(d) 
level by means of the Gaussian 03 series of programs.78 The standard Berny algorithm in 
redundant internal coordinates and default criteria of convergence were employed. Harmonic 
vibrational frequencies were calculated for all the stationary points. For each optimized 
ground state the frequency analysis showed the absence of imaginary frequencies. Standard 
thermochemistry analysis was used to calculate the free energies. TD-DFT calculations were 
obtained at the B3LYP/6-31+G(d,p)//B3LYP/6-31G(d) level. In order to cover the whole 180-
400 nm range, 60 to 75 transition were calculated. The CD spectra was then obtained applying 
a 0.25 eV Gaussian bandshape. 
 
Experimental procedures 
 
General procedure for the asymmetric organocatalytic Friedel-Crafts/amination tandem 
sequence of α-substituted α,β−unsaturated aldehydes. 
 
 
All the reactions were carried out in undistilled chloroform. In an ordinary vial equipped with a 
Teflon-coated stir bar, 9-Amino(9-deoxy)epi-hydroquinine A (0.04 mmol, 200 μL of a 0.2 M 
CHCl3 solution, 20 mol%) was added to 200 μL of solvent. After the addition of TFA (0.06 mmol, 
5 μL, 30 mol%), the solution was stirred for 5 minutes at room temperature before adding the 
α-substituted enal 2 (0.2 mmol). The mixture was then allowed to stir for further 5 minutes at 
room temperature before the addition of indole derivative 3 (0.24 mmol, 1.2 equiv.). After 5 
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minutes, azodicarboxylate (0.3 mmol, 1.5 equiv.) was added and stirring continued at the 
indicated temperature and for the indicated time. The crude reaction mixture was diluted with 
CH2Cl2 (1 mL) and flushed through a short plug of silica, using CH2Cl2/ AcOEt 1/1 as the eluent. 
Solvent was removed in vacuo and the residue was purified by flash chromatography to yield 
the desired product 5.  
 
diethyl 1-(2-methyl-3-(2-methyl-1H-indol-3-yl)-1-oxopentan-2-
yl)hydrazine-1,2-dicarboxylate 5a. The reaction was carried out 
over 48 hours in CHCl3 at room temperature following the general 
procedure to furnish the crude product (d.r.= 8:1 was determined 
by integration of one set of 1H-NMR signal: δmajor 5.84 ppm bs, δminor 5.18 ppm bs). The title 
compound was isolated by flash column chromatography (hexane/acetone = 8/2) in 57% yield 
as mixture of diastereoisomers in 6:1 ratio and 99% ee (major diastereoisomer). The ee was 
determined by HPLC analysis on a Daicel Chiralcel OD-H column: hexane/i-PrOH 9:1, flow rate 
0.75 mL/min, λ = 214, 254 nm: τmajor = 13.8 min., τminor = 19.9 min. [α]rt
D= - 55.4 (c = 0.73, CHCl3, 
99% ee, dr=6:1). HRMS: (m/z) calculated for C21H29N3O5: 403.2107, found: 403.2107. 
1H NMR 
(400 MHz, CDCl3 25°C): Major diastereoisomer, major rotamer: δ 0.61 (t, 3H, J = 7.19 Hz), 1.12 
(s, 3H), 1.22-1.38 (m, 6H), 1.87-2.01 (m, 1H), 2.04-2.15 (m, 1H) 2.37 (s, 3H), 3.32 (dd, 1H, J1= 
12.4 Hz, J2=3.2 Hz), 3.94-4.40 (m, 4H), 5.82 (bs, 1H), 7.02-7.18 (m, 2H), 7.29-7.43 (m, 2H), 7.94 
(bs, 1H), 9.74 (s, 1H). 13CNMR (100 MHz, CDCl3 25°C): δ 12.6 (CH3), 13.2 (CH3), 14.3 (CH3), 14.4 
(CH3), 19.97 (C), 22.03 (CH3), 45.62 (CH), 62.3 (CH2), 63.4 (CH2), 64.4 (CH2), 108.8 (C), 111.5 
(CH), 118.1 (CH), 120.5 (CH), 121.2 (CH), 127.2 (C), 134.5 (C), 136.1 (C), 156.2 (C), 156.7 (C), 
197.9 (C). Additional peaks and line broadenings are observed due to rotameric species. 
 
dibenzyl 1-(2-methyl-3-(2-methyl-1H-indol-3-yl)-1-oxopentan-2-
yl)hydrazine-1,2-dicarboxylate 5b. The reaction was carried out 
over 48 hours in CHCl3 at room temperature following the general 
procedure to furnish the crude product (d.r.= 6:1 was determined by 
integration of one set of 1H-NMR signal: δmajor 0.57 ppm t, δminor 0.68 ppm t). The title 
compound was isolated by flash column chromatography (hexane/acetone = 8/2) in 49% yield 
as mixture of diastereoisomers in 7.5:1 ratio and 99% ee (major diastereoisomer). The ee was 
determined by HPLC analysis on a Daicel Chiralcel OD-H column: hexane/i-PrOH 85:15, flow 
rate 0.75 mL/min, λ = 214, 254 nm: τmajor = 17.64 min., τminor = 23.24 min. [α]rt
D= - 21.3 (c = 1.50, 
CHCl3, 99% ee, 7.5:1 dr). 
1H NMR (400 MHz, CDCl3 25°C): Major diastereoisomer, major 
rotamer δ 0.57 (t, 3H, J = 7.18 Hz), 1.31 (s, 9H), 1.14 (s, 3H), 1.81-1.93 (m, 1H), 2.04-2.15 (m, 
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1H), 2.34 (s, 3H), 3.30 (dd, 1H, J1= 11.9 Hz, J2=3.2 Hz), 4.96-5.40 (m, 5H), 5.94 (bs, 1H), 6.90 (m, 
1H), 7.06-7.39 (m, 15H), 7.91 (bs, 1H), 9.78 (bs, 1H). 13C NMR (150 MHz, CDCl3 25°C): δ 12.6 
(CH3), 13.2 (CH3), 19.9 (CH3), 22.03 (CH2), 45.62 (CH), 67.8 (CH2), 68.1 (CH2), 73.18 (C), 108.8 (C), 
111.4 (CH), 118.0 (CH), 120.4 (CH), 120.7 (CH), 121.3 (CH), 121.5 (CH), 127.0  (C), 128.2 (CH), 
128.4 (C), 128.6 (CH), 128.7 (CH), 128.8 (CH), 134.4 (C), 135.7 (C), 136.0 (C), 156.5 (C), 156.7 
(C), 197.7 (C). Additional peaks and line broadenings are observed due to rotameric species. 
 
di-tert-butyl 1-(2-methyl-3-(2-methyl-1H-indol-3-yl)-1-oxopentan-
2-yl)hydrazine-1,2-dicarboxylate 5c. The reaction was carried out 
over 24 hours in CHCl3 at room temperature following the general 
procedure to furnish the crude product (d.r.= 11:1 was determined by integration of one set of 
1H-NMR signal: δmajor 9.73 ppm, bs, δminor 9.58 ppm, bs). The title compound was isolated by 
flash column chromatography (DCM/Et2O = 98/2) in 80% yield as mixture of diastereoisomers 
in 7.3:1 ratio and 98% ee (major diastereoisomer). The ee was determined by HPLC analysis 
Daicel Chiralcel OD-H column: hexane/i-PrOH 95:5, flow rate 0.60 mL/min, λ = 214, 254 nm: 
τmajor = 14.63 min., τminor = 16.32 min. [α]rt
D= -41.3 (c = 2.00, CHCl3, 98% ee, dr=7.3:1). HRMS: 
(m/z) calculated for C25H37N3O5: 459.2733, found: 459.2734. 
1H NMR (600 MHz, CHCl3 -30°C): 
sum of rotamer (a+b) δ 0.54 (m, 6H, J= 7.2 Hz) (a+b), 1.31 (bs, 9H) (a), 1.41 (s, 9H) (b), 1.51 (s, 
9H) (a), 1.56 (s, 9H) (b), 1.85-2.13 (m, 4H) (a+b), 2.29 (s, 3H) (a), 2.31 (s, 3H) (b), 3.18-3.24 (m, 
2H,) (a+b), 5.22 (bs, 1H) (a), 5.35 (bs, 1H) (b), 6.98-7.15 (m, 4H) (a+b), 7.25-7.39 (m, 4H) (a+b), 
8.30 (bs, 1H) (a), 8.36 (bs, 1 H) (b), 9.62 (bs, 1H) (a), 9.75 (bs, 1H) (b) 13CNMR (150 MHz, CHCl3 -
30°C): δ 12.7 (CH3) (a+b),  13.4 (CH3) (a), 13.5 (CH3) (b), 20.1 (CH3) (a), 20.5 (CH3) (b), 22.1 (CH2) 
(a), 22.2 (CH2) (b), 28.3 (C (CH3)3) (a), 28.4 (C (CH3)3) (a), 28.4 (C (CH3)3) (b), 28.5 (C (CH3)3) (b), 
45.7 (CH) (a), 45.9 (CH) (b), 71.8 (C) (a), 71.9 (C) (b), 81.7 (C) (a), 81.12 (C) (b), 82.7 (C) (a), 82.7 
(C) (a), 108.2 (C) (a), 108.7 (C) (b), 111.6 (CH) (a), 111.7 (CH) (b), 117.8 (CH) (a), 118.2 (CH) (b), 
120.0 (CH) (a), 120.1 (CH) (b), 120.9 (CH) (a), 121.3 (CH) (b), 126.8 (C) (a), 127.1 (C) (b), 134. 6 
(CH) (a), 134.7 (CH) (b), 135.9 (C) (a), 136 (C) (b), 155.3 (C) (a), 155.8 (C) (b), 155.9 (C) (a), 156.2 
(C) (b), 198.3 (C) (a), 198.9 (C) (b). Additional peaks  and line broadenings are observed due to 
rotameric species. 
 
di-tert-butyl 1-(3-(1H-indol-3-yl)-2-methyl-1-oxopentan-2-
yl)hydrazine-1,2-dicarboxylate 5d. The reaction was carried out 
over 96 hours in CHCl3 at –10°C following the general procedure to 
furnish the crude product (d.r.= 3:1 was determined by integration of one set of 1H-NMR signal: 
δmajor 9.57 ppm bs, δminor 9.60 ppm bs). The title compound was isolated by flash column 
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chromatography (DCM/Ethyl Acetate, gradient from 98/2 to 95/5) in 51% yield as mixture of 
diastereosimers in 3:1 ratio. Major diastereoisomer ee = 94%;  minor diastereoisomer ee= 99%. 
The ee was determined by HPLC analysis on Daicel Chiralpak AD-H column: hexane/i-PrOH 9:1, 
flow rate 0.75 mL/min, λ = 214, 254 nm: Major diastereoisomer τmajor = 30. 62 min., τminor = 16.34 
min; minor diastereoisomer  τmajor = 20. 37 min., τminor = 10.03 min [α]rt
D= -25.4 (c = 1.10, CHCl3, 
94% ee, dr=3:1). HRMS: (m/z) calculated for C24H35N3O5: 445.2577, found: 445.2577. 
1H NMR 
(400 MHz, CHCl3 25°C): δ 0.62-0.69 (m, 3H), 1.34 (bs, 3H), 1.42 (bs, 9H), 1.43 (bs, 9H), 1.54-1.76 
(m, 1 H), 1.97-2.13 (m, 1H), 3.34 (dd, 1H, J1= 12.8 Hz, J2=2.8 Hz), 5.92 (bs, 1H), 6.98 (bs, 1H), 
7.00-7.24 (m, 2H), 7.29-7.45 (m, 1H), 7.50-7.66 (m, 1H) 8.37 (bd, J=13.7), 9.68 (bs, 1H). 13CNMR 
(100 MHz, CHCl3 25°C): δ 12.9 (CH3), 19.9 (CH3), 24.4 (C), 28.3 (C (CH3)3), 28.4 (C (CH3)3), 31.1 
(CH2), 45.0 (CH), 72.2 (C), 81.4 (C), 111.8 (CH), 114.8 (C), 119.3 (CH), 120.0 (CH), 122.3 (CH), 
122.4 (CH), 123.6 (C), 136.5 (C), 155.6, 198.6. Additional peaks  and line broadenings are 
observed due to rotameric species.  
 
di-tert-butyl 1-(3-(5-chloro-1H-indol-3-yl)-2-methyl-1-
oxopentan-2-yl)hydrazine-1,2-dicarboxylate 5e. The reaction 
was carried out over 65 hours in CHCl3 at 0°C following the 
general procedure to furnish the crude product (d.r.= 4:1 was 
determined by integration of one set of 1H-NMR signal: δmajor 9.65 ppm bs, δminor 9.60 ppm bs). 
The title compound was isolated by flash column chromatography (DCM/Et2O, gradient from 
98/2 to 95/5) in 43% yield as mixture of diastereoisomers in 3:1 ratio and 91% ee (major 
diastereoismer). The ee was determined by HPLC analysis on a Daicel Chiralcel OD-H column: 
hexane/i-PrOH 95:5, flow rate 0.3 mL/min, λ = 214, 254 nm: τmajor = 41.84 min., τminor = 37.9 min. 
[α]rt
D= -15.1 (c = 0.6, CHCl3, 91% ee, dr=3:1). 
1H NMR (400 MHz, CHCl3 25°C): Major 
diastereoisomer, major rotamer δ 0.64 (t, 3H, J=7.3 Hz), 1.44-1.45 (19H), 2.00-2.15 (m, 1H), 
3.25 (d, 1H, J=11.4 Hz), 5.81 (bs, 1H), 7.01 (bs, 1H), 7.15-7.19 (m, 2H), 7.30-7.34 (m, 1H), 7.54 
(bs, 1H), 8.24 (bs, 1H), 9.66 (bs, 1H). 13CNMR (125 MHz, CHCl3 -20°C): sum of diastereoisomer 
and rotamers: δ 13.0, 13.4, 19.8, 25.5, 28.2, 28.3, 28.4, 30.1, 30.5, 31.6, 81.8, 82.3, 82.9, 83.1, 
113.0, 118.5, 118.8, 122.6, 122.8, 123.11, 125.6, 125.8, 125.9, 126.1, 155.2, 155.6, 155.8, 155.9, 
197.8, 198.2, 198.9, 199.1.  
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di-tert-butyl 1-(3-(5-methoxy-1H-indol-3-yl)-2-methyl-1-
oxopentan-2-yl)hydrazine-1,2-dicarboxylate 5f. The reaction 
was carried out over 96 hours in CHCl3 at -10°C following the 
general procedure to furnish the crude product (d.r.= 3:1 was 
determined by integration of one set of 1H-NMR signal: δmajor 9.65 ppm, bs, δminor 9.61 ppm, bs). 
The title compound was isolated by flash column chromatography (DCM/Et2O = 98/2) in 54% 
yield as mixture of diastereoisomers in 3:1 ratio.  Major diastereoisomer ee=96% ; minor 
diastereoisomer ee= 99%. The ee was determined by HPLC analysis on a Daicel Chiralpack AD-H 
column: hexane/i-PrOH 9:1, flow rate 0.75 mL/min, λ = 214, 254 nm: Major diastereoisomer 
τmajor = 38.96 min., τminor = 19.43 min. [α]rt
D= -15.5 (c = 1.02, CHCl3, 96% ee, dr= 3:1). HRMS: (m/z) 
calculated for C25H37N3O6: 475.2682, found: 475.2682. Major diastereoisomer, major rotamer 
1H NMR (600 MHz, CHCl3 -30°C): δ 0.64 (m, 3H), 1.40-1.52 (m, 21H), 2.01-2.14 (m, 2 H), 3.29 (d, 
1H, J= 11.3 Hz), 3.91 (s, 3H), 6.44 (bs, 1H), 6.84-7.01 (m, 3H), 7.25-7.36 (m, 1H), 7.50-7.66 (m, 
1H) 8.64 (bs, 1H), 9.69 (bs, 1H). 13CNMR (125 MHz, CHCl3 -30°C): δ 12.7 (CH3), 19.2 (CH3), 25.5 
(CH2), 27.9 (C (CH3)3), 28.1 (C (CH3)3), 31.1 (CH2), 44.8 (CH), 55.9 (CH3), 71.8 (C), 81.7 (C), 82.4 
(C), 100.7 (CH),  112.0 (CH), 112.3 (CH), 114.1 (CH), 124.1 (CH), 128.2 (C), 131.4 (CH), 131.7 
(CH), 154.3 (C), 155.3 (C), 155.7 (C), 198.6 (C). Additional peaks  and line broadenings are 
observed due to rotameric species. 
 
di-tert-butyl1-(2-methyl-3-(5-methyl-1H-indol-3-yl)-1-oxopentan-
2 yl)hydrazine-1,2-dicarboxylate 5g. The reaction was carried out 
over 96 hours in CHCl3 at -10°C following the general procedure to 
furnish the crude product (d.r.= 3:1 was determined by 
integration of one set of 1H-NMR signal: δmajor 9.67 ppm, bs, δminor 9.65 ppm, bs). The title 
compound was isolated by flash column chromatography (DCM/Et2O = 98/2) in 47% yield as 
mixture of diastereoisomers in 3:1 ratio.  Major diastereoisomer ee=91% ; minor 
diastereoisomer ee= 99%. The ee was determined by HPLC analysis on a Daicel Chiralpack AD-
H column: hexane/i-PrOH 9:1, flow rate 0.75 mL/min, λ = 214, 254 nm: Major diastereoisomer 
τmajor = 20.62 min., τminor = 12.36 min. [α]rt
D= -18.3 (c = 1.02, CHCl3, 91% ee, dr= 3:1). Major 
diastereoisomer, major rotamer 1H NMR (600 MHz, CHCl3 25°C): δ 0.68 (m, 3H), 1.38-1.52 (m, 
22H), 2.02-2.17 (m, 1 H), 2.51 (s, 3H), 3.32 (d, 1H, J1= 12.1 Hz), 5.99 (bs, 1H), 6.95 (bs, 1H), 7.01-
7.09 (m, 1H), 7.28-7.41 (m, 2H), 8.30 (bs, 1H), 9.71 (bs, 1H). 13CNMR (125 MHz, CHCl3 25°C): δ 
12.9 (CH3), 19.9 (CH3), 24.5 (CH2), 28.3 (C (CH3)3), 45.0 (CH), 72.0 (C), 81.3 (C),82.3 (C), 111.3 
(CH), 111.7 (CH), 118.7 (C), 119.0 (C), 123.7 (CH), 123.9 (CH), 129.2 (C), 134.8 (C), 155.5 (C), 
198.7 (C). Additional peaks  and line broadenings are observed due to rotameric species. 
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General procedure for the asymmetric organocatalytic sulpha-Michael/amination tandem 
sequence of α−substituted α,β−unsaturated aldehydes. 
 
 
All the reactions were carried out in undistilled chloroform or toluene. In an ordinary vial 
equipped with a Teflon-coated stir bar, 9-Amino(9-deoxy)epi-hydroquinine A (0.04 mmol, 200 
μL of a 0.2 M CHCl3 solution, 20 mol%) was added to 200 μL of solvent. After the addition of TFA 
(0.06 mmol, 5 μL, 30 mol%), the solution was stirred for 5 minutes at room temperature before 
adding the α-substituted enal 2 (0.2 mmol). The mixture was then allowed to stir for further 5 
minutes at room temperature before the addition of thiol (0.24 mmol, 1.2 equiv.) and then 
stirred at the indicated temperature. After 5 minutes, azodicarboxylate (0.3 mmol, 1.5 equiv.) 
was added and stirring continued for the indicated time. The crude reaction mixture was 
diluted with CH2Cl2 (1 mL) and flushed through a short plug of silica, using CH2Cl2/AcOEt 1/1 as 
the eluent. Solvent was removed in vacuo and the residue was purified by flash 
chromatography to yield the desired product.  
 
General procedure for the reduction and cyclization to form oxazolidinones. 
The crude reaction mixture (0.2 mmol scale referred to aldehyde) was diluted with MeOH (2 
mL) and  cooled to 0°C before the addition of NaBH4 (0.6 mmol, 3 equiv.) After 10 minutes, 2 M 
solution of NaOH (2 mL) and THF (2 mL) were successively added and the crude reaction 
mixture was stirred for 2 hours. After standard aqueous work-up, the product was purified by 
flash-chromatography on silica gel. 
di-tert-butyl 1-((2R,3S)-3-(tert-butylthio)-2-methyl-1-oxopentan-2-
yl)hydrazine-1,2-dicarboxylate 7a. The reaction was carried out over 65 
hours in CHCl3 at 0°C following the general procedure to furnish the crude 
product (d.r.= 6.5:1, determined by integration of one set of 1H-NMR signals: 
δmajor 3.03 ppm d, δminor 3.29 ppm d). The title compound was isolated by flash column 
chromatography (hexane/diethyl ether = 9/1) in 54% yield as single diastereoisomer and > 99% 
ee. The ee was determined by HPLC analysis on a Daicel Chiralpak AD-H column: hexane/i-
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PrOH 98:2, flow rate 0.75 mL/min, λ = 214, 254 nm: τmajor = 19.74 min., τminor = 14.95 min. [α]rt
D= 
+ 5.3 (c = 1.16, CHCl3, > 99% ee). HRMS: (m/z) calculated for C20H38N2O5S: 418.2501, found: 
418.2502. 1H NMR (600 MHz, CDCl3 -20°C): Major rotamer δ 1.02 (t, 3H, J = 6.65 Hz), 1.31 (s, 
9H), 1.40-1.42 (9H), 1.44 (bs, 3H), 1.46 (s, 9H+1H), 2.03 (bs, 1H), 2.95 (d, 1H, J = 8.4 Hz), 6.42 (s, 
1H), 9.65 (s, 1H). 13CNMR (150 MHz, CDCl3 -20°C): δ 13.1 (CH3), 19.8 (CH3), 26.5 (CH2), 28.2 
(C(CH3)3), 28.5 (C(CH3)3), 32.5 (C (CH3)3), 44.2 (CH), 51.8 (C), 72.2 (C), 81.7 (C), 82.7 (C), 155.4 
(C), 155.6 (C), 197.9 (C). Additional peaks and line broadenings are observed due to rotameric 
species. 
 
 
di-tert-butyl1-(3-(benzylthio)-2-methyl-1-oxopentan-2-yl)hydrazine-1,2-
dicarboxylate 7b. The reaction was carried out over 65 hours in toluene 
at –20°C following the general procedure to furnish the crude product 
(d.r.= 6:1 was determined by integration of one set of 1H-NMR signal: δmajor 9.50 ppm bs, δminor 
9.73 ppm bs). The title compound was isolated by flash column chromatography 
(hexane/acetone = 97/3) in 27% yield as single diastereoisomer and 89% ee. The ee was 
determined by HPLC analysis on a Daicel Chiralcel OD-H column: hexane/i-PrOH 98:2, flow rate 
0.75 mL/min, λ = 214, 254 nm: τmajor = 10.09 min., τminor = 8.46 min. [α]rt
D= - 3.2 (c = 1.16, CHCl3, 
89% ee). HRMS: (m/z) calculated for C23H36N2O5S: 452.2346, found: 452.2345. 
1H NMR (600 
MHz, CDCl3 -30°C): Major rotamer δ 0.93 (t, 3H, J = 7.30 Hz), 1.29 (s, 3H), 1.39 (s, 9H), 1.44 (bs, 
9H+1H), 1.87 (bs, 1H), 2.69 (d, 1H, J = 9.9 Hz), 3.67-3.74 (m, 2H), 6.1 (bs, 1H), 7.26-7.32 (m, 5 
H), 9.50 (bs, 1 H). 13CNMR (150 MHz, CDCl3 -30°C): δ 12.9 (CH3), 19.1 (CH3), 25.4 (CH2), 28.3 
(C(CH3)3), 28.4 (C(CH3)3), 38.7 (CH2), 53.8 (CH), 72.3 (C), 81.8 (C), 83.0 (C), 127.7 (CH), 129.0 
(CH), 138.2 (C), 155.5 (C), 155.6(C), 196.3 (C). Additional peaks and line broadenings are 
observed due to rotameric species.  
 
di-tert-butyl-1-(4-(benzylthio)-3-formylheptan-3-yl)hydrazine-1,2-
dicarboxylate 7c. The reaction was carried out over 48 hours in CHCl3 at 
40°C following the general procedure to furnish the crude product (d.r.= 
4:1 was determined by integration of one set of 1H-NMR signal: δmajor 3.09 
ppm. d, δminor 3.41 ppm. d). The title compound was isolated by flash column chromatography 
(hexane/acetone = 95/5) in 45% yield as mixture of diastereoisomers in 4.5:1 ratio and 92% ee 
(major diastereoisomer). The ee was determined after reduction and cyclization to form 
oxazolidinone by HPLC analysis on a Daicel Chiralpak AD-H column: hexane/i-PrOH 9:1, flow 
rate 0.75 mL/min, λ = 214, 254 nm: τmajor = 11.23 min., τminor = 8.37 min. [α]rt
D= + 1.5 (c = 1.02, 
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CHCl3, 92% ee). HRMS: (m/z) calculated for C25H40N2O5S: 480.2658, found: 480.2658. 
1H NMR 
(400 MHz, CD3CN 60°C): Sum of rotamers (a+b) δ 0.80-0.98 (m, 6H), 1.29-1.38 (bs, 2H), 1.46 (s, 
9H), 1.50 (s, 9H), 1.59-1.91 (bs, 3H), 2.08-2.27 (bs, 2H), 3.14 (d, 1H, J = 7.86 Hz), 3.74-3.88 (m, 
2H), 7.27-7.36 (m, 5H), 9.47-9.56 (2 bs, 1H) 13CNMR (100 MHz, CD3CN 60°C): δ 13.2, 13.4, 20.1, 
24.8, 27.6, 27.8, 35.0, 38.7, 50.9, 75.1, 82.4, 127.3, 128.7, 129.2, 138.9, 155.8, 195.2. 
Additional peaks and line broadenings are observed due to rotameric species.  
 
tert-butyl 4-(1-(benzylthio)propyl)-2-oxo-4-phenyloxazolidin-3-ylcarbamate 
7d. The reaction was carried out over 48 hours in CHCl3 at 40°C following the 
general procedure to furnish the crude product (d.r.= 4:1 was determined by 
integration of one set of 1H-NMR signal: δmajor 10.37 ppm. bs, δminor 10.02 
ppm. bs). The crude reaction mixture was reduced and cyclized to form oxazolidinone 7d. The 
title compound was isolated by flash column chromatography (DCM/Et2O = 97/3) in 47% yield 
as single diastereoisomer and 92% ee. The ee was determined by HPLC analysis on a Daicel 
Chiralpak AD-H column: hexane/i-PrOH 9:1, flow rate 0.75 mL/min, λ = 214, 254 nm: τmajor = 
13.82 min., τminor = 12.73 min. [α]rt
D= + 88.0 (c = 1.10, CHCl3, 92% ee, dr=4.5:1). HRMS: (m/z) 
calculated for C24H30N2O4S: 442.1925, found: 442.1926. 
1H NMR (400 MHz, CD3CN 60°C): δ 0.96 
(t, 3H, J= 7.16), 1.3 (bs, 9H + 1H), 1.57 (bs, 1H), 3.39 (dd, 1H, J1= 9.85 Hz, J2=2.8 Hz), 3.87 (dA-B, 
1H, J=12.8), 3.92 (dA-B, 1H J=12.8 ), 4.53 (d, 1H, J=10.0), 4.81 (d, 1H, J =10.0 Hz), 6.43 (bs, 1H), 
7.32-7.47 (m, 10H) 13CNMR (100 MHz, CD3CN 60°C): δ 12.5, 26.9, 28.5, 39.1, 55.3, 69.8, 71.4, 
82.3, 127.6, 128.7, 129.4, 129.8, 130.0, 130.4, 139.7, 140.0, 155.5, 156.6.  
 
di-tert-butyl-1-(1-(tert-butylthio)-2-methyl-3-oxo-1-phenylpropan-2-
yl)hydrazine-1,2-dicarboxylate 7e. The reaction was carried out over 48 
hours in CHCl3 at 40°C following the general procedure to furnish the crude 
product (d.r.= 20:1 was determined by integration of one set of 1H-NMR 
signal: δmajor 9.81 ppm. bs, δminor 9.59 ppm). The title compound was isolated by flash column 
chromatography (DCM/Et2O = 98/2) in 40% yield as a single diastereoisomer and 99% ee. The 
ee was determined by HPLC analysis on a Daicel Chiralcel OD-H column: hexane/i-PrOH 98:2, 
flow rate 0.75 mL/min, λ = 214, 254 nm: τmajor = 6.06 min., τminor = 5.50 min. [α]rt
D= + 38.9 (c = 
1.10, CHCl3, 99% ee). HRMS: (m/z) calculated for C24H38N2O5S: 466.2502, found: 466.2501. 
1H 
NMR (600 MHz, CDCl3 -20°C): Major diastereoisomer, sum of rotamers (a+b) δ 1.16 (a)-1.17 (b) 
(s, 9H), 1.22 (a)-1.26 (b) (s, 3H), 1.40 (s, 9H) (a),1.44 (s, 9H) (b), 4.39 (a)- 4.94 (b) (bs, 1 H), 4.67 
(a)- 4.70 (b) (bs,1 H), 7.26-7.37 (m, 5 H), 9.79 (a)- 9.81 (b) (bs, 1H). 13CNMR (100 MHz, CDCl3 -
20°C): δ 16.2 (a)-16.5 (b) (CH3), 28.2 (C(CH3)3), 28.3 (C(CH3)3), 31.4 (a)-31.5 (b) (C(CH3)3), 45.0 
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(a)-45.1 (b) (C), 48.2 (a)- 48.8 (b) (CH), 69.7 (a)-70.2 (b) (C), 81.6 (a)-81.9 (b) (C), 82.7 (a)-82.8 
(b) (C), 127.8-128.2 (CH), 128.6- 128.8 (CH), 129.5-129.7 (CH), 140.4 (a)-140.6 (b) (C), 154.8 (a)-
154.9 (b) (C), 155.0 (a)- 155.3 (b) (C), 197.0 (a)-197.1(b) (C). Additional peaks and line 
broadenings are observed due to rotameric species. 
 
tert-butyl (5S,6R)-6-(tert-butylthio)-2-oxo-3-oxa-1-azaspiro[4.5]decan-1-
ylcarbamate 8a. The reaction was carried out over 65 hours in CHCl3 at 10°C 
following the general procedure to furnish the crude product. The crude 
reaction mixture was reduced and cyclized to form oxazolidinone 8a (d.r.= 
8:1 was determined by integration of one set of 1H-NMR signal: δmajor 1.35 ppm s, δminor 1.31 
ppm s). The title compound was isolated by flash column chromatography (DCM/Et2O = 95/5) 
in 40% yield as single diastereoisomer and > 99% ee. The ee was determined by HPLC analysis 
on a Daicel Chiralcel OD-H column: hexane/i-PrOH 98:2, flow rate 0.75 mL/min, λ = 214, 254 
nm: τmajor = 21.13 min., τminor = 31.87 min. [α]rt
D= + 20.3 (c = 0.98, CHCl3, > 99% ee). HRMS: (m/z) 
calculated for C17H30N2O4S: 358.1925, found: 358.1926. 
1H NMR (400 MHz, CDCl3 25°C): δ 1.18-
1.31 (m, 3H), 1.36 (s, 9H), 1.49 (s, 9H), 1.65-1.83 (m, 3H), 1.98-2.09 (m, 1 H), 2.15-2.23 (m, 1H), 
2.75 (dd, 1H, J1 =12.4 Hz, J2 =3.7 Hz), 4.10 (dA-B, 1H, J=9.07 Hz), 4.27 (dA-B, 1H, J=9.07 Hz), 6.02 
(bs, 1H) 13CNMR (100 MHz, CDCl3 20°C): δ 22.5 (CH2),  25.9 (CH2), 28.3 (C(CH3)3), 32.2 (C(CH3)3), 
34.9 (CH2), 36.8 (CH2), 44.4 (C), 46.0 (CH), 64.2 (C), 69.4 (CH2), 82.7 (C), 155.6 (C), 156.8 (C). 
 
Determination of the Relative and Absolute Configuration  
Compound 7a.  
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The absolute configuration of compound 7a was assigned to be (2S,3R) by anomalous 
dispersion X-ray crystallographic analysis of the corresponding oxazolidinone derivative 9. All 
the other relative and absolute configurations for both compound classes 5 and 7 were 
assigned by analogy, considering an uniform mechanistic pathway. 
 
General procedure for formation of compound  9 
To a solution of 1-bromonaphtalene (1.5 mmol, 2 equiv. compared to compound 7a) in dry THF 
(4 mL), n-BuLi (1 mL, 1.6 M in Hexane) was added slowly at – 78°C. After stirring at this 
temperature for 15 minutes, a solution of 7a (0.75 mmol) in 1 mL of THF was added. The 
mixture was warmed to ambient temperature and allowed to stir for further 15 minutes. An 
aqueous work-up with NH4Cl and extraction with Et2O furnished the crude product 9a. The pure 
compound was isolated by flash cromatography (Hex: Et2O = 8:2), followed by HPLC purification 
on a C18 Column (acetonitrile/H2O 90:10 v/v). 
 
tert-butyl 4-(1-(tert-butylthio)propyl)-4-methyl-5-(naphthalen-1-yl)-2-
oxooxazolidin-3-ylcarbamate 9. 
1H NMR (600 MHz, CD3CN 50°C): δ 0.84 (s, 
3H), 1.25 (t, 3H, J= 7.2 Hz), 1.41 (s, 9H), 1.45 (s, 9H), 1.58-1.67 (bs, 1 H), 
2.10-2.17 (bs, 1H), 3.01 (dd, 1H, J1 = 6.07 Hz, J2 = 2.7 Hz), 6.57 (bs, 1H), 
7.56-7.65 (m, 4H), 7.94-7.99 (m, 2H), 8.43 (bs, 1H). 13CNMR (125 MHz, CD3CN 50°C): δ 0.8 
(CH3),  12.6 (CH3, bs),  25.7 (CH2), 27.6 (C(CH3)3), 31.7 (C(CH3)3), 44.4 (C), 54.6 (CH), 68.6 (C), 
80.0 (C), 81.6 (C bs), 123.6 (CH), 125.3 (CH), 125.5 (CH), 126.2 (CH), 126.7 (CH), 129.2 (CH), 
129.3 (CH), 131.3 (C), 133.1 (C), 133.8 (C), 155.2 (C), 155.7 (C). 
 
Crystal Data for compound 9 
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Crystals were obtained from hexane/Et2O solution by slow evaporation. Molecular formula: 
C26H36N2O4S, Mr = 472.63, Orthorhombic, space group P212121 (No. 14), a = 10.9758(9), b = 
23.5089(16), c = 23.7659(19), V = 6132.3(9) Å3, T = 298(2) °K, Z = 8, ρc = 1.024 g cm–3, F(000) = 
2032, graphite-monochromated MoKα radiation (λ = 0.71073 Å), µ(MoKα) = 0.133 mm–1, 
colourless brick (0.4 × 0.2 × 0.2 mm3), empirical absorption correction with SADABS 
(transmission factors: 0.9738 – 0.9486), 2400 frames, exposure time 20 s, 2.04 ≤ θ ≤ 26.00, –
13≤ h ≤ 13, –29 ≤ k ≤ 29, –29 ≤ l ≤ 29, 46587 reflections collected, 9815 independent reflections 
(Rint = 0.0466), solution by direct methods (SHELXS97) and subsequent Fourier syntheses, full-
matrix least-squares on Fo
2 (SHELX97), hydrogen atoms refined with a riding model, data / 
restraints / parameters = 9815/ 0 / 608, S(F2) = 1.041, R(F) = 0.0862 and wR(F2) = 0.1771 on all 
data, R(F) = 0.0676 and wR(F2) = 0.1639 for 7349 reflections with F0 > 4σ( F0), weighting 
scheme w = 1/[σ2(Fo
2) + (0.1132P)2 + 0.000P] where P = (Fo
2 + 2Fc
2)/3, largest difference peak 
and hole 0.499 and –0.297 e Å–3. Flack parametera: 0.05(8). The asymmetric unit contains two 
independent molecules. Crystallographic data (excluding structure factors) for the structure 
reported in this paper have been deposited with the Cambridge Crystallographic Data Centre 
as supplementary publication no. CCDC-XXXXXX. Copies of the data can be obtained free of 
charge on application to CCDC, 12 Union Road, Cambridge CB21EZ, UK (fax: (+44) 1223-336-
033; e-mail: deposit@ccdc.cam.ac.uk). 
a Flack, H. D. Acta Cryst. 1983, A39, 876-881 
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General procedure for N-Boc deprotection of compound 8a 
 
The Boc-oxazolidinone 8a (20 mg, 0.056 mmol) was dissolved in a solution of 1 M HCl in diethyl 
ether (4 mL) and stirred at room temperature for 3 h. The reaction was concentrated under a 
stream of N2. The residue was dissolved in EtOAc and washed with saturated aqueous NaHCO3 
(2x) and brine, dried over MgSO4 and concentrated to give a pale yellow solid. The resulted 
crude mixture was then purified by flash cromatography ( hexane/ EtOAc 6/4) to give 
compound 8b as a white solid. 
 
(5S,6R)-1-amino-6-(tert-butylthio)-3-oxa-1-azaspiro[4.5]decan-2-one 8b. 
ESI: [M+Na]+ 281. 1H NMR (600 MHz, CDCl3): δ 1.97-1.31 (m, 2H), 1.34 (s, 9H), 
1.36-1.45 (m, 1H), 1.65-1.80 (m, 3H), 1.88-1.97 (m, 1H), 2.15-2.20 (bs, 1H), 
2.91 (dd,1 H, J1=12.7 Hz, J2= 4.2 Hz), 3.67 (bs, 2 H), 3.96 (dA-B, 1H, J=9.1 Hz), 
4.19 (dA-B, 1H, J=9.1 Hz). 
13CNMR (100 MHz, CDCl3): δ 22.6 (CH2),  26.1 (CH2), 
32.2 (C(CH3)3), 35.2 (CH2), 35.9 (CH2), 44.2 (C), 45.6 (CH), 64.1 (C), 68.9 (CH2), 159.0 (C). 
 
Relative Configuration Absolute Configuration of 8a and 8b 
In the case of compound 7, a different stereochemical outcome for the organocascade might 
be envisaged, due to the use of a cyclic aldehyde. The steric interactions in the active iminium 
ion (formed with catalyst 1) might determine a different face shielding. Thus, an independent 
determination of the relative and absolute configuration is required. Unfortunately, despite 
several attempts, in this case we did not obtain suitable crystals. However, due to the low 
conformational freedom, the absolute configuration of compound 8a (derived by reduction-
cyclization sequence directly from 7) and its derivative 8b can be assigned by means of a 
combined use of NMR spectroscopy, chiroptical methods and quantum-mechanical 
calculations.  
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Figure S1: DPFGSE-NOE spectra obtained for 8a. trace a): control spectrum; trace b): NOE 
spectrum obtained on saturation of H-2; traces c) and d): NOE spectra obtained on 
saturation of the two diastereotopic hydrogens H7’ and H7”. Observed NOE (blue) are 
indicated as arrows in the DFT optimized structure (the hydrogen atoms of the t-butyl groups 
have been removed for clarity) 
 
 
Full assignment of 1H and 13C NMR signals of 8a was obtained by HSQC and HMBC bi-
dimensional sequences. For 8a, NOE spectra were acquired in order to establish the relative 
stereochemistry of the two stereogenic centres (Figure S1). 
In particular, saturation of the H-2 signal(trace b) showed nearly equivalent NOE effects on the 
H-3’, H-6’, H-4’ hydrogens, and on the t-butyl signal. These NOE constraints imply that H-2 is in 
the axial position of the cyclohexane ring, and that H-3 lies on the opposite sides of the ring 
with respect to the CH2 in position 7. This relationship is confirmed when the signals of the two 
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diastereotopic protons belonging to C-7 are saturated (traces c and d). On saturation of H-7’ 
NOE effects are observed on H-6” and H-5”, whereas on saturation of H-7” a significant 
enhancement is observed only for the signal of H3”, being the equatorial position of C-2 
occupied by the sulphur atom. The relative stereochemistry is therefore trans (i.e. 1R*2S*), 
and the DFT calculated structure6 matches very well the experimental NOE ratios. It is worth 
mentioning that the relative stereochemistry is the same determined by X-ray analysis for 
compound 7a. 
 
Conformational analysis and absolute configuration determination. 
Compounds 8a and 8b are viscous oils, therefore the use of the Bijovet method, based 
on anomalous X-ray dispersion, to unambiguously assign the absolute configuration 
(AC) is precluded. Recently, the determination of the absolute configurations (ACs) of 
chiral molecules using the chiroptical techniques of optical rotation (OR), electronic 
circular dichroism (ECD), and vibrational circular dichroism (VCD) has been 
revolutionized by the development of density functional theory (DFT) methods for the 
prediction of these properties. In the present case, theoretical calculation of ECD 
spectra and optical rotation was carried out by means of TD-DFT method, since this 
technique has been successfully employed several times to predict ECD spectra and to 
assign the AC of organic molecules79. It is worth to note that the relative 
stereochemistry has been already fixed by the NOE analysis, therefore only the 
conformation of the molecule can modify the shape of the ECD spectrum. 
Compound 8b, in which the Boc protecting group was removed, was considered more 
suitable for the following analysis because the presence of the protecting group in 8a 
increases the conformational freedom of the compound, thus complicating the 
conformational analysis. A preliminary conformational search, starting from the 
relative configuration derived from NOE spectra, has been carried out using Monte 
Carlo searching together with the MMFF94 molecular mechanics force field (as 
implemented in Titan 1.0.5). Due to the rigidity of the two fused rings, the 
conformational freedom is very low, and limited to the position of the t-butyl group. 
All the conformations yielded by MM within a 5 kcal/mol window were then optimized 
using DFT at the B3LYP/6-31G(d) level, and the harmonic vibrational frequencies of 
each conformation were calculated at the same level to confirm their stability (no 
imaginary frequencies observed), and to evaluate the free energy of each 
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conformation. After DFT minimization, only one stable conformation was found. This 
structure is fully compatible with the experimental NOE data, in particular for the 
conformation of the exocyclic S-But moiety. Calculation of the Electronic Circular 
Dichroism spectrum was carried out using TD-DFT method at the B3LYP/6-
311++G(2d,p)//B3LYP/6-31G(d) level, and assuming 1S, 2R, absolute configuration80. 
Rotational strength were calculated in both length and velocity representation.  Since 
the resulting values are very similar, errors due to basis set incompleteness are very 
small.81 The ECD spectra was then obtained by applying a 0.25 eV Gaussian shaped line 
width (Figure S2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2. Top: calculated (red) and experimental (black) UV spectra of 8b. Bottom: 
experimental (black) and calculated ECD spectra (red), (the simulated spectrum has 
been red-shifted by 6 nm). Molecular CD (Δε) is expressed in L mol-1cm-1. 
Concentration in acetonitrile was 2.05·10
-4
 M, and a 1 cm cell was used. 
 
The agreement between calculated and experimental spectra is whatever fairly good, 
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over the relatively limited spectral range of the experimental CD spectrum82, therefore 
the TD-DFT simulation supports the conclusion that the AC of 8b is 1S, 2R. This 
configuration is opposite to that obtained for 7a by X-ray analysis. 
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2.1.3. Asymmetric addition of oxindoles to α,β-unsaturated adehydes and ketones: 
aminocatalytic strategy for the costruction of chiral all-carbon quaternary 
stereocenters 
Discussion 
Nowadays the art and science of total synthesis reached an incredible levels of efficiency being 
oftenbecouse is an important  field where numerous chemists challenge each other.83 
Analysing a target molecule one of the most important point in which focus the attention is 
the presence of all-carbon quaternary stereocenters. This chiral motifs can be found not only 
in a wide range of important and useful compounds in pharmaceutical and medicinal contexts, 
but also in a large variety of natural products.84 The difficult in the forging this kind of 
stereogenic elements arise from the steric congestion imposed by the four attached carbon 
and the limited number of C-C bond forming reactions that reliably assemble quaternary chiral 
centers. The challenge is more captivating when this motif is adjacent to a chiral tertiary 
stereocenter or, continuing this line of thought, to a quaternary one. 
Although a number of elegant solutions have recently been devised for achieving this goal, 
certain types of reaction frameworks still present significant obstacles and provide platforms 
for novel catalyst design and innovation in synthetic methods. An important transformation 
that presents promising opportunities for setting quaternary stereocenters is the Michael 
reaction (Scheme 1). From its discover the Amminocatalisys85 setted up the conditions for the 
enantioselctive Michael addition to α,β-usaturated aldehydes providing their functionalization 
with a wide range of nucleophile. Its development was due to the high efficiency and 
generality demonstrated by some “privileged” organocatalysts such as MacMillan 
imidazolidinones2d (I) and the silyl-protected diarylprolinols catalysts (II)86 that have 
consolidated asymmetric aminocatalysis as a reliable and 
powerful synthetic tool for the chemo- and enantioselective functionalization of carbonyl 
compounds.  
Scheme 1: Challenging task in asymmetric iminuim ion activation of carbonyl compounds 
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Despite their great efficiency the privileged catalyst seem not able to address the problem of 
the d.r. control during the addition of prochiral disustituted and, in particular, trisubstituted 
carbon nucleophiles to the α,β-usaturated aldehydes (Scheme 2).87 
Scheme 2: Iminium ion activation of α,β-unsaturated aldehydes with privileged secondary 
amine catalyst. 
89 
 
N
H
N
Me
Me
Ph
O Me
N
H
Ar
Ar
OTMS
I II
R1R2
R3
R
N
R2R1
R3
R
N
*
O
R
*
R1
R3
R2
*
O
R
*
R2
R3
R1
nucleophile attack 
the iminium ion with 
its Re face
nucleophile attack 
the iminium ion with 
its Si face
 
This catalysts fix perfectly the attack face and the geometry of the iminium ion through non 
bond interactions as described in the previous chapter, but on the other hand they are not 
able to control the approach of the nucleophile, bearing the product with high 
enantioselctivity but with poor diasterocontrol. In this context, we investigated the 
unprecedented asymmetric conjugate addition of oxindoles to α,β-unsaturated aldehydes, 
which would readily give access to structurally complex oxindoles endowed with a quaternary 
stereogenic center at C3 adjacent a tertiary one.88,89 Chiral 3,3-disubstituted oxindole 
frameworks are attractive targets in organic synthesis because of their promising biological 
activities7a-b as well as wide-ranging utility as synthetic intermediates for alkaloids, drug 
candidates, and clinical pharmaceutical.7b-c For preliminary studies (reported in Table 1), we 
selected the reaction between 3-methyl oxindole 1a and cinnamaldehyde 2a.  
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Table 1: Optimization studies.[a] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[a] For additional studied additives and conditions, see the Supporting Information. DCA: 
dichloroacetic acid. [b] Determined by 1H NMR analysis of the crude mixture. [c] Determined 
by chiral HPLC analysis. [d] Reaction carried out at –10 °C in AcOEt as the solvent for 66 h.  [e] 
10 mol% of VIIa was employed. 
 
We first test the “privileged” secondary amines I and II as iminium catalysts for this challenging 
reaction (entries 1-2); their employment afforded poor results, whereas the silyl protected 
diarylprolinol II provided,  as expected, very high enantioselectivity, but complete absence of 
Entry catalysts additive (mol%)
 
[%] conv
[b] 
dr
[b] 
[%] ee
[c]
 
1 I DCA (20) 53 1.1:1 5 
2[d] II pNO2-C6H4CO2H (20) >95 1.1:1 92 
3 III pNO2-C6H4CO2H (20) >95 1:1 7 
4 IV pNO2-C6H4CO2H (20) 84 1:1 2 
5 Va pNO2-C6H4CO2H (20) 55 4.5:1 84 
6 Vb pNO2-C6H4CO2H (40) <5 - - 
7 Vc pNO2-C6H4CO2H (20) 20 1.2:1 40 
8 Va PhCO2H (20) 51 6:1 90 
9[e] Va PhCO2H (50) 35 7:1 90 
N
H
O
Me
Ph
CHO
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diastereocontrol, furnishing an almost 1:1 mixture of the two diastereoisomers. This evidence 
supports the lack of substrate-controlled stereoselectivity in the process.  
Interested by the recent studies on the ability of containing thiourea moiety- catalysts of 
inducing high stereocontrol through a cooperative mechanism, we hypothesized that the 
crucial factor to achieve a good diastereocontrol, while maintaining high level of 
enantioselectivity, might be the use of a bifunctional catalyst capable to synergistically arrange 
and activate both the reagents, enforcing high diastereocontrol during the C-C bond forming 
event. Encouraged by the proved ability of primary amine thiourea catalysts in a variety of 
enamine-based transformations,90 we sought to extend the potential application of this 
catalyst architecture also in iminium activation91 of simple α,β-unsaturated aldehydes.92 We 
then performed an extensive screening of chiral primary amines incorporating a thiourea 
framework, which led to the identification of Va as a promising iminium catalyst.  
The new catalyst Va, readily synthesized from commercially available compounds through a 
one-step procedure,93 was able to induce high level of stereocontrol with good catalytic 
activity (entry 5). Moreover, the poor catalytic performance and the very low selectivity 
observed with Vb and Vc suggested a critical role of the thiourea moiety during the 
stereoselective C-C bong forming step (entries 6 and 7). Further optimization experiments 
revealed that both the nature and the amount of the acidic additive were the crucial 
parameters to obtain high levels of stereoselectivity and reaction efficiency. 
By using 50 mol% of benzoic acid,94 it was possible to reduce the catalyst loading to 10 mol%, 
still maintaining high diastereo- and enantio-control and significant reactivity (entry 9). The 
scope of the conjugate addition of oxindoles to enals under the optimized conditions, thus 
using as catalytic salt 10 mol% of chiral primary amine thiourea Va and 50% of benzoic acid in 
toluene 0.5M at room temperature, is as summarized in Table 2. 
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Table 2: Diastereo- and enantio-selective conjugate addition of oxindoles to enals catalyzed by 
VIIa.[a] 
 
 
 
 
 
Entry R
1
, R
2
 Ar 3 [%] yield
[b] 
dr
[c] 
[%] ee
[d]
 
1 Me, H Ph a 71 7:1 90 
2 Bn, H Ph b 80 (73) 7:1 92 (>99) 
3[e] Butyl, H Ph c 65 5:1 73 
4 Bn, Me Ph d 55 5:1 81 
5 Me, H pNO2-C6H4 e 70 (56) 7.5:1 88 (>99) 
6[e] Bn, H pNO2-C6H4 f 52 (47) 11.5:1 93 
7 Bn, H pCl-C6H4 g 85 (77) 5.7:1 85 (97) 
8[e] Bn, H pCN-C6H4 h 56 12:1 83 
9[e] Me, H Naphthyl i 71 13.2:1 80 
10[e] Bn, H Naphthyl j 55 (49) >19:1 89 (>99) 
[a] Unless noted, the reactions were carried out on a 0.2 mmol scale with 1.5 equiv of 2 and 
[1]0 = 0.5 M in toluene for 5 days in the presence of 10 mol% of VIIa and 50 mol% of PhCO2H. 
[b] Isolated yield (sum of diastereomers). When possible, the two diastereoisomers were 
separated: the yield of the single major diastereomer is given in brackets. [c] Determined by 1H 
NMR of the crude mixture. [d] Determined by chiral HPLC analysis. In brackets are reported the 
ee obtained after a single crystallization. [e] ee determined on the corresponding alcohols 
after reduction with NaBH4. 
 
As shown, different combinations of substituted oxindoles and a variety of aldehydes are 
suitable substrates for the reaction, affording high enantioselectivity and good 
diastereoselectivity.95 These results are in sharp contrast with the very low diastereocontrol 
(dr’s from 1:1 to 2:1) obtained in the same process by using II as the iminium catalyst (see 
Supplementary Information for details). Importantly, by using bifunctional catalyst Va the main 
diastereoisomer can be isolated by column chromatography in many cases (entries 2, 5-7 and 
N
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Ar
CHO
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+
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*
*1 2 3
R2
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10). This observation, taken together with the possibility to obtain a single diastereomer in 
almost enantiopure form after a single crystallization (entries 2, 5, 7 and 10), renders this novel 
catalytic system a useful synthetic route to valuable chiral scaffolds with contiguous 
quaternary and tertiary stereocenters. 
The best combination of substrates for the transformation, in terms of diastereocontrol, was 
observed for enals bearing a naphthyl β-substituent (up to 19:1 dr, entries 9 and 10) and by 
using oxindole having a benzyl substituent. Unfortunately only the aromatic aldehydes 
undergo to the Michael addition of 3-substituted oxindoles under this reaction condition. The 
relative and absolute configuration of compound 3e was determined to be (3S,3’R) by 
anomalous dispersion X-ray crystallography of the corresponding tosylated alcohol 4, obtained 
by simple aldehyde reduction (Scheme 3).96 
Scheme 3: X-ray structure of toluene-4-sulfonic acid (S)-3-((R)-3-methyl-2-oxo-2,3-dihydro-1H-
indol-3-yl)-3-(4-nitro-phenyl)-propyl ester 4. 
 
 
 
 
 
 
 
 
As previously discussed, we suggested a simultaneously activation of both reagents partners 
by the bifunctional catalyst to explain the improved stereoselectivity of the reaction compared 
to the “privileged” chiral amines-catalyzed reaction. Generally the stereoselective one-step 
construction of highly congested products such as 3 is dependent on the capability of the 
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catalyst to simultaneously activate the Michael donor and the acceptor while orienting them 
by means of a network of H-bond interactions. Thus, we performed a series of probe 
experiments with the aim of confirm our hypothesis. Modifications of the catalyst scaffold 
revealed that the presence of the primary amine97 as well as the thiourea group play an active 
role during the catalysis (compare entries 6-8 in Table 1). To gain some insight into the 
substrate-catalyst interactions, we run the reaction using catalyst VIIa in combination with 50 
mol% of PhCO2H, cinnamaldehyde 2a and the N-methyl oxindole as the nucleophile.
98 The very 
poor reactivity and selectivity observed (less than 10% conversion after 5 days, 1.4:1 dr) 
strongly suggest a direct interactions of the amidic nitrogen in the nucleophilic component 
with the catalyst. These experiments suggested that a plausible bifunctional activation mode 
of the chiral primary amine thiourea Va could be possible, where the thiourea moiety activates 
the oxindole, stabilizing its enol form, and the primary amine activates the unsaturated 
aldehyde via iminium ion formation.99 
In summary, we demonstrated for the first time that a chiral primary amine thiourea catalyst, 
which during the last two years have been successfully applied in many enamine-based 
asymmetric transformations is also efficient for iminium ion activation of α,β-unsaturated 
aldehydes.  
The use of this catalyst furnished a solution to a longstanding problem in asymmetric 
synthesis: the formation of framework with quaternary stereocenters. Moreover using 
oxindoles as 3-substitued carbon nucleophiles we synthesized a chiral quaternary stereocenter 
adjacent to a tertiary one, affording functionalized oxindolic structure. This motif are 
contained in a wide range of compounds with potential biological activity and useful 
intermediates for other drug candidates. 
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With the aim of expand our previous studies in the iminium ion activation of α,β-unsatureted 
ketones we envisaged that the 9-Epi HQ-NH2
100 could promote efficiently the 4-addition of 3-
substituted oxindoles to β-enones101 (Scheme 4) this transformation as described before allow 
to the synthesis of densely β-functionalized carbonyl compounds contain a chiral quaternary 
stereocenter adjacent to a tertiary one. 
Scheme 4: Michael addition of oxindoles to α,β-unsaturated cyclic ketones activated by a 
primary amine catalyst 
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The proposed 1-4 addition of oxindoles to α,β-usaturated ketones was first evalutate using 
cyclohexen-2-one and a slight excess of 3-Benzil oxindoles in the presence of catalytic amount 
of primary amine catalyst as start point of our screening.  
Figure 1: The primary amine catalysts used within this study 
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Initial results showed that 20 mol% of catalyst A in combination with an acidic co-catalyst (40 
mol%) effectively promoted the reaction, furnishing the product with high enantioselectivity 
but moderate levels of relative stereocontrol (entry 1). All the attempts to improve the 
diastereoselectivity, either by lowering the reaction temperature or by using an external base 
to co-catalyze the process, did not reach useful synthetic standards (entries 2 and 3). 
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Table 3: Optimizzation studies of the Michael addition of oxindoles to cyclic ketones  
N
O
Bn
N
(R)
O
(S)
Bn
+
5a: R=H
5b: R=Boc 6a 7
R
O
catalyst (20 mol%)
acid (40 mol%)
O
R
toluene 0.2M
 
entry amine acid
b 
R ºC, h Conv (%)
c 
dr 
c 
ee (%)
d 
1 A p-NBA H rt,72 >95 2.4:1 80 (79) 
2 A p-NBA H 0, 72 32 3.5:1 91 (81) 
3e A p-NBA H 0,72 <5 - - 
4 A p-NBA Boc rt,24 >95 5.5:1 92 (89) 
5 C benzoic Boc 0,48 37 2.5:1 82 (91) 
6 A NBDP Boc rt,24 >95 4.2:1 93 (79) 
7 A benzoic Boc rt,24 >95 5.6:1 97 (84) 
8 A benzoic Boc 0,48 92 6.6:1 96 (93) 
9 f A benzoic Boc rt,24 >95 5.2:1 96 (84) 
[a] The reactions were carried out on a 0.1 mmol scale with 1.2 equiv of 1 and [2a]0 = 0.2 M in 
toluene.[b] Abbreviations: p-NBA, 4-nitrobenzoic acid; NBDP, N-Boc-D-phenylglycine.[c] 
Determined by 1H NMR analysis of the crude mixture.[d] Determined by HPLC analysis on chiral 
stationary phases. Numbers in parenthesis refer to the enantiomeric excess of the minor 
diastereoisomer.[e] Reaction carried out in the presence of 1.5 equiv of DABCO [f] 10 mol% of A 
and 20 mol% of benzoic acid was used  
 
Inspired by recent studies on the Michael addition of oxindoles to nitrostyrenes102 we focused 
on using N-Boc-protected oxindole 5b as the nucleophilic component. Surprisigly the reaction 
manifold was directed toward a more diastereo- and enantioselective path (entry 4). This was 
probably due to steric effects. Another effect of the Boc protection was, as expected, the 
lowering of the pKa of the oxindole103 and consequently an improvement of its reactivity.  
Running the reaction in the presence of multifunctional catalyst C, which in principle may 
simultaneously activate both the electrophilic and nucleophilic components, no improvements 
were observed (entry 5). Finally, by varying the acidic additives, we found that 10 mol% of the 
primary amine A in combination with benzoic acid (20 mol%) provided the best results, 
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efficiently catalyzing the process in toluene (0.2 M) at room temperature over 24 hours (5.2:1 
dr, 96% ee, entry 9), and we chose this condition as the optimal for further exploration. 
Experiments that probe the scope of the reaction are summarized in table 2. 
Table 2: Primary Amine-catalyzed Asymmetric Conjugate Addition of N-Boc Oxindoles to Cyclic 
Enonesa 
N
O
R1
N O
R1
6 7Boc
O A or B (10 mol%)
PhCO2H (20 mol%)
O
Boc
toluene 0.2M
RT / 24 hn
n
R2
R2
X
X
X
X
5
+
 
entry R
1
, R
2 
Cat n, X
 
3 Yield (%)
b 
dr 
c 
ee (%)
d 
1 Bn, H A 1, H 7a 80 5.2:1 96 
2 Bn, H B 1, H 7a 94 5.2:1 98 e 
3 Bn, H A 1, Me 7b 30 5.7:1 92 
4f,g Bn, H A 0, H 7c 55 5.5:1 46 
5g Bn, H A 2, H 7d 62 2.8:1 97 
6 Me, H A 1, H 7e 94 4:1 95 
7 Me, H B 1, H 7e 94 6:1 97 e 
8g Me, H A 2, H 7f 70 2.5:1 95 
9f Ph, H A 1, H 7g 95 1.6:1 98 
10 3Cl-PhCH2, Cl A 1, H 7h 85 4:1 94 
[a] The reactions were carried out at room temperature on a 0.2 mmol scale with 1.2 equiv of 
5 and [6]0 = 0.2 M in toluene. [b] Isolated yield (sum of diastereomers). [c] Determined by 
1H 
NMR analysis of the crude mixture. [d] Determined by HPLC analysis on chiral stationary 
phases. [e] The opposite enantiomer of 7 has been obtained. [f] Reaction at 0 ºC. [g] Reaction 
carried out in the presence of 20 mol% of the catalyst over 48 hours. 
 
Cyclohexen-2-one 6a gave the reaction product in both the enantiomers under the catalysis of 
the tow chiral amine A and B (entries 1 and 2, Table 4). In addition other cyclic enones proved 
to be suitable substrates. The use of the cyclohexenone bearing two methyl groups at the 5-
position led to the formation of product 7b with decreased yield but high stereocontrol (entry 
3). While 2-cycloheptenones afforded good results when reacted with oxindole 5b (entry 5), 2-
cyclopentenone followed a remarkably lower enantioselective path (entry 4). Oxindole with a 
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methyl substituent at the 3-position gave similar results in the conjugate additions (entries 6–
8). Using the more reactive 3-phenyl oxindole afforded almost perfect enantiocontrol, albeit at 
the expense of the relative stereochemistry (entry 9). 
To determine the relative and absolute configuration of the reaction products the keto-
oxindole 8 was deprotected and further converted to the N-Tos derivate 8 (Scheme 5).104 
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Interestingly, the presented organocatalytic method allowed the fast and highly 
stereoselective synthesis of 7h (entry 10, see also Figure 1), a compound which has shown 
promising biological properties as an anticancer agent and which has been patented by 
Hoffmann-La Roche recently. 
Figure 2: promising anti-cancer agent patented by Hoffmann-LaRoche105 
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Moreover we conduced also pioneering studies for the extension of this protocol to another 
class of heterocycle compound that had never been employed asymmetric catalytic conjugate 
additions.106 We tested the reaction of 3-benzyl benzofuranone 9 with cyclohexen-2-one 6a 
under the catalysis of amines A and B (Scheme 5). Notably, both the antipodes of the 
corresponding product 10 bearing a quaternary stereocenter were prepared with good 
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chemical yield and high enantioselectivity, even if the absence of the steric hinderance 
provided by the protecting group, has dramatic effects in the diastereocontrol of the reaction  
Scheme 6: Enantioselctive fictionalization of Benzoforannones with α,β-usaturated 
cyclohexanone 
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In summary, we have presented a novel and easy way to access densely functionalized 
molecules that contain vicinal quaternary and tertiary stereocenters..17 The research is based 
on the development of the first, highly stereoselective addition of oxindole to cyclic enones, 
using a readily available chiral primary amine catalyst. The utility of this reaction is related also 
at the synthesis in one step of a library of molecules that might exhibit biological activity. 
Concluding, we have extended this asymmetric organocatalytic transformation includding an 
unprecedented compounds class, benzofuranone derivatives. 
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Experimental Part 
 
 
General Methods. The 1H and 13C NMR spectra were recorded at 400 MHz and 100 MHz, 
respectively. The chemical shifts (δ) are referenced to residual signals of the solvents (CHCl3 – 
7.26 ppm for 1H NMR and 77.0 ppm for 13C NMR). Coupling constants are given in Hz. Carbon 
types were determined by DEPT 13C NMR experiments. The following abbreviations are used to 
indicate the multiplicity: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad 
signal. Purification of reaction products was carried out by flash chromatography (FC) on silica 
gel (230-400 mesh) according to the method of Still.xviii Organic solutions were concentrated 
under reduced pressure on a Büchi rotary evaporator. Mass spectra were obtained from the 
Department of Organic Chemistry “A. Mangini” Mass Spectroscopy facility. Optical rotations 
are reported as follows: [α]rtD (c in g per 100 mL, solvent). All reactions were carried out in air 
and using undistilled solvent, without any precautions to exclude moisture unless otherwise 
noted.  
 
Materials. Commercial grade reagents and solvents were used without further purification; 
otherwise, where necessary, they were purified as recommended.xix 3-methylindolin-2-one 1a, 
cinnamaldehyde 2a (E)-3-(4-nitrophenyl)acrylaldehyde, buthyllithium (1.6 M in hexane), 
indolin-2-one, benzylbromide, 5-methylindolin-2,3-dione, piperidine, 4-iodobenzonitrile, 1-
chloro-4-iodobenzene, 2-bromonaphthalene, (R)-(+)-1-(2-aminonaphthalen-1-yl)naphthalene-
2-amine Vb, 1-isothiocyanato-3,5-bis(trifluoromethyl)benzene were purchased from Aldrich 
and used as received. Chiral primary amine catalysts, 9-Amino(9-deoxy)epi-hydroquinine A, its 
pseudo-enantiomer 9-Amino(9-deoxy)epi-hydroquinidine B and 6’-hydroxy-9-amino-9-
deoxyepiquinine C and were prepared from commercially available hydroquinine, 
hydroquinidine and quinine, respectively, following the literature procedure.xx 2-Cyclohexen-1-
one 6a, 5,5-dimethyl-2-cyclohexen-1-one, 2-Cyclopenten-1-one, 2-Cyclohepten-1-one, 3-
Methyl-2-oxindole, 6-Chloro-2-oxindole, were purchased from Aldrich or Alfa Aesar and used 
                                                           
xviii
 W. C. Still, M. Kahn, A. J. Mitra, J. Org. Chem. 1978, 43, 2923.  
xix
 W. L. F. Armarengo, D. D. Perrin, In Purification of Laboratory Chemicals, 4th ed.; Butterworth 
Heinemann: Oxford, 1996. 
xx
 (a) S. H.; McCooey, S. J.; Connon. Org. Lett. 2007, 9, 599-602; (b) Chen, W.; Du, W.; Duan, Y.-Z.; 
Wu, Y.; Yang, S.-Y.; Chen, Y.-C. Angew. Chem. Int. Ed. 2007, 46, 7667 –7670. 
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as received. N-Boc-Oxindole 5 derivativesxxi and 3-benzyl benzofuranone 8xxii have been 
prepared according to the previously reported literature procedure. 
Different substituted oxindoles were prepared following the literature procedures.xxiii α,β-
Unsaturated aldehydes 2 were purchased from Aldrich or Lancaster and used as received or 
synthesized following the literature procedures.xxiv The “privileged” organocatalysts I-II were 
purchased from Aldrich and used as received. 
Determination of Diastereomeric Ratios. The diastereomeric ratio was determined by 1H NMR 
analysis of the crude reaction mixture. 
Determination of Enantiomeric Purity. Chiral HPLC analysis was performed on an Agilent 
1100-series instrumentation. Daicel Chiralpak AD-H or AS-H columns and Daicel Chiralcel OD-H 
with i-PrOH/hexane as the eluent were used. HPLC traces were compared to racemic samples 
prepared by carrying out the reactions with racemic IIa as the catalyst. 
 
Organocatalytic Asymmetric Addition of Methyl Oxindole 1a to Cinnamaldehyde 2 Catalyzed 
by Va 
 
 
 
 
 
Solvent Screena 
N
H
O
Me
Ph CHO+
2 - 1.5 equiv1a - 1 equiv.
N
H
Me
Ph
CHO
O
3a
*
*
Va (20 mol%)
pNO2PhCO2H (20 mol%)
SOLVENT 0.5M
23 °C, 18h
 
 
                                                           
xxi
 (a) D. Villemin, B. Martin, Synth. Commun. 1998, 28, 3201-3208. (b) L. Canoira, J. G. Rodriguez, J. 
Heterocyclic Chem. 1985, 22, 1511-1518. (c) Rajeswaran, W. G.; Cohen, L. A. Tetrahedron, 1998, 54, 
11375-11380; (d) Hamashima, Y.; Suzuki, T.; Takano, H.; Shimura, Y.; Sodeoka, M. J. Am. Chem. Soc. 
2005, 127, 10164; (e) Kato, Y.; Furutachi, M.; Chen, Z.; Mitsunuma, H.; Matsunaga, S.; Shibasaki, M. J. 
Am. Chem. Soc. 2009, 131, 9168–9169. 
xxii
 M. Msaddek, M. Rammah, K. Ciamala, J. Vebrel, B. Laude, Synthesis, 1997, 1495-1498. 
xxiii
 (a) D. Villemin, B. Martin, Synth. Commun. 1998, 28, 3201-3208. (b)L. Canoira, J. G. Rodriguez, J. 
Heterocyclic Chem. 1985, 22, 1511-1518. 
xxiv
 G. Battistuzzi, S. Cacchi, G. Fabrizi, Org. Lett. 2003, 5, 777-780. 
NH2
N
H
N
H
S
CF3
CF3
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Table S1. Solvent Screen a 
Solvent Conv (%) – 18h
b 
dr (%)
b 
ee (%)
c 
Toluene 55 4.5:1 84/31 
DCM 52 2:1 67/38 
CHCl3 38 3:1 73/40 
Acetone 53 1.1:1 31/6 
THF 27 2:1 47/36 
a Open-air reactions were carried out in undistilled solvent using a 1.5:1 ratio of 2a to 1a, 20 
mol% of the catalyst, 20 mol% of the acid on a 0.1 mmol scale. b Determined by 1H NMR of the 
crude mixture. c ee of 3a was determined by HPLC analysis (AD-H column). 
 
Acids Screen a 
N
H
Me
O
Ph
CHO
1a - 1 equiv.
+
2 - 1.5 equiv.
Va (20% mol)
ACID (20% mol)
toluene 0.5M
23°C, 18h
N
H
Me
Ph
CHO
O
3a  
 
Table S2. Solvent Screena 
Acid Conv (%) – 18h
b 
dr (%)
b 
ee (%)
c 
pNO2PhCO2H 55 4.5:1 84/31 
TFA 77 1:3 <5 
oF-PhCO2H 38 5:1 86/40 
PhCO2H 51 6:1 90/52 
a Open-air reactions were carried out in undistilled solvent using a 1.5:1 ratio of 2a to 1a, 20 
mol% of the catalyst, 20 mol% of the acid on a 0.1 mmol scale. b Determined by 1H NMR of the 
crude mixture. c ee of 3a was determined by HPLC analysis (AD-H column). 
 
Organocatalytic Asymmetric Addition of Oxindole 1a,b to α,β-Unsaturated Aldehydes 2 
Catalyzed by IIa 
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N
H Ar
OTMS
Ar
Ar = 3,5-(CF3)2-C6H3
IIa
 
 
IIa (20 mol%)
pNO2PhCO2H (20 mol%)
AcOEt 0.5M
0 C° / 65h
N
H
R1
O
R2
CHO
1a-b - 1 equiv.
+
2 - 1.5 equiv.
N
H
R1
R2
CHO
O
3
*
*
 
 
Table S3. Confronting the Privileged Catalyst IIa with Vaa 
R
1
 R
2
 Conv dr
b
 
IIa ee (%) 
major  minor
 
VIa 
dr                ee 
Me Me 80% 2.4:1 30 55 2.3:1 24 
Me p-NO2Ph 80% 1.1:1 89 90 7.5:1 88 
Me Ph >95% 1:1 93 89 7:1 90 
Bn Ph >95% 1.1:1 96 91 7:1 92 
a Open-air reactions were carried out in undistilled solvent using a 1.5:1 ratio of 2 to 1, 20 
mol% of the catalyst IIa, 20 mol% of the acid on a 0.1 mmol scale. b Determined by 1H NMR of 
the crude mixture. c ee of 3 was determined by HPLC analysis (AD-H column). d ee of 3 was 
determined by HPLC analysis (OD-H column). 
 
Experimental procedures 
 
Synthesis of the Chiral Primary Amine Thiourea Catalyst VIIa. (R)-1-(3,5-
bis(trifluoromethyl)phenyl)-3-(1-(2-aminonaphthalen-1-yl)naphthalene-2-yl)thiourea. 
 
 
 
 
 
 
NH2
NH2F3C
CF3
N C
S +
DCM, rt, 4h N
H
NH2
S
N
H
CF3
CF3
VIIa
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Under argon atmosphere, 1-isothiocyanato-3,5-bis(trifluoromethyl)benzene (1.8 mmol, 329 
µL) is added dropwise to a solution of (R)-(+)-1-(2-aminonaphthalen-1-yl)naphthalene-2-amine 
(2.16 mmol, 1.2 equiv., 610 mg) in dry CH2Cl2 (9 ml) and the reaction is stirred for 4 hours at 
room temperature. Dichloromethane is evaporated under reduced pressure and the crude 
mixture is purified by flash chromatography (hexane/ethyl acetate 9:1). Catalyst Va is obtained 
in 70% yield as a pale yellow solid. 1H NMR (400 MHz, CDCl3): δ 3.57 (br s, 2H), 6.84 (d, J = 8.4 
Hz, 1H), 6.96 (d, J = 8.7 Hz, 1H), 7.04-7.20 (m, 2H), 7.28-7.39 (m, 2H), 7.45 (s, 2H), 7.49-7.58 (m, 
1H), 7.60 (br s, 1H), 7.67-7.78 (m, 2H), 7.90-8.12 (m, 5H). 13C NMR (150 MHz, CDCl3): δ 111.9 
(C), 118.1 (CH), 119.7 (CH), 121.4 (C), 122.8 (CH), 123.0 (CH), 124.1 (C), 124.9 (CH), 126.0 (CH), 
126.8 (CH), 127.4 (CH), 127.5 (CH), 128.2 (C), 128.4 (CH), 128.5 (CH), 128.9 (C), 129.5 (C), 129.6 
(CH), 130.4 (CH), 131.6 (C), 131.9 (C), 132.3 (C), 132.7 (C), 132.8 (C), 133.1 (C), 133.8 (C), 138.5 
(C), 141.8. 
 
Synthesis of (R)-N-(1-(2-aminonaphthalen-1-yl)naphthalene-2-yl)acetamide Vc 
 
 
 
 
 
Acetic anhydride(0.5 mmol, 52 µL) is added at 0 °C to a solution of acetic acid (5 mmol, 300 µL 
) and Vb (0.5 mmol, 142 mg) in anhydrous dichloromethane (5 ml) under argon atmosphere. 
The reaction is stirred overnight at room temperature, then a 2N NaOH solution is added and 
the resulting mixture is extracted with dichloromethane. Flash chromatography over silica gel 
(Hexane/ethyl acetate 1:2) furnished the desired compound in 75% yield. 1H-NMR and 13C-
NMR spectra were consistent with that previously reported.xxv  
Synthesis of α,β-Unsaturated Aldehydes 2: 
 
(E)-3-(4-chlorophenyl)acrylaldehyde  has been obtained in a 80% yield following the literature 
procedure. 1H-NMR and 13C-NMR spectra were consistent with that previously reported.4 
 
(E)-4-(3-oxoprop-1-enyl)benzonitrile  has been obtained in a 50% yield following the literature 
procedure. 1H-NMR and 13C-NMR spectra were consistent with that previously reported.4 
 
NH2
NH2 Ac2O, AcOH
CH2Cl2
rt
NH2
NHAc
Vb Vc
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(E)-3-(naphthalen-2-yl)acrylaldehyde  has been obtained in a 75% yield following the 
literature procedure. 1H-NMR and 13C-NMR spectra were consistent with that previously 
reported.4 
 
Synthesis of Oxindoles Derivatives 
 
N
H
O
1b
N
H
O
1) piperidine, Benzaldehyde
EtOH, reflux
2) NaBH4, EtOH, 0°C to rt
 
 
3-benzylindolin-2-one 1b: In 50 ml flask containing a suspension of indolin-2-
one (6 mmol, 798 mg) in absolute ethanol (6 ml) benzaldehyde (6.6 mmol, 
660 µL) and piperidine (12 mmol, 1.18 ml) are added in sequence and the 
resulting solution is refluxed for 3 hours. Then the reaction flask is removed 
from the oil bath and cooled to ambient temperature and the solvent 
removed under reduced pressure. The crude mixture is dissolved again in 20 ml of ethanol and 
added dropwise to a previously prepared suspension of NaBH4 (6.6 mmol, 249.74 mg) in 10 ml 
of absolute ethanol at 0 °C. Once the addition is complete the resulting mixture is vigorously 
stirred for 3 hours at room temperature. The reaction is quenched by addition of 20 ml of a 
saturated solution of NH4Cl and the extracted with ethyl acetate (3 x 20 ml). The organic phase 
is anhydrified with MgSO4, filtered and the solvent evaporated under reduced pressure. Flash 
chromatography over silica gel (eluent mixture hexane/diethyl ether 1:1) furnished the desired 
compound as a pale yellow solid in 87% yield. The NMR spectra is consistent with the one 
previously reported.3 
 
N
H
O
N
H O
1) piperidine, Butyraldehyde
EtOH, reflux
2) NaBH4, EtOH, 0°C to rt
1c
 
 
3-butylindolin-2-one 1c:In 50 ml flask containing a suspension of 
indolin-2-one (9 mmol, 798 mg) in absolute ethanol (9 ml) 
                                                                                                                                                                          
xxv
 J. Wang, H. Li, W. Duan, L. Zu, W. Wang, Org. Lett. 2005, 7, 4713 – 4716. 
N
H
O
1b
N
H
O
1c
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butyraldehyde (9.9 mmol, 881 μL) and piperidine (18 mmol, 1.778 ml) are added in sequence 
and the resulting solution is refluxed for 6 hours. Then the reaction flask is removed from the 
oil bath and cooled to ambient temperature and the solvent removed under reduced pressure. 
The crude mixture is dissolved again in 30 ml of ethanol and added dropwise to a previously 
prepared suspension of NaBH4 (9.9 mmol, 376.62 mg) in 25 ml of absolute ethanol at 0 °C. 
Once the addition is complete the resulting mixture is vigorously stirred at room temperature 
overnight. The reaction is quenched by addition of 20 ml of a saturated solution of NH4Cl and 
the extracted with ethyl acetate (3 x 30 ml). The organic phase is anhydrified with MgSO4, 
filtered and the solvent evaporated under reduced pressure. Flash chromatography over silica 
gel (eluent mixture hexane/diethyl ether 1:1) furnished the desired compound as a pale 
orange oil in 60% yield. 1H NMR (400 MHz, CDCl3) δ: 0.87 (t, J = 7.1 Hz, 3H), 1.20-1.47 (m, 4H), 
1.83-2.09 (m, 2H), 3.47 (t, J = 6.1 Hz, 1H), 6.94 (d, J = 7.7 Hz, 1H), 6.97-7.05 (m, 1H), 7.14-7.25 
(m, 2H), 9.72 (br s, 1H); 13C NMR (150 MHz, CDCl3): δ 13.9 (CH3), 22.7 (CH2), 27.9 (CH2), 30.2 
(CH2), 46.2 (CH), 109.8 (CH), 122.0 (CH) 123.8 (CH), 127.6 (CH), 129.8 (C), 141.7 (C), 181.2 (C). 
 
N
H
O
O
N
H
O2) NaBH4, EtOH, 0°C to rt
1)benzyltriphenylphosphonium bromide
n-BuLi 1.6M in hexane
THF, 0°C to rt
1d  
 
Benzyltriphenylphosphonium bromide: Triphenylphosphine (17.5 mmol, 
4.6 g) is added to a solution of benzylbromide (17.5 mmol, 3g) in benzene 
and the resulting mixture is refluxed for 12 hours. The white solid is 
filtered and washed with diethyl ether (3 x 20 ml) and hexane (3 x 20 ml) and then is dried 
under high vacuum for 3 hours. The titled compound has been obtained in 95% yield.   
 
 
3-benzylidene-5-methylindolin-2-one: Benzyltriphenylphosphonium 
bromide (1 mmol, 432.06 mg) is placed in a flame dried three nacked 
50 ml flask under argon atmosphere and anhydrous THF (10 ml) is 
added. To the resulting suspension buthyllithium (1.6 M in hexane, 1 
mmol., 0.625 ml) is added dropwise at 0 °C and the deep red mixture 
is stirred for 1 hour at that temperature. After that a solution of 5-methylindolin-2,3-dione (1 
mmol., 161.16 mg) in anhydrous THF (15 ml) is added in 30 minutes at 0 °C and the resulting 
PPh3Br
N
H
O
1d
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solution is stirred for 6 hours. The reaction is poured in a saturated solution of NH4Cl at 0 °C 
and then extracted with DCM (3 x 20 ml). The organic phase is dried over magnesium sulphate, 
filtered and the solvent removed under reduced pressure. The crude mixture is dissolved in 10 
ml of ethanol and added dropwise to a previously prepared suspension of NaBH4 (2.0 mmol, 
75.68 mg) in 5 ml of absolute ethanol at 0 °C. Once the addition is complete the resulting 
mixture is vigorously stirred at room temperature overnight. The reaction is quenched by 
addition of 20 ml of a saturated solution of NH4Cl and the extracted with ethyl acetate (3 x 30 
ml). The organic phase is anhydrified with MgSO4, filtered and the solvent evaporated under 
reduced pressure. Flash chromatography over silica gel (eluent mixture hexane/ethyl acetate 
8:2) furnished the desired compound as a pale orange solid in 82% yield. 
1H NMR (400 MHz, CDCl3) δ: 2.23 (s, 3H), 2.94 (dd, J = 13.7, 9.1 Hz, 1H), 3.48 (dd, J = 13.7, 4.5 
Hz, 1H), 3.71 (dd, J = 9.1, 4.5 Hz, 1H), 6.57 (s, 1H), 6.75 (d, J = 7.9 Hz, 1H), 6.93-7.00 (m, 1H), 
7.14-7.31 (m, 5H), 8.70 (br s, 1H); 13C NMR (150 MHz, CDCl3): δ 21.1 (CH3), 36.6 (CH2), 47.6 
(CH), 109.4 (CH), 125.4(CH) 126.5 (CH), 128.0 (CH), 128.1 (CH), 129.0 (C), 129.3 (CH), 131.2 (C), 
137.8 (C), 138.9 (C), 179.7 (C). 
 
N
O
N O
1) piperidine, Butyraldehyde
EtOH, reflux
2) Zn, AcOH, HCl(cat.)
 
 
3-benzyl-1-methylindolin-2-one: In 50 ml flask containing a suspension 
of 1-methylindolin-2-one (2 mmol, 294.36 mg) in absolute ethanole (3 
ml) benzaldehyde (2.2 mmol, 224 µL) and piperidine (4 mmol, 395 µL) 
are added in sequence and the resulting solution is refluxed for 4 
hours. Then the reaction flask is removed from the oil bath and cooled to ambient 
temperature and the solvent  
removed under reduced pressure. The crude mixture is dissolved in acetic acid (3 ml) then zinc 
powder (11.9 mmol, 780 mg) and HCl (50 µL) are added and the resulting solution is stirred for 
24 hours at room temperature. The reaction mixture is then filtered over a pad of celite which 
is washed with ethyl acetate (20 ml) three times. The collected organic phase is placed in a 
separatory funnel and washed with a saturated solution of NaHCO3 (3 x 20 ml) and with a 
saturated solution of NaCl (2 x 20 ml) and then dried over MgSO4. After removal of the solvent 
under reduced pressure the crude mixture is purified by flash chromatography to give the 
titled compound in 90% yield. 1H NMR (400 MHz, CDCl3) δ: 2.88 (dd, J = 13.7, 9.4 Hz, 1H), 3.15 
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(s, 3H), 3.50 (dd, J = 13.7, 4.5, 1H), 3.71 (dd, J = 9.4, 4.5 Hz, 1H), 6.74 (d, J = 8.1 Hz, 2H), 6.88-
6.95 (m, 1H), 7.13-7.30 (m, 6H); 1H NMR (400 MHz, CDCl3): δ 26.0 (CH3), 36.7 (CH2), 46.9 (CH), 
107.8 (CH), 122.0 (CH), 124.4 (CH), 126.5 (CH), 127.8 (CH), 128.1 (CH), 128.3 (C), 129.3 (CH), 
137.8 (C), 144.1 (C), 176.9 (C). 
 
General Procedure for the Organocatalytic Asymmetric Conjugate Addition of Oxindoles to 
Enals. All the reactions were carried out in undistilled toluene without any precautions to 
exclude water. In an ordinary test tube equipped with a magnetic stirring bar, catalyst (R)-1-
(3,5-bis(trifluoromethyl)phenyl)-3-(1-(2-aminonaphthalen-1-yl)naphthalene-2-yl)thiourea Va 
(0.02 mmol, 11.1 mg) was dissolved in 400 μL of toluene. After addition of 0.1 mmol (12.2 mg) 
of benzoic acid, the solution was stirred for 5 minutes at room temperature. After addition of 
α,β-unsaturated aldehyde (0.3 mmol), the mixture was stirred for 10 minutes. Then the 
oxindole derivative (0.20 mmol) was added in one portion and the tube was closed with a 
rubber stopper and stirring was continued for the indicated time (5 days). Then the crude 
reaction mixture was diluted with 1:1 mixture of dichloromethane and ethyl acetate (1 mL) 
and flushed through a plug of silica gel, using the same mixture as the eluent. Solvent was 
removed in vacuo, and the residue was purified by flash chromatography to yield the desired 
compound. When the separation of the two diastereoisomers by Chiral HPLC analysis was not 
possible, the compounds were reduced to the corresponding alcohols. The crude mixture was 
dissolved in THF (2 ml) and NaBH4 (2 eq. based on the starting oxindole) was added at 0 °C. 
Once the addition was complete the reaction was stirred for further 5 minutes at that 
temperature then the ice bath was removed and the vigorous stirring continued for 1 hour at 
room temperature. Once the reaction was finished, THF was removed under reduced pressure 
and the residual material was quenched with a saturated solution of NH4Cl at room 
temperature and then extracted with DCM. MgSO4 was added to the organic phase then 
filtered and the solvent removed under reduced pressure to give a mixture of alcohols which 
can be easily separated by flash chromatography using mixtures of DCM and ethyl acetate. 
 
3-(3-methyl-2-oxoindolin-3-yl)-3-phenylpropanal – 3a (table 2 entry 
1). 
The reaction was carried out at 23 °C using 0.2 mmol (29.4 mg) of 3-
methylindolin-2-one 1a 0.3 mmol (38 µL) of cinnamaldehyde 2, 0.010 
mmol ( 10% mol, 11.1 mg) of Va and 0.1 mmol (50% mol, 12.2 mg) of 
benzoic acid in 400 µL of toluene following the general procedure. From the crude mixture the 
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dr = 7.0:1 was determined by integration of 1H-NMR signal (δmajor 1.45 ppm, δminor 1.34 ppm - 
s). The title compound was isolated by column chromatography (hexane/AcOEt = gradient 
from 8/2 to 7/3) as a colourless solid in 71% yield and 90% ee (major diasteroisomer). The ee 
was determined by HPLC analysis on a Diacel Chiralpak AD-H column: 9/1 hexane/i-PrOH, flow 
rate 0.75 mL/min, λ = 214, 254 nm: major diastero τminor = 19.5min, τmajor = 17.7 min, [α]
rt
D= 
+1.55 (c = 0.916, CHCl3, dr = 84:16) 
1H NMR (400 MHz, CDCl3), dr: = 4.17:1: δ 1.45 (s, 3H), 2.92-
3.31 (m, 4H), 3.82-3.93 (dd J = 10.3, 4.9 Hz, 1H), 6.46 (d, J = 7.4 Hz, 1H), 6.78-6.88 (m, 2H), 
6.93-7.05 (m, 5H), 7.06-7.20 (m, 5H), 7.38 (d, J = 7.1 Hz, 1H), 9.53 (m, 1H); 13C NMR (150 MHz, 
CDCl3): δ 21.0 (CH3), 44.0 (CH2), 46.6 (CH), 51.8 (C), 109.7 (CH), 122.2 (CH), 124.1 (CH), 127.4 
(CH), 127.9 (CH), 128.4 (CH), 129.0 (CH), 132.2 (C), 130.0 (CH), 138.1 (C), 140.5 (C), 181.1 (C), 
200.6 (CH).Exact mass (m/z): 279.1256, calculated: 279.1259. 
 
 
3-(3-benzyl-2-oxoindolin-3-yl)-3-phenylpropanal – 3b (table 2 
entry 2).  
The reaction was carried out at 23 °C using 0.15 mmol (33.4 
mg) of 3-benzylindolin-2-one 1b, 0.225 mmol (28 µL) of 
cinnamaldehyde 2, 0.015 mmol ( 10% mol, 8.3 mg) of Va and 
0.075 mmol (50% mol, 9.1 mg) of benzoic acid in 300 µL of 
toluene following the general procedure. From the crude mixture the dr = 7.0:1 was 
determined by integration of 1H-NMR signal (δmajor 9.53 ppm, δminor 9.49 ppm - m). The title 
compound was isolated as a single diastereoisomer by column chromatography (CH2Cl2/AcOEt 
= gradient from 98/2 to 95/5) as a colourless solid in 73% yield and 92% ee (major 
diasteroisomer) Rf (0.35). After single recrystallization of the major diasteroisomer from DCM 
and hexane a colourless solid was obtained in 55% yield and 99% ee. The ee was determined 
by HPLC analysis on a Daicel Chiralcel OD-H column: 8/2 hexane/i-PrOH, flow rate 0.75 
mL/min, λ = 214, 254 nm: major diastero τminor = 10.3 min, τmajor = 13.8 min, [α]
rt
D= - 47.27 (c = 
0.760, CHCl3, >99% ee) 
1H NMR (400 MHz, CDCl3):  2.92-3.31 (m, 4H), 3.82-3.93 (dd, J = 10.3, 
4.9 Hz, 1H), 6.46 (d, J = 7.4 Hz, 1H), 6.78-6.88 (m, 2H), 6.93-7.05 (m, 5H), 7.06-7.20 (m, 5H), 
7.38 (d, J = 7.1 Hz, 1H), 9.53 (m, 1H); 13C NMR (150 MHz, CDCl3): δ 41.2 (CH2), 44.4 (CH2), 46.9 
(CH), 58.2 (C), 109.4 (CH), 122 (CH), 124.7 (CH), 126.5 (CH), 127.4 (CH), 127.6 (CH), 128.0 (CH), 
128.5 (CH), 129.4 (CH), 129.7 (C), 130.0 (CH), 135.4 (C), 138.0 (C), 141.0 (C), 178.7 (C), 200.6 
(CH). Exact mass (m/z): 355.1570, calculated: 355.1572. 
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3-butyl-3-(3-hydroxy-1-phenylpropyl)indolin-2-one - 3c (table 2 entry 
3). 
The reaction was carried out at 23 °C using 0.30 mmol (56.7 mg) of 3-
butylindolin-2-one 1c, 0.45 mmol (56.7 µL) of cinnamaldehyde 2, 0.03 
mmol ( 10% mol, 16.65 mg) of VIa and 0.15 mmol (50% mol, 18.3 mg) 
of benzoic acid in 600 µL of toluene following the general procedure. From the crude mixture 
the dr = 5:1 was determined by integration of 1H-NMR signal (δmajor 3.70 ppm, δminor 3.76 ppm – 
m) and the conversion based on the starting oxindole derivative was 80%. The crude mixture 
of two diastereoisomers was tranferred in a 25 ml two necked flask and dissolved under argon 
with 2 ml of anhydrous THF then NaBH4, 0.60 mmol (22.70 mg) was added at 0 °C. After 1 hour 
under vigorous stirring at room temperature, the solvent was evaporated and a solution of 
saturated NH4Cl was added to the solid mixture. The aqueous solution was extracted with 
dichloromethane (3 x 20 ml) and dried over MgSO4. NMR analysis of the crude mixture showed 
quantitative conversion into the corresponding alcohols as a mixture of diasteroisomers. The 
d.r. = 5:1 was determined by integration of 1H-NMR signal (δmajor 6.80 ppm, δminor 6.83 ppm – br 
d). The title compound as a single diastereoisomer was isolated by column chromatography 
(CH2Cl2/AcOEt = 4:1) as a colourless solid in 36.5% yield and 73% ee (major diasteroisomer) Rf 
(0.30). The ee was determined by HPLC analysis on a Diacel Chiralpak AD-H column (80/20 
hexane/i-PrOH, flow rate 0.75 mL/min, λ = 214, 254 nm: major diastero τminor = 8.9 min, τmajor = 
12.3 min). [α]rtD=  +29.59 (c = 1.025, CHCl3, 73% ee).
1H NMR (400 MHz, CDCl3): δ 0.75 (t, J = 7.3 
Hz, 3H), 0.93-1.42 (m, 5H), 1.85-195 (m, 1H), 1.97-2.14 (m, 2H), 2.24-2.35 (m, 2H), 3.20 (dd, J = 
12.51, 2.71, 1H), 3.26-3.37 (m, 1H), 3.38-3.48 (m, 1H), 6.67 (d, J = 7.6 Hz, 1H), 6.75-6.83 (m, 
2H), 6.98-7.11 (m, 4h), 7.20 ( dt, J = 7.6, 1.3 Hz, 1H), 7.28-7.32 (m, 1H), 7.62 (br s, 1H); 13C NMR 
(150 MHz, CDCl3): δ 13.8 (CH3), 22.9 (CH2), 26.6 (CH2), 32.5 (CH2), 35.3 (CH2), 49.3 (CH2), 57.4 
(C), 61.0 (CH2), 109.3 (CH), 122.0 (CH), 124.1 (CH), 126.9 (CH), 127.7 (CH), 127.9 (CH), 128.9 (C), 
131.3 (C), 139.0 (C), 141.5 (C), 181.1 (C). Exact mass (m/z): 323.1882, calculated: 323.1885. 
 
3-benzyl-3-(3-hydroxy-1-phenylpropyl)-5-methylindolin-2-one – 
3d (Table 2, entry 4). The reaction was carried out at 23 °C using 
0.273 mmol (36.8 mg) of 3-benzyl-5-methylindolin-2-one 1d, 
0.4095 mmol (39.1 µL) of cinnamaldehyde 2, 0.0273 mmol ( 10% 
mol, 15.15 mg) of VIa and 0.1365 mmol (50% mol, 16.65 mg) of 
benzoic acid in 546 µL of toluene following the general procedure. From the crude mixture the 
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dr = 5.0:1 was determined by integration of 1H-NMR signal (δmajor 3.87 ppm, δminor 3.97 ppm - 
dd) and the conversion based on the starting oxindole was 80%. The crude mixture of two 
diastereoisomer was tranferred in a 25 ml two necked flask and dissolved under argon with 2 
ml of anhydrous THF then NaBH4, 0.546 mmol (20.66 mg) was added at 0 °C. After 1 hour 
under vigorous stirring at room temperature, the solvent was evaporated and a solution of 
saturated NH4Cl was added to the solid mixture. The aqueous solution was extracted with 
dichloromethane (3 x 20 ml) and dried over MgSO4. NMR analysis of the crude mixture showed 
quantitative conversion into the corresponding alcohols as a mixture of diasteroisomers. The 
d.r. = 5.0:1 was determined by integration of 1H-NMR signal (δmajor 3.14 ppm, δminor 2.69 ppm - 
d). The title compound was isolated as a single diastereoisomer by column chromatography 
(CH2Cl2/AcOEt = 4/1) as a colourless solid in 48% yield and 81% ee (major diasteroisomer) Rf 
(0.30). The ee was determined by HPLC analysis on a Diacel Chiralpak AD-H column (80/20 
hexane/i-PrOH, flow rate 0.75 mL/min, λ = 214, 254 nm: major diastero τminor = 17.4 min, τmajor = 
8.4 min). [α]rtD=  -22.37 (c = 0.9125, CHCl3, 81% ee). 
1H NMR (400 MHz, CDCl3): δ 1.68 (br s, 1H), 
2.20 (tdd, J = 12.7, 6.2, 4.6 Hz, 1H), 2.50 ( m, 4H), 3.14 (d, J = 12.7 Hz, 1H), 3.31 (d, J = 12.7 Hz, 
1H), 3.34-3.43 (m, 2H), 3.44-3.55 (m, 1H), 6.31 (d, J = 7.8 Hz, 1H), 6.76-6.85 (m, 2H), 6.86-7.03 
(m, 6H), 7.04-7.17 (m, 4H), 7.31 (s, 1H); 13C NMR (150 MHz, CDCl3): δ 21.4 (CH3), 32.9 (CH2), 
41.7 (CH2), 49.5 (CH), 58.9 (C), 61.0 (CH2), 109.0 (CH), 125.5 (CH), 126.2 (CH), 127.0 (CH), 127.5 
(CH), 127.8 (CH), 128.5 (CH), 129.2 (CH), 130.0 (CH), 130.4 (C), 131.1 (C), 136.1 (C), 138.8 (C), 
139.1 (C), 179.5 (C). Exact mass (m/z): 371.1884, calculated: 371.1885. 
 
3-(3-methyl-2-oxoindolin-3-yl)-3-(4-nitrophenyl)propanal 3e (table 2 
entry 5). The reaction was carried out at 23 °C using 0.2 mmol (29.4 
mg) of 3-methylindolin-2-one 1a, 0.3 mmol (53 mg) of (E)-3-(4-
nitrophenyl)acrylaldehyde 2, 0.010 mmol ( 10% mol, 11.1 mg) of VIIa 
and 0.1 mmol (50% mol, 12.2 mg) of benzoic acid in 400 µL of toluene 
following the general procedure. From the crude mixture the dr = 7.5:1 
was determined by integration of 1H-NMR signal (δmajor 9.58 ppm, δminor 9.63 ppm - m). The 
product was isolated as a mixture of diastereoisomers in 70% yield and 88% ee of the major 
disteroisomer (d.r. = 86:14). After single recrystallization from DCM and hexane the first 
diastereoisomer was isolated as colourless solid in 56% yield and >99% ee. The ee was 
determined by HPLC analysis on a Diacel Chiralpak AD-H column: 85/15 hexane/i-PrOH, flow 
rate 0.75 mL/min, λ = 214, 254 nm: major diastero τminor = 24.3 min, τmajor = 25.46 min, minor 
diastero τminor = 20.5 min, τmajor = 19.10 min. [α]
rt
D= -28.54 (c = 0.825, CHCl3, >99% ee) 
1H NMR 
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(400 MHz, CDCl3) mixture of diasteroisomer dr = 9:1: δ 1.44 (s, 3H), 3.07-3.13 (m, 2H), 3.80-
3.86 (m, 1H), 6.72-6.80 (m, 1H), 7.09-7.16 (m, 3H), 7.20-7.31 (m, 3H), 7.74 (br s, 1H), 7.94-7.99 
(m, 2H), 9.57 (t, J = 1.2 Hz, 1H); 13C NMR (150 MHz, CDCl3): δ 21.3 (CH3), 44.0 (CH2), 45.9 (CH), 
51.5 (C), 110.1 (CH), 122.7 (CH), 123.0 (CH), 123.8 (CH), 128.4 (C), 128.9 (CH), 129.9 (CH), 130.0 
(C), 140.3 (C), 146.1 (C), 180.7 (C), 199,1 (CH). 
Exact mass (m/z): 338.1264, calculated: 338.1267. 
 
 
3-benzyl-3(3-hydroxy-1-(4-nitrophenyl)propyl)indolin-2-one 3f – 
(table 2, entry 6) The reaction was carried out at 23 °C using 0.15 
mmol (33.4 mg) of 3-benzylindolin-2-one 1a, 0.225 mmol (40 mg) of 
(E)-3-(4-nitrophenyl)acrylaldehyde 2, 0.015 mmol ( 10% mol, 8.3 mg) 
of VIIa and 0.075 mmol (50% mol, 9.1 mg) of benzoic acid in 300 µL 
of toluene following the general procedure. From the crude mixture the dr = 11.5:1 was 
determined by integration of 1H-NMR signal (δmajor 9.60 ppm, δminor 9.65 ppm – br s) and the 
conversion based on the starting oxindole derivative was 57%. The crude mixture of two 
diastereoisomer was tranferred in a 25 ml two necked flask and dissolved under argon with 2 
ml of anhydrous THF then NaBH4, 0.30 mmol (11.35 mg) was added at 0 °C. After 1 hour under 
vigorous stirring at room temperature, the solvent was evaporated and a solution of saturated 
NH4Cl was added to the solid mixture. The aqueous solution was extracted with 
dichloromethane (3 x 20 ml) and dried over MgSO4. NMR analysis of the crude mixture showed 
quantitative conversion into the corresponding alcohols as a mixture of diasteroisomers. The 
d.r. = 11.5:1 was determined by integration of 1H-NMR signal (δmajor 3.14 ppm, δminor 2.77 ppm - 
d). The title compound was isolated as a single diastereoisomer by column chromatography 
(CH2Cl2/AcOEt = 4/1) as a colourless solid in 47% yield and 93% ee (major diasteroisomer) Rf 
(0.57). The ee was determined by HPLC analysis on a Diacel Chiralpak AD-H column (75/25 
hexane/i-PrOH, flow rate 0.75 mL/min, λ = 214, 254 nm: major diastero τminor = 37.15 min, τmajor 
= 10.6 min). [α]rtD= +37.7 (c = 0.910, CHCl3, 92% ee). 
1H NMR (400 MHz, CDCl3):  1.41 (br s, 
1H), 2.17-2.29 (m, 1H), 2.40-2.53 ( m, 1H), 3.17 (d, J = 12.9 Hz, 1H), 3.26-3.40 (m, 2H), 3.49-3.57 
(m, 1H), 3.47-3.57 (m, 1H), 3.65 (dd, J = 12.5, 2.37 Hz, 1H), 6.40-6.49 (m, 1H), 6.78-6.84 (m, 
2H), 6.95-7.06 (m, 3H), 7.07-7.12 (m, 2H), 7.13-7.19 (m, 2H), 7.53-7.60 (m, 1H), 7.91-7.97 (m, 
2H); 13C NMR (150 MHz, CDCl3): δ 32.6 (CH2), 41.7 (CH2), 48.9 (CH), 58.7 (C), 60.3 (CH2), 109.6 
(CH), 122.2 (CH), 122.9 (CH), 124.8 (CH), 126.6 (CH), 127.7 (CH), 128.7 (CH), 129.3 (C), 130.0 
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(CH), 130.1 (CH), 135.3 (C), 141.0 (C), 146.9 (C), 147.0 (C), 178.7 (C). Exact mass (m/z): 
402.1577, calculated: 402.1580. 
 
3-(3-benzyl-2-oxoindolin-3-yl)-3-(4-chlorophenyl)propanal – 
3g (Table 2, entry 7). The reaction was carried out at 23 °C 
using 0.20 mmol (44.6 mg) of 3-benzylindolin-2-one 1b, 0.3 
mmol (49.8 mg) of (E)-3-(4-chlorophenyl)acrylaldehyde 2, 0.02 
mmol ( 10% mol, 11.1 mg) of VIIa and 0.10 mmol (50% mol, 
12.2 mg) of benzoic acid in 400 L of toluene following the 
general procedure. From the crude mixture the dr = 5.7:1 was determined by integration of 1H-
NMR signal (δmajor 3.87 ppm, δminor 3.93 ppm - dd). The title compound was isolated by column 
chromatography (CH2Cl2/AcOEt = 19/1) as a colourless solid in 85% yield and 85% ee (major 
diasteroisomer) Rf (0.56). After single recrystallization of the major diasteroisomer from DCM 
and hexane a colourless solid was obtained in 77% yield and 97% ee. The ee was determined 
by HPLC analysis on a Diacel Chiralpak AD-H column (80/20 hexane/i-PrOH, flow rate 0.75 
mL/min, λ = 214, 254 nm: major diastero τminor = 18.14 min, τmajor = 15.47 min). [α]
rt
D=  -18.94 (c 
= 0.940, CHCl3, 97% ee). 
1H NMR (400 MHz, CDCl3): 3.05-3.13 (m, 2H), 3.18 (s, 2H), 3.87 (dd, J 
= 9, 6.3 Hz, 1H), 6.44-6.50 (m, 1H), 6.71-6.85 (m, 2H), 6.90-7.04 (m, 6H), 7.06-7.17 (m, 4H), 
7.37-7.44 (m, 1H), 9.55 (t, J = 1.7 Hz, 1H); 13C NMR (150 MHz, CDCl3):  41.3 (CH2), 44.4 (CH2), 
46.0 (CH), 58.1 (C), 109.6 (CH), 122.1 (CH), 124.6 (CH), 126.5 (CH), 127.7 (CH), 128.2 (CH), 128.7 
(CH), 129.3 (C), 130.0 (CH), 130.7 (CH), 133.3 , 135.3 (C), 136.7 (C), 141,0 (C), 178.5 (C) 199.9 
(CH). Exact mass (m/z): 389.1182, calculated: 389.1183. 
 
4-(1-(3-benzyl-2-oxoindolin-3-yl)-3-hydroxypropyl)benzonitrile 
3h (table 2 entry 8). The reaction was carried out at 23 °C using 
0.20 mmol (44.6 mg) of 3-benzylindolin-2-one 1a, 0.3 mmol (49.8 
mg) of (E)-4-(3-oxoprop-1-enyl)benzonitrile 2, 0.02 mmol ( 10% 
mol, 11.1 mg) of VIIa and 0.10 mmol (50% mol, 12.2 mg) of 
benzoic acid in 400 µL of toluene following the general procedure. 
From the crude mixture the dr = 12:1 was determined by integration of 1H-NMR signal (δmajor 
9.58 ppm, δminor 9.63 ppm – br s) and the conversion based on the starting oxindole derivative 
was 89%. The crude mixture of two diastereoisomers was tranferred in a 25 ml two necked 
flask and dissolved under argon with 2 ml of anhydrous THF then NaBH4, 0.40 mmol (15.136 
mg) was added at 0 °C. After 1 hour under vigorous stirring at room temperature, the solvent 
was evaporated and a solution of saturated NH4Cl was added to the solid mixture. The 
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aqueous solution was extracted with dichloromethane (3 x 20 ml) and anhydrified with MgSO4. 
NMR analysis of the crude mixture showed quantitative conversion into the corresponding 
alcohols as a mixture of diasteroisomers. The d.r. = 12.0:1 was determined by integration of 
1H-NMR signal (δmajor 6.45 ppm, δminor 6.52 ppm - m). The title compound was isolated as a 
single diastereoisomer by column chromatography (CH2Cl2/AcOEt = 4:1) as a colourless solid in 
52% yield and 83% ee (major diasteroisomer) Rf (0.25). The ee was determined by HPLC 
analysis on a Diacel Chiralpak AD-H column (90/10 hexane/i-PrOH, flow rate 0.75 mL/min, λ = 
214, 254 nm: major diastero τminor = 41.70 min, τmajor = 12.80 min). [α]
rt
D=  +22.09 (c = 0.825, 
CHCl3, 83% ee).
1H NMR (400 MHz, CDCl3): δ 1.60 (br s, 1H), 2.10-2,23 (m, 1H), 2.36-2.49 (m, 
1H), 3.13 (d, J = 12.9 Hz, 1H), 3.24-3.38 (m, 2H), 3.46-3.59 (m, 2H), 6.43-6.49 (m, 1H), 6.76-6.83 
(m, 2H), 6.93-7.06 (m, 5H), 7.08-7.17 (m, 2H), 7.17-7.22 (br s, 1H), 7.31-7.41 (m, 2H), 7.50-7.59 
(m, 1H); 13C NMR (150 MHz, CDCl3): δ 32.5 (CH2), 41.7 (CH2), 49.1 (CH), 58.8 (C), 60.3 (CH2), 
109.6 (CH), 110.9 (C), 118.7 (C), 122.2 (CH), 124.8 (CH), 126.5 (CH), 127.6 (CH), 128.6 (CH), 
129.5 (C), 129.9 (CH), 130.0 (CH), 131.5 (CH), 135.3 (C), 141.0 (C), 144.8 (C), 179.0 (C). Exact 
mass (m/z): 382.1683, calculated: 382.1681. 
 
3-(3-hydroxy-1-(naphthalen-2-yl)propyl)-3-methylindolin-2-one – 
3i (Table 2, entry 9). The reaction was carried out at 23 °C using 
0.25 mmol (36.8 mg) of 3-methylindolin-2-one 1a, 0.375 mmol 
(68.25 mg) of (E)-3-(naphthalen-2-yl)acrylaldehyde 2, 0.025 mmol ( 
10% mol, 13.87 mg) of VIa and 0.125 mmol (50% mol, 15.25 mg) of 
benzoic acid in 500 µL of toluene following the general procedure. From the crude mixture the 
dr = 13.3:1 was determined by integration of 1H-NMR signal (δmajor 1.49 ppm, δminor 1.38 ppm - 
s) and the conversion based on the starting oxindole derivative was 85%. The crude mixture of 
two diastereoisomer was tranferred in a 25 ml two necked flask and dissolved under argon 
with 2 ml of anhydrous THF then NaBH4, 0.5mmol (18.92 mg) was added at 0 °C. After 1 hour 
under vigorous stirring at room temperature, the solvent was evaporated and a solution of 
saturated NH4Cl was added to the solid mixture. The aqueous solution was extracted with 
dichloromethane (3 x 20 ml) and dried over MgSO4. NMR analysis of the crude mixture showed 
quantitative conversion into the corresponding alcohols as a mixture of diasteroisomers. The 
d.r. = 13.0:1 was determined by integration of 1H-NMR signal (δmajor 1.47 ppm, δminor 1.33 ppm - 
s). The title compound was isolated as a single diastereoisomer by column chromatography 
(CH2Cl2/AcOEt = 3/2) as a colourless solid in 53% yield and 80% ee (major diasteroisomer) Rf 
(0.25). The ee was determined by HPLC analysis on a Diacel Chiralpak AD-H column (80/20 
hexane/i-PrOH, flow rate 0.75 mL/min, λ = 214, 254 nm: major diastero τminor = 10.0 min, τmajor = 
H
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10.9 min). [α]rtD= +67.91 (c = 0.925, CHCl3, 80% ee). 
1H NMR (400 MHz, CDCl3): δ 1.47 (s, 3H), 
1.59-1.79 (brs, 1H), 2.10-2.26 (m, 1H), 2.27-2.40 (m, 1H), 3.24-3.49 (m, 3H), 6.62 (d, J = 7.7 Hz, 
1H), 6.91 (dd, J = 8.5, 1.4 Hz, 1H), 7.10 (dt, J = 1.1, 7.5 Hz, 1H), 7.20 (dt, J = 1.3, 7.7 Hz, 1H), 
7.28-7.41 (m, 4H), 7.43-7.54 (m, 2H), 7.55-7.63 (m, 1H), 7.64-7.77 (m, 1H); 13C NMR (150 MHz, 
CDCl3): δ 21.5 (CH3), 32.3 (CH2), 49.2 (CH), 52.5 (C), 60.8 (CH2), 109.6 (CH), 122.1 (CH), 124.1 
(CH), 125.5 (CH), 126.6 (CH), 127.1 (CH), 127.3 (CH), 127.9 (CH), 128.0 (CH), 128.2 (CH), 132.5 
(C), 132.7 (C), 132.9 (C), 136.7 (C), 140.7 (C), 181.7 (C). Exact mass (m/z): 331.1571, calculated: 
331.1572. 
 
3-(3-benzyl-2-oxoindolin-3-yl)-3-(naphthalen-2-yl)propanal – 3j 
(Table 2, entry 10). The reaction was carried out at 23 °C using 
0.32 mmol (71.2 mg) of 3-benzylindolin-2-one xx, 0.48 mmol 
(87.36 mg) of (E)-3-(naphthalen-2-yl)acrylaldehyde 2, 0.032 mmol 
( 10% mol, 17.76 mg) of VIIa and 0.16 mmol (50% mol, 19.52 mg) 
of benzoic acid in 640 µL of toluene following the general 
procedure. From the crude mixture the dr = 20:1 was determined by integration of 1H-NMR 
signal (δmajor 9.54 ppm, δminor 9.48 ppm - m). The title compound was isolated as a single 
diastereoisomer by column chromatography (CH2Cl2/AcOEt = 9/1) as a colourless solid in 55% 
yield and 89% ee (major diasteroisomer) Rf (0.52). After single recrystallization of the major 
diasteroisomer from CDCl3 and hexane a colourless solid was obtained in 49% yield and >99% 
ee. The ee was determined by HPLC analysis on a Daicel Chiralcel OD-H column (80/20 
hexane/i-PrOH, flow rate 0.75 mL/min, λ = 214, 254 nm: single diastero τ  = 19.6 min). [α]
rt
D=  -
1.64 (c = 0.800, CHCl3, 99% ee). 
1H NMR (400 MHz, CDCl3): δ = 3.15 (ddd, J = 16.4, 4.1, 1.4 Hz, 
1H), 3.20-3.31 (m, 3H), 4.05 (dd, J = 11.2, 4.2 Hz, 1H), 6.37-6.43 (m, 1H), 6.81-6.86 (m, 2H), 
6.93-7.03 (m, 4H), 7.08-7.18 (m, 3H), 7.36-7.43 (m, 2H), 7.44-7.50 (m, 2H), 7.57-7.62 (d, J = 8.7 
Hz, 1H), 7.63-7.68 (m, 1H), 7.69-7.75 (m, 1H), 9.53-9.56 (dd, J = 2.4 Hz, 1.5, 1H); 13C NMR (150 
MHz, CDCl3): δ = 41.3 (CH2), 44.5 (CH2), 46.9 (CH), 58.4 (C), 109.6 (CH), 122.0 (CH), 124.7 (CH), 
125.9 (CH), 125.9 (CH), 126.4 (CH), 127.0 (CH), 127.4 (CH), 127.5 (CH), 127.6 (CH), 127.9 (CH), 
128.5 (CH), 128.6 (CH), 129.7 (C), 130.0 (CH), 132.6 (C), 132.9 (C), 135.3 (C), 135.6 (C), 141.1 
(C), 179.0 (C), 200.5 (CH). Exact mass (m/z): 405.1725, calculated: 405.1728. 
 
Determination of the Absolute Configuration. 
N
H
O
O
H
3j
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The absolute configuration of compound 3e was assigned to be (3S,3’R) by X-ray 
crystallographic analysis of the corresponding protected alcohol toluene-4-sulfonic acid (S)-3-
((R)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl)-3-(4-nitro-phenyl)-propyl ester 4. All the other 
relative and absolute configurations for compounds 3 were assigned by analogy, considering 
an uniform mechanistic pathway. The single diasteroisomer of 3e 0.112 mmol (36.4 mg) was 
dissolved under argon in 2 ml of anhydrous THF and then NaBH4, 0.224 mmol (8.5 mg) was 
added at 0 °C. After 1 hour under vigorous stirring at room temperature, the solvent was 
evaporated and a solution of saturated NH4Cl was added to the solid mixture. The aqueous 
solution was extracted with dichloromethane (3 x 10 ml) and dried over MgSO4. NMR analysis 
of the crude mixture showed quantitative conversion into the corresponding alcohol which 
was used for the next step without further purification. The crude alcohol 0.112 mmol. was 
dissolved in 4 ml of pyridine and p-tosyl chloride 0.448 mmol. (85.41 mg) was added at room 
temperature. After 18 hours of vigorous stirring at room temperature water was added (15 ml) 
and the crude mixture was extracted with diethyl ether (3 x 10 ml). The combined organic 
phases were washed with 1M HCl solution (3 x 10 ml) and then dried over MgSO4. The title 
compound was purified as by column chromatography (CH2Cl2/AcOEt = 95/5) as a colourless 
solid in 50% yield. [α]rtD= +32.7 (c = 0. 5, CHCl3, >99% ee).
1H NMR (400 MHz, CDCl3): δ = 1.43 (s, 
3H), 2.07-2.19 (m, 1H), 2.43 (s, 3H), 2.44-2.53 (m, 1H), 3.29 (dd, J = 12.7, 2.8 Hz, 1H), 3.52 (m, 
1H), 3.93 (m, 1H), 7.75 (m, 2H), 6.84 (m, 2H), 7.10 (dt, J = 7.5, 1.0 Hz), 7.21-7.30 (m, 3H), 7.60 
(m, 2H), 7.82 (m, 2H); 13C NMR (150 MHz, CDCl3): δ = 21.56 (CH), 21.60 (CH3), 28.8 (CH2), 48.4 
(CH3), 51.9 (C), 67.4 (CH2), 109.9 (CH), 122.6 (CH), 124.0 (CH), 127.8 (CH), 128.8 (CH), 129.7 
(CH), 129.8 (CH), 131.3 (C), 132.5 (C), 140.3 (C), 145.1 (C), 145.4 (C), 147.0 (C), 180.2 (C). 
Single crystals suitable for X-ray crystallographic analysis were obtained by means of slow 
crystallization from a mixture of DCM-hexane. 
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Crystal Data for compound 4 
 
 
 
Crystals obtained from evaporation of a hexane/DCM solution, molecular formula: 
C25H24N2O6S, Mr = 480.32, monoclinic, space group P21 (No. 4), a = 11.2607(12), b = 8.5360(9), c 
= 13.1993(14) Å,  β =110.6240(10), V = 1186.6(2) Å3, T = 296(2)°K, Z = 2, ρc = 1.345 g cm–3, 
F(000) = 504, graphite-monochromated MoK radiation (λ = 0.71073 Å), µ(MoK) = 0.180 mm–1, 
colourless needle (0.40 × 0.1 × 0.1 mm3), empirical absorption correction with SADABS 
(transmission factors: 0.9314 – 0.9822), 2400 frames, exposure time 25 s, 1.65 ≤ θ ≤ 28.56, –
15≤ h ≤ 14, –11 ≤ k ≤ 11, –17 ≤ l ≤ 17, 13702 reflections collected, 5514 independent reflections 
(Rint = 0.0200), solution by direct methods (SHELXS97
a) and subsequent Fourier syntheses, full-
matrix least-squares on Fo
2 (SHELX97), hydrogen atoms refined with a riding model except for 
the N-H hydrogen, that was experimentally localized and isotropically refined. Data / restraints 
/ parameters ratio was 5514 / 1 / 312, S(F2) = 1.039, R(F) = 0.0438 and wR(F2) = 0.0961 on all 
data, R(F) = 0.0373 and wR(F2) = 0.922 for 4800 reflections with I > 2σ(I), weighting scheme w = 
1/[σ2(Fo2) + (0.0440P)2 + 0.1070P] where P = (Fo2 + 2Fc2)/3, largest difference peak and hole 
0.156 and –0.225 e Å–3. Absolute structure Flack parameter: 0.03(6). Crystallographic data 
(excluding structure factors) for the structure reported in this paper have been deposited with 
the Cambridge Crystallographic Data Centre as supplementary publication no. CCDC-710802. 
Copies of the data can be obtained free of charge on application to CCDC, 12 Union Road, 
Cambridge CB21EZ, UK (fax: (+44) 1223-336-033; e-mail: deposit@ccdc.cam.ac.uk). 
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Determination of Enantiomeric Purity. HPLC analysis on chiral stationary phase was 
performed on an Agilent 1100-series instrumentation. Daicel Chiralpak AD-H, AS-H, IA or IC 
columns and Daicel Chiralcel OD-H with i-PrOH/hexane as the eluent were used. HPLC traces 
were compared to racemic samples prepared by carrying out the reactions in the presence of 
1.5 equivalents of K2CO3 in THF as the solvent (RT, 48 hours reaction time). 
 
General Procedure for the Organocatalytic Asymmetric Conjugate Additions of Oxindoles and 
Benzofuranones to Cyclic Enones 
 
 
All the reactions were carried out with no precautions to exclude moisture in undistilled 
toluene. In an ordinary vial equipped with a magnetic stir bar, amine A or B (0.02 mmol, 6.5 
mg, 10 mol%) and benzoic acid (0.04 mmol, 4.9 mg, 20 mol%) were dissolved in 1 mL of 
toluene. After stirring at r.t. for 10 minutes, the cyclic enones 2 (0.2 mmol) was added, 
followed by the addition of N-Boc oxindole 1 or benzofuranone 5 (0.24 mmol, 1.2 equiv). The 
vial was sealed, and the mixture stirred for the indicated time at r.t. The crude mixture was 
diluted with CH2Cl2 and flushed through a short plug of silica, using dichloromethane/ethyl 
acetate 1:1 as the eluent. Solvent was removed in vacuo and the Michael adduct 3 or 6 was 
purified by flash column chromatography (silica gel, hexane-EtOAc).  
 
(R)-tert-butyl 3-benzyl-2-oxo-3-((S)-3-oxocyclohexyl)indoline-1-carboxylate (Table 4, entry 1). 
The reaction was carried out following the general procedure to 
furnish the crude product: (d.r. 5:1 determined by integration of 1H-
NMR signal: δmajor 3.04 ppm. d, δminor 3.05 ppm. d.).The title compound 
was isolated as a mixture of diastereoisomers by column 
chromatography (hexane/acetone = 90/10) in 80% yield 96% ee (major 
diastereoisomer) and 90% ee (minor diastereoisomer). HPLC analysis on a Daicel Chiralpak AD-
H column: 98/2 hexane/i-PrOH, flow rate 0.50 mL/min, λ = 214, 254 nm: major 
diastereoisomer τmajor = 34.1 min, τminor = 41.7 min; minor diastereoisomer τmajor = 43.5 min, 
N
O
O
Boc7a
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τminor = 32.9 min; HRMS calcd for (C26H29NO4): 419.2096, found 419.2092. [α]rt
D= - 17.37 (c = 
0.98, CHCl3, d.r. = 5:1, 96% ee). 
1H NMR (400 MHz, CDCl3): δ  1.47-1.64 (m, 2H), 1.55 (s, 9H), 1.70-1.81 (m, 1H), 1.97-2.12 (m, 
1H), 2.15-2.32 (m, 1H), 2.32-2.50 (m, 2H), 2.55-2.61 (m, 2H), [CH2 A-B type spectrum (3.04, d, 
1H, Jgem= -12.8 Hz), (3.30, d, 1H, Jgem= -12.8 Hz)], 6.72-6.77 (m 2H), 6.93-7.06 (m, 3H), 7.13-7.31 
(m, 3H), 7.52-7.57 (m, 1H). 
13C NMR (150 MHz, CDCl3): δ 25.1 (CH2), 26.4 (CH2), 28.3 3X(CH3), 41.4 (CH2), 42.2 (CH2), 43.0 
(CH2), 46.2 (CH), 57.4 (C), 84.3 (C), 115.0 (CH), 123.6 (CH), 124.4 (CH), 126.9 (CH), 127.9 (CH), 
128.6 (CH), 129.3 (C), 130.0 (CH), 135.1 (C), 140.3 (C), 148.8 (C), 177.2 (C), 210.6 (C). 
 
(S)-tert-butyl 3-benzyl-2-oxo-3-((R)-3-oxocyclohexyl)indoline-1-carboxylate (Table 4, entry 2). 
The reaction was carried out following the general procedure to 
furnish the crude product: (d.r. 5:1 determined by integration of 1H-
NMR signal: δmajor 3.04 ppm. d, δminor 3.05 ppm. d.).The title compound 
was isolated as a mixture of diastereoisomers by column 
chromatography (hexane/acetone = 90/10) in 94% yield 96% ee (major 
diastereoisomer) and 90% ee (minor diastereoisomer). HPLC analysis on a Daicel Chiralpak AD-
H column: 98/2 hexane/i-PrOH, flow rate 0.50 mL/min, λ = 214, 254 nm: major 
diastereoisomer τmajor = 41.7 min, τminor =34.1 min  ; minor diastereoisomer τmajor = 32.9 min, 
τminor = 43.5 min;  [α]rt
D= + 16.9 (c = 0.98, CHCl3, dr = 5.2:1, 98% ee). 
 
(R)-tert-butyl 3-benzyl-3-((S)-3,3-dimethyl-5-oxocyclohexyl)-2-oxoindoline-1-carboxylate 
(Table 4, entry 3). 
The reaction was carried out following the general procedure to 
furnish the crude product: (d.r. 5.7:1 determined by integration of 
1H-NMR signal: δmajor 0.86 ppm. s, δminor 0.95 ppm. s.). The title 
compound was isolated as a mixture of diastereoisomers by column 
chromatography (hexane/acetone = 90/10) in 30% yield and 92% 
ee, (major diastereoisomer) and 88% ee (minor diastereoisomer), 
d.r. 5.7:1. HPLC analysis on a Daicel Chiralpak AD-H column: 98/2 hexane/i-PrOH, flow rate 
0.550 mL/min, λ = 214, 254 nm: major diastereoisomer τmajor = 17.67 min, τminor = 20.39 min; 
minor diastereoisomer τmajor = 28.40 min, τminor = 20.70 min; [α]rt
D= + 1.4 (c = 0.87, CHCl3, 92% 
ee, d.r. =  5.7:1). 
1H NMR (600 MHz, CDCl3): δ 0.86 (s, 3H), 1.00 (s, 3H), 1.33-1.39 (m, 1H), 1.43-1.52 (m, 2H), 1.55 
(s, 9H), 2.09 (m, 1H), 2.18 (m, 2H), 2.54-2.66 (m, 3H), [CH2 A-B type spectrum (3.01, d, 1H, Jgem= 
N
O
O
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-12.8 Hz), (3.30, d, 1H, Jgem= -12.8 Hz)], 6.71-6.76 (m, 2H), 6.94-7.00 (m, 2H), 7.01-7.05 (m, 1H), 
7.17-7.24 (m, 2H), 7.25-7.28 (m, 1H), 7.51-7.56 (m, 1H). 
13C NMR (150 MHz, CDCl3): δ 25.4(CH3), 28.0 (3 CH3), 31.9 (CH3), 34.3 (C), 39.3 (CH2), 41.6 (CH2), 
41.7 (CH2), 42.4 (CH2), 54.2 (CH2), 56.9 (C), 84.1 (C), 114.8 (CH), 123.0 (CH), 124.2 (CH), 126.6 
(CH), 127.6 (CH), 128.3 (CH), 129.2 (C), 129.7 (CH), 134.7 (C), 140.0 (C), 148.5 (C), 177.1 (C), 
210.6 (C). 
 
(R)-tert-butyl 3-benzyl-2-oxo-3-((S)-3-oxocyclopentyl)indoline-1-carboxylate (Table 4, entry 
4). 
The reaction was carried out following the general procedure to 
furnish the crude product: (d.r. 5.5:1 determined by integration of 1H-
NMR signal: δmajor 3.10 ppm. d, δminor 3.06 ppm. d.). The title compound 
was isolated as a mixture of diastereoisomers by column 
chromatography (hexane/ethyl acetate =85/15 to 70/30) in 55% yield and 46% ee. HPLC 
analysis on a Daicel Chiralcel OD-H column: 85/15 hexane/i-PrOH, flow rate 0.75 mL/min, λ = 
214, 254 nm: major diastereoisomer τmajor = 11.8 min, τminor = 14.2 min;  [α]rt
D= - 14.1.0 (c = 1.00, 
CHCl3, 46% ee). 
1H NMR (600 MHz, CDCl3): δ 1. 54 (s, 9H), 1.57-169 (m, 1H), 1.87-1.98 (m, 1H),  2.02-2.18 (m 
1H), 2.28 (dd, 1H, J1= 19.3 Hz, J2= 8.9 Hz), 2.42 (dd, 1H, J1= 18.6 Hz, J2= 7.4 Hz), 2.53 (dd, 1H, 
J
1=18.6 Hz, J2= 12.0 Hz), 2.77-2.90 (m,1H), [CH2 A-B type spectrum (3.10, d, 1H, Jgem= -14.1 Hz), 
(3.31, d, 1H, Jgem= -14.1 Hz)], 6.76-6.82 (m, 2H), 6.95-7.07 (m, 3H),  7.14-7.29 (m, 3H), 7.57 (d, 
1H, 8.07 Hz). 
13C NMR (150 MHz, CDCl3): δ  25.1 (CH2), 28.3 (3 CH3), 38.6 (CH2), 39.9 (CH2), 43.1 (CH2), 45.0 
(CH), 56.1 (C), 84.5 (C), 115.1 (CH), 123.8 (CH), 124.4 (CH), 127.0 (CH), 128.0 (CH), 130.0 (CH), 
130.5 (C), 135.1 (C), 140.1 (C), 148.8 (C), 177.2 (C), 217.1 (C). 
 
(R)-tert-butyl 3-benzyl-2-oxo-3-((S)-3-oxocycloheptyl)indoline-1-carboxylate (Table 4, entry 
5). 
The reaction was carried out following the general procedure using 
catalyst A to furnish the crude product: (d.r. 2.8:1 determined by 
integration of 1H-NMR signal: δmajor 6.72-6.75 ppm. m, δminor 6.69-6.71 
ppm. m). The title compound was isolated as a mixture of 
diastereoisomers by column chromatography (hexane/acetone = 
N
O
Boc
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90/10 to 85/15) in 62% yield and 98% ee. HPLC analysis on a Daicel Chiralcel OJ-H column: 98/2 
hexane/i-PrOH, flow rate 0.75 mL/min, λ = 214, 254 nm: major diastereoisomer τmajor = 23.7 
min, τminor = 19.5 min;   [α]rt
D= -29.9 (c = 1.10, CHCl3, dr = 2.8:1, 98% ee). 
1H NMR (400 MHz, CDCl3): δ 1.30-1.46 (m, 2H),1.53 (s, 9H), 1.64-1.82 (m, 1H), 1.83-2.09 (m, 
3H), 2.43-2.66 (m, 4H), 2.66-2.76 (m, 1H), 3.04-3.35 (m, 2H), 6.67-6.75 (m, 2H), 6.93-7.07 (m, 
3H), 7.09- 7.32 (m, 3H), 7.48-7.55 (m, 1H). 
13C NMR (100 MHz, CDCl3): δ 24.9 (CH2), 28.3 (3 CH3), 29.6 (CH2), 31.5 (CH2), 43.3 (CH2), 43.4 
(CH2), 43.47 (CH), 43.7 (CH2), 45.6 (C), 58.15 (C), 84.2 (C), 115.1 (CH), 123.7 (CH), 124.4 (CH), 
126.9 (CH), 127.8 (C), 128.6, (CH), 128.8 (C), 130,0 (CH), 135.0 (C), 140.3 (C), 148.8 (C), 177.6 
(C), 213.5 
 
(R)-tert-butyl 3-methyl-2-oxo-3-((S)-3-oxocyclohexyl)indoline-1-
carboxylate (3e) (Table 4, entry 6). 
The reaction was carried out at room temperature over 24 hours 
following the general procedure to furnish the crude product as a 4/1 
mixture of diastereoisomers (d.r. 4:1 determined by HPLC and GC-MS analysis of the crude 
mixture).  The title compound was isolated as a white solid by column chromatography 
(hexane/AcOEt = 90/10) in 94% yield (as a 4:1 mixture of diastereoisomers) and 95% ee. HPLC 
analysis on a Daicel Chiralpak IC column: 8/2 hexane/i-PrOH, flow rate 1.0 mL/min, λ = 254 nm: 
Major diastereomer (95% ee): τminor = 17.7 min, τmajor = 25.5 min; Minor diastereomer (85% ee): 
τmajor = 11.2 min, τminor= 19.3 min. HRMS calcd for (C20H25NO4+Na): 366.1681, found 366.1670. 
[α]rt
D= -36.9 (c = 0.63, CHCl3, dr 4:1, 95% eemajor, 85% eeminor). 
1H NMR (400 MHz, CDCl3, mixture of diastereomers 1.5:1): δ 1.34 - 1.57 (m, 5H), 1.64 (s, 10H), 
1.97 -2.04 (m, 1H), 2.13 -2.23 (m, 2H), 2.31-2.41 (m, 2H), 2.45-2.51 (m, 1H), 7.14 - 7.19 (m, 2H), 
7.28 - 7.33 (m, 1H), 7.84 (d, J = 8.8Hz, 1H,). 13C NMR (100 MHz, CDCl3): δ 22.0, 25.1, 25.9, 28.1  
41.2, 42.6 46.9  51.0, 84.8 115.2 122.9, 124.8, 128.6, 132.1 (CH), 139.4 (C), 149.2, 178.2 (C), 
210.8.  
 
(R)-tert-butyl-3-methyl-2-oxo-3-((S)-3-oxocycloheptyl)indoline-1-
carboxylate (3f) (Table 4, entry 8). 
The reaction was carried out at room temperature over 48 hours 
following the general procedure and using 20 mol% of catalyst A to 
furnish the crude product as a 2.5/1 mixture of diastereoisomers (d.r. 
2.5:1 determined by integration of 1H-NMR signal: δmajor 1.46 s, δminor 1.44 ppm. s).  The title 
N
(R) O
Boc
Me
(S) O
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compound was isolated as a colorless oil by column chromatography (hexane/AcOEt = 90/10) 
in 70% yield (as a 2.5:1 mixture of diastereoisomers) and 95% ee. HPLC analysis on a Daicel 
Chiralpak IC column: 9/1 hexane/i-PrOH, flow rate 1.0 mL/min, λ = 254 nm: Major 
diastereomer (95% ee): τminor = 30.3 min, τmajor = 58.5 min; Minor diastereomer (93% ee): τmajor = 
18.9 min, τminor = 33.9 min. HRMS calcd for (C21H27NO4+Na): 380.1838, found 380.1833. [α]rt
D= -
61.7 (c = 0.72, CHCl3, dr 2.5:1, 95% eemajor, 93% eeminor). 
1H NMR (400 MHz, CDCl3, mixture of diastereomers 2.5:1): δ 1.19 - 1.35 (m, 2H), 1.44 
(s,3H,minor), 1.46 (s,3H,maior), 1.48 -1.56 (m, 1H), 1.64 (s, 9H,major), 1.64 (s, 9H,minor), 1.84-
1.98(m,3H), 2.16 - 2.14 (m, 1H), 2.36-2.57 (m, 4H), 7.12 - 7.18 (m, 2H), 7.27 - 7.32 (m, 1H), 
7.81- 7.84(m, 1H,). 
13C NMR (100 MHz, CDCl3): δ 23.2  24.1 24.8, 28.3, 28.8, 29.4, 31.0, 32.0, 43.6, 44.1  44.3, 44.8, 
45.1, 51.5, 51.8, 84.7, 115.2, 122.8, 123.1, 124.7, 128.4, 131.4, 131.8, 139.4,  149.2, 178.6, 
178.8, 213.2, 213.5. 
 
(S)-tert-butyl 2-oxo-3-((S)-3-oxocyclohexyl)-3-phenylindoline-1-
carboxylate (3g) (Table 4, entry 9). 
The reaction was carried out at 0°C over 18 hours following the general 
procedure to furnish the crude product as a 1.5/1 mixture of 
diastereoisomers (d.r. 1.5:1 determined by integration of 1H-NMR signal: 
δmajor 7.98 d, δminor 7.95 ppm. d).  The title compound was isolated as a 
white solid by column chromatography (hexane/AcOEt = 85/15) in 95% yield (as a 1.5:1 
mixture of diastereoisomers) and 98% ee. HPLC analysis on a Daicel Chiralpak IC column: 8/2 
hexane/i-PrOH, flow rate 1.0 mL/min, λ = 254 nm: Major diastereomer (98% ee): τminor = 9.8 
min, τmajor = 12.5 min; Minor diastereomer (88% ee): τminor = 14.7 min, τmajor = 32.2 min. HRMS 
calcd for (C25H27NO4+Na): 428.1838, found 428.1847. [α]rt
D= +26.2 (c = 0.65, CHCl3, dr 1.5:1, 
98% eemajor, 88% eeminor). 
1H NMR (400 MHz, CDCl3, mixture of diastereomers 1.5:1): δ 1.61 (m, 9H), 1.54-1.76 (m, 3H), 
1.92-2.05 (m, 2H), 2.09-2.20 (m, 1H), 2.25-2.39 (m, 2H), 2.95-3.05(m, 1H), 7.23-7.46 (m, 9H), 
7.95 (d, J = 7.8, 1H, minor), 7.98 (d, J = 8.3, 1H, major). 13C NMR (100 MHz, CDCl3): δ 24.5 (CH2), 
24.7 (CH2), 25.7 (CH2), 26.5 (CH2), 28.0 (CH3), 40.9 (CH2), 41.1 (CH2), 42.6 (CH2), 43.1 (CH2), 46.5 
(CH), 46.6 (CH), 59.8 (C), 59.9 (C), 84.7 (CH), 115.4 (CH), 115.5 (CH), 124.2 (CH), 124.3 (CH), 
125.59 (CH), 125.63 (CH), 127.3 (CH), 127.4 (CH), 127.7 (CH), 127.8 (CH),  127.91 (CH), 127.99 
(CH), 128.7 (CH), 128.8 (CH), 128.9 (CH), 136.6 (C), 137.4 (C), 140.2, 148.9 (C), 149.0 (C), 175.5 
(C), 175.9 (C), 209.8 (C), 209.9 (C). 
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(R)-tert-butyl 3-(3-chlorobenzyl)-6-chloro-2-oxo-3-((S)-3-oxocyclohexyl)indoline-1-
carboxylate (Table 4, entry 10). 
The reaction was carried out following the general procedure to 
furnish the crude product: (d.r. 4:1 determined by integration of 1H-
NMR signal: δmajor 6.76 ppm. m, δminor 6.82 ppm. m.). The title 
compound was isolated as a mixture of diastereoisomers by column 
chromatography (hexane/acetone = 85/15) in 85% yield and 94% ee 
(major diastereisomer) and 94% ee (minor diastereoisomer). HPLC 
analysis on a Daicel Chiralcel OD-H column: 95/5 hexane/i-PrOH, flow rate 0.600 mL/min, λ = 
214, 254 nm: major diastereoisomer τmajor = 25.2 min, τminor = 40.7 min; minor diastereoisomer 
τmajor = 31.1 min, τminor = 34.7 min. 
 
N
O
O
Boc
Cl
Cl N
O
OCl
Cl
H
TFA
DCM 0.5M
7h  
 
Compund 7h (0.18 mmol, 1 equiv.) was dissolved in 360 μL of dichloromethane then TFA was 
slowly added at room temperature. The resulting mixture was stirred at room temperature for 
6 hours then it was diluited with ethyl acetate and a saturated solution of NaHCO3 was added 
at 0°C. The organic phase was separated and water was extracted 3 times with ethyl acetate. 
Organic phase was anhydrified with MgSO4 filtered and the solvent removed under reduced 
pressure. The crude mixture (d.r. 4:1 determined by integration of 1H-NMR signal: δmajor 8.02 
ppm. bs, δminor 8.12 ppm. bs.) was purified by flash column chromatography using 
dichloromethane/ethyl acetate 95:5 as the eluent mixture. (R)-3-(3-chlorobenzyl)-6-chloro-3-
((S)-3-oxocyclohexyl)indolin-2-one was obtained as single diastereosiomers in 40% and 94% ee. 
HPLC analysis on a Daicel Chiralcel OD-H column: 90/10 hexane/i-PrOH, flow rate 0.650 
mL/min, λ = 214, 254 nm: τmajor = 30.4 min, τminor = 33.9 min. 
1H NMR (600 MHz, CDCl3): δ 1.48-1.62 (m, 2H), 1.82-1.89 (m, 1H), 2.05-2.12 (m, 1H), 2.16-2.27 
(m, 1H), 2.32-2.43 (m, 3H), 2.49-2.56 (m, 1H), [CH2 A-B type spectrum (3.04, d, 1H, Jgem= -12.9 
Hz), (3.22, d, 1H, Jgem= -12.9 Hz)], 6.66-6.74 (m, 2H), 6.83 (bs, 1H), 6.96 (t, J = 7.9 Hz, 1H), 7.03-
7.06 (m, 1H), 7.08 (dd, J1 = 7.9 Hz, J2 = 1.9 Hz, 1H), 7.20 (d, J = 8.1 Hz), 7.42 (bs, 1H). 
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13C NMR (150 MHz, CDCl3): δ 24.7 (CH2), 25.9 (CH2), 40.1 (CH2), 41.0 (CH2), 42.5 (CH2), 45.4 
(CH), 57.2 (C), 110.4 (CH), 122.4 (CH), 125.0 (CH), 126.9 (CH), 127.9 (CH), 128.2 (C), 129.0 (CH), 
129.9 (CH), 133.5 (C), 134.1 (C), 137.2 (C), 142.1 (C), 179.5 (C), 210.1 (C). 
 
(R)-3-benzyl-3-((S)-3-oxocyclohexyl)benzofuran-2(3H)-one (6) 
(Scheme 2). 
The reaction was carried out at room temperature over 72 hours 
following the general procedure to furnish the crude product as a 2/1 
mixture of diastereoisomers (d.r. 2:1 determined by HPLC of the crude mixture).  The title 
compound was isolated as a white solid by column chromatography (hexane/AcOEt = 90/10) in 
61% yield (as a 2:1 mixture of diastereoisomers) and 94% ee. HPLC analysis on a Daicel 
Chiralpak IA column: 97/3 hexane/i-PrOH, flow rate 1.0 mL/min, λ = 254 nm: Major 
diastereomer (94% ee): τmajor = 26.1 min, τminor= 30.4 min; Minor diastereomer (95% ee): τminor = 
19.34 min, τmajor = 24.43 min. [α]rt
D= 6.3 (c = 0.51, CHCl3, dr 4:1, 95% eemajor, 95% eeminor). 
1H NMR (400 MHz, CDCl3, mixture of diastereomers 1.5:1): δ 1.45 - 1.67 (m, 3H), 2.05 - 2.11 (m, 
1H), 2.17-2.33 (m, 1H), 2.37 -2.63 (m, 4H),3.13-3.17(m,1H), 3.26-3.32(m,1H),6.78 - 6.89 (m, 
3H), 7.01-7.09 (m, 3H), 7.16 - 7.3 (m, 3H) 
13C NMR (100 MHz, CDCl3): δ 22.6,  24.6, 26.2, 41.1  42.7, 45.7, 57.2, 110.7, 124.0, 127.0, 127.5, 
128.1, 129.1, 129.2, 134.5, 153.2, 177.6, 209.5. 
 
Organocatalytic Conjugate Additions of Oxindoles to linear trans-4-phenyl-3-buten-2-one 
 
 
N
O
Boc
Me
Ph
Me
O
N
O
Boc
Me
O
Ph
Me
+
A (20 mol%)
PhCO2H (40 mol%)
toluene 0.2 M
0 C - 24 h10 11
 
 
The reactions was carried out with no precautions to exclude moisture in undistilled toluene. 
In an ordinary vial equipped with a magnetic stir bar, amine A (0.04 mmol, 13 mg, 20 mol%) 
and benzoic acid (0.08 mmol, 9.6 mg, 40 mol%) were dissolved in 0.5 mL of toluene. After 
stirring at 0°C for 10 minutes, the kenones 10 (0.2 mmol) was added, followed by the addition 
of N-Boc 3-methyl-oxindole (0.24 mmol, 1.2 equiv) in toluene (0.5 mL). The vial was sealed, 
and the mixture stirred for 24 hours at 0°C. The crude mixture was diluted with CH2Cl2 and 
flushed through a short plug of silica, using dichloromethane/ethyl acetate 1:1 as the eluent. 
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Solvent was removed in vacuo to furnish the crude product as a 1.4/1 mixture of 
diastereoisomers (d.r. 1.4:1 determined by integration of 1H-NMR signal: δmajor 2.41 s, δminor 
2.37 ppm. s).  The title compound was isolated as a colorless oil by column chromatography 
(hexane/AcOEt = 90/10) in 72% yield (as a 1.5:1 mixture of diastereoisomers) and 95% ee. 
HPLC analysis on a Daicel Chiralpak IC column: 9/1 hexane/i-PrOH, flow rate 1.0 mL/min, λ = 
254 nm: Major diastereomer (95% ee): τmajor = 11.9 min, τminor = 16.3 min; Minor diastereomer 
(94% ee): τminor = 14.5 min, τmajor = 19.0 min. HRMS calcd for (C24H27NO4+Na): 416.1838, found 
416.1829. [α]rt
D= +6.3 (c = 0.53, CHCl3, dr 1.4:1, 95% eemajor, 94% eeminor). 
1H NMR (400 MHz, CDCl3, mixture of diastereomers 1.5:1): δ 1.43 (s, 3H, minor), 1.46 (s, 
3H,major), 1.52(s,9H,major), 1.61(s,9H,minor), 1.97(s,3H,major), 2.02(s, 3H,minor), 3.61-3.64 
(m, 4H), 3.60-3.72 (m, 2H), 6.79-6.83 (m, 2H), 6.92-6.96 (m, 2H), 7.05-7.19 (m, 10H), 7.26-7.31 
(m, 1H),7.53 (d J = 8.8Hz 1H), 7.63 (d J = 7.6Hz 1H) 
13C NMR (100 MHz, CDCl3): δ 21.1, 22.5, 28.2 ,30.6, 43.4, 43.7, 48.9, 51.5, 51.8, 83.9, 84.2, 
114.7, 114.9, 123.6, 123.7, 124.0, 124.2, 127.2, 127.4, 127.7, 127.8, 128.1  128.6, 128.8, 128.9, 
130.7, 131.8, 137.9, 138.5, 138.7, 139.6, 148.7, 148.9, 178.1, 178.7, 206.4, 207. 
 
Absolute and Relative Configuration Determination  
X-Ray Structure Analysis. 
The absolute and relative configurations of compound 4 (Scheme 1) were assigned by X-ray 
crystallographic analysis. CCDC 771490 contains the supplementary crystallographic data for 
this compound. These data can be obtained free of charge from the Cambridge 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif  
 
Synthesis of N-Tos derivative 4 (Scheme 1)xxvi 
N O
Me
7e dr 4:1, 95%ee
i) TFA/DCM
O
Boc
ii) NaH/TsCl
12
single isomer 
after crystallization
N
(R)
Me (S)
H
O
Tos
O
70% yield over two steps
N
H O
Me
O
 
Compound 7e (0.2 mmol) was dissolved in DCM (5 mL) and TFA (3 equiv) was added at room 
temperature. After 16 h, the reaction was diluted with DCM (5 mL), washed successively with 
                                                           
xxvi K. Jiang, J. Peng, H.-L. Cui, Y.-C. Chen Chem. Comm. 2009, 3955-3957. 
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saturated Na2CO3 and brine. The organic layer was dried over Na2SO4 and concentrated in 
vacuo. Then the product was purified by chromatography to yield the pure N-H free oxindole 
derivative as a white solid. NaH (2 equiv) was suspended in THF (3 mL), and a solution of the 
above compound (0.15 mmol) in THF (2 mL) was slowly added at 0 °C. Then TosCl (1.3 equiv) 
was added. After 6 h, the reaction was quenched with water (0.5 mL). The mixture was diluted 
with EtOAc (5 mL), washed with brine. The organic layer was dried (Na2SO4), and concentrate 
in vacuo. The crude product was purified by flash chromatography PE/EA (10:1) to afford 12 as 
a white solid (0.14 mmol, 70% overall yield). 1H NMR (400 MHz, CDCl3, mixture of 
diastereomers 4:1): δ 1.28 (s, 3H), 1.32-1.45 (m, 2H), 1.83-1.91 (m, 1H), 2.01-2.28 (m, 2H), 2.39 
(s, 3H, minor), 2.43 (s, 3H, major), 2.02(s, 3H,minor), 7.07-7.22 (m, 2H), 7.29-7.37 (m, 4H), 
7.93-7.99 (m, 4H). HPLC analysis on a Daicel Chiralpak IA column: 85/15 hexane/i-PrOH, flow 
rate 1.0 mL/min, λ = 254 nm: Major diastereomer (95% ee): τmajor = 32.4 min, τminor = 37.9 min; 
Minor diastereomer: τminor = 34.1 min, τmajor = 39.4 min. HPLC analysis on a crystal 
morphologically similar to the one used for X-ray ananlysis demonstrated the presence of 
single enantiomer of the major diasteroisomer (τmajor = 32.4 min, single pick).  
 
Single Crystal X-ray Diffraction Data: 
X-ray structure determinations: Crystals of compound 4 were obtained by slow evaporation in 
a mixture of Hexane and Diethyl-ether in a 1:1 portion at room temperature. The measured 
crystals were stable under atmosphere conditions; nevertheless they were prepared under 
inert conditions immersed in perfluoropoly-ether as protecting oil for manipulation. 
Data Collection. Measurements were made on a Bruker-Nonius diffractometer equipped with 
an APPEX 2 4K CCD area detector, a FR591 rotating anode with MoKα radiation, Montel mirrors 
and a Kryoflex low temperature device (T = -173 °C). Full-sphere data collection was used with 
ω and ϕ scans.  
Programs used: Data collection Apex2 V2009 1.0 (Bruker-Nonius 2008), data reduction Saint + 
Version 7.60A (Bruker AXS 2008) and absorption correction SADABS V. 2008-1 (2008). 
Structure Solution. SHELXTL Version 6.10 (Sheldrick, 2000) was used.xxvii 
Structure Refinement. SHELXTL-97-UNIX VERSION. 
                                                           
xxvii G. M. Sheldrick (1998) SHELXTL Crystallographic System Ver. 5.10, Bruker AXS, Inc.: 
Madison, Wisconsin. 
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(1) Crystal data for TX1 at 100 K: C22 H23 N1 O4 S1 397.47 gmol
-1, orthorhombic, P212121, a =  
11.0798(8) Å, b =  11.7870(6) Å, c =  14.9095(7) Å, 1947.14(19)  Å3, Z = 4, ρcalcd = 1.356 Mg/m
3, 
R1 = 0.0373 (0.0418), wR2 = 0.1039 (0.1096), for 6622 reflections with I>2σ(I) (for 7224 
reflections [Rint: 0.0189] with a total measured of 13438 reflections), 255 parameters, 
goodness-of-fit on F2 = 0.875, largest diff. peak (hole) = 0.629 (-0.214) e Å-3. Absolute structure 
Flack Parameter: 0.07(4) 
CCDC 771490 
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2.2 MOLECULES 
Spiro Oriented Synthesis: Organocatalytic Asymmetric construction of Spirocyclic 
oxindoles 
 
“There is excitement, adventure and challenge, 
 and there can be great art in organic synthesis” 
 
R. B. Woodward107 
 
One of the goal of organic synthesis is the construction of a give organic compound from 
readily available starting materials and reagents in the most efficient and environmentally safe 
way.108 
Nature, since millions of years, assembled her targets using this philosophy, through cascade 
reactions where simple raw materials are converted into complex metabolites employing 
numerous chemical processes in which the product of one step is the reagent for the next one. 
In general is possible to observe that all life is regulated through cascade reaction from the 
Krebs’ cycle to the neurotransmission. In the field of organic chemistry the development of 
domino reactions represented an impressive breakthrough,109 in fact with the introduction of 
this synthetic strategy was possible build intricate molecular architecture in one step avoiding 
time-consuming and costly protection/deprotection processes as well as the purification of 
intermediates.110 
Then the design of cascades reaction to address the synthesis of molecules of considerable 
structural and stereochemical complexity became a significant intellectual challenge and can 
be one of the most impressive activities in the target oriented synthesis.  
Recently spirooxindoles have attracted the attention of organic chemist for two main reasons: 
the first is connected to their unique structural challenge, and the second derived from their 
biological activity, indeed the spirooxindolic motif is the principal core of a wide range of 
natural products and medicinal interesting compounds (Figure 1).111, 112 
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Figure 1: Some naturally occurring and bioactive spirocyclic oxindoles. 
N
HMeO
O
N
N
H O
O H
Me
Me
Spirotryprostatin A
N
H
O
OEt
O
Br
NNRTIs HIV-1 inhibitor
Me
Me
 
 
N
H
O
O N
Gelsemine
N
H
O
O
Et
Cl
Cl
inibitor of MDM2-p53 interaction  
 
For these reasons both the academic and the industrial world, start to evaluate small library of 
this class of compounds finding good drug candidates for the treatment of e.g. cancer,113 
tuberculosis,114 and malaria.115 
Despite the great interest that this class of compounds have aroused in the scientific 
community, their molecular and stereochemical complexity still represents a significant 
deterrent for their synthesis. 
116 The construction of a highly hindered, strained spirocyclic quaternary chiral centre is in fact 
not a trivial task, especially in an enantioselective fashion.117 
During my Phd studies I provided to address the problem of the enantioselective synthesis of 
spyrooxidoles developing three asymmetric protocols, that are here discussed on the basis of 
the synthetic strategy employed to prepare them 
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2.2.1. Aminocatalytic cascade reactions for the construction of highly densely 
functionalized Spirooxindoles 
 
Discussion 
As affirmed the design of cascade reactions to address the synthesis of molecules of 
considerable structural and stereochemical complexity became a significant intellectual 
challenge and can be considered one of the most impressive activities in the target oriented 
synthesis. In organocatalysis this term is undoubtedly associated with the extraordinary 
studies of the Jørgensen’s, MacMillan’s and Enders’ groups. 
The ability of an aminocatalyst to combine two orthogonal activation modes, as LUMO-
lowering and HOMO-raising activation, allowed the design of tandem118 and cascade119 
sequences for the functionalizzation of α,β-unsaturated aldehydes and ketones. 
We applied this philosophy to the one step synthesis of complex spirooxindolic derivates. 
Central of our approach was the identification of a suitable compound bearing the oxindole 
moiety capable to change its polarity during the reaction (Figure 1). 
Figure 1: Suitable compound for the design of aminocatalytic cascade reaction for the 
synthesis of spirooxindoles. 
N
H
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We minded that, likewise reported in the cascade of Enders et al. for nitrostyrene, the 
substrates 1 acted as Michael acceptor and then, after the nucleophile addition, became a 3-
substituted oxindole that is an electronrich compound as described in chapter 2.1.3..  
We performed the tricomponent reaction between cynnamaldehyde 2, crotonaldehydes 3 and 
3-benzylidenindolin-2-one 1a in the presence of 15 mol% of Hayashi’s catalyst and 15 mol% of 
ortho-Fluoro Benzoic Acid (Table 1, entry 1). 
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Table 1: Scope of the asymmetric construction of cyclohexen spirooxindoles through triple 
organocascade reaction. 
NHR1
O
O
CHO
R2
E
E
I R3
N
H
Ph
TMSO
Ph
R3
R2
R1 NHO
23
1
4
R4
o-F Benzoic Acid
R4
O H
15 mol%
toluene, 40 °C, 48 h
 
Entry R
1 
R
2 
R
3
 R
4 
Yield (%)
[a] 
dr
[b]
 ee (%)
[c]
 
1 Ph Me Ph H 74 12:1 >99 
2 Ph Me p-MeOPh H 70 16:1 >99 
3 Ph Me p-NO2Ph H 35 >19:1 >99 
4 Ph Me p-FPh H 50 >19:1 >99 
5 Ph Me o-MePh H 50 >19:1 98 
6 Ph Me Ph Cl 47 12:1 >99 
7 Ph Me Ph Me 40 12:1 >99 
8 propyl Me Ph H 40 19:1 98 
9 CO2Et Me Ph H 60 12:1 >99 
10 C(=O)Ph Me Ph H 46 >19:1 >99 
11 CO2Et Me Me H 58 >19:1 98 
12 CO2Et n-butyl Ph H 65 >19:1 >99 
13 CO2Et benzyl Ph H 65 19:1 >99 
14 CO2Et allyl Ph H 64 19:1 >99 
[a] Yield of the isolated major diastereomer. [b] The diastereomeric ratio (dr) was determined 
by 1H NMR analysis of the crude reaction mixture. [c] The enantiomeric excess (ee) were 
determined by HPLC analysis on chiral stationary phases. 
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Surprisingly the reaction afforded smoothly almost one stereoisomer between the 16 
possible,120 in good yield. Extending this methodology to other substrates we synthesized a 
small library of cyclohexen spirooxidoles bearing four contiguous sterocenters whereof a 
quaternary one. 
The high diastereoselction obtained suggests that in the first step of the reaction a retro-
Michael process occurs that allowed at only one diastereoisomer (the thermodynamic) to 
react in the Michael/aldol step driving the reaction pathway to the final product in very high 
diastereoisomeric ratio (Scheme 1).121, 2a 
Scheme 1: Proposed mechanism of the Michael/Michael/aldol Organocascade reaction 
promoted by Hayashi’s Catalyst 
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Extending our studies on the synthesis of others highly functionalized spirooxindole, we then 
focused on the development of a complementary organocascade strategy founded on the 
unique possibility that primary amine catalyst offered to activate α,β-unsaturated ketones. . 
In the design plan the chiral inductor, through the condensation with the substrates, might 
formed a dienamine intermediate I. This α-nucleophilic species might attack the compound 1 
and then, once formed a LUMO-lowered iminium-ion II, undergo the intramolecular 
cyclizzation (Scheme 2).  
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Scheme 2: Tandem reaction (dienamine/iminium ion) for the synthesis of spirocyclic oxindolic 
cyclohexanones 
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We thought the 9-amino(9-deoxy)epi-hydroquinidine A, that is used by our group for the 
activation of encumbered substrates, could activate efficiently the pseudo Diels-Alder 
reaction122 between the 3-alkylidene oxindole 1 and the ketone 5. 
Preliminary studies showed that the 9-amino(9-deoxy)epi-hydroquinidine is able to activate 
the reaction between oxindole and α,β-unsaturated ketones. 
After a standard condition screening, with the aim to enhance the formation of nucleophilic 
dienamine intermediate I instead of the LUMO-lowered iminium ion, we selected a catalyst 
salt formed by primary amine A (20 mol%) and ortho-Fluoro Benzoic Acid (30 mol%), 
demonstrating that the pKa and the amount of acidic additive have a crucial role favoring the 
formation of one intermediate (read iminium ion) or the other (read dienamine or enamine). 
With this conditions in hands we analyzed the generality of the tandem double Michael 
addition for the formation of spirocyclic oxindolic cyclohexanones (Scheme 3). 
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Scheme 3: Scope of the tandem double Michael addition (enamine-iminium activation 
sequence)
[a], [b], [c]
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[a] Yield of isolated product calculated on the sum of the 
diastereomers. [b] The diastereomeric ratio (dr) was determined 
by 1H NMR analysis of the crude reaction mixture. [c] The 
enantiomeric excess (ee) were determined by HPLC analysis on 
chiral stationary phases. 
The reaction shows good generality toward both the substrates especially in terms of 
electronic contribute, bearing to the formation of highly congested chiral spiro-oxindoles with 
up to four stereocenters whereof a quaternary one (6a-g). Notably using the pseudoenatiomer 
of the amine catalyst A, prepared from hydroquinidine, it is possible to access to the antipode 
of the products with similar results (ent-6a, ent-6g, ent-6i). Moreover, the presented 
organocascade furnishes good results with cyclohexenone derivatives. In fact in this project we 
have described the enatioselctive synthesis of bicyclo[2.2.2]octanes 6h and 6i bearing a spiro-
oxindole moiety. In confirming of the challenge behind the synthesis of such substrates, the 
spiro-bicycle 6h was  a completely unknown complex scaffold with two contiguous all-carbon 
quaternary stereocentres.123 As last part of the project we have applied this oganocascade to 
the construction of the spirooxidole 6f, that was recently patented by Hoffmann-La Roche as 
new kind of anticancer agent and tested as racemic mixture.124 The one step enantioselective 
synthesis of compounds having this structure-activity might enable the identification of a more 
selective and potent antitumor lead. 
In summary we showed two complementary aminocatalytic approaches for the 
enantioselective synthesis of chiral spirooxindoles having a six member ring. In particular we 
developed a formal [2+2+2] annulation strategy in the first case, whilst in the second case a 
formal Diels-Alder reaction where an α,β-unsaturated ketone was activated through a 
dienamine/iminium ion pathway. Both this reactions describe a trivial way for the construction 
of a class of natural inspired molecules starting from easily available raw materials thus setting 
the condition for further evaluations of their biological activity.  
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Experimental Part 
 
General. 
The 1H and 13C NMR spectra were recorded at 400 MHz and 100 MHz, respectively, or at 600 
MHz for 1H and 150 MHz for 13C. All the 1H and 13C signals were assigned by means of g-COSY, 
g-HSQC and g-HMBC 2D-NMR sequences. NOE spectra were recorded using the DPFGSE-NOE 
sequence,125 using a mixing time of 2.00 s and “rsnob” 20 ÷ 50 Hz wide selective pulses, 
depending on the crowding of the spectra region. The chemical shifts (δ) for 1H and 13C are 
given in ppm relative to residual signals of the solvents (CHCl3 and CD3CN). Coupling constants 
are given in Hz. When 2D-NMR were not performed, carbon types were determined from DEPT 
13C NMR experiments. The following abbreviations are used to indicate the multiplicity: s, 
singlet; d, doublet; t, triplet; q, quartet; m, multiplet; bs, broad signal. Purification of reaction 
products was carried out by flash chromatography (FC) on silica gel (230-400 mesh) according 
to the method of Still.126 Organic solutions were concentrated under reduced pressure on a 
Büchi rotary evaporator. High Resolution Mass spectra were obtained from the Department of 
Organic Chemistry “A. Mangini” Mass Spectroscopy facility. X-ray data were acquired at the 
Department of Physical and Inorganic Chemistry X-ray Crystallography facility, on a Bruker 
APEX-2 difractometer. Optical rotations are reported as follows: [α]rtD (c in g per 100 mL, 
solvent). All reactions were carried out in air and using undistilled solvent, without any 
precautions to exclude moisture unless otherwise noted. 
 
Materials. Commercial grade reagents and solvents were used without further purification; 
otherwise, where necessary, they were purified as recommended.127 Chiral primary amine 
catalysts, 9-Amino(9-deoxy)epi-hydroquinine A and the pseudo-enantiomer 9-Amino(9-
deoxy)epi-hydroquinidine C, were prepared from commercially available hydroquinine and 
hydroquinidine, respectively, following the literature procedure.128 Catalysts (S) and (R)-B were 
purchased from Aldrich and used as received.  
Substituted oxindoles were prepared following the literature procedures.129 Unsaturated 
ketones 2 and aldehydes 5 were purchased from Aldrich or Lancaster and used as received or 
synthesized following the literature procedures.130  
 
Determination of Diastereomeric Ratios 
The diastereomeric ratio was determined by 1H NMR analysis of the crude reaction mixture. 
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Determination of Enantiomeric Purity. Chiral HPLC analysis was performed on an Agilent 
1100-series instrumentation. Daicel Chiralpak AD-H or AS-H columns and Daicel Chiralcel OD-H 
with i-PrOH/hexane as the eluent were used. HPLC traces were compared to racemic samples 
prepared by performing the reactions using a 1:1 mixture of (S)- and (R)-B as the catalyst for 
the synthesis of compound 6. Racemic mixtures for compounds 3 and 7 were obtained by 
mixing the two antipodes obtained performing the reaction with catalyst 9-Amino(9-deoxy)epi-
hydroquinine A and the pseudo-enantiomer 9-Amino(9-deoxy)epi-hydroquinidine C separately. 
 
Calculations. MM conformational searches were performed using the MonteCarlo method 
implemented in Titan 1.0.5.131 Geometry optimization were carried out at the B3LYP/6-31G(d) 
level by means of the Gaussian 03 series of programs.132 The standard Berny algorithm in 
redundant internal coordinates and default criteria of convergence were employed. Harmonic 
vibrational frequencies were calculated for all the stationary points. For each optimized 
ground state the frequency analysis showed the absence of imaginary frequencies. Standard 
thermochemistry analysis was used to calculate the free energies. TD-DFT calculations were 
obtained at the B3LYP/6-31+G(d,p)//B3LYP/6-31G(d) level. In order to cover the whole 180-
400 nm range, 60 to 75 transition were calculated. The CD spectra was then obtained applying 
a 0.25 eV Gaussian bandshape 
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Supplementary Figures 
Supplementary Figure 1. Achieving both the enantiomers of the tandem double Michael 
additions toward spiro-oxindolic cyclohexanones 3. 
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Supplementary Figure 2. Direct synthesis of antitumor agent ent-7. 
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Supplementary Figure 3. Triple organocascade using catalyst (R)-IIIc. 
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Stereochemical evidence for a step-wise mechanism of the organocatalytic tandem reaction. 
The domino multicomponent reaction between an α,β-unsaturated ketone 5 and the oxindole 
derivative 1 described in Figure 2 of the main text may proceed via two competitive reaction 
pathways: a concerted [4+2] cycloaddition reaction (Diels-Alder reaction) or a double Michael 
addition sequence following an enamine-iminium activation path. Both processes, that lead to 
the one step construction of spiroindolinone derivatives 6, would first promote the formation 
of the dienamine intermediate I by catalyst A condensation with 5. consideiring a stepwise 
mechanism, the second intramolecular conjugate addition step would be so quick that 
intermediate II could not be detected by 1H-NMR spectroscopy. 
It is generally accepted that the Diels-Alder reaction must follow one of two alternative paths, 
the first being a synchronous pericyclic process and the other a two-step or two-stage one 
where an zwitterionic intermediate is involved. It has been generally assumed that in the latter 
case the rate-determining step must be the formation of this intermediate, its collapse to 
product being rapid.133 
On the basis of the regio- and stereo-specific nature of the Diels-Alder reaction (always a cis 
addition) and the diastereoselectivity of the union, based on the Alder endo rule,134 we can 
extrapolate some evidence from the relative configuration of products 6. Our considerations 
are summarized as Supplementary Figure 4. 
The selective formation of trans-spiro-oxindole cyclohexanones 6 would arise from an exo-
transition state of a cycloaddition path. The classical endo-transition state in the Diels–Alder 
route should produce the cis-isomer 6. However, the formation of this compound has never 
been observed under the present reaction conditions. Importantly, the obtained anti-
compounds 6 do not epimerize under the reaction conditions, even in the presence of a base 
(pyrrolidine 50 mol%). At the same extent, no scrambling of the double-bond geometry in 
compound 1 have been observed. 
The observed trans-relationship in compounds 6 is in sharp contrast with the study by Barbas 
and colleagues135 on the organocatalytic formation of spirocyclic compounds, believed to 
proceed by way of a concerted pericyclic pathway, resulting in the selective formation of the 
cis isomer.  
A further evidence pointing to a step-wise mechanism comes from the relative configurations 
of compounds 6g and 6h. Despite the trans geometry of the dienophile 1 is reflected in the 
relative spatial arrangement of compounds 6a-f, compounds 6g and 6h show a cis relationship, 
a clear evidence for a double-Michael reaction sequence.  
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Supplementary Figure 4. Stepwise or concerted? 
 
 
 
 
Finally, the relative trans relationship between the C2-C5 substituents of the cyclohexenone 
ring of compound 6f should require a Diels-Alder mechanism to proceed through a relatively 
unstable E-E s-cis dienophile.  
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Structural and Absolute Configuration Determination 
 
Introduction  
 
The present organocascade reactions are emblematic of the recent progress by asymmetric 
synthesis toward the achievement of stereochemical and structural complexity. In this 
framework, the unambiguous determination of the relative and absolute configuration of the 
complex compounds yielded by the reactions is absolutely necessary. 
Since many years, the anomalous dispersion X-ray crystallography (the “Bijovet method”) has 
been the elective method136 for the determination of absolute configuration and, thanks to the 
rapid development of high-resolution difractometers, it is now used routinely. The obvious 
limitations of the X-ray method is the need for diffraction-quality single crystals, and for the 
presence of an heavy atom in the molecule (i.e. Z > Si). While the second limitation is often 
negotiable by the organic chemists, the crystallization step is often unconquerable. 
Recently, the determination of the absolute configuration (AC) of chiral molecules by means of 
the chiroptical techniques of optical rotation (OR), electronic circular dichroism (ECD), and 
vibrational circular dichroism (VCD) has been revolutionized by the development of density 
functional theory (DFT) methods for the prediction of these properties. Theoretical calculation 
of ECD and VCD have been successfully employed in recent years to assign the AC of organic 
molecules137. The determination of the AC by chiroptical methods on newly synthesised 
molecules requires the knowledge of the relative configuration of the chiral centres. If the 
relative configuration is not known, all the relative configurations together with the related 
conformations must be calculated and taken into account in the final simulation of the 
chiroptical spectra, leading to a completely unusable and unreliable approach. 
Fortunately, high resolution NMR spectroscopy, in particular the NOE experiments coupled 
with bi-dimensional spectra, can easily unravel the relative configuration of the chiral centres, 
and can also provide precious information about the molecular conformation in solution. 
In the following analysis of the organocascade products, the AC will be determined exploiting 
all the mentioned techniques, i.e. anomalous dispersion X-ray diffraction when feasible, and 
coupled NMR/ECD/TD-DFT approach when the former cannot be applied.  
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Tandem double Michael addition for the synthesis of spiro-oxindolic cyclohexanones 6 
 
Compounds 6b, 6f and 6h were selected as representative samples in order to determine the 
relative and absolute configuration of the stereogenic centres.  
 
Compound 6b  
 
Compound 6b was selected for the NMR analysis because of its relatively simple NMR 
spectrum in the aromatic region. Full assignment of the protons signals (and carbons as well) 
was obtained by gs-HSQC, gs-HMBC and g-COSY 2D-NMR spectra. Owing to the crowding of 
the aromatic region of the 1H spectrum, unambiguous identification of the signals of the 
oxindole ring and of the two aromatic rings is essential for the correct interpretation of the 
subsequent NOE spectra. 
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Supplementary Figure 5. Top: aliphatic (top) and aromatic (bottom) regions of the 1H NMR 
spectrum of compound 6b (600 MHz in CD3CN solution), assigned by means of g-COSY and gs-
HMBC spectrum.  
 
Analysis of the proton spectrum in the aliphatic region (Supplementary Figure 5, top trace), 
show that both the signals of H-2 and H-6 have a large coupling constant with H-3 and H-5 
(14.0 and 9.5 Hz, respectively), indicating a relative disposition in which the dihedral is near to 
180°138. NOE spectra were obtained by means of the DPFGSE-NOE sequence73, and saturating 
the signals corresponding to the hydrogens of the cyclohexanone, to the ortho-protons of the 
two aromatic rings, and to the hydrogen of the oxaindole peri to the spiranic carbon (H-A). 
Seleted traces are shown in Supplementary Figure 6. 
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Supplementary Figure 6. DPFGSE-NOE spectra obtained for 6b (600 MHz in CD3CN). Trace a): 
control spectrum. Traces b-e: NOE spectra obtained on saturation of H-2, H-6, H-3 and H3’. 
Observed NOE are indicated as double arrows in the DFT-optimized structure (“control” NOE 
are not indicated for clarity). 
The most indicative spectrum corresponds to trace b, in which the signal corresponding to H-2 
is irradiated. Large NOE effects are visible on the ortho signals of the phenyl in position 2139, on 
the peri signal of the oxindole (H-A in Supplementary Figure 6), and on the signal of one 
distereotopic hydrogen H-3. Smaller enhancements are also visible for the ortho hydrogens of 
the phenyl in position 6, and for H-5. These NOE indicate that H-2 places itself close to the 
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aromatic ring of oxindole, and far from H-6. The two aromatic rings are therefore in a trans 
relationship. Saturation of H-6 (trace c) further confirms this hypothesis: NOE enhancements 
are observed for the ortho protons of Ph(6)10, on the second hydrogen belonging to carbon 3 
(H-3’), and on the signal of H-5, while no effect was observed on the hydrogens of oxindole. 
There are, however, some incongruence between the observed NOEs and the results deduced 
from the proton spectrum. If a chair conformation of the cyclohexanone ring is taken into 
account and the two aromatic rings are in a trans relationship, they have to occupy axial and 
equatorial positions, respectively. In this case, a trans-diaxial coupling constant can play only 
for the proton that occupies the axial position (H-2), and not for the other hydrogen in the 
equatorial position (H-6). Secondly, in this conformation NOE between H-6 and H-3 cannot be 
observed, because of the relative 1-4 disposition on the ring. These consideration strongly 
indicate that the ciclohexanone ring assumes a twisted-boat conformation, in which both the 
aromatic rings are in a pseudo-equatorial position, probably to reduce steric hindrance.140 
Traces d) and e) of Supplementary Figure 6 fully support this hypothesis: on saturation of H-3, 
NOE effect is not observed on H-5, that would be in a 1-3 diaxial disposition in the chair 
conformation, and far from H-3 in the case of the twisted boat conformation. From the NOE 
analysis, the relative configuration of the three chiral carbons is therefore 1R*,2R*,6R*.  
 
Supplementary Scheme 1 
Twisted Boat Chair
 
DFT calculations (B3LYP/6-31G(d) level)78 for both the chair and twisted-boat conformation 
were carried out in order to evaluate their energy difference. Both conformations corresponds 
to energy minima, and the chair conformation is calculated to be more stable than the twisted 
boat by 1.1 kcal/mol (see Supplementary Scheme 1 and Table 1). The coupling constant data 
and the NOE spectra suggest, however, that the twisted boat conformation has a larger 
population in solution (acetonitrile) with respect to that derived from the calculations (14%). In 
fact, the observed J-coupling of H-5 (9.5 Hz) is the weighted average between a pseudo-diaxial 
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coupling in the twisted boat conformation (about 14 Hz) and a equatorial-axial coupling in the 
chair conformation (about 6 Hz). The population of the twisted boat conformation can be 
calculated to be about 44% (i.e. 14·0.44 + 6·0.56 = 9.5 Hz). 
 
Supplementary Table 1: Calculated relative energies (ΔE) and free energies (ΔG) of the two 
conformations of 6b (in kcal/mol, B3LYP/6-31G(d) level). Populations percentages (P) are 
calculated assuming Boltzmann statistics at T=25°C. 
 
Molecule Conf. ΔE ΔG P(%) 
6b 
a (chair) 0.00 0.00 86 
b (twisted boat) 1.74 1.07 14 
 
Due to the absence of an “heavy” atom, the Bijovet method based on anomalous X-ray 
dispersion to assign the absolute configuration of 6b is precluded. In the present case, 
theoretical calculation of ECD spectra was carried out by means of TD-DFT method, since this 
technique has been successfully employed several times to predict ECD spectra and to assign 
the AC of organic molecules137. Compound 6b is a relatively rigid molecule, and starting from 
the information obtained by NOE analysis, only two conformations should be populated. In any 
case, a conformational search has been carried out using Monte Carlo searching together with 
the MMFF94 molecular mechanics force field (as implemented in Titan 1.0.5).77 All 
conformations within a 5 kcal/mol window were then optimized using DFT at the B3LYP/6-
31G(d) level78, and the harmonic vibrational frequencies of each conformation were calculated 
at the same level to confirm their stability (no imaginary frequencies observed), and to 
evaluate the free energy of each conformation. After DFT minimization, the MMFF structures 
grouped into the two conformations, named a-b (see Supplementary Table 1), already 
deduced by NMR analysis. 
Calculation of the Electronic Circular Dichroism spectrum was carried out using TD-DFT method 
at the B3LYP/6-31+G(d,p)//B3LYP/6-31G(d) level, and assuming 1S, 2S, 6S absolute 
configuration141. Rotational strength were calculated in both length and velocity 
representation.  Since the resulting values are very similar, errors due to basis set 
incompleteness are very small.142 Electronic excitation energies and rotational strengths have 
been calculated for the two conformation, and the ECD spectra were obtained by applying a 
0.25 eV Gaussian shaped line width (Supplementary Figure 7). The spectra show different 
shapes, indicating that the relative population of the two conformations has a great influence 
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on the spectrum. The final simulated ECD spectrum (bottom in Supplementary Figure 7) was 
obtained taking into account the 76:14 population ratio determined assuming Boltzmann 
statistics from the calculated free energies at the B3LYP/6-31G(d) level (Supplementary Table 
1). The agreement between calculated and experimental spectrum is fairly good, and the TD-
DFT simulation therefore supports the conclusion that the AC of 6b is 1S, 2S, 6S.  
6  
Supplementary Figure 7. Top: calculated ECD spectra for the two conformations a-b of 6b. 
Bottom: experimental (black) and calculated ECD spectra (red), weighted on the calculated 
free energies of the conformations (the simulated spectrum has been blue-shifted by 4 nm). 
Molecular CD (Δε) is expressed in L mol-1cm-1. 
 
Being the ECD spectrum very sensible to conformational weighting, further indications are 
desirable, and many attempts were carried out in order to crystallize the similar compounds 6c 
or 6d, that bears an heavy atom like chlorine, but suitable single crystals were never obtained. 
In a serendipitous way, some crystals were obtained on a batch of the enantiomer of 6c, left 
(by accident) to air in a solution of hexane/Et2O/methanol. This compound, ent-6c, was 
obtained using pseudo-enantiomer 9-Amino(9-deoxy)epi-hydroquinidine B in the reaction, 
therefore the configuration at all the stereogenic centres is opposite with respect to 6c. When 
subjected to anomalous dispersion X-ray analysis, these crystals showed 1R, 2R, 6R 
stereochemistry, therefore the configuration of 6c is 1S, 2S, 6S, as correctly deduced by the TD-
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DFT simulation of 6b. In order to avoid any error, an HPLC analysis on chiral stationary phases 
was performed by dissolving the very same crystal used for X-ray analysis, to confirm that the 
crystal used had opposite absolute configuration with respect to 6c (see Supplementary Figure 
8) 
a)
b)
c)
10 14 18 min
 
Supplementary Figure 8: a): HPLC trace on chiral stationary phase of the racemic mixture of 
6c. b): HPLC trace of the sample prepared using A catalyst. c): HPLC trace of the solution 
obtained by dissolving the crystal used for X-ray diffraction. 
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Supplementary Figure 9. Top: front view of one molecule of ent-6c extracted from the X-ray 
data, showing the twisted boat conformation of the cyclohexanone ring. Bottom: full view of 
the crystal structure, showing three independend molecules and a molecule of methanol 
(solvent). 
The triclinic crystal cell (P1 space group) contains three independent molecules, and a 
molecule of methanol (Supplementary Figure 9). All the three independent molecules show a 
twisted boat conformation of the cyclohexanone ring, and the experimental structure is 
identical to that calculated by DFT calculation in the case of 6b. 
 
Compound 6f 
 
Compound 6f bears four stereogenic carbons, and it is conformationally more flexible with 
respect to 6b, because of the presence of the CO2Et group, that can assume two different 
orientations. All the attempts to crystallize 6f or an analogue containing a chlorine atom were 
unsuccessful. As in the case of 6b, the relative configuration was deduced from NMR analysis. 
All the signal in the 1H and 13C spectrum were routinely assigned by means of 2D-spectra (gs-
HSQC, gs-HMBC and COSY), and the relative configuration deduced from NOE spectra. 
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Supplementary Figure 10. Aliphatic region of the 1H NMR spectrum of compound 6f (600 MHz 
in CDCl3), assigned by means of g-COSY and gs-HMBC spectrum. 
 
Analysis of the 1H spectrum of 6f shows that the signals of H-6 and H-2 (Supplementary Figure 
10) show very different coupling constants. In the case of H-6, the coupling constants with the 
two hydrogens H-5 and H-5’ are 13.4 and 4.8 Hz, whereas in the case of H-2 the coupling 
constant with H-3 is 6.0 Hz. These values suggest that H-6 occupies an axial position and it is 
coupled with the axial hydrogen belonging to C-5 (H-5ax). Secondly, H-2 is probably in 
equatorial position and coupled with H-3 (the other possibility is that H-2 and Me(3) are both 
axial, therefore the 6.0 Hz J-coupling would be an axial-equatorial one). NOE spectra were 
acquired using the DPFGSE-NOE sequence, and saturating the signals of H-2, H-3, H-6, and 
Me(3) (Supplementary Figure 11).  
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Supplementary Figure 11. DPFGSE-NOE spectra obtained for 6f (600 MHz in CDCl3). Trace a): 
control spectrum. Traces b-e: NOE spectra obtained on saturation of H-6, H-3, H-2 and Me(3). 
Observed NOE are indicated as double arrows in the DFT-optimized structure (“control” NOEs 
are not indicated for clarity). 
 
On saturation of H-6 (trace b), large NOE effects are seen on the ortho-hydrogens10 of the 
phenyl ring, on the equatorial hydrogen H-5eq, and on the signal corresponding to the peri 
hydrogen of the oxindole ring (H-A). The latter NOE indicates that H-2 is close to the aromatic 
ring of oxindole. The lack of a 1-3 diaxial NOE on H-2 indicates, on the other hand, that the 
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hydrogen in position 2 is in the equatorial position, and that the CO2Et group occupies the axial 
position. This trans relationship between the phenyl and CO2Et groups is confirmed when H-2 
is saturated (trace c). In this case, in fact, NOE effects are observed for the signal of Me(3) and 
H-5ax, but neither on the H-A signal of oxaindole, nor for the ortho signals of Ph(6). Finally, 
saturation of H-3 and Me(3) (traces c and e) suggest that in compound 6f the conformation of 
the cyclohexanone ring is a chair, and that the Methyl group occupies the equatorial position. 
In fact, a 1-3 diaxial NOE is observed on H-5ax when H-3 is irradiated, whereas a strong NOE is 
observed only on H-2 when Me(3) is saturated. NOE results therefore suggest that the relative 
stereochemistry of 6f is 1R*,2R*,3S*,6S* 
 Compound 6f is a molecule more flexible than 6b, because the CO2Et group can have 
different orientations due to rotation of the C(2)-CO bond. Moreover, the presence of a 
twisted boat conformation cannot be excluded, even if the NOE data indicate the prevalence 
in solution of the chair conformation. As in the case of 6b, a conformational search has been 
carried out using Monte Carlo searching together with the MMFF94 molecular mechanics force 
field (as implemented in Titan 1.0.5). All conformations within a 10 kcal/mol window were 
then optimized using DFT at the B3LYP/6-31G(d) level78 and the harmonic vibrational 
frequencies of each conformation were calculated at the same level to confirm their stability 
(no imaginary frequencies observed), and to evaluate the free energy of each conformation. 
After DFT minimization, two pairs of conformation named a-d (see Supplementary Table 2), 
were picked out. The first pair has the cyclohexane in a chair conformation, and differs from 
the orientation of the CO2Et group. The two chair conformations are much more stable than 
the second pair, which corresponds to a twisted boat conformation of the cycle, therefore 
confirming the NOE results. The difference in energy is very large, and only the chair structures 
need to be included in the following ECD simulation. 
 
158 
 
 
Supplementary Table 2: Calculated relative energies (ΔE) and free energies (ΔG) of the 
conformations of 6f (in kcal/mol, B3LYP/6-31G(d) level). Populations percentages (P) are 
calculated assuming Boltzmann statistics at T=25°C. 
 
Molecule Conf. ΔE ΔG P(%) 
6f  
a (chair) 0.00 0.00 96 
b (chair) 1.59 1.85 4 
c (twisted boat) 6.20 6.29 - 
d (twist boat) 7.25 7.63 - 
 
As in the case of 6b, calculation of the Electronic Circular Dichroism spectrum of 6f was carried 
out using TD-DFT method at the B3LYP/6-31+G(d,p)//B3LYP/6-31G(d) level, and assuming 1R, 
2R, 3S, 6S absolute configuration.80 Rotational strength were calculated in both length and 
velocity representation. Since the resulting values are very similar, errors due to basis set 
incompleteness are very small.81 Electronic excitation energies and rotational strengths have 
been calculated for the two conformation of 3f, and the ECD spectra were obtained by 
applying a 0.25 eV Gaussian shaped line width (Supplementary Figure 12). The spectra show 
the same trend and differs for the intensity of the Cotton effects, indicating that the different 
orientation of the CO2Et has not a great influence on the spectrum. The final simulated ECD 
spectrum (bottom in Supplementary Figure 12) was obtained taking into account the 96:4 
population ratios determined assuming Boltzmann statistics from the calculated free energies 
at the B3LYP/6-31G(d) level (Supplementary Table 2). The agreement between calculated and 
experimental spectrum is fairly good, the trend and position of the four Cotton effects are 
correctly simulated. The TD-DFT simulation therefore supports the conclusion that the AC of 6f 
is 1R, 2R, 3S, 6S. It is worth to note that the AC of 6f is structurally the same obtained for 6b 
and 6c, the difference in the stereochemical descriptors being ascribable to the different 
numbering order of the cyclohexanone carbons, and to the different priority of the 
substituents in the case of the spiranic carbon. (1R in 6f, 1S in 6b and 6c) 
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Supplementary Figure 12. Calculated ECD spectra for the two conformations a-b of 
6f. Bottom: experimental (black) and calculated ECD spectra (red), weighted on the 
calculated free energies of the conformations. Molecular CD (∆ε) is expressed in L mol-
1cm-1. 
 
Compound 6h 
 
Compound 6h is a very rigid and crowded molecule, and its stereochemical analysis has 
been carried out exclusively by NMR and ECD calculations. As in the previous 
compounds, 2D-NMR spectra helped in the assignment of the proton signals. Due the 
rigidity of the triciclic system, and to the presence of an aromatic ring in a spatially 
locked disposition, the proton spectrum of the triciclic system is spread over a very 
large chemical shift range, and some signals are overlapped by the solvent used for 
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NMR (Acetonitrile-d3) Supplementary Figure 13 shows the aliphatic region of the 
HSQC spectrum, and indicates the relationship of the three pair of diastereotopic 
hydrogens. 
 
 
Supplementary Figure 13. Aliphatic region of the edited-gsHSQC spectrum of 6h 
(600 MHz in CD3CN). The blue cross peaks indicate the CH2 signals, whereas the red 
cross-peaks indicate the CH signals. The signals of OCH2 and of the two methyl groups 
are outside the region shown. Assignment of the signals is deduced from the gs-HMBC 
spectrum (not shown). 
 
DPFGSE NOE spectra73 were acquired to determine the orientation of the oxindole ring 
and the position of the CO2Et group. (Supplementary Figure 14). Saturation of H-2 
(trace b) yields large NOEs on H-3, H-7 and H-A of oxindole, indicating that the 
aromatic ring of oxindole is on the same side of H-2, and that H-2 places itself in the 
endo position of the triciclic system, close to H-7. Saturation of the H-A signal (trace a) 
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yields NOE on H-2 (a cross check), and on the two endo hydrogens H-7 and H-8. These 
NOE confirm that the aromatic system of oxindole is in the endo position. This 
disposition also implies that the two oxygens of oxindole and CO2Et are both in eso 
position, and close to the carbonyl in position 4. The results obtained by NOE spectra 
conclude that the relative stereochemistry of 6h is 1R*,2R*,3R*,6R* 
 
 
Supplementary Figure 14. DPFGSE-NOE spectra obtained for 6h (CD3CN solution). 
Trace a): control spectrum. Traces b-e: NOE spectra obtained on saturation of H-A, H-
2, H-3 and Me(6). Observed NOE are indicated as double arrows in the DFT-optimized 
structure (“control” NOEs are not indicated for clarity). 
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With the exception of the CO2Et group, compound 6h is very rigid, and the 
conformational analysis by MMFF can be safely skipped, because only the two 
conformations in which the CO2Et group is turned by 180° need to be considered. These 
were optimized using DFT at the B3LYP/6-31G(d) level,78 and the harmonic vibrational 
frequencies were calculated at the same level to confirm their stability (no imaginary 
frequencies observed), and to evaluate the free energy of each conformation 
(Supplementary Table 3). 
 
Supplementary Table 3: Calculated relative energies (ΔE) and free energies (ΔG) of the 
conformations of 6h (in kcal/mol, B3LYP/6-31G(d) level). Populations percentages (P) are 
calculated assuming Boltzmann statistics at T=25°C. 
 
Molecule Conf. ΔE ΔG P(%) 
6h  
a 0.00 0.00 85 
b 0.10 1.23 15 
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Supplementary Figure 15. calculated ECD spectra for the two conformations a-b of 6h. 
Bottom: experimental (black) and calculated ECD spectra (red), weighted on the calculated 
free energies of the conformations. Molecular CD (Δε) is expressed in L mol-1cm-1. 
 
As in the case of 6b and 6f, calculation of the Electronic Circular Dichroism spectrum of 6h was 
carried out using TD-DFT method at the B3LYP/6-31+G(d,p)//B3LYP/6-31G(d) level, and 
assuming 1R, 2R, 3R, 6R absolute configuration.80 Rotational strength were calculated in both 
length and velocity representation. Since the resulting values are very similar, errors due to 
basis set incompleteness are very small.81 Electronic excitation energies and rotational 
strengths have been calculated for the two conformation of 6h, and the ECD spectra were 
obtained by applying a 0.25 eV Gaussian shaped line width (Supplementary Figure 15). The 
spectra show the same trend and differ only for the intensity of the Cotton effects, indicating 
that the different orientations of the CO2Et have not a great influence on the trend of the 
spectrum. The final simulated ECD spectrum (bottom in Supplementary Figure 15) was 
obtained taking into account the 85:15 population ratio determined assuming Boltzmann 
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statistics from the calculated free energies at the B3LYP/6-31G(d) level (Supplementary Table 
3). The agreement between calculated and experimental spectrum is very good, therefore the 
TD-DFT simulation assign the AC of 6b as 1R, 2R, 3R, 6R. Except for the carbon in position 2, 
the AC obtained is structurally the same obtained for 6b and 6c, the difference in the 
stereochemical descriptors of carbons 1, 3 and 6 being the effect of the different numbering 
order, and to the different priority order of the substituents in the case of the spiranic carbon. 
 
Triple Organocascade leading to compounds 4 
 
Stereochemical assignment was separately done on selected examples for the two 
classes of compounds 4, i.e. the ones bearing two aromatic groups in position 2 and 6 of 
the cyclohexene ring, and the ones bearing one aromatic substituent and a CO2Et group 
in position 6 and 2, respectively.  
 
Compound 4a 
 
Compounds 4a-4g, bearing two aromatic substituents in position 2 and 6 of the 
cyclohexene ring, did not yield crystal suitable for X-ray diffraction analysis. 
Accordingly, the relative stereochemistry has been determined by NMR spectroscopy, 
and absolute configuration determined by chiroptical methods, as in the cases of 6b, 6f, 
6h. Compound 4a, bearing two phenyl rings, was selected to determine the 
stereochemistry of this series. Assignment of the NMR protons signals (and carbons as 
well) was obtained by gs-HSQC, gs-HMBC and g-COSY 2D-NMR spectra. Owing to 
the crowding of the aromatic region of the 1H spectrum, unambiguous identification of 
the signals of the oxindole ring and of the two phenyl groups is essential to the correct 
interpretation of the subsequent NOE spectra. It is worth to note that the aromatic region 
of the 1H spectrum shows, at ambient temperature, very broad signals, that sharpens on 
lowering the temperature. At -10°C, five separated signals are observed for the 
hydrogens belonging to the phenyl in position 2 (red diamonds in Supplementary Figure 
16). This observation implies that the rotation of the phenyl ring around the C2-Ar axis 
is slow on the NMR time scale. For this reason all the NMR spectra were recorded at -
10°C, in order to have well resolved signals.  
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Supplementary Figure 16. Aromatic region of the 1H NMR spectrum of compound 4a (600 MHz 
at -10°C in CD3CN solution), assigned by means of g-COSY spectrum. Blue circles indicate the 
signals belonging to the oxaindole ring; red diamonds indicate the signals of Ph(2); black 
square indicates the signals of Ph(6); the black arrow indicates the H-4 signal. The numbers 
below the spectrum indicate the integrated areas. 
At -10°C also the signals corresponding to the ortho and meta hydrogens of the phenyl ring in 
position 6 are quite broad (black square in Supplementary Figure 16), indicating that also the 
rotation of this ring is not completely free. A second interesting feature of the proton 
spectrum is the chemical shift of the oxindolic proton peri to the spiranic carbon C(1), that is 
found at 5.40 ppm. This unusual shielding is probably due to the proximity of the phenyl ring in 
position 2 (see below). 
Assignment of the two pair of ortho hydrogens was obtained by saturation of the H-6 
signal (doublet, 3.13 ppm), yielding NOE on the ortho hydrogens of Ph(6) at 7.00 ppm, 
and by saturation of the H-2 signal (singlet, 4.85 ppm), yielding NOE on the ortho 
hydrogens of Ph(2) at 6.56 ppm and 7.26 ppm (even if the rotation is slow in the NMR 
time scale, it can still exchange the two protons during the mixing time of the NOE 
sequence). 
The relative configuration of the four stereogenic centres has been determined by NOE 
experiments, saturating the signals corresponding to H-A, H-2, H-6 and Me(5) (See 
Supplementary Figure 17). On selective saturation of the methyl group in position 5 
(1.13 ppm, trace e), large positive NOE are observed on H-4, H-5 (these are “control” 
NOEs)10 and on H-6. The latter NOE implies that the hydrogen in position 6 lies on the 
same side of Me(5), and Ph(6) places itself on the opposite side of the cyclohexene ring. 
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Small positive NOE are also detected for the two ortho hydrogen of Ph(2), indicating 
that Ph(2) is probably on the same side of H-6. 
On saturation of H-6 (trace d), large positive NOE are observed on Me(5), on the ortho-
hydrogens of Ph(6)10, on the ortho hydroges of Ph(2) (H-C in Supplementary Figure 
17), and on the oxindole hydrogen peri to the spiranic carbon (H-A). These effects 
indicate that H-6 is close to the hydrogen of the oxindole, and confirm that Ph(2) is on 
the same side of H-6. This latter result is further confirmed when H-2 is saturated. NOE 
effects are visible only on the ortho hydrogens of Ph(2), and no effect is observed either 
on H-A or H-6. Finally, saturation of H-A of the oxindole ring confirms that it is close 
to H-6. In conclusion, all the NOE constraints indicate that the relative configuration of 
4a is 1R*,2R*,5S*,6S*.  
The hindered rotation of the phenyl in position 2, and the slow rotation of the phenyl in 
position 6 are symptomatic of a rigid core system, with conformational flexibility 
limited to the conformation of the aldehyde group. However, NOE spectrum obtained 
on saturation of the aldehyde signal yields NOE enhancement only on H-4, and not on 
H-2, showing that there is only one populated conformation, in which the H-CO 
hydrogen is close to H-4. Compound 4a is therefore quite rigid, and the conformational 
analysis could be driven by the NOE constraints. Anyway, conformational search was 
performed by MM methods starting from the relative configuration obtained by NOE 
analysis. In the first 5 kcal/mol window, MMFF calculations find only two energy 
minima, corresponding to the two previously pictured structures, that differ by the 180° 
rotation of the CHO group. These two structures were then optimized by DFT at the 
B3LYP/6-31g(d) level, and the best structure fully agrees with the NOE constraints, 
also for the conformation of the CHO group. 
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Supplementary Figure 17: DPFGSE-NOE spectra obtained for 4a (at -10°C in 
CD3CN). Trace a): control spectrum. Traces b-e: NOE spectra obtained on saturation of 
H-A, H-2, H-6 and Me(5). Observed NOE are indicated as arrows in the DFT-optimized 
structure. 
 
The second structure has an energy higher by 2.49 kcal/mol, therefore the molecule can be 
considered conformationally rigid, and only one conformation has to be considered for the 
calculation of the ECD spectrum. Analysis of the optimized structures shows that the oxindole 
hydrogen H-A is located exactly in the centre of the phenyl ring in position 2, its distance from 
the aryl plane being about 3.2Å. This feature explains the upfield shift of this hydrogen, 
because of the ring currents of the aryl ring.143 
Electronic excitation energies and rotational strengths have been calculated for the best 
geometry using TD-DFT at the B3LYP/6-31+G(d,p)//B3LYP/6-31G(d) and assuming 1R, 2R, 5S, 
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6S absolute configuration (Supplementary Figure 18). Rotational strength were calculated in 
both length and velocity representation. The calculated values are very similar, therefore 
errors due to basis set incompleteness are very small. The agreement between calculated and 
experimental spectrum is fairly good, and correctly simulates the signs of the experimental 
Cotton effects. The TD-DFT simulation indicates that the AC of 4a is 1R, 2R, 5S, 6S. 
 
Supplementary Figure 18. Experimental (black) and calculated ECD spectra (red) for the single 
conformation of 4a. Molecular CD (Δε) is expressed in L mol-1cm-1. 
 
 
Compound 4n 
 
In the case of compound 4n, crystal suitable for X-ray diffraction were obtained by slow 
evaporation of an hexane/dichloromethane solution. When subjected to X-ray analysis, 
compound 4n showed relative stereochemistry 1R*, 2S*, 5R*, 6S* (see Supplementary Figure 
19). The X-ray structure shows that the allyl group in position 3 is disordered, and occupies two 
different crystallographic positions, each one populated at 57% and 43%, respectively. Due to 
the absence of an “heavy” atom, the Bijovet method based on anomalous X-ray dispersion to 
assign the absolute configuration is precluded. However, evaluation of the Flack parameters 
obtained on the two enantiomorphic structures suggests that the 1S, 2R, 5S, 6R configuration 
is the more probable. Starting from the two conformation observed in the X-ray diffraction, a 
conformational search has been carried out using Monte Carlo searching together with the 
MMFF94 molecular mechanics force field (as implemented in Titan 1.0.5). All conformations 
within a 5 kcal/mol window were then optimized using DFT at the B3LYP/6-31G(d) level78, and 
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the harmonic vibrational frequencies of each conformation were calculated at the same level 
to confirm their stability (no imaginary frequencies observed), and to evaluate the free energy 
of each conformation. After DFT minimization, the MMFF structures group into eight stable 
conformations, named a-h in Supplementary Table 4. 
 
 
Supplementary Figure 19. Left: X-ray diffraction structure. Right: Lowest energy structure 
obtained by DFT calculations. 
 
These eight conformations correspond to the combinations of the orientations of the three 
exocylic groups, i.e. the groups allyl, CO2Et and CHO. Two of them are almost identical to the 
geometries obtained by X-ray data and the global minimum a comfortably corresponds to one 
of these two conformations. 
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Supplementary Table 4: Calculated relative energies (ΔE) and free energies (ΔG) of the 
conformations of Q (in kcal/mol, B3LYP/6-31G(d) level). Populations percentages (P) are 
calculated assuming Boltzmann statistics at T=25°C. 
 
Molecule Conf. ΔE ΔG P(%) 
4n 
a 0.00 0.00 72 
b 1.31 1.07 12 
c 0.82 0.98 14 
d 1.98 2.12 2 
e 2.55 2.30 - 
f 3.50 3.32 - 
g 3.38 3.20 - 
h 4.22 4.03 - 
 
Electronic excitation energies and rotational strengths have been calculated for the first of the 
four conformations of 4n, using TD-DFT at the B3LYP/6-31+G(d,p)//B3LYP/6-31G(d) and 
assuming 1S, 2R, 5S, 6R absolute configuration, with the results shown in Supplementary 
Figure 20. Rotational strength were calculated in both length and velocity representation. The 
resulting values are very similar, therefore errors due to basis set incompleteness are very 
small.81 The four ECD spectra obtained (top in Supplementary Figure 20) show similar shapes, 
indicating that the conformation of the exocylic groups does not exert a great influence on the 
spectrum. The final simulated ECD spectra was obtained taking into account the 72:12:14:2 
population ratios determined assuming Boltzmann statistics from the calculated free energies 
at the B3LYP/6-31G(d) level (Supplementary Table 4). The agreement between calculated and 
experimental spectrum is very good, and correctly simulates the signs of the observed Cotton 
effects. The TD-DFT simulation therefore supports the conclusion that the AC of 4n is 1S, 2R, 
5S, 6R. 
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Supplementary Figure 20. Top: calculated ECD spectra for the four conformations of 4n. 
Bottom: experimental (black) and calculated ECD spectra (red), weighted on the calculated 
free energies of the four conformations a-d. Molecular CD (Δε) is expressed in L mol-1cm-1. 
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TABLE OF RESULTS 
 
Compd. 
Relative  
configuration 
Absolute 
Configuration 
Method 
6b 1R*, 2R*, 6R* 1S, 2S, 3S NMR-ECD/TD-DFT 
ent-6c - 1R, 2R,6R A.D. X-Ray 
6f 1R*, 2R*, 3S*, 6S* 1R, 2R, 3S, 6S NMR-ECD/TD-DFT 
6h 1R*, 3R*, 3R*, 6R* 1R, 2R, 3R, 6R, NMR-ECD/TD-DFT 
4a 1R*, 2R*, 5S*, 6S* 1R, 2R,5S,6S X-Ray-ECD/TD-DFT 
4n 1R*, 2S*, 5R*, 6S* 1S, 2R, 5S, 6R NMR-ECD/TD-DFT 
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Crystal Data for 4n 
 
 
Crystals obtained from hexane/dichloromethane solution, molecular formula: C26H25NO4, Mr = 
415.47, monoclinic, space group P21 (No. 3), a = 9.1003(11), b = 9.3928(12), c = 13.8607(17), β 
= 106,0440(10) Å, V = 1138.6(2) Å3, T = 298(2) K, Z = 2, ρc = 1.212 g cm–3, F(000) = 440, 
graphite-monochromated MoKα radiation (λ = 0.71073 Å), µ(MoKα) = 0.082 mm–1, colourless 
plates (0.40 × 0.40 × 0.25 mm3), empirical absorption correction with SADABS (transmission 
factors: 0.9681 – 0.9799), 2400 frames, exposure time 15 s, 1.53 ≤ θ ≤ 27.50, –11≤ h ≤ 11, –12 
≤ k ≤ 12, –17 ≤ l ≤ 17, 12891 reflections collected, 5172 independent reflections (Rint = 0.0205), 
solution by direct methods (SHELXS97) and subsequent Fourier syntheses, full-matrix least-
squares on Fo
2 (SHELX97), hydrogen atoms refined with a riding model, data / restraints / 
parameters = 5172/ 72 / 309, S(F2) = 1.023, R(F) = 0.0539 and wR(F2) = 0.1409 on all data, R(F) 
= 0.0476 and wR(F2) = 0.1329 for 4471 reflections with I > 2σ(I), weighting scheme w = 
1/[σ2(Fo
2) + (0.0897P)2 + 0.072400P] where P = (Fo
2 + 2Fc
2)/3, largest difference peak and hole 
0.283 and –0.147 e Å–3. Flack parametera: -0.7(12). The allyl group is disordered over two 
different positions, accordingly it was split into two parts and refined (final optimized ratio 
57:43). Crystallographic data (excluding structure factors) for the structure reported in this 
paper have been deposited with the Cambridge Crystallographic Data Centre as 
supplementary publication no. CCDC-726678. Copies of the data can be obtained free of 
charge on application to CCDC, 12 Union Road, Cambridge CB21EZ, UK (fax: (+44) 1223-336-
033; e-mail: deposit@ccdc.cam.ac.uk). 
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a Flack, H. D. Acta Cryst. 1983, A39, 876-881 
 
Crystal Data for ent-6c 
 
 
Crystals obtained from hexane/Et2O/methanol solution, molecular formula: C25H21NO4Cl ·CH4O, 
Mr = 412.55, Triclinic, space group P1 (No. 1), a = 9.368(3), b = 13.827(4), c = 14.074(4), α = 
116.552(4), β = 98.650(4), γ = 96.680(4), V = 1577.1(9) Å3, T = 298(2) K, Z = 3, ρc = 1.303 g cm–3, 
F(000) = 648, graphite-monochromated MoKα radiation (λ = 0.71073 Å), µ(MoKα) = 0.205 mm–1, 
colourless plates (0.3 × 0.3 × 0.05 mm3), empirical absorption correction with SADABS 
(transmission factors: 0.9410 – 0.9898), 2400 frames, exposure time 25 s, 1.66 ≤ θ ≤ 27.50, –
12≤ h ≤ 12, –17 ≤ k ≤ 17, –18 ≤ l ≤ 18, 17596 reflections collected, 13581 independent 
reflections (Rint = 0.0232), solution by direct methods (SHELXS97) and subsequent Fourier 
syntheses, full-matrix least-squares on Fo
2 (SHELX97), hydrogen atoms refined with a riding 
model, data / restraints / parameters = 13581/ 3 / 804, S(F2) = 1.011, R(F) = 0.1160 and wR(F2) 
= 0.1509 on all data, R(F) = 0.0574 and wR(F2) = 0.1225 for 7776 reflections with I > 2σ(I), 
weighting scheme w = 1/[σ2(Fo
2) + (0.0546P)2 + 0.4625P] where P = (Fo
2 + 2Fc
2)/3, largest 
difference peak and hole 0.228 and –0.298 e Å–3. Flack parametera: 0.00(7). The unit cell 
contains three independent molecules and a molecule of methanol. Crystallographic data 
(excluding structure factors) for the structure reported in this paper have been deposited with 
the Cambridge Crystallographic Data Centre as supplementary publication no. CCDC-726679. 
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Copies of the data can be obtained free of charge on application to CCDC, 12 Union Road, 
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General procedure for Tandem double Michael addition for the synthesis of spiro-oxindolic 
cyclohexanone derivatives 6a-i. 
 
N
H
O
R1
O
+
N
H
O
R3
R1
O
R2
R2 A, 20 mol%
oF-C4H4CO2H (30 mol%)
toluene 1M, 60 °C, 72h
1 2 6
R3
 
 
All the reaction were carried out in undistilled toluene. In an ordinary vial equipped with a 
Teflon-coated stir bar, 9-Amino(9-deoxy)epi-hydroquinine A (0.08 mmol., 26 mg, 20 mol%) was 
dissolved in 0.4 mL of toluene and 2-fluorobenzoic acid (0.12 mmol., 16.8 mg, 30 mol%) was 
added. The resulting solution was stirred at room temperature for 10 minutes then α,β-
unsaturated ketone 2 (0.8 mmol., 2.0 equiv.) was added, followed by the addition of oxindole 
derivative 1 (0.4 mmol.). The vial was immerged in a oil bath at the indicated temperature and 
stirring continued for the indicated time. The crude mixture was flushed through a short plug 
of silica, using dichloromethane/diethyl ether 1:1 as the eluent (100 ml). Solvent was removed 
in vacuo and d.r was determined by 1H NMR analysis. Compound 3 was isolated by flash 
column chromatography using hexane/diethyl ether or dichloromethane /diethyl ether as the 
eluent mixtures. 
 
(6a). The reaction was carried out following the general 
procedure using A as the catalyst to furnish the crude product 
(d.r. >19:1 was determined by integration of 1H-NMR signal: 
δmajor 6.18 ppm. d, δminor 6.25 ppm. d). The title compound was 
isolated by flash column chromatography (hexane/diethyl ether 
= 6/4) in 59% yield and 98% ee. The ee was determined by HPLC 
analysis on a Daicel Chiralpak AD-H column: hexane/i-PrOH 
85:15, flow rate 0.75 mL/min, λ = 214, 254 nm: τmajor = 16.56 min., τminor = 24.19 min. [α]rt
D= -
N
H
O
O
6a
(2S,6S)-2,6-
diphenylspiro[cyclohexane-1,3'-
indoline]-2',4-dione
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112.9 (c = 0.96, CHCl3, 98% ee). HRMS: (m/z) calculated for C25H21NO2: 367.1572, found: 
367.1573. 1H NMR (600 MHz, CDCl3): δ 2.71 (dd, 1H, J1 = 15.8 Hz, J2 = 3.8 Hz), 2.98 (dd, 1H, J1 = 
16.0 Hz, J2 = 6.0 Hz), 3.62 (dd, 1H, J1 = 16.1 Hz, J2 = 6.0 Hz), 3.69 (t, 1H, J = 6.0 Hz), 3.78 (dd, 1H, 
J1 = 14.1 Hz, J2 = 3.8 Hz), 3.95 (dd, 1H, J1 = 15.7 Hz, J2 = 14.0 Hz), 6.19 (d, 1H, J = 7.7 Hz), 6.51 (d, 
1H, J = 7.7 Hz), 6.71 (dt, 1H, J1 = 7.6 Hz, J2 = 0.8 Hz), 6.86-6.91 (m, 2H), 6.92-6.97 (m, 2H), 6.97-
7.05 (m, 4H), 7.18-7.25 (m, 3H), 7.74 (bs, 1H). 13CNMR (150 MHz, CDCl3): δ 41.8 (CH), 42.6 (CH), 
45.5(CH2), 46.6 (CH2), 55.8 (C), 109.0 (CH), 121.6 (CH), 125.9 (CH), 127.1 (CH), 127.4(CH), 127.9 
(CH), 127.9 (CH), 128.0 (CH), 128.2 (CH), 129.3 (CH), 130.0 (C), 137.9 (C), 139.9 (C), 180.2 (C), 
211.0 (C). 
 
(ent-6a). The reaction was carried out following the general 
procedure using C as the catalyst to furnish the crude product (d.r. 
>19:1 was determined by integration of 1H-NMR signal: δmajor 6.18 
ppm. d, δminor 6.25 ppm. d). The title compound was isolated as 
single diasteroisomer by flash column chromatography 
(hexane/diethyl ether = 6/4) in 37% yield and 90% ee. The ee was 
determined by HPLC analysis on a Daicel Chiralpak AD-H column: 
hexane/i-PrOH 85:15, flow rate 0.75 mL/min, λ = 214, 254 nm: τmajor = 22.56 min., τminor = 15.69 
min.  
 
(3b). The reaction was carried out following the general 
procedure using A as the catalyst to furnish the crude 
product (d.r. 6:1 was determined by integration of 1H-
NMR signal: δmajor 2.97 ppm. dd, δminor 3.09 ppm. dd). 
The compound was isolated as a mixture of 
diasteroisomers (d.r = 4:1 determined by integration of 
1H-NMR signal: δmajor 2.97 ppm. dd, δminor 3.09 ppm. dd) by flash column chromatography 
(diethyl ether/hexane = 6/4) in 76% yield and 92% ee on the major diasteroisomer. After 
crystallization compound 3b was obtained as single diasteroisomer in 37% yield and 99% ee. 
The ee was determined by HPLC analysis on a Daicel Chiralpak AD-H column: hexane/i-PrOH 
80:20, flow rate 0.75 mL/min, λ = 214, 254 nm: τmajor = 21.55 min., τminor = 37.02 min. [α]rt
D= -
174.4 (c = 0.75, CHCl3, 99% ee). HRMS: (m/z) calculated for C26H20N2O2: 392.1525, found: 
392.1525. 1H NMR (600 MHz, CD3CN): δ 2.54 (dd, 1H, J1 = 16.2 Hz, J2 = 3.3 Hz), 3.17 (ABX 
system, 2H, J1 = 16.7 Hz, J2 = 9.6.3 Hz, J3 = 5.0 Hz), 3.79 (dd, 1H, J1 = 16.2 Hz, J2 = 14.0 Hz), 3.90 
(dd, 1H, J1 = 9.4 Hz, J2 = 5.0 Hz), 3.95 (dd, 1H, J1 = 14.0 Hz, J2 = 3.3 Hz), 6.48 (d, 1H, J = 7.7 Hz), 
N
H
O
O
ent-6a
(2R,6R)-2,6-
diphenylspiro[cyclohexane-1,3'-
indoline]-2',4-dione
N
H
O
O
6b
NC
4-((1S,2S,6S)-2',4-dioxo-2-phenylspiro
[cyclohexane-1,3'-indoline]-6-yl)benzonitrile
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6.78-6.84 (m, 2H), 6.94-7.04 (m, 5H), 7.23-7.18 (m, 3H), 7.41 (m, 2H), 8.12 (bs, 1H). 13CNMR 
(150 MHz, CD3CN): δ 41.6 (CH2), 41.8 (CH2), 45.8 (CH), 45.9 (CH), 56.6 (C), 109.4 (CH), 111.0 (C), 
117.8 (C), 118.9 (C), 121.8 (CH), 126.0 (CH), 127.5 (CH), 128.4 (CH), 128.6 (CH), 129.3 (CH), 
129.9 (CH), 130.7 (C), 131.9 (CH), 140.2 (C), 141.4 (C), 144.7 (C), 179.8 (C), 209.9 (C). 
The relative and absolute configurations for 3b have been inferred by using NMR NOE analyses 
coupled with TD-DFT calculations of the electronic circular dichroism (ECD) spectra, see 
Structural Assignment section.  
 
(6c). The reaction was carried out following the general 
procedure using A as the catalyst to furnish the crude 
product (d.r. 4:1 was determined by integration of 1H-
NMR signal: δmajor 6.18 ppm. d, δminor 6.38 ppm. d). The 
compound was isolated as a mixture of diasteroisomers 
(d.r = 4:1 determined by integration of 1H-NMR signal: 
δmajor 2.97 ppm. dd, δminor 3.09 ppm. dd) by flash column chromatography (diethyl 
ether/hexane = 1.1/1) in 65% yield and 89% ee on the major diasteroisomer. After 
crystallization compound 3c was obtained as single diasteroisomer in 21% yield and 99% ee. 
The ee was determined by HPLC analysis on a Daicel Chiralpak AD-H column: hexane/i-PrOH 
80:20, flow rate 0.75 mL/min, λ = 214, 254 nm: τmajor = 11.58 min., τminor = 18.57 min. [α]rt
D= -
113.9 (c = 0.67, CHCl3, 99% ee). MS (ESI): 424 (M
+ + Na, 100%), 440 (M+ +K, 10%). 1H NMR (600 
MHz, CDCl3): δ 
1H NMR (600 MHz, CDCl3): δ 2.67 (dd, 1H, J1 = 15.9 Hz,  J2 = 3.7 Hz), 2.97 (dd, 1H, 
J1 = 16.3 Hz, J2 = 6.3 Hz), 3.59 (dd, 1H, J1 = 16.2 Hz, J2 = 5.9 Hz), 3.69 (t, 1H, J = 6.2 Hz), 3.75 (dd, 
1H, J1 = 14.1 Hz, J2 = 3.7 Hz), 3.87-3.94 (m, 1H), 6.18 (d, 1H, J = 7.5 Hz), 6.53 (d, 1H, J = 7.7 Hz), 
6.72 (t, 1H, J = 7.7 Hz), 6.81 (d, 2H, J = 8.6 Hz), 6.91-6.95 (m, 2H), 6.97-7.02 (m, 3H), 7.18-7.23 
(m, 3H), 7.38 (bs, 1H). 13CNMR (150 MHz, CDCl3): δ 41. 8 (CH), 42.4 (CH), 45.0 (CH2), 46.5 (CH2), 
55.7 (C), 109.2 (CH), 121.5 (CH), 125.8 (CH), 127.5 (CH), 128.0 (CH), 128.1 (CH), 128.2 (CH), 
129.2 (CH), 129.6 (CH), 129.7 (C), 133.0 (C), 136.4 (C), 139.6 (C), 139.7 (C), 179.6 (C), 210.5 (C). 
 
 
(ent-6c). The reaction was carried out following the 
general procedure using C as the catalyst to furnish the 
crude product (d.r. 5:1 was determined by integration of 
1H-NMR signal: δmajor 6.18 ppm. d, δminor 6.38 ppm. d) 
The compound was isolated as single diasteroisomer by 
3cNH
O
O
Cl
(1S,2S,6S)-2-(4-chlorophenyl)-6-phenylspiro
[cyclohexane-1,3'-indoline]-2',4-dione
ent-6c
N
H
O
O
Cl
(1R,2R,6R)-2-(4-chlorophenyl)-6-phenylspiro
[cyclohexane-1,3'-indoline]-2',4-dione
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flash column chromatography (diethyl ether/hexane = 1.1/1) in 45% yield and 89% ee. After 
crystallization compound ent-3c was obtained as single diasteroisomer in 10% yield and 99% 
ee. The ee was determined by HPLC analysis on a Daicel Chiralpak AD-H column: hexane/i-
PrOH 80:20, flow rate 0.75 mL/min, λ = 214, 254 nm: τmajor = 18.88 min., τminor = 11.73 min.  
The relative and absolute configurations for ent-3c have been inferred by means of X-ray 
crystallography, see Structural Assignment section.  
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(6d). The reaction was carried out following the general 
procedure using A as the catalyst to furnish the crude product 
(d.r. = 7:1 was determined by integration of 1H-NMR signal: 
δmajor 5.99 ppm. d, δminor 6.38 ppm. d). The title compound was 
isolated as single diasteroisomer by flash column 
chromatography (hexane/diethyl ether = 2/1) in 82% yield and 
94% ee. The ee was determined by HPLC analysis on a Daicel Chiralpak AD-H column: hexane/i-
PrOH 80:20, flow rate 0.75 mL/min, λ = 214, 254 nm: τmajor = 11.05 min., τminor = 16.79 min. 
[α]rt
D= -107.1 (c = 1.05, CHCl3, 94% ee). 
1H NMR (600 MHz, CDCl3): δ 2.72 (1H, dd, J1 = 16.0 Hz, 
J2 = 4.0 Hz), 2.95 (dd, 1H, J1 = 18.0 Hz, J2 = 7.4 Hz), 3.61-3.67 (m, 2H), 3.73 (dd, 1H, J1 = 14.0 Hz, 
J2 = 3.8 Hz), 3.93 (dd, 1H, J1 = 15.7 Hz, J2 = 14.2 Hz), 6.01 (d, 1H, J = 2.1 Hz), 6.48 (d, 1H, J = 8.2 
Hz), 6.88-6.92 (m, 2H), 6.92-6.98 (m, 3H), 7.00-7.08 (m, 3H), 7.24-7.32 (m, 3H), 8.12 (bs, 1H). 
13CNMR (150 MHz, CDCl3): δ 41.6 (CH), 42.5 (CH), 45.4 (CH2), 46.7 (CH2), 56.1 (C), 110.0 (CH), 
126.3 (CH), 126.7 (C), 127.3 (CH), 127.7 (CH), 127.9 (CH), 128.0 (CH), 128.1 (CH), 128.2 (CH), 
129.3 (CH), 131.7 (C), 137.6 (C), 138.4 (C), 139.4 (C), 180.0 (C), 210.6 (C). 
 
(6e). The reaction was carried out following the 
general procedure using A as the catalyst to 
furnish the crude product (d.r. = 12:1 was 
determined by integration of 1H-NMR signal: 
δmajor 3.65 ppm. m, δminor 6.05 ppm. d). The title 
compound was isolated as single diasteroisomer 
by flash column chromatography (dichloromethane/diethyl ether = 9.5/0.5) in 80% yield and 
91% ee. After crystallization compound 3e was obtained as single diasteroisomer in 38% yield 
and 97% ee.The ee was determined by HPLC analysis on a Daicel Chiralpak AD-H column: 
hexane/i-PrOH 90:10, flow rate 0.75 mL/min, λ = 214, 254 nm: τmajor = 14.36 min., τminor = 23.11 
min. [α]rt
D= -83.1 (c = 1.06, CHCl3, 97% ee). 
1H NMR (600 MHz, CDCl3): δ 0.66 (d, 3H, J = 6.5 Hz), 
0.80 (d, 3H, J = 6.5 Hz), 0.90-0.97 (m, 1H), 1.14-1.20 (m, 1H), 1.42-1.51 (m, 1H), 2.46 (dd, 1H, J1 
= 15.7 Hz, J2 = 3.3 Hz), 2.52-2.60 (m, 2H), 3.0-3.07 (m, 1H), 3.49 (dd, 1H, J1 = 14.6 Hz, J2 = 3.3 
Hz), 3.62 (dd, 1H, J1 = 15.4 Hz, J2 = 14.1 Hz), 6.69 (d, 1H, J = 7.9 Hz), 6.72 (d, 1H, J =1.8 Hz), 6.83 
(bs, 1H), 6.99 (t, 1H, J = 8.0 Hz), 7.05-7.10 (m, 2H), 7.26 (d, 1H, J = 8.0 Hz), 7.80 (bs, 1H). 
13CNMR (150 MHz, CDCl3): δ 21.18 (CH3), 23.5 (CH3), 25.0 (CH), 37.3 CH), 40.2 (CH2), 40.7 (CH2), 
41.7 (CH2), 46.3 (CH), 55.8 (C), 110.5 (CH), 122.3 (CH), 125.6 (CH), 126.3 (CH), 127.6 (CH), 128.2 
(CH), 129.2 (C), 129.3 (CH), 133.8 (CH), 134.1 (C), 139.6 (C), 141.6 (C), 180.1 (C), 210.1 (C).  
N
H
O
6d
Cl
O
(2S,6S)-5'-chloro-2,6-diphenylspiro
[cyclohexane-1,3'-indoline]-2',4-dione
N
H
O
O
6e
Cl
Cl
(1S,2S,6R)-6'-chloro-2-(3-chlorophenyl)-6-isobutylspiro
[cyclohexane-1,3'-indoline]-2',4-dione
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(6g). The reaction was carried out following the 
general procedure using catalyst A to furnish the 
crude product (d.r. = 7:1:1 was determined by 
integration of 1H-NMR signal: δmajor 6.66 ppm. d, 
δminor 6.61 ppm. d, δminor 6.55 ppm. d). The title 
compound was isolated as single diasteroisomer 
by flash column chromatography (dichloromethane/diethyl ether = 30/1) in 63% yield and 97% 
ee. The ee was determined by HPLC analysis on a Daicel Chiralpak AD-H column: hexane/i-
PrOH 90:10, flow rate 0.75 mL/min, λ = 214, 254 nm: τmajor = 24.54 min., τminor = 27.18 min. 
[α]rt
D= -88.9 (c = 1.09, CH3CN, 97% ee). HRMS: (m/z) calculated for C23H23NO4: 377.1627, found: 
377.1628. 1H NMR (600 MHz, CDCl3): δ 1.07 (d, 3H, J = 6.9 Hz), 1.22 (t, 3H, J = 7.2 Hz), 2.64 (dd, 
1H, J1 = 14.4 Hz, J2 = 5.0 Hz), 3.08 (d, 1H, J = 5.7 Hz), 3.77 (t, 1H, J = 13.7 Hz), 4.02 (q, 1H, J = 6.5 
Hz), 4.13-4.20 (m, 1H), 4.22-4.29 (m, 1H), 4.33 (dd, 1H, J1 = 13.5 Hz, J2 = 4.6 Hz), 6.65 (d, 1H, J = 
7.7 Hz), 6.95-7.05 (m, 6H), 7.08-7.14 (m, 2H), 8.26 (s, 1H). 13CNMR (150 MHz, CDCl3): δ 11.5 
(CH3), 14.1 (CH3), 40.0 (CH), 42.6 (CH2), 45.8 (CH), 53.1 (C), 55.0 (CH), 61.0 (CH2), 109.8 (CH), 
122.2 (CH), 124.1 (CH), 127.2 (CH), 128.8 (CH), 128.5 (CH), 128.6 (CH), 129.2 (C), 138.9 (C), 
139.8 (C), 171.5 (C), 179.0 (C), 209.2 (C). 
The relative and absolute configurations for 6c have been inferred by using NMR NOE analyses 
coupled with TD-DFT calculations of the electronic circular dichroism (ECD) spectra, see 
Structural Assignment section. 
 
(ent-6g). The reaction was carried out following 
the general procedure using C as the catalyst to 
furnish the crude product. (d.r. = 4:1:1 was 
determined by integration of 1H-NMR signal: 
δmajor 6.64 ppm. d, δminor 6.60 ppm. d, δminor 6.55 
ppm. d). The title compound was isolated as 
single diasteroisomer by flash column chromatography (dichloromethane/diethyl ether = 30/1) 
in 56% yield and 93% ee. The ee was determined by HPLC analysis on a Daicel Chiralpak AD-H 
column: hexane/i-PrOH 90:10, flow rate 0.75 mL/min, λ = 214, 254 nm: τmajor = 26.93 min., τminor 
= 24.94 min.  
 
N
H
O
COOEt
O
6g
Me
(1R,2R,3S,6S)-ethyl 3-methyl-2',4-dioxo-6-phenylspiro
[cyclohexane-1,3'-indoline]-2-carboxylate
N
H
O
COOEt
O
Me
ent-6g
(1S,2S,3R,6R)-ethyl 3-methyl-2',4-dioxo-6-phenylspiro
[cyclohexane-1,3'-indoline]-2-carboxylate
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(6h). The reaction was carried out at 40 °C following 
the general procedure using A as the catalyst to 
furnish the crude product (d.r >19:1). The title 
compound was isolated as single diasteroisomer by 
flash column chromatography 
(dichloromethane/diethyl ether = 5/1) in 28% yield 
and 89% ee. The ee was determined by HPLC analysis 
on a Daicel Chiralpak AD-H column: hexane/i-PrOH 90:10, flow rate 0.75 mL/min, λ = 214, 254 
nm: τmajor = 35.54 min., τminor = 16.34 min. [α]rt
D= -24.5 (c = 1.00, CHCl3, 89% ee). 
1H NMR (600 
MHz, CDCl3): δ 1.10 (t, 3H, J = 7.2 Hz), 1.59-1.67 (m, 1H), 2.0-2.09 (m, 3H), 2.12 (dd, J1 = 19.2 
Hz, J2 = 2.8 Hz), 2.21-2.33 (m, 1H), 2.91 (q, 1H, J = 2.7 Hz), 3.20 (d, 1H, J = 2.2 Hz), 3.46 (dt, 1H, 
J1 = 19.2 Hz, J2 = 2.7 Hz), 4.02 (q, 2H, J = 7.1 Hz), 6.91 (d, 1H, J = 7.8 Hz), 7.10 (dt, 1H, J1 = 7.5 Hz, 
J2 = 0.7 Hz), 7.27 (dt, 1H, J1 = 7.7 Hz, J2 = 1.2 Hz), 7.35 (d, 1H, J = 7.6 Hz), 7.89 (bs, 1H). 
13CNMR 
(150 MHz, CDCl3): δ 13.8 (CH3), 21.1 (CH2), 23.2 (CH2), 36.9 (CH), 39.4 (CH2), 43.7 (CH), 50.1 
(CH), 51.6 (C), 61.1 (CH2), 110.0 (CH), 122.4 (CH), 124.0 (CH), 128 (CH), 133.7 (C), 140.7 (C), 
170.8 (C), 179.6 (C), 211.6 (C). 
 
(ent-6h). The reaction was carried out at 40 °C 
following the general procedure using C as the 
catalyst to furnish the crude product (d.r >19:1). The 
title compound was isolated as single diasteroisomer 
by flash column chromatography 
(dichloromethane/diethyl ether = 5/1) in 18% yield 
and 85% ee. The ee was determined by HPLC analysis 
on a Daicel Chiralpak AD-H column: hexane/i-PrOH 90:10, flow rate 0.75 mL/min, λ = 214, 254 
nm: τmajor = 16.2 min., τminor = 35.1 min.  
 
(6i). The reaction was carried out at 60 °C following 
the general procedure using A as the catalyst to 
furnish the crude product (d.r >19:1). The title 
compound was isolated as single diasteroisomer by 
flash column chromatography 
(dichloromethane/diethyl ether = 7/3) in 24% yield 
and 97% ee. The ee was determined by HPLC analysis 
on a Daicel Chiralpak AD-H column: hexane/i-PrOH 80:20, flow rate 0.75 mL/min, λ = 214, 254 
6h
O
CO2Et
NH
O
(1R,2S,3R)-ethyl 2',5-dioxospiro
[bicyclo[2.2.2]octane-2,3'-indoline]-3-carboxylate
ent-6h
O
EtO2C
HN
O
(1S,2R,3R)-ethyl 2',5-dioxospiro
[bicyclo[2.2.2]octane-2,3'-indoline]-3-carboxylate
6i
Me
O
CO2Et
NH
O
(1R,2R,3R,6R)-ethyl 1-methyl-2',5-dioxospiro
[bicyclo[2.2.2]octane-2,3'-indoline]-3-carboxylate
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nm: τmajor = 41.45 min., τminor = 15.43 min. [α]rt
D= -110.6 (c = 0.38, CHCl3, 97% ee). MS (ESI): 350 
(M+ +Na, 100%), 366 (M+ +K, 10%), 328 (M+ +1, 1%). 1H NMR (600 MHz, CD3CN): δ 0.56 (s, 3H), 
1.04 (t, 3H, J = 7.2 Hz), 1.40 (m, 1H), 191 (d, 1H, J = 18.9 Hz), 2.07-2.19 (m, 3H), 2.72 (q, 1H, J = 
2.7 Hz), 3.18 (dd, 1H, J1 = 18.9 Hz, J2 = 3.2 Hz), 3.29 (d, 1H, J = 2.1 Hz), 3.81-3.88 (m, 1H), 3.93-
3.99 (m, 1H), 6.93 (d, 1H; J = 7.8 Hz), 7.10 (dt, 1H, J1 = 7.6 Hz, J2 = 1.1 Hz), 7.29 (dt, 1H, J1= 7.6 
Hz, J2 = 1.2 Hz), 7.43 (d, 1H, J = 7.5 Hz), 8.43 (bs, 1H). 
13CNMR (150 MHz, CD3CN): δ 13.4 (CH3), 
20.6 (CH3), 23.6 (CH2), 28.4 (CH2), 39.5 (C), 44.2 (CH), 45.4 (CH2), 51.1 (CH), 55.1 (C), 60.7 (CH2), 
109.6 (CH), 122.3 (CH), 124.8 (CH), 128.8 (CH), 133.4 (C), 142.5 (C), 171.4 (C), 179.3 (C), 211.9 
(C). 
The relative and absolute configurations for 6i have been inferred by using NMR NOE analyses 
coupled with TD-DFT calculations of the electronic circular dichroism (ECD) spectra, see 
Structural Assignment section. 
 
(ent-6i). The reaction was carried out at 60 °C 
following the general procedure using C as the 
catalyst to furnish the crude product (d.r >19:1). The 
title compound was isolated as single diasteroisomer 
by flash column chromatography 
(dichloromethane/diethyl ether = 7/3) in 20% yield 
and 82% ee. The ee was determined by HPLC analysis 
on a Daicel Chiralpak AD-H column: hexane/i-PrOH 80:20, flow rate 0.75 mL/min, λ = 214, 254 
nm: τmajor = 15.64 min., τminor = 43.64 min.  
 
(6f). The reaction was carried out following the 
general procedure using A as the catalyst to 
furnish the crude product (d.r. = 4.5:1 was 
determined by integration of 1H-NMR signal: δmajor 
3.07 ppm. dd, δminor 2.98 ppm. m). The title 
compound was isolated as single diasteroisomer 
by flash column chromatography 
(dichloromethane/diethyl ether = 9/1) in 70% yield and 84% ee. The ee was determined by 
HPLC analysis on a Daicel Chiralpak AD-H column: hexane/i-PrOH 80:20, flow rate 0.75 mL/min, 
λ = 214, 254 nm: τmajor = 8.12 min., τminor = 9.70 min. [α]rt
D= -113.5 (c = 0.17, CHCl3, 84% ee). 
HRMS: (m/z) calculated for C21H19Cl2NO2: 387.0793, found: 387.0791. 
1H NMR (600 MHz, 
CDCl3): δ 0.81 (t, 3H, J = 7.0 Hz), 1.18-1.27 (m, 1H), 1.27-1.35 (m, 1H), 2.40 (m, 1H), 2.46 (dd, 
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1H, J1 = 15.7 Hz, J2 = 3.1 Hz), 2.59 (dd, 1H, J1 = 16.4 Hz, J2 = 10.3 Hz), 3.06 (dd, 1H, J1 = 16.6 Hz, J2 
= 4.1 Hz), 3.48 (dd, 1H, J1 = 14.1 Hz, J2 = 3.2 Hz), 3.63 (m, 1H), 6.68-6.71 (m, 2H), 6.82 (bt, 1H), 
7.01 (t, 1H, J = 7.9 Hz), 7.06-7.1 (m, 2H), 7.14 (bs, 1H). 
 
13CNMR (150 MHz, CDCl3): δ 11.9 (CH3), 24.2 (CH2), 40.1 (CH2), 41.5 (CH2), 41.7 (CH), 46.4 
(CH), 55.8 (C), 110.3 (CH), 122.3 (CH), 125.7 (CH), 126.3 (CH), 127.7 (CH), 128.3 (CH), 129.2 (C), 
129.3 (CH), 133.9 (C), 134.2 (C), 139.5 (C), 141.5 (C), 179.6 (C), 210.0 (C). 
 
(ent-6f). The reaction was carried out following 
the general procedure using C as the catalyst to 
furnish the crude product (d.r. = 2.6:1 was 
determined by integration of 1H-NMR signal: δmajor 
3.07 ppm. dd, δminor 2.98 ppm. m). The title 
compound was isolated as single diasteroisomer 
by flash column chromatography 
(dichloromethane/diethyl ether = 9/1) in 25% yield and 77% ee. The ee was determined by 
HPLC analysis on a Daicel Chiralpak AD-H column: hexane/i-PrOH 80:20, flow rate 0.75 mL/min, 
λ = 214, 254 nm: τmajor = 9.71 min., τminor = 8.15 min.  
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Gneral procedures for Triple organocascade for the synthesis of spiro-oxindole derivatives 4. 
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All the reactions were carried out in undistilled solvent without any precautions to exclude 
water and moisture. In an 10 mL flask equipped with a magnetic stirring bar, catalyst (S)-IIIc 
(19.5 mg, 0.06 mmol., 15 mol%), ortho-fluoro benzoic acid (8.4 mg, 0.06 mmol, 15 mol%) and 
aldehyde 4 (0.8 mmol, 2.0 equiv.) were dissolved in toluene (6.0 mL, 0.067 M). After 5 minutes 
stirring at room temperature, oxindole derivative 1 (0.6 mmol, 1.5 equiv.) 
and α,β−unsaturated aldehydes 5 (0.4 mmol, 1.0 equiv.) were sequentially added, and the 
mixture was stirred at 40 °C for 48 hours. Then the crude reaction mixture was directly charged 
on a chromatography column and flushed through a short plug of silica, using a 1:1 mixture of 
diethyl ether and dichloromethane as the eluent. After 1H NMR analysis to check the 
distereomeric ratio, the crude residue was purified by flash column chromatography using 
hexane/acetone, hexane/ethyl acetate or dichloromethane/diethyl ether as the eluent 
mixtures, to yield the spiro-oxindolic cyclohexene carbaldehyde 6. When the separation of the 
two enantiomers by HPLC analysis on chiral stationary phases was not possible, in situ 
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reduction (NaBH4 in THF) was carried out, and the enantiomeric excess was evaluated on the 
corresponding alcohol. 
 
 
(4a) The reaction was carried out following the 
general procedure using (S)-IIIc as the catalyst to 
furnish the crude product. (d.r. 12:1 was determined 
by integration of 1H-NMR signal: δmajor 5.35 ppm. d, 
δminor 5.59 ppm. d). The title compound was isolated 
by flash column chromatography (hexane/acetone = 
2/1) in 74% yield, and >99% ee. The ee was determined by HPLC analysis on a Daicel Chiralpak 
AD-H column: hexane/i-PrOH 80:20, flow rate 0.75 mL/min, λ = 214, 254 nm: τmajor = 10.19 
min., τminor =  14.12 min. [α]rt
D= -75.7 (c = 0.80, CHCl3, >99% ee). HRMS: (m/z) calculated for 
C27H23NO2: 393.1729, found: 393.1728. 
1H NMR (600 MHz, CD3CN): δ 1.11 (d, 3H, J = 7.1 Hz), 
3.13 (d, 1H, J = 7.7 Hz), 3.61-3.65 (m, 1H), 3.97 (s, 1H), 5.40 (d, 1H, J = 7.7 Hz), 6.36 (t, 1H, J = 
7.5 Hz), 6.53-6.56 (m, 2H), 6.86 (t, 1H, J = 7.5 Hz), 6.97-7.00 (m, 5H), 7.07 (t, 1H, J = 8.77 Hz), 
7.26-7.31 (m, 3H), 7.44 (t, 1H, J = 6.9 Hz), 8.39 (bs, 1H), 9.48 (s, 1H). 13CNMR (150 MHz, CD3CN): 
δ 17.9 (CH3), 35.4 (CH), 45.2 (CH), 49.2 (CH), 54.7 (C), 108.7 (CH), 120.2 (CH), 126.8 (CH), 126.9 
(CH), 127.5 (CH), 127.6 (CH), 127.7 (CH), 128.1 (CH), 128.2 (CH), 128.3 (CH), 129.7 (C), 133.4 
(CH), 138.7 (C) 139.6 (C), 139.8 (C), 141.1 (C), 157.6 (CH), 179.6 (C), 193.7 (CH). 
 
(alc-4a) To a stirred solution of aldehyde 6a (82 mg, 0.2 mmol.) in THF 
(1.5 mL) NaBH4 (24 mg, 0.6 mmol., 3 eq.) was slowly added at 0°C. Once 
the addition was finished the reaction was stirred for further 5 minutes 
then the ice bath was removed and stirring continued for 1 hour at 
room temperature. Solvent was removed under reduced pressure and the residual material 
was quenched with a saturated solution of NH4Cl at room temperature and extracted with 
dichloromethane. The organic phase was dried over MgSO4 then filtered and the solvent 
removed under reduced pressure to give the crude alcohol which was purified by flash 
chromatography using hexane/acetone = 2/1 as the eluent mixture. The title compound was 
isolated as white solid in 50% yield and >99% ee. HPLC analysis on a Daicel Chiralpak AD-H 
column: hexane/i-PrOH 80:20, flow rate 0.75 mL/min, λ = 214, 254 nm: τmajor = 12.90 min., τminor 
=  13.91 min. [α]rt
D= -36.7 (c = 0.80, CHCl3, >99% ee). HRMS: (m/z) calculated for C27H25NO2: 
395.1885, found: 395.1883. 1H NMR (400 MHz, CDCl3): δ 1.02 (d, 3H, J = 6.2 Hz), 3.00 (d, 1H, J = 
10.7 Hz), 3.27-3.31 (m, 1H), 3.65 (s, 1H), 3.83 (d, 1H, J = 12.4 Hz), 4.00 (d, 1H, J = 12.4 Hz), 5.40 
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(d, 1H, J = 7.8 Hz), 6.17 (s, 1H), 6.41 (t, 1H, J = 7.0 Hz), 6.48-651 (m, 2H), 6.81-6.83 (m, 1H), 6.92 
(bs, 5H), 7.07 (t, 1H, J = 6.6 Hz), 7.27-7.30 (m, 1H), 7.42-7.45 (m, 2H), 7.77 (bs, 1H). 13CNMR 
(100 MHz, CDCl3): δ 20.1 (CH3), 33.6 (CH), 49.0 (CH), 49.8 (CH), 56.2 (C), 66.3 (CH2), 108.7 (CH), 
120.8 (CH), 126.6 (CH), 126.9 (CH), 127.4 (CH), 127.7 (CH), 127.8 (CH), 127.9 (CH), 128.3 (CH), 
128.6 (CH), 130.4 (C), 132.2 (CH), 133.9 (CH), 134.2 (C), 139.4 (C), 139.7 (C), 139.8 (C), 180.7 
(C). 
 
(ent-4a) The reaction was carried out following the 
general procedure using (R)-IIIc as the catalyst to furnish 
the crude product (d.r. 13:1 was determined by 
integration of 1H-NMR signal: δmajor 5.42 ppm. d, δminor 
5.65 ppm. d). The title compound was isolated by flash 
column chromatography (hexane/acetone = 2/1) in 76% 
yield, and >99% ee. The ee was determined by HPLC analysis on a Daicel Chiralpak AD-H 
column: hexane/i-PrOH 80:20, flow rate 0.75 mL/min, λ = 214, 254 nm: τmajor = 14.12 min., τminor 
=  10.19 min. [α]rt
D= +75.0 (c = 0.80, CHCl3, >99% ee).  
 
(ent-alc-4a) To a stirred solution of aldehyde ent-6a (82 mg, 0.2 
mmol.) in THF (1.5 mL) NaBH4 (24 mg, 0.6 mol., 3 eq.) was slowly 
added at 0°C. Once the addition was finished the reaction was stirred 
for further 5 minutes then the ice bath was removed and stirring 
continued for 1 hour at room temperature. Solvent was removed 
under reduced pressure and the residual material was quenched with a saturated solution of 
NH4Cl at room temperature and extracted with dichloromethane. The organic phase was dried 
over MgSO4 then filtered and the solvent removed under reduced pressure to give the crude 
alcohol which was purified by flash chromatography using hexane/acetone = 2/1 as the eluent 
mixture. The title compound was isolated as white solid in 50% yield and >99% ee. HPLC 
analysis on a Daicel Chiralpak AD-H column: hexane/i-PrOH 80:20, flow rate 0.75 mL/min, λ = 
214, 254 nm: τmajor = 12.90 min., τminor =  13.90 min. [α]rt
D= +33.5 (c = 1.00, CHCl3, >99% ee). 
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(4b) The reaction was carried out following the general 
procedure using (S)-IIIc as the catalyst to furnish the 
crude compound (d.r. 16:1 was determined by 
integration of 1H-NMR signal: δmajor 5.73 ppm. d, δminor 
5.52 ppm. d). The title compound was isolated by flash 
column chromatography (hexane/acetone = 2/1) in 70% 
yield. The ee value was determined on the 
corresponding alcohol after reduction of the isolated aldehyde. [α]rt
D = -54.9 (c = 1.00, CHCl3, 
>99% ee). HRMS: (m/z) calculated for C28H25NO3: 423.1834, found: 423.1835. 
1H NMR (600 
MHz, CDCl3): δ 1.17 (d, 3H, J = 7.7 Hz), 3.07 (d, 1H, J = 10.3 Hz), 3.27-3.31 (m, 1H), 3.80 (s, 3H), 
3.91 (s, 1H), 5.48 (d, 1H, J = 8.4 Hz), 6.46-6.49 (m, 2H), 6.54 (dd, 1H, J1 = 8.4 Hz, J2 = 2.5 Hz), 
6.65 (dd, 1H, J1 = 8.5 Hz, J2 = 2.9 Hz), 6.86 (t, 1H, J = 7.8 Hz), 6.88-7.00 (m, 7H), 7.08-7.21 (m, 
2H),  9.53 (s, 1H). 13CNMR (150 MHz, CDCl3): δ 19.0, 35.1, 44.5, 49.8, 55.2, 55.3, 108.7, 113.3, 
113.4, 120.9, 125.6, 127.0, 127.3, 127.7, 128.1, 128.7, 129.5, 130.9, 133.5, 134.7, 138.7, 138.8, 
139.6, 156.9, 159.0, 179.7, 193.3. 
 
(alc-4b) To a stirred solution of aldehyde 4b (0.2 mmol., 84 mg) 
in THF (1.5 mL) NaBH4 (0.6 mmol., 24 mg, 3 eq.) was slowly 
added at 0°C. Once the addition was finished the reaction was 
stirred for further 5 minutes then the ice bath was removed 
and stirring continued for 1 hour at room temperature. Solvent 
was removed under reduced pressure and the residual 
material was quenched with a saturated solution of NH4Cl at room temperature and extracted 
with dichloromethane. The organic phase was dried over MgSO4 then filtered and the solvent 
removed under reduced pressure to give the crude alcohol which was purified by flash 
chromatography using hexane/acetone = 2/1 as the eluent mixture. The title compound was 
isolated as white solid in 50% yield and 99% ee. The ee was determined by HPLC analysis on a 
Daicel Chiralpak AD-H column: hexane/i-PrOH 80:20, flow rate 0.75 mL/min, λ = 214, 254 nm: 
τmajor = 7.11 min., τminor = 8.34 min. [α]rt
D= -113.1 (c = 2.00, CHCl3, 99% ee). HRMS: (m/z) 
calculated for C28H27NO3: 425.1991, found: 425.1994. 
1H NMR (400 MHz, CDCl3): δ 1.02 (d, 3H, J 
= 7.1 Hz), 2.36 (bs, 1H), 2.99 (d, 1H, J = 10.8 Hz), 3.27-3.31 (m, 1H), 3.61 (s, 1H), 3.83 (s, 3H), 
3.85 (bs, 1H), 3.99-4.02 (m, 1H), 5.52 (d, 1H, J = 7.2 Hz), 6.15 (s, 1H), 6.40-6.64 (m, 3H), 6.63 (d, 
1H, J = 8.98 Hz), 6.83 (t, 1H, J = 6.3 Hz), 6.92 (s, 5H), 6.99 (d, 1H, J = 8.5 Hz), 7.36 (d, 1H, J = 8.5 
Hz), 8.11 (bs, 1H). 13C NMR (100 MHz, CDCl3): δ 20.1 (CH3), 33.7 (CH), 48.3 (CH), 49.8 (CH), 55.5 
(CH3), 56.4 (C), 66.2 (CH2), 108.7 (CH), 113.2 (CH), 113.6 (CH), 120.8 (CH), 126.6 (CH), 127.1 
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(CH), 127.4 (CH), 127.9 (CH), 129.6 (CH), 130.6 (C), 131.4 (C), 131.8 (CH), 134.6 (C), 134.8 (CH), 
139.9 (C), 140.0 (C), 159.2 (C), 180.9 (C). 
 
(4c) The reaction was carried out 
following the general procedure using (S)-
IIIc as the catalyst to furnish the crude 
product (d.r. >19:1 was determined by 
integration of 1H-NMR signal: δmajor 5.32 
ppm. d, δminor 5.51 ppm. d). The title 
compound was isolated by flash column chromatography (hexane/acetone = 2/1) in 35% yield 
and >99% ee. The ee was determined by HPLC analysis on a Daicel Chiralpak AD-H column: 
hexane/i-PrOH 80:20, flow rate 0.75 mL/min, λ = 214, 254 nm: τmajor = 19.09 min, τminor = 30.39 
min. [α]rt
D = -82.8 (c = 2.00, CHCl3, >99% ee). HRMS: (m/z) calculated for C27H22N2O4: 438.1580; 
found: 438.1576. 1H NMR (600 MHz, CDCl3): δ 1.20 (d, 3H, J = 8.0 Hz), 3.00 (d, 1H, J = 10.4 Hz), 
3.66-3.68 (m, 1H), 4.05 (s, 1H), 5.42 (d, 1H, J = 7.5 Hz), 6.46 (t, 1H, J = 7.5 Hz), 6.52 (d, 1H, J = 
7.3 Hz), 6.79 (bs, 1H), 6.88-6.98 (m, 6H), 7.22 (s, 1H), 7.30 (s, 1H), 7.35 (bs, 1H), 7.97 (bs, 1H), 
8.27 (bs, 1H), 9.53 (s, 1H). 13CNMR (150 MHz, CDCl3): δ 18.7 (CH3), 34.9 (CH), 45.1 (CH), 49.7 
(CH), 54.5 (C), 109.2 (CH), 120.9 (CH), 123.06 (CH), 123.07 (CH), 126.3 (CH), 127.1 (CH), 128.0 
(CH), 128.1 (CH), 128.3 (CH), 128.5 (CH), 128.9 (CH), 134.3 (C), 137.5 (C), 137.9 (C), 139.7 (C), 
146.5 (C), 147.2 (C), 157.7 (CH), 179.2 (C), 192.4 (CH). 
 
(4d) The reaction was carried out 
following the general procedure using 
(S)-IIIc as the catalyst to furnish the crude 
product. (d.r. >19:1 was determined by 
integration of 1H-NMR signal: δmajor 5.48 
ppm. d, δminor 5.68 ppm. d). The title 
compound was isolated by flash column chromatography (dichloromethane/diethyl ether = 
9/1) in 50% yield, and >99% ee. The ee was determined by HPLC analysis on a Daicel Chiralpak 
AD-H column: hexane/i-PrOH 80:20, flow rate 0.75 mL/min, λ = 214, 254 nm: τmajor = 10.98 
min., τminor =  15.73 min. [α]rt
D= -44.0 (c = 0.40, CHCl3, >99% ee). HRMS: (m/z) calculated for 
C27H22FNO2: 411.1635, found: 411.1632. 
1H NMR (600 MHz, CDCl3): δ 1.17 (d, 3H, J = 7.2 Hz), 
3.03 (d, 1H, J = 10.1 Hz), 3.59-3.63 (m, 1H), 3.94 (s, 1H), 5.45 (d, 1H, J = 7.2 Hz), 6.47-6.49 (m, 
2H), 6.58 (bs, 1H), 6.81 (bs, 1H), 6.86 (t, 1H, J = 7.2 Hz), 6.93-6.98 (m, 6H), 7.06 (bs, 1H), 7.12 
(bs, 1H), 7.20-7.24 (m, 1H), 9.53 (s, 1H). 13CNMR (150 MHz, CDCl3):δ 18.9 (CH3), 31.1 (CH), 35.1 
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(CH), 44.8 (CH), 49.8 (CH), 55.1 (C), 108.9 (CH), 114.9 (bs, 2CH), 121.0 (CH), 127.0 (CH), 127.1 
(CH), 127.9 (CH), 128.1 (bs,2CH), 128.9 (CH), 129.2 (CH), 134.8 (C), 135.2 (C), 138.5 (C), 138.6 
(C), 139.7 (C), 156.9 (CH), 162.4 (d, 1CF, J = 244 Hz), 179.4 (CH), 179.5 (C), 192.9 (CH). 
 
(4e) The reaction was carried out following the 
general procedure using (S)-IIIc as the catalyst to 
furnish the crude product. (d.r. >19:1 was 
determined by integration of 1H-NMR signal: 
δmajor 5.42 ppm. d, δminor 5.68 ppm. d). The title 
compound was isolated by flash column 
chromatography (hexane/acetone = 2/1) in 50%. yield and 98% ee. The ee was determined by 
HPLC analysis on a Daicel Chiralpak AD-H column: hexane/i-PrOH 80:20, flow rate 0.75 mL/min, 
λ = 214, 254 nm: τmajor = 10.15 min., τminor =  12.32 min. [α]rt
D= -63.8 (c = 1.00, CHCl3, 98% ee). 
HRMS: (m/z) calculated for C28H25NO2: 407.1885, found: 407.1884. 
1H NMR (600 MHz, CDCl3): δ 
1.19 (d, 3H, J = 7.5 Hz), 1.54 (s, 3H), 3.17 (d, 1H, J = 10.1 Hz), 3.62-3.65 (m, 1H), 4.26 (s, 1H), 
5.40 (d, 1H, J = 7.6 Hz), 6.42 (t, 1H, J = 7.2 Hz), 6.47 ( d, 1H, J = 7.2 Hz), 6.86 (t, 1H, J = 7.2 Hz), 
6.94 (bs, 6H), 7.12-7.17 (m, 2H), 7.20-7.24 (m, 2H), 7.74 (bs, 1H), 9.53 (s, 1H). 13CNMR (150 
MHz, CDCl3):δ 17.9 (CH3), 18.6 (CH3), 35.1 (CH), 40.0 (CH), 49.1 (CH), 54.4 (C), 108.5 (CH), 120.4 
(CH), 125.9 (CH), 125.9 (CH), 126.9 (CH), 127.3 (CH), 127.7 (CH), 128.1 (CH), 128.6 (CH), 129.6 
(CH), 130.1 (CH), 138.1 (C), 139.3 (C), 139.5 (C), 139.7 (C), 14.34 (C), 157.0 (CH), 179.6 (C), 
193.5 (CH). 
 
(4f) The reaction was carried out following 
the general procedure using (S)-IIIc as the 
catalyst to furnish the crude product (d.r. 
12:1 was determined by integration of 1H-
NMR signal: δmajor 5.28 ppm. d, δminor 5.51 
ppm. d). The title compound was isolated by 
flash column chromatography (hexane/acetone = 2/1) in 47% yield, and >99% ee. The ee was 
determined by HPLC analysis on a Daicel Chiralpak AD-H column: hexane/i-PrOH 80:20, flow 
rate 0.75 mL/min, λ = 214, 254 nm: τmajor = 20.50 min., τminor =  32.00 min. [α]rt
D= -72.0 (c = 1.0, 
CHCl3, >99% ee). HRMS: (m/z) calculated for C27H22ClNO2: 427.1339, found: 427.1337. 
1H NMR 
(600 MHz, CDCl3): δ 1.18 (d, 3H, J = 7.1 Hz), 3.06 (d, 1H, J = 10.0 Hz), 3.58-3.61 (m, 1H), 3.96 (s, 
1H), 5.24 (d, 1H, J = 1.8 Hz), 6.42 (d, 1H, J = 7.9 Hz), 6.62 (d, 1H, J = 6.9 Hz), 6.83 (d, 1H, J = 8.9 
Hz), 6.93-6.99 (m, 5H), 7.15-7.24 (m, 3H), 7.32 (t, 1H, J = 7.4 Hz), 7.41-7.43 (m, 1H), 7.77 (bs, 
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1H), 9.53 (s, 1H). 13CNMR (150 MHz, CDCl3): δ 18.9 (CH3), 35.0 (CH), 45.4 (CH), 49.7 (CH), 55.7 
(C) 109.8 (CH), 126.3 (CH), 127.2 (CH), 127.4 (CH), 127.5 (CH), 127.7 (CH), 128.1 (CH), 128.2 
(CH), 128.3 (CH), 131.3 (C), 133.7 (CH), 138.3 (C), 138.3 (C), 138.4 (2C), 156.7 (CH), 179.6 (C), 
192.9 (CH). 
 
(4g) The reaction was carried out following the 
general procedure using (S)-IIIc as the catalyst to 
furnish the crude product (d.r. 12:1 was 
determined by integration of 1H-NMR signal: δmajor 
5.12 ppm. d, δminor 5.36 ppm. d). The title 
compound was isolated by flash column 
chromatography (hexane/acetone = 2/1) in 47% yield, and >99% ee. The ee was determined by 
HPLC analysis on a Daicel Chiralpak AD-H column: hexane/i-PrOH 80:20, flow rate 0.75 mL/min, 
λ = 214, 254 nm: τmajor = 8.84 min., τminor =  11.87 min. [α]rt
D= -53.0 (c = 0.50, CHCl3, >99% ee). 
HRMS: (m/z) calculated for C28H25NO2: 407.1885, found: 407.1885. 
1H NMR (600 MHz, CDCl3): δ 
1.17 (d, 3H, J = 8.0 Hz), 1.86 (s, 3H), 3.07 (d, 1H, J = 13.4 Hz), 3.57-3.63 (m, 1H), 3.93 (s, 1H), 
5.09 (d, 1H, J = 7.5 Hz), 6.36 (d, 1H, J = 7.5 Hz), 6.64 (bs, 1H), 6.65 (d, 1H, J = 7.4 Hz), 6.94-6.97 
(m, 6H), 7.14 (bs, 1H), 6.18 (bs, 1H), 7.20-7.21 (m, 1H), 7.28 (t, 1H, J = 7.4 Hz), 7.29 (bs, 1H), 
9.53 (s, 1H). 13CNMR (150 MHz, CD3CN): δ 19.0 (CH3), 21.1 (CH3), 35.2 (CH), 45.6 (CH), 49.7 
(CH), 55.2 (C), 108.2 (CH), 126.9 (CH), 127.6 (CH), 127.8 (CH), 128.0 (CH), 129.4 (CH), 130.0 
(CH), 133.9 (CH), 137,1 (C), 138.6 (C), 139.0 (2C), 156.9 (CH), 179.8 (C), 193.0 (CH). 
 
(4h) The reaction was carried out following the 
general procedure using (S)-IIIc as the catalyst to 
furnish the crude product (d.r. >19:1 was 
determined by integration of 1H-NMR signal: 
δmajor 5.42 ppm. d, δminor 5.63 ppm. d). The title 
compound was isolated by flash column 
chromatography (hexane/acetone = 2/1) in 40% yield and 98% ee. The ee was determined by 
HPLC analysis on a Daicel Chiralcel OD-H column: hexane/i-PrOH 85:15, flow rate 0.75 mL/min, 
λ = 214, 254 nm: τmajor = 12.40 min., τminor = 17.87 min. [α]rt
D= -48.5 (c = 0.50, CHCl3, 98% ee). 
HRMS: (m/z) calculated for C24H25NO2: 359.1885, found: 359.1886. 
1H NMR (400 MHz, CDCl3): δ 
0.56 (t, 3H, J = 7.1 Hz), 0.87-1.17 (m, 6H), 1.44 (d, 3H, J = 9.1 Hz), 1.96-2.00 (m, 1H), 3.06-3.09 
(m, 1H), 3.79 (s, 1H), 5.41 (d, 1H, J = 7.4 Hz), 6.55 (t, 1H, J = 7.3 Hz), 6.81 (d, 1H, J = 7.3 Hz), 
6.99-7.33 (m, 6H), 9.46 (s, 1H). 13CNMR (100 MHz,CDCl3): δ 14.7 (CH3), 19.6 (CH3), 22.1 (CH2), 
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33.4 (CH2), 35.4 (CH), 41.25 (CH), 45.4 (CH), 54.7 (C), 109.0 (CH), 110.1 (CH), 121.2 (CH), 126.7 
(CH), 127.5 (m, 2 CH), 127.9 (CH), 128.1 (CH), 130.2 (C), 138.2 (C), 139.0 (C), 140.5 (C), 157.5 
(CH), 179.9 (C), 193.00 (CH).  
 
 
(6i) The reaction was carried out following 
the general procedure using (S)-IIIc as the 
catalyst to furnish the crude product (d.r. 
12:1 was determined by integration of 1H-
NMR signal: δmajor 5.58 ppm. d, δminor 5.68  
ppm. d). The title compound was isolated 
by flash column chromatography (hexane/acetone = 2/1) in 50%, and >99% ee. The ee was 
determined by HPLC analysis on a Daicel Chiralpak AD-H column: hexane/i-PrOH 80:20, flow 
rate 0.75 mL/min, λ = 214, 254 nm: τmajor = 19.44 min., τminor =  26.46 min. [α]rt
D= -86.0 (c = 1.00, 
CHCl3, >99% ee). HRMS: (m/z) calculated for C24H23NO4: 389.1626, found: 389.1627. 
1H NMR 
(600 MHz, CDCl3): δ 0.52 (t, 3H, J = 7.0 Hz), 1.16 (d, 3H, J = 7.8 Hz), 2.75 (d, 1H, J = 10.5 Hz), 
3.33-3.38 (m, 1H), 3.49-3.55 (m, 2H), 3.67 (s, 1H), 5.22 (d, 1H, J = 7.8 Hz), 6.28-6.35 (m, 2H), 
6.54 (d, 1H, J = 8.6 Hz), 6.76-6.86 (m, 4H), 6.99-7.09 (m, 2H), 7.52 (bs, 1H), 9.25 (s, 1H). 
13CNMR(150 MHz, CDCl3):δ 13.5 (CH3), 18.6 (CH3), 31.9 (CH), 44.5 (CH), 50.2 (CH), 51.3 (C), 60.7 
(CH2), 108.1 (CH), 120.9 (CH), 126.5 (CH), 127.6 (CH), 127.9 (CH), 128.1 (CH), 128.4 (CH), 133.3 
(CH), 137.9 (CH), 138.3 (C), 140.5 (C), 144.8 (C), 154.9 (CH), 162.07 (C), 171.9 (C), 178.5 (C), 
192.4 (CH). 
 
(4j) The reaction was carried out following the 
general procedure using (S)-IIIc as the catalyst 
to furnish the crude product (d.r. >19:1 was 
determined by integration of 1H-NMR signal: 
δmajor 5.34 ppm. d, δminor 5.53 ppm. d). The title 
compound was isolated by flash column 
chromatography (hexane/ethyl acetate = 3/1) in 46% yield, and >99% ee. The ee was 
determined by HPLC analysis on a Daicel Chiralcel OD-H column: hexane/i-PrOH 80:20, flow 
rate 0.75 mL/min, λ = 214, 254 nm: τmajor = 35.17 min., τminor =  56.25 min. [α]rt
D= -85.0 (c = 1.00, 
CHCl3, >99% ee). HRMS: (m/z) calculated for C28H23NO3: 421.1678, found: 421.1678. 
1H NMR 
(600 MHz, CDCl3): δ 1.27 (d, 3H, J = 7.6 Hz), 3.68-3.71 (m, 1H), 3.94 (s, 1H), 4.23 (d, 1H, J = 10.6 
Hz), 5.15 (d, 1H, J =7.6 Hz), 6.16 (t, 1H, J = 7.4 Hz), 6.63 (bs, 1H), 6.68 (d, 1H, J = 7.8 Hz), 6.86 (t, 
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1H, J = 7.9 Hz) 7.10-7.29 (m, 6H), 7.39-7.51 (m, 4H), 8.00 (bs, 1H), 9.52 (s, 1H). 13CNMR (150 
MHz, CD3CN): δ 19.4 (CH3) 33.4 (CH), 45.0 (CH), 49.5 (CH), 52.0 (C), 109.4 (CH), 120.6 (CH), 
126.4 (CH), 127.2 (CH), 127.5 (CH), 127.9 (CH), 128.1 (CH), 128.3 (CH), 128.5 (CH), 128.7 (CH), 
133.4 (CH), 133.8 (CH), 138.5 (C), 138.6 (2C), 140.9 (C), 156.2 (CH), 178.9 (C), 192.7 (CH), 201.4 
(C). 
 
(4k) The reaction was carried out following the 
general procedure using (S)-IIIc as the catalyst 
to furnish the crude product.. (d.r. >19:1 was 
determined by integration of 1H-NMR signal: 
δmajor 9.49 ppm. d, δminor 9.51 ppm. d). The title 
compound was isolated by flash column 
chromatography (hexane/ethyl acetate = 2/1) in 58% yield and 98% ee. The ee was 
determined by HPLC analysis on a Daicel Chiralpak AD-H column: hexane/i-PrOH 80:20, flow 
rate 0.75 mL/min, λ = 214, 254 nm: τmajor = 25.79 min., τminor =  50.08 min. [α]rt
D= -78.0 (c = 0.10, 
CHCl3, 98% ee). HRMS: (m/z) calculated for C19H21NO4: 327.1471, found: 327.1470. 
1H NMR 
(600 MHz, CDCl3): δ 0.82 (t, 3H, J = 14.1 Hz), 1.17 (d, 3H, J = 7.5 Hz), 1.24 (d, 3H, J = 7.5 Hz), 
2.78 (q, 1H, J = 13.8 Hz), 2.98 (d, 1H, J = 9.60 Hz), 3.46-3.48 (m, 1H), 3.75-3.85 (m, 2H), 6.74 (s, 
1H), 6.80 (d, 1H, J = 6.90 Hz), 6.96 (t, 1H, J = 6.9 Hz), 7.15-7.24 (m, 2H), 7.72 (bs, 1H), 9.47 (s, 
1H). 13CNMR (150 MHz, CDCl3): δ 13.9 (CH3), 18.1 (CH3), 18.7 (CH3), 32.4 (CH), 33.1 (CH), 49.9 
(CH), 51.0 (C), 61.0 (CH2), 109.8 (CH), 121.5 (CH), 126.42 (CH), 128.8 (C), 129.3 (C), 141.1 (C), 
141.6 (C), 154.9 (CH), 172.2 (CH), 179.1 (C), 193.5 (CH). 
 
(4l) The reaction was carried out following the 
general procedure using (S)-IIIc as the catalyst 
to furnish the crude product (d.r. >19:1 was 
determined by integration of 1H-NMR signal: 
δmajor 5.49 ppm. d, δminor 5.70 ppm., d). The 
title compound was isolated by flash column 
chromatography (hexane/ethyl acetate = 3/1) in 50% yield, and >99% ee. The ee was 
determined by HPLC analysis on a Daicel Chiralcel OD-H column: hexane/i-PrOH 80:20, flow 
rate 0.75 mL/min, λ = 214, 254 nm: τmajor = 11.27 min., τminor =  21.84 min. [α]rt
D= -46.0 (c = 0.10, 
CHCl3, >99% ee). HRMS: (m/z) calculated for C27H29NO4: 431.2097, found: 431.2024. 
1H NMR 
(600 MHz, CDCl3): δ 0.74 (t, 3H, J = 6.2 Hz), 0.93-0.99 (m, 3H), 1.39-2.15 (m, 6H),3.10 (d, 1H, J = 
12.0 Hz), 3.52-3.54 (m, 1H), 3.70-3.74 (m, 2H), 3.89 (s, 1H), 5.45 (d, 1H, J = 7.7 Hz), 6.52-6.55 
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(m, 2H), 6.74 (d, 1H, J = 7.8 Hz), 7.00-7.07 (m, 3H),  7.09-7.24 (m, 3H), 7.56 (bs, 1H), 9.48 (s, 
1H). 13CNMR (150 MHz, CDCl3): δ 13.8 (CH3), 14.1 (CH3), 23.1 (CH2), 28.6 (CH2), 32.5 (CH2), 36.8 
(CH), 44.8 (CH), 48.6 (CH), 51.6 (C), 60.9 (CH2), 109.1 (CH), 121.1 (CH), 126.9 (CH), 127.8 (CH), 
128.1 (CH), 128.2 (CH), 128.6 (CH), 138.3 (C), 139.0 (C), 140.7 (C), 153.8 (CH), 172.2 (C), 178.5 
(C), 192.7 (CH).  
 
(4m) The reaction was carried out following the 
general procedure using (S)-IIIc as the catalyst 
to furnish the crude product (d.r. 19:1 was 
determined by integration of 1H-NMR signal: 
δmajor 5.40 ppm. d, δminor 5.52 ppm. d). The title 
compound was isolated by column 
chromatography (hexane/ethyl acetate = 3/1) in 65% yield. The ee value was determined on 
the corresponding alcohol after reduction of the isolated aldehyde. [α]rt
D= -97.0 (c = 0.10, 
CHCl3, >99% ee). HRMS: (m/z) calculated for C30H27NO4: 465.1940, found: 465.1942. 
1H NMR 
(600 MHz, CDCl3): δ 0.78 (t, 3H, J = 7.6 Hz), 2.85-2.88 (m, 1H), 3.16 (d, 1H, J = 11.5 Hz), 3.23 (dd, 
1H, J1 = 13.6 Hz, J2 = 4.3 Hz), 3.74-3.81 (m, 3H), 3.87-3.90 (m, 1H), 5.38 (d, 1H, J = 7.8 Hz), 5.98 
(bs, 1H), 6.49 (bs, 1H), 6.53 (t, 1H, J = 7.5 Hz), 6.75 (d, 1H, J = 7.5 Hz), 6.94 (bs, 2H), 7.06 (t, 1H, J 
= 7.6 Hz), 7.14 (t, 1H, J = 7.5 Hz), 7.17 (d, 1H, J = 1.8 Hz), 7.35-7.42 (m, 6H), 9.42 (s, 1H). 13CNMR 
(150 MHz, CD3CN): δ 13.8 (CH3), 38.3 (CH2), 38.4 (CH), 44.5 (CH), 47.1 (CH), 51.6 (C), 61.0 (CH2), 
109.0 (CH), 121.1 (CH), 126.9 (CH), 127.2 (CH), 133.3 (C), 137.2 (C), 138.0 (C), 139.5 (C), 140.5 
(C), 152.8 (CH), 172.2 (C), 178.3 (C), 192.3 (CH). 
 
(alc-4m) To a stirred solution of aldehyde 4m (0.2 mmol., 96 mg) in 
THF (1.5 mL) NaBH4 (0.6 mmol., 24 mg, 3 eq.) was slowly added at 
0°C. Once the addition was finished the reaction was stirred for 
further 5 minutes then the ice bath was removed and stirring 
continued for 1 hour at room temperature. Solvent was removed 
under reduced pressure and the residual material was quenched 
with a saturated solution of NH4Cl at room temperature and 
extracted with dichloromethane. The organic phase was dried over MgSO4 then filtered and 
the solvent removed under reduced pressure to give the crude alcohol which was purified by 
flash chromatography using hexane/ethyl acetate = 3/1 as the eluent mixture. The title 
compound was isolate as white solid in 57% yield and >99% ee. The ee was determined by 
HPLC analysis on a Daicel Chiralpak AD-H column: hexane/i-PrOH 80:20, flow rate 0.75 mL/min, 
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λ = 214, 254 nm: τmajor = 8.47 min., τminor =  18.22 min. [α]rt
D= -119.0 (c = 0.10, CHCl3, >99% ee). 
HRMS: (m/z) calculated for C30H29NO4: 467.2097, found: 467.2097. 
1H NMR (600 MHz, CDCl3): δ 
0.75 (t, 3H, J = 7.2 Hz), 1.19 (d, 3H, J = 6.2 Hz), 2.33 (bs, 1H), 2.74- 2.76 (m, 1H), 3.02-3.06 (m, 
1H), 3.49 (s, 1H), 3.58 (bs, 1H), 3.69-3.74 (m, 3H), 3.87-3.89 (m, 1H), 5.38 (d, 1H, J = 7.5 Hz), 
6.13 (s, 1H), 6.28 (d, 1H, J = 7.6 Hz), 6.28 (d, 1H, J = 7.6 Hz), 6.36 (d, 1H, J = 7.7 Hz), 6.50 (t, 1H, J 
= 7.7 Hz), 6.78 (d, 1H, J = 7.0 Hz), 6.96 (t, 1H, J = 7.0 Hz), 7.01-7.04 (m, 3H), 7.15 (t, 1H, J = 7.0 
Hz), 7.29-7.35 (m, 5H), 8.26 (bs, 1H). 13CNMR (150 MHz, CDCl3): δ 13.8 (CH3), 25.5 (CH), 29.5 
(CH), 37.0 (CH), 39.2 (CH), 47.0 (CH), 47.8 (CH), 52.6 (C), 60.7 (CH2), 66.0 (CH2), 109.2 (CH), 
121.0 (CH), 126.7 (2CH), 127.5 (CH), 127.7 (CH), 128.1 (CH), 128.2 (CH), 128.3 (CH), 128.4 (CH), 
128.5 (CH), 129.2 (CH), 130.6 (CH), 133.5 (CH), 135.7 (C), 138.1 (C), 138.5 (C), 140.8 (C), 173.0 
(C), 179.5 (C) 
 
(4n) The reaction was carried out following the 
general procedure using (S)-IIIc as the catalyst 
to furnish the crude product (d.r. 19:1 was 
determined by integration of 1H-NMR signal: 
δmajor 5.47 ppm. d, δminor 5.58 ppm. d). The title 
compound was isolated by flash column 
chromatography (dichloromethane/diethyl ether = 4/1) in 64% yield and >99% ee. The ee was 
determined by HPLC analysis on a Daicel Chiralcel OD-H column: hexane/i-PrOH 80:20, flow 
rate 0.75 mL/min, λ = 214, 254 nm: τmajor = 14.47 min., τminor =  24.68 min. [α]rt
D= -76 (c = 1.00, 
CHCl3, >99% ee). HRMS: (m/z) calculated for C26H25NO4: 415.1784, found: 415.1785. 
1H NMR 
(600 MHz, CDCl3): δ 0.75 (t, 3H, J = 6.7 Hz), 2.31-2.36 (m, 1H), 2.61-2.64 (m, 1H), 3.14 (d, 1H, J = 
10.7 Hz), 3.66-3.68 (m, 1H), 3.73-3.91 (m, 2H), 3.91 (s, 1H), 5.28-5.31 (m, 2H), 5.47 (d, 1H, J = 
7.59 Hz),  5.96-5.99 (m, 1H), 6.54 (t, 1H, J = 7.7 Hz), 6.56 (bs, 1H), 6.77 (d, 1H, J = 7.0 Hz), 7.07-
7.10 (m, 2H), 7.19 (s, 1H), 7.19-7.27 (m, 2H),7.35 (bs, 1H), 7.45 (bs, 1H), 9.49 (s, 1H). 13CNMR 
(150 MHz, CD3CN): δ 13.5 (CH3), 29.5 (CH), 36.6 (CH), 37.0 (CH2), 44.7 (CH), 47.9 (CH), 51.7 (C), 
60.9 (CH2), 109.4 (CH), 119.4 (CH), 121.1 (CH), 126.9 (CH), 127.4 (CH), 127.8 (CH), 128.1 (CH), 
128.2 (CH), 128.7 (CH), 133.5 (C), 134.2 (CH), 138.3 (C), 139.50 (C), 140.9 (C), 153.0 (CH), 172.1 
(C), 179.1 (C), 192.6 (CH). 
 
                                                           
125
 (a) Stott, K.; Stonehouse, J.; Keeler, J.; Hwand, T.-L.; Shaka, A. J. J. Am. Chem. Soc. 1995, 117, 4199. 
(b) Stott, K.; Keeler, J.; Van, Q. N.; Shaka, A. J. J. Magn. Resonance 1997, 125, 302. (c) Van, Q. N.; 
Smith, E. M.; Shaka, A. J. J. Magn. Resonance 1999, 141, 191. (d) See also: Claridge, T.D.W. High 
Resolution NMR Techniques in Organic Chemistry; Pergamon: Amsterdam, 1999. 
4n NH
O
EtOOC
Ph
CHO
(1S,2R,5S,6R)-ethyl 5-allyl-3-formyl-2'-oxo-2-
phenylspiro[cyclohex[3]ene-1,3'-indoline]-6-carboxylate
195 
 
                                                                                                                                                                          
126
 W. C. Still, M. Kahn, A. J. Mitra, J. Org. Chem. 1978, 43, 2923.  
127
 W. L. F. Armarengo, D. D. Perrin, In Purification of Laboratory Chemicals, 4th ed.; Butterworth 
Heinemann: Oxford, 1996. 
128
 B. Vakulya, Sz. Varga, A. Csámpai, T. Soos, Org. Lett. 2005, 7, 1967. 
129
 (a) G. Tacconi, A. Gamba, F. Marinone, G. Desioni, Tetrahedron, 1971, 27, 561-579; (b) F. Z. 
Macaev, O. M. Radul, I. N. Shterbet, S. I. Pogrebnoi, N. S. Sucman, S. T. Malinocskii, A. N. Barba, M. 
Gdaniec, Chemistry of Heterocyclic Compound, 2007, 43, 298; (c) G. Tacconi, A. G. Invernizzi, G. 
Desimoni, J. Chem. Soc., Perkin 1, 1976, 1872-1879; (d)H. G. Lindwall, J. S. Maclennan, J. Am. Chem. 
Soc., 1932, 54, 4739-4744.  
130
 a) M. E. Krafft, J. A. Wright, Chem. Commun., 2006, 2977-2979; b) G. Battistuzzi, S. Cacchi, G. 
Fabrizi, Org. Lett. 2003, 5, 777-780. 
131
 Montecarlo algorithm (version 1.0.3), MMFF force field, as implemented in Titan 1.0.5, Wavefunction 
Inc., Irvine, CA.  
132
 Program Gaussian 03, Revision E.01, Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; 
Robb, M. A.; Cheeseman, J. R.; Montgomery, Jr., J. A.; Vreven, T.; Kudin, K. N.; Burant, J. C.; Millam, 
J. M.; Iyengar, S. S.; Tomasi, J.; Barone, V.; Mennucci, B.; Cossi, M.; Scalmani, G.; Rega, N.; Petersson, 
G. A.; Nakatsuji, H.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, 
T.; Honda, Y.; Kitao, O.; Nakai, H.; Klene, M.; Li, X.; Knox, J. E.; Hratchian, H. P.; Cross, J. B.; 
Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, 
R.; Pomelli, C.; Ochterski, J. W.; Ayala, P. Y.; Morokuma, K.; Voth, G. A.; Salvador, P.; Dannenberg, J. 
J.; Zakrzewski, V. G.; Dapprich, S.; Daniels, A. D.; Strain, M. C.; Farkas, O.; Malick, D. K.; Rabuck, A. 
D.; Raghavachari, K.; Foresman, J. B.; Ortiz, J. V.; Cui, Q.; Baboul, A. G.; Clifford, S.; Cioslowski, J.; 
Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Martin, R. L.; Fox, D. J.; Keith, T.; 
Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Challacombe, M.; Gill, P. M. W.; Johnson, B.; Chen, 
W.; Wong, M. W.; Gonzalez, C.; Pople, J. A.; Gaussian, Inc., Wallingford CT, 2004. 
133
 (a) Corey, E. J. Angew. Chem. Int. Edn Engl. 2002, 41, 1650–1667. (b) Nicolaou, K. C.; Snyder, S. A.; 
Montagnon, T.; Vassilikogiannakis, G. Angew. Chem. Int. Edn Engl. 2002, 41, 1668–1698. (c) Dewar, M. 
J. S.; Olivella, S.; Rzepa, H. S. J. Am. Chem. Soc. 1978, 100, 5650-5659. 
134
 (a) K. Alder, G. Stein, F. von Budedenbrock, W. Eckardt, W. Frercks, S. Schneider, Justus Liebigs 
Ann. Chem. 1934, 514, 1- 33; (b) K. Alder, G. Stein, M. Liebmann, E. Rolland, Justus Liebigs Ann. 
Chem. 1934, 514, 197-211; (c) K. Alder, G. Stein, E. Rolland, G. Schulze, Justus Liebigs Ann. Chem. 
1934, 514, 211-227. 
135
 (a) Ramachary, D. B., Chowdari, N. S.; Barbas III, C. F. Angew. Chem. Int. Ed. 2003, 42, 4233–4237. 
(b) Ramachary, D. B.; Chowdari, N. S.; Barbas III, C. F. Synlett 2003, 1910-1914. 
136
 Bijvoet, J.M.; Peerdeman A.F.; van Bommel, A.J. Nature 1951, 168, 271–272 
137For recent examples of this method to assign the absolute configurations of organic molecules, see: (a) 
Diedrich, C.; Grimme, S. J. Phys. Chem. A 2003, 107, 2524; (b) Casarini, D.; Lunazzi, L.; Mancinelli, 
M.;  Mazzanti, A.; Rosini, C.  J. Org. Chem. 2007, 72, 7667; (c) Goel, A.; Singh, F.V; Kumar, V.; 
Reichert, M.;  Goulder, T. A. M; Bringmann, G. J. Org. Chem. 2007, 72, 7765; (d) Stephens, P. J.; Pan, J. 
J.; Devlin, F. J.; Cheeseman, J. R. J. Nat. Prod. 2008, 71, 285. For a review: (e) Berova, N.; Di Bari, L.; 
Pescitelli, G. Chem. Soc. Rev. 2007, 36, 914. 
138
 Karplus, M. J. Am. Chem. Soc. 1963, 85, 2870-2871. 
139
 this is a NOE enhancement that must be observed, and it serves as a check of the reliability of the 
experiment. 
140
 The twist boat conformation has been has been found to occur in a number of six-membered rings, see: 
(a) Bushweller, C. H. J. Am. Chem. Soc. 1969, 91, 6019-6024. (b) Weiser, J.; Golan, O.; Fitjer, L.; Biali, 
S. E. J. Org. Chem. 1996, 61, 8277-8284. (c) Gill, G.; Pawar, D. M.; Noe, E. A. J. Org. Chem. 2005, 70, 
10726-10731. (e) Thanikasalam,K.; Jeyaraman, R.; Panchanatheswaran, K.; Low, J. N.; Glidwell, C. Acta 
Cryst. 2006, C62, o324-o327. (f) Lunazzi, L.; Mazzanti, A.; Rafi, S.; Rao; H.S.P. J. Org. Chem. 2008, 73, 
678-688 
141
 The use of a relatively small basis set is dictated by the dimension of the molecules, and by the need of 
keeping the computational time into reasonable times (about 24-48 hours on a 8-core Xeon X7355 
server). 
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2.2.2. Organocatalytic Michael addition/Alkylation domino reaction applied to the 
nitrocyclopropanation of Oxindoles 
 
Discussion 
Continuing the studies on the synthesis of spirooxindoles, we then focused on the construction 
of strained cyclopropyl oxindoles. This class of compounds was recently evaluated in medicinal 
chemistry as HIV non nucleoside transcriptase inhibitor.144 
Figure 1: novel oxindole as HIV-1 non nucleoside reverse transcriptase inhibitor 
N
H
O
Br
O
EtO
1  
 
In particular the molecule in Figure 1 was successfully docked into HIV-1 NNRTI site.1, 145 Having 
established our target we minded that, for the construction of this class of compounds, a 
suitable retrosynthetic strategy could be the addition of C1 donator-acceptor synthon to a C2 
acceptor-donator synthon (Scheme 1). 
Scheme 1: Retrosynthetic analysis to the synthesis of cyclopropyl spirooxindoles 
N
H
O
Br
O
EtO
N
H
O
CO2Et
C+
1 2 3  
We envisaged that the synthon 2 could be rationalized by an alkyliden oxindoles, and the 
synthon 3 could be the idealization of Bromonitromethane or Bromomalonate. This substrates 
can be easily activated by chiral base and through a Michael addition/alkylation tandem 
sequence have been recently used for the cyclopropanation of carbonyl compounds.146,147 
Our investigation started by reacting Bromonitromethane 4 (E)-ethyl 2-(2-oxoindolin-3-
ylidene)acetate 5a in presence of 40 mol% of Quinine and 1 equivalent of NaHCO3 as 
scavenger of the HBr that is developed during the reaction (Table 1 entry 1).  
Table 1: Catalyst Screening for the cyclopropanation of 3-alkylidenoxindoles[a] 
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N
O
NO2
H
EtOOC
N
O
H
NO2
Br
+
Tol 0.2 M, 
NaHCO3 1 equiv.
Chiral Base
EtOOC
5 4 6  
N MeMe
N
H
N
H
S
CF3
CF3
N BnBn
N
H
N
H
S
CF3
CF3
7a 7b  
Entry Catalyst T (°C) time (h) Conv [%]
[b] 
dr
[b] 
ee [%]
[c] 
1 Qn (40%) rt 65 60 3:1 41 
2 Qd (40%) rt 65 49 8:1:1 30 
3 (DHQ)2PHAL (10%) rt 65 69 2.3:1 0 
4 7a (10%) rt 65 88 14:1 77 
5 7b (10%) rt 65 - - - 
6 HQd-TIOUREA 7c (10%)  rt 65 81 8.8:1 79 
[a] The reactions were performed on a 0.2 mmol scale [b] Determined by 1H NMR analysis 
of the crude mixture. [c] Determined by HPLC analysis on chiral stationary phases.  
 
Surprisingly the reaction afforded the desired product with good yield and promising 
stereoselectivity. After the chiral base screening, where both face-shielding and bifunctional 
catalyst were examinated, 9-Epi-HQ-tiourea has furnished the best enantioselctivity148 (entry 
6) even if this result was not yet satisfactory. Following the optimization strategy that we used 
for the “Asymmetric addition of oxindoles to α,β-unsaturated ketones” chapter xx we moved 
to the use of N-Boc-3Alkyliden Oxindoles, minding that the N-H protection could have a 
beneficial effect on both rate and stereoselctivity of the reaction.149 
As highlighted in table 2 running the reaction with (E)-tert-butyl 3-(2-ethoxy-2-oxoethylidene)-
2-oxoindoline-1-carboxylate 8a good conversion of the substrate in the desiderated product 
was obtained together with excellent stereoselctivity (Table 2 entry 1). 
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Table 2: Further optimization for the cyclopropanation of 3-alkylidenoxindoles
[a]
 
N
O
NO2
Boc
EtOOC
N
O
Boc
NO2
Br
+
Solv 0.2 M, 
Base 1 equiv.
EtOOC
8a 4 9a
7c (10 mol%)
 
N
N
H
S
N
H N
OMeF3C
CF3
7c  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[a] Unless otherwise specified, the reactions were performed at room 
temperature on a 0.1 mmol scale with 10 mol% of 7c, 1.5 equiv of 4, 1 equiv of 
Base and [8a]0 = 0.2 M. [b] Determined by 
1H NMR analysis of the crude 
mixture. [c] Determined by HPLC analysis on chiral stationary phases. [d] 
Reaction performed with 5 mol% of 7c. [e] Reaction performed at 0 °C.  
 
Further optimization was achieved evaluating the reaction media and the nature of the 
external additive. In MTBE the reaction time lowed up to 24h (entries 1-7), and in presence of 
a stronger organic base as triethylamine the reaction has a slight decrease of 
performanceswhereas employing 1 equivalent of Na2CO3 it was observed an improvement of 
turnover number, leading to a good conversion in the desired product even with only 5% of 
catalyst (entries 7-9). Finally carrying out the reaction at 0°C in 48 hours the best conditions for 
this synthetic approach to cyclopropyl spirooxindoles were indentified (entry 10). 
We then examined the generality of the asymmetric organocatalytic nitrocyclopropanation of 
N-Boc Alkyliden oxindoles under the optimized condition (Table 3). 
Entry Base
 
Solvent Time [h] Conv [%].
[b]
 d.r.
[b]
 [%] ee
[c]
 
1
 NaHCO3 Toluene 65 63 18:1 98 
2 NaHCO3 DCM 24 57 9.8:1 96 
3
 NaHCO3 CH3CN 24 40 9.4:1 82 
4 NaHCO3 THF 24 67 9.4:1 97 
5 NaHCO3 MTBE 24 76 16:1 98 
7
[d] NaHCO3 MTBE 24 47 16:1 98 
8
[d]
 Et3N MTBE 24 48 5.3:1 93 
9
[d] Na2CO3 MTBE 24 70 16:1 98 
10
[d],[e]
 Na2CO3 MTBE 48 full
 19:1 98 
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Table 3: Synthesis of nitro cyclopropyl spirooxindoles with two adjacent tertiary stereogenic 
centers.[a] 
N
O
NO2
Boc
R1
N
O
Boc
NO2
Br
+
MTBE 0.2 M, 
Na2CO3 1 equiv.
EtOOC
8a-i 4 9a-i
7c- 7d (5-10 mol%) R
 
[a] Unless otherwise specified, the reactions were performed on a 0.2 mmol scale with 5 
mol% of 7c, 1.5 equiv of 4, 1 equiv of Na2CO3 and [8a]0 = 0.2 M. [b] Sum of 
diastereoisomers. [c] Determined by 1H NMR analysis of the crude mixture. [d] 
Determined by HPLC analysis on chiral stationary phases. [e] Reaction performed with 5 
mol% of 7d. [f] Reaction performed with 10 mol% of 7d. [g] 99% ee after single 
crystallization. [h] Reaction performed with 2 mol% of 7d. 
 
Entry 8 R
 
R
1
 T [°C] t [h] Yield
[b]
 [%] d.r.
[c]
 ee
[d]
 [%] 
1
 a H COOEt 0 48 77 19:1 98 
2 b H COPh 0 72 52 9:1 90 
3
[e] b H COPh rt 72 82 >19:1 98 
4 c H n-butyl rt 72 60 3:1 93 
5
[f]
 c H n-butyl rt 72 75 4:1 92 
6
[e]
 d H Ph rt 72 83 7.7:1.6:1 90 
7
[e]
 e H 2-MePh rt 48 80 3:1 90 
8 f 5-Br COOEt rt 24 76 9:1 87 
9
[e]
 f 5-Br COOEt 0 72 74 >19:1 93 
10
[e] g 5-Cl Ph rt 48 84 8.6:1.3:1 90 
11
[e]
 h 6-Cl Ph rt 48 65 12:2:1 89 
12
[g]
 i 5-Me Ph rt 72 60 7:1 91 
13
[h]
 a H COOEt rt 72 99 11:1 97 
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Notably both the antipodes of the products are synthesized with high yield and high diastero- 
and enantioselection by appropriate selection of the catalyst (9-Epi-HQd-Tiourea 7c, and9-Epi-
HQd-Tiourea 7d). 
All the reactions furnished good yields in 48 or 72 hours using 5% or in one case 10% of 
catalyst (entry 5). Alkyliden oxindoles substituted in 3 position with electron withdrawing 
group underwent smoothly to the nitrocyclopropanation protocol giving impressive 
stereoselctivity (entries 1-3). Thanks to their great reactivity it was possible, by adjusting the 
reaction time, decrease the catalyst loading up to 2 mol% maintaining similar level of 
streoinduction. 
Alkyl and aromatic substituent also proved to be suitable for the construction of the 
correspondent spirooxindoles in high enantiomeric excess, but with a slight decrease of the 
diastereoisomeric ratio (entries 4-7). Changing the electronic content, with groups in 5 and 6 
position of the aromatic ring of the oxindole the reaction gave good results too (entries 8-13). 
As mentioned before (Chapter xx) such level of diastereoselctivity can be justified admitting a 
bifunctional macchanism, considering that it is possible to obtain 8 stereoisomers divided in 4 
couples of distereoisomers as outcome of the reaction.  
The increasing of the diastereomeric ratio after the protection of oxindolic N-H with Boc group 
suggests that this moiety favors the coordination, via H-bonding interaction, between the 
oxindole and the tiourea part of the catalyst,150 while the quinuclidinic basic functionality 
actives the Bromonitromethane (Scheme 1). 
Scheme 2: Proposed transition state for the nitrocyclopropanation of Alkyliden Oxindoles 
HNH
N
N
OMeH
H
N
S
CF3
CF3
N
O
R1
O
O
NO2
Br
1
2
 
 
This double activation justify the stereochemical outcome of the reaction. In fact the H-bonds 
place the oxindole in the right spatial position to  undergo the Michael addition by the 
nucleophile on its Si-face. In this way two of the three stereocenters are forged since it is 
plausible that the intramolecular Alkylation occurs through SN2 pathway. 
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Encouraged by our good results we set the condition for the synthesis of cyclopropyl 
spirooxindoles having two adjacent quaternary stereocenters whereof one all carbon 
substituted. 
In scheme 3 are highlighted the satisfying preliminary results obtained using 1-Bromo-1-
nitromethane and N-Boc-3-Alkyliden Oxindoles as substrates. 
Scheme 3: Preliminary results of the synthesis of cyclopropyl spirooxindoles bearing two 
adjacent quaternary stereocenters. 
N
O
NO2
Boc
R1
N
O
Boc
NO2
Br
+
MTBE 0.2M, 48 - 72h
Na2CO3 1 equiv.,
rt.
catalyst 7d (5-10 mol%)
Me
R1 Me
8a: R = H, R1 = COOEt
8d: R = H, R1 = n-butyl
8f: R = Br, R1 = COOEt
8j: R = F, R1 = COOEt
10 11a, d, f,  j
R R
 
N
O
NO2
Boc
EtOOC Me
 
N
O
NO2
Boc
Me
 
N
O
NO2
Boc
EtOOC Me
Br
 
91% yield,[d] 5:1 d.r.,[e]
>99% ee[f]
11a 
65% yield,[d] 3:1 d.r.,[e]
92% ee[f]
11b
[a] 
65% yield,[d] 1.5:1 d.r.,[e]
96% ee[f]
11f
[b] 
N
O
NO2
Boc
EtOOC Me
Br
 
N
O
NO2
Boc
EtOOC Me
F
 
71% yield,[d] 2:1 d.r.,[e]
96.4% ee[f]
ent-11f
[c] 
71% yield,[d] 4:1 d.r.,[e]
96% ee[f]
11j
[b] 
Unless otherwise specified, the reactions were performed on a 0.2 mmol scale with 5 mol% of 
7d, 1.5 equiv of 10, 1 equiv of Na2CO3 and [8a]0 = 0.2 M. [a] Reaction performed with 20 mol% 
of 7d. [b] Reaction performed with 5 mol% of 7d. [c] Reaction performed with 10 mol% of 7c. 
[d] Sum of diastereoisomers. [e] Determined by 1H NMR analysis of the crude mixture. [f] 
Determined by HPLC analysis on chiral stationary phases. 
 
The reaction summarized in Scheme 3 afforded the product with good yield and enantiomeric 
excess. Unfortunately the diastereomeric ratio seemed to be dependent on the oxindole 
architecture giving appreciable dr values only in two cases (products 11a and 11j). The relative 
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and absolute configuration of 9a and 11a were assigned by NOE-NMR analyses and through 
time dependent (TD) DFT calculations of the electronic circular dichroism (ECD) spectra (see 
experimental part for details) 
 
This outcome together with the inversion of the configuration of one chiral center (C3) could 
be explained admitting another reaction pathway (Scheme 4).  
Scheme 4: Postulated reaction pathway for the formation of cyclopropyl oxindole bearing two 
quateranary sterecenters: MA/intramolecular SN1 tandem sequence. 
HNH
N
N
OMeH
H
N
S
CF3
CF3
N
O
R1
O
O
O2N
Br
Me
NH
N
N
OMeH
H
N
S
CF3
CF3
Br
O2N
Me
R1 N Boc
OH
 
 
In scheme 4 is reported the postulated transition state for the addition of 1-Bromo-1-
NitroEthane to 3-Alkyliden Oxindoles. The observation of the experimental results promted us 
to hypothesize that after the MA of the BromoEthane to the oxindole, the reaction does not 
follow an intramolecular SN2 pathway because of the high steric hindrance in proximity of the 
tetrasubstituted carbon bearing the bromine leaving group (Figure 2). 
Figure 2: Micheal adduct formed during the ciclopropanation of spirooxindole with 1-Bromo-1-
NitroEthane 
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For this reason it is possible suppose that the real mechanism of the second step is an 
intramolecular SN1 reaction where the thiourea moiety drives to the formation of a 
carbocation through anion binding activation and the quinuclidine stabilized the enol form of 
the oxindole.  
Concluding we developed an unprecedented reported protocol for the synthesis of higly 
densely functionalized ciclopropyl oxindoles bearing three stereocenters whereof one spiranic 
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all carbon substituted quaternary one. This methodology was also applied to the construction 
of more complex cyclopropylic compounds with two adjacent quaternary stereocenters. The 
low catalyst loading together with the availability of the starting material, lead us to believe 
that this methodology is also a good start point for the stereoselective synthesis of bioactive 
compounds libraries. 
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Experimental part 
 
General. 
The 1H and 13C NMR spectra were recorded at 300 MHz and 75 MHz, 400 MHz and 100 MHz, or 
at 600 MHz for 1H and 150 MHz respectively for 13C. All the 1H and 13C signals were assigned by 
means of g-COSY, g-HSQC and g-HMBC 2D-NMR sequences. NOE spectra were recorded using 
the DPFGSE-NOE sequence,151 using a mixing time of 2.00 s and “rsnob” 20 ÷ 50 Hz wide 
selective pulses, depending on the crowding of the spectra region. The chemical shifts (δ) for 
1H and 13C are given in ppm relative to residual signals of the solvents (CHCl3 and CD3CN). 
Coupling constants are given in Hz. When 2D-NMR were not performed, carbon types were 
determined from DEPT 13C NMR experiments. The following abbreviations are used to indicate 
the multiplicity: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; bs, broad signal. 
Purification of reaction products was carried out by flash chromatography (FC) on silica gel 
(230-400 mesh) according to the method of Still.152 Organic solutions were concentrated under 
reduced pressure on a Büchi rotary evaporator. Mass spectra were obtained by electron spray 
ionization (ESI). All reactions were set up in the air and using undistilled solvent, without any 
precautions to exclude moisture unless otherwise noted. 
 
Materials. Commercial grade reagents and solvents were used without further purification; 
otherwise, where necessary, they were purified as recommended.153 Chiral tiourea catalysts, 9-
epi-9-thiourea-9-deoxy-dihydroquinidine 7c, and its pseudoenantiomer 9-epi-9-thiourea-9-
deoxy-dihydroquinine 7d, were prepared from commercially available hydroquinidine, quinine 
and quinidine, respectively, following the literature procedure.154  
α-bromonitromethane 4, from Aldrich and used as received. α-bromonitroethane 10 were 
prepared following the literature procedures.155 N-Boc protected oxindoles 8a-i has been 
prepared following the literature procedures.156 
 
Determination of Diastereomeric Ratios 
The diastereomeric ratio was determined by 1H NMR analysis of the crude reaction mixture, 
and confirmed by HPLC analysis on chiral stationary phase columns. 
 
Determination of Enantiomeric Purity. HPLC analysis on chiral stationary phase was 
performed on an Agilent 1100-series instrumentation. Daicel Chiralpak AD-H, AS-H columns 
and Daicel Chiralcel OD-H with i-PrOH/hexane as the eluent were used. HPLC traces for 
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compounds  9a-i, 11a, 11d, 11f and 11j were compared to racemic samples prepared by 
mixing the two product antipodes obtained performing the reaction with catalyst 9-epi-9-
thiourea-9-deoxy-dihydroquinidine 7c, and the pseudo-enantiomer 9-epi-9-thiourea-9-deoxy-
dihydroquinine 7d separately.  
 
Calculations. MM conformational searches were performed using the MonteCarlo method 
implemented in Titan 1.0.5.157 Geometry optimization were carried out at the B3LYP/6-31G(d) 
level by means of the Gaussian 03 series of programs.158 The standard Berny algorithm in 
redundant internal coordinates and default criteria of convergence were employed. Harmonic 
vibrational frequencies were calculated for all the stationary points. For each optimized 
ground state the frequency analysis showed the absence of imaginary frequencies. Standard 
thermochemistry analysis was used to calculate the free energies. TD-DFT calculations were 
obtained at the B3LYP/6-31+G(d,p)//B3LYP/6-31G(d) level. In order to cover the whole 180-
400 nm range, 60 to 75 transition were calculated. The CD spectra was then obtained applying 
a 0.25 eV Gaussian bandshape 
 
Assignment of the relative and absolute configuration of compounds 9a, 6a and 7a. 
 
Compound 9a, 11a and 12a were selected in order to determine the relative and absolute 
configuration of a prototype compound of each class. In both cases, Full assignment of 1H and 
13C NMR signals was preliminarily determined by HSQC and HMBC bi-dimensional sequences, 
and NOE spectra were acquired in order to establish the relative stereochemistry.  
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Figure S1: DPFGSE-NOE spectra obtained for 9a (25°C, 600 MHz, CD3CN). Trace a): control 
spectrum, trace b: NOE spectrum obtained on saturation of H-4’; trace c): NOE spectrum 
obtained on saturation of H-3; trace d): NOE spectrum obtained on saturation of H-2. Relevant 
NOEs are indicated in blue, “control” NOEs are in green. The spectral region displayed does not 
show the Boc and Methyl signals. 
 
In the case of compound 9a, saturation of the signal corresponding to the peri aromatic 
nitrogen H-4’ (trace b in figure S1) showed a strong NOE effect on H-2 and a weak 
enhancement on H-3, indicating that H-2 is directed towards the aromatic ring and H-3 is on 
the opposite side of the three-membered ring (i.e. H-2 and H-3 are in a trans relationship.). 
This arrangement was also confirmed by the saturation of the signals of H-3 and H-2 (traces c 
and d, respectively). When H-3 is saturated, NOE is observed only on H-2, because of the 
proximity constraints imposed by the cyclopropane. On the contrary, when H-2 is saturated, 
H -4 ’ 
H -3 
H -2 
H -3
H-4’ H -3 
H-4 ’
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strong NOEs are observed for H-3 and H-4’. All the NOE data thus confirm that the relative 
stereochemistry is 1R*,2R*,3S*.  
The same NMR approach was used for the determination of the relative configuration of 11a 
and 12a, a derivative of compound 11a that where the Boc group was removed (Figure S2). 
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Figure S2: DPFGSE-NOE spectra obtained for compound 7a (25°C, 600 MHz, CD3CN). Trace a): 
control spectrum, trace b: NOE spectrum obtained on saturation of H-4’; trace c): NOE 
spectrum obtained on saturation of H-3; trace d): NOE spectrum obtained on saturation of Me-
2. Relevant NOEs are indicated in blue, “control” NOEs are in green. The spectral region 
displayed does not show the  methyl signal of the ester moiety. 
 
In this compound the configuration at C-1 is reversed with respect to 4a. Saturation of H-4’ 
shows NOE effect only on the methyl group in position 2: this implies that the methyl of 
carbon in position 2 is directed towards the aromatic ring and the nitro group towards the 
oxygen of the oxaindole. The lack of NOE effect on H-3 (at 3.55 ppm) indicates that H-3 is on 
the opposite side of the cyclopropane, and that the COOEt moiety is on the same side of Me-2 
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(i.e. a trans relationship between the methyl and H-3). This disposition is confirmed when the 
methyl in position 2 is saturated. In addition to a medium NOE observed on H-3, due to the 
constraints imposed by the small cycle, a very strong NOE enhancement is observed on the 
aromatic H-4’. All the NOE data confirm that the relative stereochemistry is 1R*,2R*,3S*. This 
relative configuration corresponds to the inversion of the spiranic quaternary center and it 
should be noted that the apparent identical relationship of the stereochemical descriptors 
with that of 4a is due to the different priority number of the cyclopropane carbons (the carbon 
bearing the NO2 group is the number 3 in 4a and number 2 in 7a. 
 
Conformational analysis and absolute configuration determination 
Compounds 9f-h and 11f possess the heavy atom required by the use of the Bijovet method, 
based on anomalous X-ray dispersion, to unambiguously assign the absolute configuration 
(AC).[159] However, despite several attempts, we were not able to grow good crystals neither of 
compounds 9f-h and 11f nor of the corresponding compounds in which the Boc protecting 
group was removed. For this reason the determination of the absolute configuration has been 
carried on by means of chiroptical techniqus. In particular, theoretical calculation of Electronic 
Circular Dichroism (ECD) spectra was carried out by means of the TD-DFT method, since this 
technique has emerged as a reliable technique to assign the AC, and it has been successfully 
employed many times to predict the ECD spectra of complex organic molecules.[160] It is worth 
to note that the relative stereochemistry has been fixed by the NOE analysis, therefore only 
the distribution of the molecular conformations affects the shape of the ECD spectrum.  
 
Compound 9a 
A preliminary conformational search, starting from the relative configuration derived from 
NOE spectra of 9a has been carried out using Monte Carlo searching together with the 
MMFF94 molecular mechanics force field (as implemented in Titan 1.0.5, Wavefunction inc.). 
All conformations within a 5 kcal/mol window were then optimized using DFT at the B3LYP/6-
31G(d) level,[161] and the harmonic vibrational frequencies of each conformation were 
calculated at the same level to confirm their stability (no imaginary frequencies observed), and 
to evaluate the free energy of each conformation by thermochemistry corrections. After DFT 
minimization, four conformations were found to be true energy minima, with two of them 
much more stable than the other two. (Table S1 and Figure S3). The two best conformations 
are different because of the different orientation of the COOEt group. 
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Table S1: Calculated relative energies (E) and free energies (G) of the conformations of 4a (in 
kcal/mol, B3LYP/6-31G(d) level). Populations percentages (Pop.) are calculated assuming using 
the free energies and Boltzmann statistics at T=25°C. 
 
Molecule Conf. E G Pop (ΔG) 
9a 
a 0.00 0.00 58 
b 0.01 0.20 41 
c 2.75 2.69 0.6 
d 2.83 3.07 0.4 
 
 
Figure S3. The two most stable conformations of 9a obtained by DFT calculations (B3LYP/6-
31G(d) level). Highlighted regions indicate the different disposition of the COOEt moiety. 
 
Electronic excitation energies and rotational strengths have been calculated in the gas phase 
for the four conformations of 9a using TD-DFT at the B3LYP/6-311++G(2d,p)//B3LYP/6-31G(d) 
and supposing 1R, 2R, 3S Absolute Configuration, with the results shown in Figure S4 (top). 
Rotational strengths were calculated in both length and velocity representation, the resulting 
values being  very similar. For this reason the errors due to basis set incompleteness should be 
very small, or negligible.[162] It should be noted that the ECD spectra of conformations c and d 
are quite different with respect to those of conformations a and b. This difference, however, 
has a very small effect on the final simulation because of the very small population of 
conformations c and d. The final simulated ECD spectra was obtained taking into account the 
Conf . a Conf . b
9a
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58:41 populations ratio determined assuming Boltzmann statistics from the calculated free 
energies at the B3LYP/6-31G(d) level (see Figure S5). The agreement between calculated and 
experimental spectra is very good, and the ECD simulations nicely support the conclusion that 
the absolute configuration of 9a is 1R, 2R, 3S  
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Figure S4. Top: calculated ECD spectra for the two conformation of 9a using the geometries 
obtained by gas-phase calculations. TD-DFT calculations were performed at the B3LYP/6-
311++G(2d,p) level. Bottom: experimental (black) and calculated ECD spectra (red) of 9a based 
on calculated free energies (ΔG) and geometries calculated in the gas phase. Experimental ECD 
were obtained on acetonitrile solutions (1·10-4 M) and 0.2 cm path length. Molecular CD (Δε) 
are expressed in L mol-1cm-1. Simulated spectra were red-shifted by 15 nm in order to match 
the experimental traces. 
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As evenly suggested by some authors[163], the use of more than one chirooptic method is 
always desirable in order to enhance the reliability of the assignment. In the present case 
compound 11a exhibits a value of [α]D = +183°, that is well outside the “uncertainty zone” 
suggested by some authors[164]. For this reason the calculation of the [α]D by DFT calculations 
can independently confirm the absolute configuration of 9a. The optical rotation of both the 
lowest energy conformers of 9a was calculated at the B3LYP/6-311++G(2d,p)/B3LYP/6-31g(d) 
level, yielding values of 244.1 and +215.3 for conformer a and b, respectively (see Table S2). 
When weighted by the Boltzmann statistic, the calculated optical rotation value is +229, in 
good agreement with the experimental value.[165] 
Table S2: calculated and experimental [α]D values.  
 
Molecule Conf. [α]D Pop. [α]D Exp.[α]D 
9a 
a 244.1 58 
+229 +183.3 
b 215.3 41 
c - 0.6 
d - 0.4 
11a 
a -141 0.5 
-95 -112.5 
b -95.3 99.5 
c - 0.5 
d - 0.0 
12a 
a -57.4 99.5 
-58 -121.2 
b -155.5 0.5 
 
Compounds 11a and 12a 
The same theoretical approach was employed for the determination of the AC of 11a and for 
its derivative 12a in which the Boc protecting group was removed for convenience (the 
absolute configuration is not modified during the removal of the Boc group). The 
conformational search is indeed facilitated in the case of 12a because of the absence of the 
Boc moiety. For this compound only two conformations were localized after the MM search 
(see Table 2), whereas four conformation were found for 11a, as in the case of 9a.  
The different relative configuration of 11a and 12a with respect to 9a, affects the relative 
energies of the conformations, in that essentially one conformation is populated in both cases 
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(see Table S3). This implies that the most populated conformation determines the shapes of 
the ECD spectra. 
Table S3: Calculated relative energies (E) and free energies (G) of the conformations of 6a and 
the derivative of 6a and 7a (in kcal/mol, B3LYP/6-31G(d) level). Populations percentages (Pop.) 
are calculated assuming using the free energies and Boltzmann statistics at T=25°C. 
 
Molecule Conf. E G Pop (ΔG) 
11a 
a 3.4 3.3 0.5 
b 0.0 0.0 99.0 
c 3.3 3.5 0.5 
d 6.9 6.5 0.0 
12a 
a 0.0 0.0 99.5 
b 3.6 3.4 0.5 
 
As in the case of compound 9a, the electronic excitation energies and rotational strengths 
have been calculated in the gas phase for the most populated conformations of 11a and 12a 
using TD-DFT at the B3LYP/6-311++G(2d,p)//B3LYP/6-31G(d) and supposing 1R,2R,3S absolute 
configuration, with the results shown in Figures S5. While the two experimental ECD spectra of 
11a and 12a are similar, in both cases the calculated ECD traces do predict the correct 
sequence of the cotton effects, but they do not match their wavelength. Despite the use of 
other functionals like BH&LYP and Pw1Pw91, the calculated ECD spectra show always the 
same incongruence in matching the wavelength of the simulated maxima with respect to the 
experimental ones, while the trend is correctly simulated. Since compound 11a is a 
conformationally rigid molecule having few degrees of freedom, and compound 12a is even 
less flexible, a miscalculation of the ground states geometries seems unlikely because the 
same theoretical approach was found to be appropriate in the case of compound 9a.  
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Figure S5: Top: experimental (black) and calculated ECD spectra (red) of 11a. Bottom: 
experimental (black) and calculated ECD spectra (red) of 12a. Experimental ECD were obtained 
on acetonitrile solutions (≈ 1·10-4 M) and 0.2 cm path length. Molecular CD (Δε) are expressed 
in L mol-1cm-1. Simulated spectra were red-shifted by 7 nm in order to match the experimental 
traces. 
 
 
On the other hand, compounds 11a and 12a have [α]D values of = -112.5° and -121.2°, 
therefore the calculation of the optical rotations could confirm the absolute configuration 
inferred by the ECD simulation. The optical rotations of the lowest energy conformer of 11a 
and for the two conformers of 11a were calculated at the B3LYP/6-311++G(2d,p)/B3LYP/6-
31g(d) level, providing weighted values of -95° and -58° for 11a and 12a, respectively. Being 
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these value in good agreement with the experimental value, the 1R, 2R, 3S absolute 
configuration of 11a and 12a can be reliably assigned.[165] 
 
 
General procedure for the enantioselective nitrocyclopropanation of oxindoles 
 
N
O
Boc
EtOOC
8a
N
O
NO2
Boc
+
MTBE, 0.2M,
Na2CO3 1 equiv.,
0°C/rt
7c  (5-10 mol%)
EtOOC
9a
NO2
Br
4
 
All the reactions were carried out in undistilled MTBE. In an ordinary vial equipped with a 
Teflon-coated stir bar, 9-epi-9-thiourea-9-deoxy dihydroquinidine 7c (0.01 mmol, 5.98 mg, 5 
mol%) was dissolved in 1 mL of MTBE and bromo nitromethane (0.3 mmol, 22.4 µL, 1.5 equiv.) 
was added. After 5 minutes N-Boc protected oxindole derivative (0.2 mmol, 1.0 equiv.) and 
Na2CO3 (0.2 mmol, 1 equiv.) were added. The resulting solution was stirred at the indicated 
temperature for 24-72 hours. The crude mixture was diluted with CH2Cl2 and flushed through a 
short plug of silica, using dichloromethane/ethyl acetate 1:1 as the eluent (100 ml). Solvent 
was removed in vacuo and the nitro cyclopropane adduct was isolated by flash column 
chromatography using hexane/ethyl acetate/diethyl ether as the eluent mixture. 
 
(1R,2R,3S)-1'-tert-butyl 2-ethyl 3-nitro-2'-oxospiro[cyclopropane-1,3'-
indoline]-1',2-dicarboxylate (9a), (Table 3, entry 1): The reaction was 
carried out at 0 °C following the general procedure using 7c (5 mol%, 5,96 
mg) as the catalyst to furnish after 48 h the crude product (d.r.: 19:1 
determined by integration of 1H-NMR signal: δmajor 3.83 d., δminor 3.79 ppm. d.). The title 
compound was isolated as a pale yellow oil by column chromatography (hexane/Et2O = 85/15) 
in 77% yield and 98% ee. HPLC analysis on a Daicel Chiralpak AD-H column: 98/2 hexane/i-
PrOH, flow rate 0.75 mL/min, λ = 214, 254 nm: τmajor =19.6 min, τminor =16.4 min; ESI-MS: 399 
(M++Na), 415(M++K); [α]rt
D= +183 (c = 0.8000, CHCl3, 98% ee). 
1H NMR (600 MHz, CD3CN): δ 
1.05 (t, 3H, J = 7.2 Hz), 1.41 (s, 9H), 3.86 (d, 2H, J = 6.3Hz) 3.96-4.05 (m, 2H), 5.08 (d, 2H, J = 
6.3Hz), 7.02-7.06 (m, 2H), 7.25-7.30 (m, 1H), 7.72-7.75 (m, 1H). 13C NMR (150 MHz, CDCl3): δ  
13.5 (CH3), 27.4 (C(CH3)3, 36.0 (CH), 39.9 (C), 62.2 (CH2), 70. 5 (CH), 84.9 (C), 115.6 (CH), 120.5 
(C), 122.0 (CH), 124.7 (CH), 130.2 (CH), 141.3 (C), 148.5 (C), 163.0 (C), 168.4 (C). 
 
N
O
9a Boc
EtOOC
NO2(1R)
(2R)
(3S)
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(1S,2S,3R)-1'-tert-butyl 2-ethyl 3-nitro-2'-oxospiro[cyclopropane-1,3'-
indoline]-1',2-dicarboxylate (9a), (Table 3, entry 13): The reaction was 
carried out at room temperature following the general procedure using 
7d (2 mol%, 2.4 mg) as the catalyst to furnish after 72 h the crude 
product (d.r.: 11:1 determined by integration of 1H-NMR signal: δmajor 
3.83 d., δminor 3.79 ppm. d.). The title compound was isolated as a pale yellow oil by column 
chromatography (hexane/Et2O = 85/15) in 99% yield and 97% ee. HPLC analysis on a Daicel 
Chiralpak AD-H column: 98/2 hexane/i-PrOH, flow rate 0.75 mL/min, λ = 214, 254 nm: τmajor 
=16.1 min, τminor =18.9 min; [α]rt
D=-213 (c = 1.05, CHCl3, 97% ee).  
 
 
(1R,2R,3S)-tert-butyl 2-benzoyl-3-nitro-2'-oxospiro[cyclopropane-
1,3'-indoline]-1'-carboxylate (9b), (Table 3, entry 2): The reaction was 
carried out at 0 °C following the general procedure using 7c (5 mol%, 
5,96 mg) as the catalyst to furnish after 72 h the crude product (d.r.: 
19:1 determined by integration of 1H-NMR signal: δmajor 5.51 d., δminor 
5.25 ppm. d.). The title compound was isolated as a pale yellow oil by 
column chromatography (hexane/Ethyl Acetate  = 95/5) in 52% yield and 90% ee. HPLC 
analysis on a Daicel Chiralpak AD-H column: 95/5 hexane/i-PrOH, flow rate 0.75 mL/min, λ = 
214,: τmajor = 20.3 min, τminor = 19.2 min; ESI-MS: 409(M
++1), 431 (M++Na), 447 (M++K); [α]rt
D= 
+258.5 (c = 1.26, CHCl3, 90% ee). 
1H NMR (400 MHz, CH3CN): δ 1.55 (s, 9H), 4.36 (d, 1H, J = 
6.53Hz), 5.51 (d, 1H, J= 6.3 Hz), 7.28 (dd, 1H, J =0.96 Hz, J = 7.7 Hz), 7.37-7.45 (m, 3H), 7.48 
(dt,1H, J =1.36 Hz, J = 7.7 Hz ), 7.55-7.61 (m, 1H), 7.77-7.82 (m, 2H), 7.96-8.02 (m,1H) .13C NMR 
(100 MHz, CDCl3): δ 28.3 (C(CH3)3, 40.2 (CH), 41.8 (C), 70.3 (CH), 85.7 (C), 116.0 (CH), 120.0 (C), 
122.0 (CH), 125.4 (CH), 128.7 2x(CH), 129.4 2x(CH), 130.7 (CH), 134.7 (CH), 135.4 (C), 141.3 (C), 
148.6 (C), 167.7(C), 186.8 (C). 
 
(1S,2S,3R)-tert-butyl 2-benzoyl-3-nitro-2'-oxospiro[cyclopropane-1,3'-
indoline]-1'-carboxylate (ent-9b), (Table 3, entry 3): The reaction was 
carried out at room temperature following the general procedure using 
7d (5 mol%, 5,96 mg) as the catalyst to furnish after 48 h the crude 
product (d.r.> 19:1 determined by integration of 1H-NMR signal: δmajor 
5.51 d., δminor 5.54 ppm. d.). The title compound was isolated as a pale yellow oil by column 
chromatography (hexane/Ethyl Acetate  = 95/5) in 82% yield and 98% ee. HPLC analysis on a 
N
O
9b Boc
NO2
O
Ph
N
O
ent-9b Boc
NO2
O
Ph
N
O
ent-9a Boc
EtOOC
NO2
218 
 
Daicel Chiralpak AD-H column: 98/2 hexane/i-PrOH, flow rate 0.75 mL/min, λ = 214,: τmajor = 
35,8 min, τminor = 38.4 min; [α]rt
D= +258.5 (c = 1.26, CHCl3, 98% ee). 
 
(1R,2R,3S)-tert-butyl 2-nitro-2'-oxo-3-propylspiro[cyclopropane-1,3'-
indoline]-1'-carboxylate (9c), (Table 3, entry 4): The reaction was 
carried out at room temperature following the general procedure using 
7c (10 mol%, 11.92 mg) as the catalyst to furnish after 48 h the crude 
product (d.r.: 3:1 determined by integration of 1H-NMR signal: δmajor 
7.90 m., δminor 7.99 ppm. m.). The title compound was isolated as a mixture of 
diastereoisomers by column chromatography (hexane/Et2O = 95/5) in 60% yield and 93% ee. 
HPLC analysis on a Daicel Chiralpak AD-H column: 95/5 hexane/i-PrOH, flow rate 0.550 
mL/min, λ = 214, 254 nm: τmajor = 9.20 min, τminor = 8.00 min; ESI-MS: 347 (M
++1), 369 (M++Na);  
1H NMR (600 MHz, CDCl3): δ 0.92 (t, 3H, J = 7.4 Hz), 1.41-1.50 (m, 2H), 1.65 (s, 9H), 1.80-1.94 
(m, 1H), 1.96-2.07 (m, 1H), 3.00 (m, 1H), 4.89 (d, 1H, J = 6.6 Hz), 7.13-7.24 (m, 2H), 7.35 (m, 
1H), 7.90 (m, 1H); 13C NMR (150 MHz, CDCl3): δ 13.3 (CH3), 21.8 (CH2), 24.6 (CH2), 24.0 ((CH3)3), 
37.5 (CH), 39.9 (C), 74.3 (CH), 85.1 (C), 122.4 (C), 140.1 (C), 148.6 (C), 169.8 (C). 
 
(1S,2S,3R)-tert-butyl 2-nitro-2'-oxo-3-propylspiro[cyclopropane-1,3'-
indoline]-1'-carboxylate (ent-9c), (Table 3, entry 5): The reaction was 
carried out at room temperature following the general procedure using 
7d (5 mol%, 5.96 mg) as the catalyst to furnish after 48 h the crude 
product (d.r.: 4:1 determined by integration of 1H-NMR signal: δmajor 
7.90 m., δminor 7.99 ppm. m.). The title compound was isolated as a mixture of 
diastereoisomers by column chromatography (hexane/Et2O = 95/5) in 75% yield and 92% ee. 
HPLC analysis on a Daicel Chiralpak AD-H column: 95/5 hexane/i-PrOH, flow rate 0.550 
mL/min, λ = 214, 254 nm: τmajor = 8.02 min, τminor = 9.20 min; [α]rt
D= - 128.2 (c = 1.173, CHCl3, 
92% ee). 
 
(1S,2S,3R)-tert-butyl 2-nitro-2'-oxo-3-phenylspiro[cyclopropane-1,3'-
indoline]-1'-carboxylate (9d), (Table 3, entry 6): The reaction was 
carried out at room temperature following the general procedure 
using 7d (5 mol%, 5.96 mg) as the catalyst to furnish after 72 h the 
crude product (d.r.: 7.7:1.6:1 determined by integration of 1H-NMR 
signal: δmajor 4.33 d., δminor 4.45 ppm. d., δminor 3.80 ppm. d.). The title compound was isolated 
as a mixture of diastereoisomers by column chromatography (hexane/Et2O =95/5 to 90/10) in 
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83% yield and 90% ee. HPLC analysis on a Daicel Chiralpak AD-H column: 90/10 hexane/i-PrOH, 
flow rate 0.750 mL/min, λ = 214, 254 nm: τmajor = 6.88 min, τminor = 11.22 min; ESI-MS: 381 
(M++1), 403 (M++Na), 419 (M++K); 1H NMR (400 MHz, CDCl3),: δ 1.59 (9H, s), 4.33 (1H, d, J = 
6.89 Hz), 5.49 (1H, d, J = 6.89 Hz), 7.19-7.25 (m, 1H), 7.28-7.43 (m, 7H), 7.91-7.95 (m, 1H); 13C 
NMR (100 MHz, CDCl3): 28.2 ((CH3)3), 41.5 (CH), 42.1 (C), 73.0 (CH), 85.3 (C), 115.5 (CH), 121.8 
(CH), 122.2 (C), 125.0 (CH), 128.7 (CH), 128.9 (2CH), 129.2 (2CH), 129.3 (C), 129.6 (CH), 130.3 
(C), 140.8 (C), 148.8 (C), 168.1(C). 
 
(1S,2S,3R)-tert-butyl 2-nitro-2'-oxo-3-o-tolylspiro[cyclopropane-1,3'-
indoline]-1'-carboxylate (9e), (Table 3, entry 7): The reaction was 
carried out at room temperature following the general procedure using 
7d (5 mol%, 5.96 mg) as the catalyst to furnish after 65 h the crude 
product (d.r.: 3:1 determined by integration of 1H-NMR signal: δmajor 
4.30 d., δminor 4.20 ppm. d.). The title compound was isolated as a 
mixture of diastereoisomers by column chromatography (hexane/Et2O = 90/10) in 80% and 
90% ee. HPLC analysis [determined after deportection of the oxindole under standard 
conditions (TFA 3 equiv, DCM 0.04M, rt, 16 h)]: 80/20 hexane/i-PrOH, flow rate 0.750 mL/min, 
λ = 214, 254 nm: τmajor = 10.93 min, τminor = 16.50 min; ESI-MS: 395 (M
++1); 1H NMR (400 MHz, 
CDCl3), mixture of diastereoisomers: δ 1.59 (s, 9H)min, 1.66 (s, 9H)max, 1.89 (s, 3H)max, 2.02 (s, 
3H)min, 4.20 (d, 1H, J = 7.0 Hz)min, 4.30 (d, 1H, J = 6.8 Hz)max, 5.12 (d, 1H, J = 6.8 Hz)max, 5.45 (d, 
1H, J = 7.0 Hz)min, 5.92 (dd, 1H, J = 7.6 Hz, J = 0.9 Hz)max, 6.82 (dd, 1H, J = 7.6 Hz, J = 0.9 Hz)max, 
7.08-7.18 (m, 2H), 7.19-7.34 (m, 8H), 7.38-7.46 (m, 2H), 7.92-7.97 (m, 2H); 13C NMR (100 MHz, 
CDCl3): δ 19.2 (CH3), 19.6 (CH3), 28.0 ((CH3)3), 28.1 ((CH3)3), 39.6 (CH), 40.2 (CH), 41.5 (2C), 71.5 
(CH), 72.8 (CH), 77.2 (C), 85.1 (C), 115.3 (CH), 115.3 (CH), 120.3 (CH), 121.5 (CH), 121.7 (C), 
122.1 (C), 124.1 (CH), 124.9 (CH), 126.1 (CH), 126.3 (CH), 127.9 (C), 128.3 (CH), 128.5 (CH), 
128.6 (CH), 129.0 (CH), 129.1 (CH), 129.4 (CH), 130.4 (CH), 130.7 (CH), 137.4 (C), 138.7 
(C),140.0 (C), 140.4 (C), 148.6 (C),148.9 (C),167.8 (C), 168.2 (C). 
 
 
(1R,2R,3S)-1'-tert-butyl 2-ethyl 5'-bromo-3-nitro-2'-
oxospiro[cyclopropane-1,3'-indoline]-1',2-dicarboxylate (9f), (Table 
3, entry 8): The reaction was carried out at room temperature 
following the general procedure using 1c (5 mol%, 5,96 mg) as the 
catalyst to furnish after 24 h the crude product (d.r.: 9:1 determined 
by integration of 1H-NMR signal: δmajor 5.28 d., δminor 6.25 ppm. d.). The title compound was 
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isolated as a pale yellow oil by column chromatography (hexane/ethyl acetate = 95/5 to 9/1) in 
76% yield and 87% ee. HPLC analysis on a Daicel Chiralpak AD-H column: 98/2 hexane/i-PrOH, 
flow rate 0.75 mL/min, λ = 214, 254 nm: τmajor =22.9 min, τminor =14.4 min; ESI-MS [determined 
after deportection of the oxindole under standard conditions (TFA 3 equiv, DCM 0.04M, rt, 16 
h)]: 355 (M++1) 79Br, 357 (M++1) 81Br, 377 (M++Na) 79Br, 379 (M++Na) 81Br, 393 (M++Na) 79Br, 
395 (M++1) 81Br; [α]rt
D= +139 (c = 1.083, CHCl3, 87% ee). 
1H NMR (400 MHz, CDCl3): δ  1.29 (t, 
3H, J = 7.2Hz), 1.62 (s, 9H), 3.82 (d, 1H, J = 6.3Hz), 4.20-4.31 (m, 2H), 5.29 (d, 1H, J = 6.3Hz), 
7.34 (d, 1H, J = 2.1Hz), 7.53 (dd, 1H, J = 2.1Hz, J = 8.6Hz), 7.84 (d, 1H, J = 8.6Hz). 13C NMR (100 
MHz, CDCl3): δ  14.3 (CH3), 28.3 (C(CH3)3), 36.3 (CH), 39.7 (C), 63.1 (CH2), 70.2 (CH), 86.1 (C), 
117.4 (CH), 118.2 (C), 122.2 (C), 125.4 (CH), 133.3 (CH), , 140.2 (C), 148.4 (C), 162.7 (C), 167.6 
(C). 
 
(1S,2S,3R)-1'-tert-butyl 2-ethyl 5'-bromo-3-nitro-2'-
oxospiro[cyclopropane-1,3'-indoline]-1',2-dicarboxylate (ent-9f), 
(Table 3, entry 9): The reaction was carried out at 0° C following the 
general procedure using 7d (5 mol%, 5,96 mg) as the catalyst to 
furnish after 72 h the crude product (d.r.: >19:1 determined by 
integration of 1H-NMR signal: δmajor 5.28 d., δminor 6.25 ppm. d.). The title compound was 
isolated as a pale yellow oil by column chromatography (hexane/ethyl acetate = 95/5 to 9/1) in 
74% yield and 93% ee. HPLC analysis on a Daicel Chiralpak AD-H column: 98/2 hexane/i-PrOH, 
flow rate 0.75 mL/min, λ = 214, 254 nm: τmajor =12.2 min, τminor =20.1 min; [α]rt
D= -143. (c = 1.00, 
CHCl3, 93% ee). 
 
(1S,2S,3R)-tert-butyl 5'-chloro-2-nitro-2'-oxo-3-
phenylspiro[cyclopropane-1,3'-indoline]-1'-carboxylate (9g), (Table 
3, entry 10): The reaction was carried out at room temperature 
following the general procedure using 7d (5 mol%, 5,96 mg) as the 
catalyst to furnish after 48 h the crude product (d.r.: 8.6:1.3:1 
determined by integration of 1H-NMR signal: δmajor 4.31 d., δminor 4.46 ppm. d, δminor 3.81 ppm. 
d.). The title compound was isolated as a pale yellow solid by column chromatography 
(hexane/acetone 9/1) in 84% yield and 90% ee. HPLC analysis on a Daicel Chiralpak AD-H 
column: 98/2 hexane/i-PrOH, flow rate 0.75 mL/min, λ = 214, 254 nm: τmajor =18.3 min, τminor 
=12.4 min; ESI-MS: 437 (M++Na), 453 (M++K). [α]rt
D= -143. (c = 1.00, CHCl3, 90% ee).
1H NMR 
(400 MHz, CDCl3): δ  1.58 (s, 9H), 4.31 (d, 1H, J = 7.33 Hz), 5.49 (d, 1H, J = 7.33 Hz), 7.27-7.39 
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(m, 7H), 7.87-7.91 (m, 1H). 13C NMR (100 MHz, CDCl3): δ   28.3 (C(CH3)3), 41.8 (C), 41.9 (CH),  
72.9 (CH), 85.7 (C), 116.8 (CH), 122.3 (CH), 123.9 (C), 120.0 (CH), 129.1 (CH), , 129.6 (CH), 130.7 
(C), 139.3 (C), 148.6 (C), 167.4 (C). 
 
(1S,2S,3R)-tert-butyl 6'-chloro-2-nitro-2'-oxo-3-
phenylspiro[cyclopropane-1,3'-indoline]-1'-carboxylate (9h), (Table 
3, entry 11): The reaction was carried out at room temperature 
following the general procedure using 7d (5 mol%, 5,96 mg) as the 
catalyst to furnish after 48 h the crude product (d.r.: 12:2:1 determined by integration of 1H-
NMR signal: δmajor 4.31 d., δminor 4.44 ppm. d, δminor 3.79 ppm. d.) The title compound was 
isolated as a pale yellow solid by column chromatography (hexane/ acetone 9/1) in 84% yield 
and 89% ee. HPLC analysis on a Daicel Chiralpak AD-H column: 90/10 hexane/i-PrOH, flow rate 
0.75 mL/min, λ = 214, 254 nm: τmajor =6.56 min, τminor =10.79 min; ESI-MS: 437 (M
++Na), 453 
(M++K); [α]rt
D= -143. (c = 1.00, CHCl3, 89% ee).
1H NMR (300 MHz, CDCl3): δ  1.59 (s, 9H), 4.31 (d, 
1H, J = 6.8 Hz), 5.47 (d, 1H, J = 6.8 Hz), 7.17-7.42 (m, 7H), 8.01 (d, 1H, J = 1.9 Hz).13C NMR (100 
MHz, CDCl3): δ 28.7 (C(CH3)3),  41.6 (CH), 41.8 (C), 72.9 (CH), 85.9 (C), 116.3 (CH), 120.6 (C), 
122. 8 (CH), , 125.1 (CH), 126.9 (CH), 128.7 2(CH), 128.9 2x(CH), 135.6 (C), 141. 5 (C), 148.6 (C), 
167.6 (C). 
 
(1R,2R,3S)-1'-tert-butyl 2-ethyl 5'-methyl-3-nitro-2'-
oxospiro[cyclopropane-1,3'-indoline]-1',2-dicarboxylate (9i), (Table 
3, entry 12): The reaction was carried out at room temperature 
following the general procedure using 7c (5 mol%, 5.96 mg) as the 
catalyst to furnish after 72 h the crude product (d.r.: 7:1 determined 
by integration of 1H-NMR signal: δmajor 4.31 d., δminor 4.45 ppm. d.). The title compound was 
isolated as a mixture of diastereoisomers by column chromatography (hexane/ethyl acetate = 
95/5) in 60% yield and 91% ee (99% ee after single crystallization from hexane/diethyl ether). 
HPLC analysis on a Daicel Chiralpak AD-H column: 95/5 hexane/i-PrOH, flow rate 0.500 
mL/min, λ = 214, 254 nm: τmajor = 19.31 min, τminor = 12.81 min; ESI-MS: 395 (M
++1), 417 
(M++Na); [α]rt
D= + 224.7 (c = 1.137, CHCl3, 91% ee, dr = 4:1). 
1H NMR (300 MHz, CDCl3): δ 1.59 
(s, 9H), 2.38 (s, 3H), 4.30 (d, 1H, J = 6.9 Hz), 5.47 (d, 1H, J = 6.9 Hz), 7.15 (m, 1H), 7.20 (m, 1H), 
7.27 (m, 5H), 7.79 (d, 1H, J = 8.3 Hz); 13C NMR (75 MHz, CDCl3): δ 21.2 (CH3), 28.0 ((CH3)3), 41.2 
(CH), 41.9 (C), 72.7 (CH), 84.9 (C), 115.1 (CH), 121.9 (C), 122.0 (CH), 128.4 (CH), 128.6 (CH), 
128.9 (CH), 129.1 (C), 129.8 (CH), 134.5 (C), 138.1 (C), 148.6 (C), 168.0 (C). 
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(1S,2R,3R)-1'-tert-butyl 3-ethyl 2-methyl-2-nitro-2'-
oxospiro[cyclopropane-1,3'-indoline]-1',3-dicarboxylate (Scheme 3, 11a): 
The reaction was carried out at room temperature following the general 
procedure using 7d (5 mol%, 5.96 mg) as the catalyst to furnish after 48 h 
the crude product (d.r.: 5:1 determined by integration of 1H-NMR signal: δmajor 3.76 s., δminor 
3.88 ppm. s.). The title compound was isolated as a mixture of diastereoisomers by column 
chromatography (hexane/AcOEt = 95/5) in 91% yield and >99% ee. HPLC analysis [determined 
after deportection of the oxindole under standard conditions (TFA 3 equiv, DCM 0.04M, rt, 16 
h)] on a Daicel Chiralpak AD-H column: 95/5 hexane/i-PrOH, flow rate 0.750 mL/min, λ = 214, 
254 nm: τmajor = 14.84 min, τminor = 21.01 min; ESI-MS [determined after deportection of the 
oxindole under standard conditions (TFA 3 equiv, DCM 0.04M, rt, 16 h)]: 291 (M++1), 313 
(M++Na), 329 (M++K); [α]rt
D= -112.5 (c = 0.820, CHCl3, >99% ee). 
1H NMR (400 MHz, CDCl3): δ  
1.25 ( t, 3H, J = 7.1 Hz), 1.62 (s, 9H), 2.21 (s, 3H), 3.77 (s, 3H), 4.11-4.27 (m, 2H), 7.15-7.21 (m, 
1H), 7.37-7.49 (m, 2H), 7.98-8.05 (m, 1H); 13C NMR (100 MHz, CDCl3): δ  13.5 (CH3), 14.2 (CH3), 
28.2 ((CH3)3), 38.7 (CH3), 41.8 (C), 77.4 (C), 85.5 (C), 115.7 (CH), 120.0 (C), 124.5 (CH), 124.7 
(CH), 129.7 (CH), 141. 9 (C), 148.8 (C), 165.0 (C), 168.5 (C). 
 
(1R,2R,3S)-tert-butyl 2-methyl-2-nitro-2'-oxo-3-
propylspiro[cyclopropane-1,3'-indoline]-1'-carboxylate (Scheme 3, 11d): 
The reaction was carried out at room temperature following the general 
procedure using 7d (20 mol%, 23.84 mg) as the catalyst to furnish after 48 
h the crude product (d.r.: 3:1 determined by integration of 1H-NMR signal: 
δmajor 8.03 d., δminor 6.91 ppm. d.). The title compound was isolated as a mixture of 
diastereoisomers by column chromatography (hexane/AcOEt = 95/5) in 65% yield and 92% ee. 
HPLC analysis on a Daicel Chiralpak AS-H column: 90/10 hexane/i-PrOH, flow rate 0.650 
mL/min, λ = 214, 254 nm: τmajor = 10.15 min, τminor = 9.49 min; ESI-MS: 383 (M
++ Na), 399 
(M++K);  [α]rt
D= - 26.9 (c = 0.93, CHCl3, 92% ee, d.r. = 4.5:1). 
 1H NMR (400 MHz, CDCl3), major 
diastereoisomer: δ 0.95 (t, 3H, J = 7.3 Hz), 1.32-1.56 (m, 3H), 1.61 (s, 9H), 1.72-1.82 (m, 1H), 
1.92 (s, 3H), 3.0 (m, 1H), 7.02 (m, 1H), 7.17 (m, 1H), 7.39 (m, 1H), 8.03 (m, 1H); 13C NMR (100 
MHz, CDCl3), major diatsereoisomer: δ 13.4 (CH3), 13.6 (CH3), 21.5 (CH2), 24.0 (CH2), 28.0 
((CH3)3), 39.1 (CH), 42.6 (C), 78.6 (C), 84.8 (C), 115.6 (CH), 121.5 (C), 122.6 (CH), 123.9 (CH), 
128.5 (CH), 141.1 (C), 148.9 (C), 169.9 (C). 
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(1R,2R,3S)-1'-tert-butyl 3-ethyl 5'-bromo-2-methyl-2-nitro-2'-
oxospiro[cyclopropane-1,3'-indoline]-1',3-dicarboxylate (scheme 3, 
11f): The reaction was carried out at room temperature following 
the general procedure using 7d (5 mol%, 5.96 mg) as the catalyst to 
furnish after 48 h the crude product (d.r.: 1.5:1 determined by 
integration of 1H-NMR signal: δmajor 3.77 s., δminor 3.89 ppm. s.). The title compound was 
isolated as a mixture of diastereoisomers by column chromatography (hexane/AcOEt = 95/5) 
in 65% yield and 96% ee. HPLC analysis on a Daicel Chiralpak AD-H column: 95/5 hexane/i-
PrOH, flow rate 0.500 mL/min, λ = 214, 254 nm: τmajor = 11.05 min, τminor = 9.20 min; ESI-MS: 369 
(M++1) 79Br, 371 (M++1) 81Br, 391(M++Na) 79Br, 393 (M++Na) 81Br, 407 (M++Na) 79Br, 409 (M+1) 
81Br; [α]rt
D= - 58.1 (c = 1.02, CHCl3, 96% ee, d.r. = 4:1). 
1H NMR (600 MHz, CDCl3): δ 1.28 (t, 3H, J 
= 7.2 Hz), 1.60 (s, 9H), 2.20 (s, 3H), 3.77 (s, 1H), 4.23 (m, 2H), 7.55 (dd, 1H, J = 8.8 Hz, J = 2.0 
Hz), 7.61 (d, 1H, J = 2.0 Hz), 7.93 (d, 1H, J = 8.8 Hz); 13C NMR (150 MHz, CDCl3): δ 13.3 (CH3), 
14.0 (CH3), 28.0 ((CH3)3), 38.8 (CH), 41.2 (C), 62.4 (CH2), 77.3 (C), 85.7 (C), 116.9 (CH), 117.4 (C), 
121.7 (C), 127.6 (CH), 132.4 (CH), 140.3 (C), 148.4 (C), 164.5 (C), 167.6 (C). 
 
(1S,2S,3R)-1'-tert-butyl 3-ethyl 5'-bromo-2-methyl-2-nitro-2'-
oxospiro[cyclopropane-1,3'-indoline]-1',3-dicarboxylate (Scheme 3, 
ent-11f): The reaction was carried out at room temperature 
following the general procedure using 7c (10 mol%, 11.92 mg) as the 
catalyst to furnish after 48 h the crude product (d.r.: 2:1 determined 
by integration of 1H-NMR signal: δmajor 3.77 s., δminor 3.89 ppm. s.). The title compound was 
isolated as a mixture of diastereoisomers by column chromatography (hexane/AcOEt = 95/5) 
in 71% yield and 97% ee. HPLC analysis on a Daicel Chiralpak AD-H column: 95/5 hexane/i-
PrOH, flow rate 0.500 mL/min, λ = 214, 254 nm: τmajor = 9.48 min, τminor = 11.05 min; [α]rt
D= + 
39.4 (c = 0.91, CHCl3, 97% ee). 
 
(1R,2R,3S)-1'-tert-butyl 3-ethyl 5'-fluoro-2-methyl-2-nitro-2'-
oxospiro[cyclopropane-1,3'-indoline]-1',3-dicarboxylate (Scheme 3, 
11j): The reaction was carried out at room temperature following the 
general procedure using 7d (5 mol%, 5.96 mg) as the catalyst to 
furnish after 48 h the crude product (d.r.: 4:1 determined by integration of 1H-NMR signal: 
δmajor 3.78 s., δminor 3.88 ppm. s.). The title compound was isolated as a mixture of 
diastereoisomers by column chromatography (hexane/AcOEt = 95/5) in 71% yield and 96% ee. 
HPLC analysis on a Daicel Chiralpak AD-H column: 95/5 hexane/i-PrOH, flow rate 0.500 
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mL/min, λ = 214, 254 nm: τmajor = 9.73 min, τminor = 8.93 min; ESI-MS: 309 (M
++ 1), 331 (M++Na), 
347 (M++K); [α]rt
D= - 69.5 (c = 0.81, CHCl3, 96% ee). 
1H NMR (400 MHz, CDCl3): δ 1.28 (t, 3H, J = 
7.1 Hz), 1.60 (s, 9H), 2.20 (s, 3H), 3.78 (s, 1H), 4.22 (m, 2H), 7.12 (dt, 1H, J = 8.9 Hz, J = 2.8 Hz), 
7.27 (dd, 1H, J = 8.7 Hz, J = 2.7 Hz), 8.02 (dd, 1H, J = 9.0 Hz, J = 4.8 Hz); 13C NMR (100 MHz, 
CDCl3): δ 13.1 (CH3), 14.0 (CH3), 28.0 ((CH3)3), 38.7 (CH), 41.5 (C), 62.3 (CH2), 77.2 (C), 85.5 (C), 
112.6 (d, CH, J = 27.2 Hz), 116.0 (d, CH, J = 23.1 Hz), 116.6 (d, CH, J = 8.1 Hz), 121.3 (d, C, J = 9.7 
Hz), 137.3 (d, C, J = 2.4 Hz), 148.5 (C), 158.1 (C), 160.6 (C), 164.6 (C), 167.9 (C). 
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3. SUMMARY AND OUTLOOK 
 
The studies conducted during my Phd thesis were focused on two different directions: 
 
1. In one case we tried to face some long standing problems of the asymmetric aminocatalysis 
as the activation of encumbered carbonyl compounds and the control of the diastereoisomeric 
ratio in the diastero- and enantioselective construction of all carbon substituted quaternary 
stereocenters adjacent a tertiary one. In this section (Challenges) was described the 
asymmetric aziridination of α,β-unsaturated ketones, the activation of α,β-unsaturated α-
branched aldehydes and the Michael addition of oxindoles to enals and enones. 
For the activation via iminium ion formation of sterically demanding substrates, as α,β-
unsaturated ketones and α,β-unsaturated α-branched aldehydes, we exploited a chiral 
primary amine in order to overcome the problem of the iminium ion formation between the 
catalyst and encumbered carbonylic componds. 
For the control of diastereoisomeric ratio in the diastero- and enantioselective construction of 
all carbon substituted quaternary stereocenters adjacent a tertiary one we envisaged that a 
suitable strategy was the Michael addition to 3 substituted oxindoles to enals activated via 
LUMO-lowering catalysis. 
In this synthetic protocol we designed a new bifunctional catalyst with an amine moiety for 
activate the aldehyde and a tioureidic fragment for direct the approach of the oxindole. 
This part of the thesis (Challenges) could be considered pure basic research, where the 
solution of the synthetic problem was the goal itself of the research. 
 
2. In the other hand (Molecules) we applied our knowledge about the carbonylic compounds 
activation and about cascade reaction to the synthesis of three new classes of spirooxindole in 
enantiopure form. 
The construction of libraries of these bioactive compounds represented a scientific bridge 
between medicinal chemistry or biology and the asymmetric catalysis. 
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“Così tra questa immensità s'annega il pensier mio: 
e il naufragar m'è dolce in questo mare”. 
L’infinito, Giacomo Leopardi 
 
